129618-40-2 | Nevirapine

Packsize	Purity	Availability	Price	Discounted Price
250mg	95%	in stock	$13.00	$9.00
1g	95%	in stock	$16.00	$11.00
5g	95%	in stock	$17.00	$12.00
10g	95%	in stock	$32.00	$22.00
25g	95%	in stock	$65.00	$45.00
100g	95%	in stock	$177.00	$124.00

Description

• Catalog Number: AD73694
• Chemical Name: Nevirapine
• CAS Number: 129618-40-2
• Molecular Formula: C15H14N4O
• Molecular Weight: 266.2979
• MDL Number: MFCD00866928
• SMILES: O=C1Nc2c(C)ccnc2N(c2c1cccn2)C1CC1

Computed Properties

• Complexity: 397
• Covalently-Bonded Unit Count: 1
• Heavy Atom Count: 20
• Hydrogen Bond Acceptor Count: 4
• Hydrogen Bond Donor Count: 1
• Rotatable Bond Count: 1
• XLogP3: 2

Literature

• Evaluating the Role of Multidrug Resistance Protein 3 (MDR3) Inhibition in Predicting Drug-Induced Liver Injury Using 125 Pharmaceuticals.

  Chemical research in toxicology 20170515

• Hepatocyte spheroids as a competent in vitro system for drug biotransformation studies: nevirapine as a bioactivation case study.

  Archives of toxicology 20170301

• Different Reactive Metabolites of Nevirapine Require Distinct Glutathione S-Transferase Isoforms for Bioinactivation.

  Chemical research in toxicology 20161219

• Transcriptional profiling suggests that Nevirapine and Ritonavir cause drug induced liver injury through distinct mechanisms in primary human hepatocytes.

  Chemico-biological interactions 20160805

• Limonoids with Anti-HIV Activity from Cipadessa cinerascens.

  Journal of natural products 20150626

• Sex differences in hepatic and intestinal contributions to nevirapine biotransformation in rats.

  Chemico-biological interactions 20150525

• Systems pharmacological analysis of drugs inducing stevens-johnson syndrome and toxic epidermal necrolysis.

  Chemical research in toxicology 20150518

• Synthesis and biological evaluation of CHX-DAPYs as HIV-1 non-nucleoside reverse transcriptase inhibitors.

  Bioorganic & medicinal chemistry 20140615

• Discovery of novel diarylpyrimidines as potent HIV NNRTIs via a structure-guided core-refining approach.

  European journal of medicinal chemistry 20140610

• Synthesis and biological evaluation of novel 2-arylalkylthio-5-iodine-6-substituted-benzyl-pyrimidine-4(3H)-ones as potent HIV-1 non-nucleoside reverse transcriptase inhibitors.

  Molecules (Basel, Switzerland) 20140530

• Structural modifications of CH(OH)-DAPYs as new HIV-1 non-nucleoside reverse transcriptase inhibitors.

  Bioorganic & medicinal chemistry 20140415

• Discovery of nitropyridine derivatives as potent HIV-1 non-nucleoside reverse transcriptase inhibitors via a structure-based core refining approach.

  European journal of medicinal chemistry 20140409

• Fused heterocyclic compounds bearing bridgehead nitrogen as potent HIV-1 NNRTIs. Part 1: design, synthesis and biological evaluation of novel 5,7-disubstituted pyrazolo[1,5-a]pyrimidine derivatives.

  Bioorganic & medicinal chemistry 20140401

• Discovery of 2-pyridone derivatives as potent HIV-1 NNRTIs using molecular hybridization based on crystallographic overlays.

  Bioorganic & medicinal chemistry 20140315

• Biological activity of sporolides A and B from Salinispora tropica: in silico target prediction using ligand-based pharmacophore mapping and in vitro activity validation on HIV-1 reverse transcriptase.

  Chemical biology & drug design 20140301

• Design and synthesis of N₁-aryl-benzimidazoles 2-substituted as novel HIV-1 non-nucleoside reverse transcriptase inhibitors.

  Bioorganic & medicinal chemistry 20140215

• Evaluation of chitosan nanoformulations as potent anti-HIV therapeutic systems.

  Biochimica et biophysica acta 20140101

• Design, synthesis and preliminary SAR studies of novel N-arylmethyl substituted piperidine-linked aniline derivatives as potent HIV-1 NNRTIs.

  Bioorganic & medicinal chemistry 20140101

• Phenylspirodrimanes with anti-HIV activity from the sponge-derived fungus Stachybotrys chartarum MXH-X73.

  Journal of natural products 20131227

• Novel piperidinylamino-diarylpyrimidine derivatives with dual structural conformations as potent HIV-1 non-nucleoside reverse transcriptase inhibitors.

  Bioorganic & medicinal chemistry letters 20131215

• Design, synthesis and biological evaluation of N2,N4-disubstituted-1,1,3-trioxo-2H,4H-pyrrolo[1,2-b][1,2,4,6]thiatriazine derivatives as HIV-1 NNRTIs.

  Bioorganic & medicinal chemistry 20131115

• Towards new C6-rigid S-DABO HIV-1 reverse transcriptase inhibitors: synthesis, biological investigation and molecular modeling studies.

  Bioorganic & medicinal chemistry 20131101

• Identification of danger signals in nevirapine-induced skin rash.

  Chemical research in toxicology 20130916

• Synthesis and evaluation of novel 3-(3,5-dimethylbenzyl)uracil analogs as potential anti-HIV-1 agents.

  Bioorganic & medicinal chemistry 20130915

• Optimization of diarylazines as anti-HIV agents with dramatically enhanced solubility.

  Bioorganic & medicinal chemistry letters 20130915

• Characterization of antiviral activity of benzamide derivative AH0109 against HIV-1 infection.

  Antimicrobial agents and chemotherapy 20130801

• Discovery of piperidine-linked pyridine analogues as potent non-nucleoside HIV-1 reverse transcriptase inhibitors.

  ChemMedChem 20130701

• 12-OH-nevirapine sulfate, formed in the skin, is responsible for nevirapine-induced skin rash.

  Chemical research in toxicology 20130520

• Novel pyridinone derivatives as non-nucleoside reverse transcriptase inhibitors (NNRTIs) with high potency against NNRTI-resistant HIV-1 strains.

  Journal of medicinal chemistry 20130509

• Cytotoxic, antitopoisomerase IIα, and anti-HIV-1 activities of triterpenoids isolated from leaves and twigs of Gardenia carinata.

  Journal of natural products 20130426

• Synthesis and biological evaluation of pyridazine derivatives as novel HIV-1 NNRTIs.

  Bioorganic & medicinal chemistry 20130401

• Synthesis and biological evaluation of phosphonate analogues of nevirapine.

  Bioorganic & medicinal chemistry letters 20130301

• Some hydrazones of 2-aroylamino-3-methylbutanohydrazide: synthesis, molecular modeling studies, and identification as stereoselective inhibitors of HIV-1.

  Archiv der Pharmazie 20130201

• Antimalaria action of antiretroviral drugs on Plasmodium berghei in mice.

  The American journal of tropical medicine and hygiene 20130109

• Synthesis and biological evaluation of triazolothienopyrimidine derivatives as novel HIV-1 replication inhibitors.

  Bioorganic & medicinal chemistry letters 20130101

• Dual inhibition of HIV-1 replication by integrase-LEDGF allosteric inhibitors is predominant at the post-integration stage.

  Retrovirology 20130101

• DB-02, a C-6-cyclohexylmethyl substituted pyrimidinone HIV-1 reverse transcriptase inhibitor with nanomolar activity, displays an improved sensitivity against K103N or Y181C than S-DABOs.

  PloS one 20130101

• Exploring dried blood spot sampling technique for simultaneous quantification of antiretrovirals: lamivudine, stavudine and nevirapine in a rodent pharmacokinetic study.

  Biomedical chromatography : BMC 20121201

• When to start, what to start and other treatment controversies in pediatric HIV infection.

  Paediatric drugs 20121201

• Synthesis and evaluation of novel 4-substituted styryl quinazolines as potential antimicrobial agents.

  Archiv der Pharmazie 20121201

• Structure-based bioisosterism design, synthesis and biological evaluation of novel 1,2,4-triazin-6-ylthioacetamides as potent HIV-1 NNRTIs.

  Bioorganic & medicinal chemistry letters 20121201

• Discovery of novel 2-(3-(2-chlorophenyl)pyrazin-2-ylthio)-N-arylacetamides as potent HIV-1 inhibitors using a structure-based bioisosterism approach.

  Bioorganic & medicinal chemistry 20121201

• Structural modifications of 5,6-dihydroxypyrimidines with anti-HIV activity.

  Bioorganic & medicinal chemistry letters 20121201

• Synthesis, biological evaluation and molecular modeling of 4,6-diarylpyrimidines and diarylbenzenes as novel non-nucleosides HIV-1 reverse transcriptase inhibitors.

  European journal of medicinal chemistry 20121201

• Evidence for nevirapine bioactivation in man: searching for the first step in the mechanism of nevirapine toxicity.

  Toxicology 20121115

• Simultaneous determination of atorvastatin and niacin in human plasma by LC-MS/MS and its application to a human pharmacokinetic study.

  Biomedical chromatography : BMC 20121101

• Rash, hepatotoxicity and hyperbilirubinemia among Kenyan infants born to HIV-infected women receiving triple-antiretroviral drugs for the prevention of mother-to-child HIV transmission.

  The Pediatric infectious disease journal 20121101

• HIV-1 mother-to-child transmission, post-test counselling, and antiretroviral prophylaxis in Northern Viet Nam: a prospective observational study.

  Scandinavian journal of infectious diseases 20121101

• Novel method to assess antiretroviral target trough concentrations using in vitro susceptibility data.

  Antimicrobial agents and chemotherapy 20121101

• Effect of efavirenz versus nevirapine in antiretroviral-naive individuals in the HIV-CAUSAL Collaboration Cohort.

  AIDS (London, England) 20121023

• From multi-residue screening to target analysis of pharmaceuticals in water: development of a new approach based on magnetic sector mass spectrometry and application in the Nairobi River basin, Kenya.

  The Science of the total environment 20121015

• Safety of nevirapine in HIV-infected pregnant women initiating antiretroviral therapy at higher CD4 counts: a systematic review and meta-analysis.

  South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde 20121008

• N348I in HIV-1 reverse transcriptase counteracts the synergy between zidovudine and nevirapine.

  Journal of acquired immune deficiency syndromes (1999) 20121001

• Emergence of lamivudine resistance hepatitis B virus mutations in pregnant women infected with HBV and HIV receiving antiretroviral prophylaxis for the prevention of mother-to-infant transmission in Malawi.

  Journal of medical virology 20121001

• Effect of competition bias in safety signal generation: analysis of a research database of spontaneous reports in France.

  Drug safety 20121001

• Arylazolyl(azinyl)thioacetanilides. Part 10: design, synthesis and biological evaluation of novel substituted imidazopyridinylthioacetanilides as potent HIV-1 inhibitors.

  Bioorganic & medicinal chemistry 20120915

• Pharmacokinetics of nevirapine in HIV-infected infants weighing 3 kg to less than 6 kg taking paediatric fixed dose combination tablets.

  AIDS (London, England) 20120910

• Integration of data from multiple sources for simultaneous modelling analysis: experience from nevirapine population pharmacokinetics.

  British journal of clinical pharmacology 20120901

• Effect modification by sex and baseline CD4+ cell count among adults receiving combination antiretroviral therapy in Botswana: results from a clinical trial.

  AIDS research and human retroviruses 20120901

• Renal function and incidence of chronic kidney disease in HIV patients: a Danish cohort study.

  Scandinavian journal of infectious diseases 20120901

• Significant pharmacokinetic interactions between artemether/lumefantrine and efavirenz or nevirapine in HIV-infected Ugandan adults.

  The Journal of antimicrobial chemotherapy 20120901

• Long-term benefits of nevirapine-containing regimens: multicenter study with 506 patients, followed-up a median of 9 years.

  Current HIV research 20120901

• One pot efficient diversity oriented synthesis of polyfunctional styryl thiazolopyrimidines and their bio-evaluation as antimalarial and anti-HIV agents.

  European journal of medicinal chemistry 20120901

• The effect of efavirenz versus nevirapine-containing regimens on immunologic, virologic and clinical outcomes in a prospective observational study.

  AIDS (London, England) 20120824

• HIV-1 reverse transcriptase (RT) polymorphism 172K suppresses the effect of clinically relevant drug resistance mutations to both nucleoside and non-nucleoside RT inhibitors.

  The Journal of biological chemistry 20120824

• Gastrointestinal-associated lymphoid tissue immune reconstitution in a randomized clinical trial of raltegravir versus non-nucleoside reverse transcriptase inhibitor-based regimens.

  AIDS (London, England) 20120824

• Bioactivation of nevirapine to a reactive quinone methide: implications for liver injury.

  Chemical research in toxicology 20120820

• Kinetics of nevirapine and its impact on HIV-1 RNA levels in maternal plasma and breast milk over time after perinatal single-dose nevirapine.

  Journal of acquired immune deficiency syndromes (1999) 20120815

• Monitoring of HIV type 1 DNA load and drug resistance in peripheral blood mononuclear cells during suppressive antiretroviral therapy does not predict virologic failure.

  AIDS research and human retroviruses 20120801

• Lipid profiles in young HIV-infected children initiating and changing antiretroviral therapy.

  Journal of acquired immune deficiency syndromes (1999) 20120801

• No increased risk of hepatotoxicity in long-term use of nonnucleoside reverse transcriptase inhibitors in HIV-infected patients.

  HIV medicine 20120801

• Diverse combinatorial design, synthesis and in vitro evaluation of new HEPT analogues as potential non-nucleoside HIV-1 reverse transcription inhibitors.

  European journal of medicinal chemistry 20120801

• Persistence versus reversion of 3TC resistance in HIV-1 determine the rate of emergence of NVP resistance.

  Viruses 20120801

• Pharmacokinetics of nevirapine in HIV-infected children under 3 years on rifampicin-based antituberculosis treatment.

  AIDS (London, England) 20120731

• New nitrogen containing substituents at the indole-2-carboxamide yield high potent and broad spectrum indolylarylsulfone HIV-1 non-nucleoside reverse transcriptase inhibitors.

  Journal of medicinal chemistry 20120726

• Effectiveness of antiretroviral therapy in HIV-infected children under 2 years of age.

  The Cochrane database of systematic reviews 20120711

• HIV type 1 mother-to-child transmission facilitated by distinctive glycosylation sites in the gp120 envelope glycoprotein.

  AIDS research and human retroviruses 20120701

• Studies on the toxicological effect of nevirapine, an antiretroviral drug, on the liver, kidney and testis of male Wistar rats.

  Human & experimental toxicology 20120701

• Treatment outcomes of recommended first-line antiretroviral regimens in resource-limited clinics.

  Journal of acquired immune deficiency syndromes (1999) 20120701

• Low-frequency nevirapine resistance at multiple sites may predict treatment failure in infants on nevirapine-based treatment.

  Journal of acquired immune deficiency syndromes (1999) 20120701

• Nevirapine-based therapy after suppression: can we switch?

  The Lancet. Infectious diseases 20120701

• Switching children previously exposed to nevirapine to nevirapine-based treatment after initial suppression with a protease-inhibitor-based regimen: long-term follow-up of a randomised, open-label trial.

  The Lancet. Infectious diseases 20120701

• Chiral resolution, absolute configuration assignment and biological activity of racemic diarylpyrimidine CH(OH)-DAPY as potent nonnucleoside HIV-1 reverse transcriptase inhibitors.

  European journal of medicinal chemistry 20120701

• Influence of CYP2B6 and ABCB1 SNPs on nevirapine plasma concentrations in Burundese HIV-positive patients using dried sample spot devices.

  British journal of clinical pharmacology 20120701

• NNRTIs: future prospects.

  Medecine et maladies infectieuses 20120701

• NNRTIs: pharmacological data.

  Medecine et maladies infectieuses 20120701

• The dual role of pharmacogenetics in HIV treatment: mutations and polymorphisms regulating antiretroviral drug resistance and disposition.

  Pharmacological reviews 20120701

• Long term outcomes of nevirapine containing antiretroviral therapy at a center in Thailand.

  The Southeast Asian journal of tropical medicine and public health 20120701

• Maternal and infant antiretroviral regimens to prevent postnatal HIV-1 transmission: 48-week follow-up of the BAN randomised controlled trial.

  Lancet (London, England) 20120630

• Three postpartum antiretroviral regimens to prevent intrapartum HIV infection.

  The New England journal of medicine 20120621

• Nevirapine versus ritonavir-boosted lopinavir for HIV-infected children.

  The New England journal of medicine 20120621

• Effects of short-course zidovudine on the selection of nevirapine-resistant HIV-1 in women taking single-dose nevirapine.

  The Journal of infectious diseases 20120615

• Design, synthesis, anti-HIV evaluation and molecular modeling of piperidine-linked amino-triazine derivatives as potent non-nucleoside reverse transcriptase inhibitors.

  Bioorganic & medicinal chemistry 20120615

• HLA-dependent hypersensitivity reaction to nevirapine in Chinese Han HIV-infected patients.

  AIDS research and human retroviruses 20120601

• Virologic suppression in nevirapine-exposed HIV-infected infants initiating antiretroviral therapy in rural Uganda.

  Journal of tropical pediatrics 20120601

• Overall benefit of antiretroviral treatment on the risk of fracture in HIV: nested case-control analysis in a health-insured population.

  AIDS (London, England) 20120601

• A randomized controlled trial of highly active antiretroviral therapy versus highly active antiretroviral therapy and chemotherapy in therapy-naive patients with HIV-associated Kaposi sarcoma in South Africa.

  Journal of acquired immune deficiency syndromes (1999) 20120601

• Patterns of HIV-1 drug resistance after first-line antiretroviral therapy (ART) failure in 6 sub-Saharan African countries: implications for second-line ART strategies.

  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20120601

• Standing genetic variation and the evolution of drug resistance in HIV.

  PLoS computational biology 20120601

• Causes and treatment outcomes of Stevens-Johnson syndrome and toxic epidermal necrolysis in 82 adult patients.

  The Korean journal of internal medicine 20120601

• Nevirapine- versus lopinavir/ritonavir-based initial therapy for HIV-1 infection among women in Africa: a randomized trial.

  PLoS medicine 20120601

• Nevirapine- and efavirenz-associated hepatotoxicity under programmatic conditions in Kenya and Mozambique.

  International journal of STD & AIDS 20120601

• Acquired epidermodysplasia verruciformis due to multiple and unusual HPV infection among vertically-infected, HIV-positive adolescents in Zimbabwe.

  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20120515

• Surveillance of HIV drug resistance in children receiving antiretroviral therapy: a pilot study of the World Health Organization's generic protocol in Maputo, Mozambique.

  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20120515

• Nevirapine prophylaxis during breastfeeding.

  Lancet (London, England) 20120512

• Use of dried blood spots for the determination of plasma concentrations of nevirapine and efavirenz.

  The Journal of antimicrobial chemotherapy 20120501

• Exploiting the anti-HIV-1 activity of acyclovir: suppression of primary and drug-resistant HIV isolates and potentiation of the activity by ribavirin.

  Antimicrobial agents and chemotherapy 20120501

• Synthesis and biological evaluation of piperidine-substituted triazine derivatives as HIV-1 non-nucleoside reverse transcriptase inhibitors.

  European journal of medicinal chemistry 20120501

• Synthesis, biological activity and docking study of imidazol-5-one as novel non-nucleoside HIV-1 reverse transcriptase inhibitors.

  Bioorganic & medicinal chemistry 20120501

• Autochthonous disseminated dermal and visceral leishmaniasis in an AIDS patient, southern Thailand, caused by Leishmania siamensis.

  The American journal of tropical medicine and hygiene 20120501

• Pregnancy and infant outcomes among HIV-infected women taking long-term ART with and without tenofovir in the DART trial.

  PLoS medicine 20120501

• Nevirapine pharmacokinetics and risk of rash and hepatitis among HIV-infected sub-Saharan African women.

  AIDS (London, England) 20120424

• Etravirine: a review of its use in the management of treatment-experienced patients with HIV-1 infection.

  Drugs 20120416

• Transmitted HIV resistance to first-line antiretroviral therapy in Lima, Peru.

  AIDS research and human retroviruses 20120401

• Simultaneous determination of simvastatin, lovastatin and niacin in human plasma by LC-MS/MS and its application to a human pharmacokinetic study.

  Biomedical chromatography : BMC 20120401

• Twenty-four-week efficacy and safety of switching virologically suppressed HIV-1-infected patients from nevirapine immediate release 200 mg twice daily to nevirapine extended release 400 mg once daily (TRANxITION).

  HIV medicine 20120401

• Pharmacokinetics of nevirapine in HIV and tuberculosis-coinfected children receiving antiretroviral fixed-dose combination tablets while receiving rifampicin-containing tuberculosis treatment and after rifampicin discontinuation.

  The Pediatric infectious disease journal 20120401

• Hcv coinfection, an important risk factor for hepatotoxicity in pregnant women starting antiretroviral therapy.

  The Journal of infection 20120401

• Truncated reverse isoxazolidinyl nucleosides: a new class of allosteric HIV-1 reverse transcriptase inhibitors.

  ChemMedChem 20120401

• Associations between ABCB1, CYP2A6, CYP2B6, CYP2D6, and CYP3A5 alleles in relation to efavirenz and nevirapine pharmacokinetics in HIV-infected individuals.

  Therapeutic drug monitoring 20120401

• A novel 3,4-dihydropyrimidin-2(1H)-one: HIV-1 replication inhibitors with improved metabolic stability.

  Bioorganic & medicinal chemistry letters 20120401

• Worldwide variation in human drug-metabolism enzyme genes CYP2B6 and UGT2B7: implications for HIV/AIDS treatment.

  Pharmacogenomics 20120401

• Effectiveness of generic and proprietary first-line anti-retroviral regimens in a primary health care setting in Lusaka, Zambia: a cohort study.

  International journal of epidemiology 20120401

• HIV drug resistance interpreted by cumulative versus last genotypes in HIV-infected patients with multiple treatment failures.

  Current HIV research 20120401

• HIV exposure through contact with body fluids.

  Prescrire international 20120401

• Influence of rifampicin on nevirapine plasma concentration in HIV-TB coinfected patients.

  Acta medica Indonesiana 20120401

• [Influences of nevirapine on cell proliferation and expression of sodium/iodide symporter in human anaplastic thyroid carcinoma cell line].

  Zhonghua yi xue za zhi 20120327

• A review of the virological efficacy of the 4 World Health Organization-recommended tenofovir-containing regimens for initial HIV therapy.

  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20120315

• Projecting the clinical benefits and risks of using efavirenz-containing antiretroviral therapy regimens in women of childbearing age.

  AIDS (London, England) 20120313

• Safety and effectiveness of efavirenz versus nevirapine-based regimens in resource-limited settings: evidence, clinical practice and modelling projections.

  AIDS (London, England) 20120313

• Hemodiafiltration with online regeneration of ultrafiltrate for severe nevirapine intoxication in a HIV-infected patient.

  AIDS (London, England) 20120313

• Design, synthesis, and biological evaluation of 1-[(2-benzyloxyl/alkoxyl)methyl]-5-halo-6-aryluracils as potent HIV-1 non-nucleoside reverse transcriptase inhibitors with an improved drug resistance profile.

  Journal of medicinal chemistry 20120308

• Oxidation of 2-hydroxynevirapine, a phenolic metabolite of the anti-HIV drug nevirapine: evidence for an unusual pyridine ring contraction.

  Molecules (Basel, Switzerland) 20120305

• Six-year retrospective review of drug reaction with eosinophilia and systemic symptoms.

  Acta dermato-venereologica 20120301

• Safety and tolerability of antiretroviral therapy among HIV-infected children and adolescents in Uganda.

  Journal of acquired immune deficiency syndromes (1999) 20120301

• Intrapartum single-dose carbamazepine reduces nevirapine levels faster and may decrease resistance after a single dose of nevirapine for perinatal HIV prevention.

  Journal of acquired immune deficiency syndromes (1999) 20120301

• Lopinavir/ritonavir single agent therapy as a universal combination antiretroviral therapy stopping strategy: results from the STOP 1 and STOP 2 studies.

  The Journal of antimicrobial chemotherapy 20120301

• Costs and benefits of multidrug, multidose antiretroviral therapy for prevention of mother-to-child transmission of HIV in the Dominican Republic.

  International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics 20120301

• Discovery of 3,4-dihydropyrimidin-2(1H)-ones with inhibitory activity against HIV-1 replication.

  Bioorganic & medicinal chemistry letters 20120301

• [Erosive and budding molluscum contagiosum: total regression under antiretroviral therapy].

  Annales de dermatologie et de venereologie 20120301

• Exploring the complexity of the HIV-1 fitness landscape.

  PLoS genetics 20120301

• Transplacental passage of nevirapine, nelfinavir and lopinavir.

  The Netherlands journal of medicine 20120301

• Elimination of paediatric HIV in KwaZulu-Natal, South Africa: large-scale assessment of interventions for the prevention of mother-to-child transmission.

  Bulletin of the World Health Organization 20120301

• Policy. 3 steps can drastically reduce mother-to-child transmission.

  AIDS policy & law 20120301

• Identification of potential drug-drug interactions between antiretroviral drugs from prescriptions in the private health-care sector in South Africa.

  International journal of STD & AIDS 20120301

• Cohort profile: The PharmAccess African (PASER-M) and the TREAT Asia (TASER-M) monitoring studies to evaluate resistance--HIV drug resistance in sub-Saharan Africa and the Asia-Pacific.

  International journal of epidemiology 20120201

• Evaluation of the safety and effectiveness of nevirapine plus coformulated tenofovir/emtricitabine as first-line therapy in routine clinical practice.

  AIDS research and human retroviruses 20120201

• Systemic exposure to rifampicin in patients with tuberculosis and advanced HIV disease during highly active antiretroviral therapy in Burkina Faso.

  The Journal of antimicrobial chemotherapy 20120201

• Different baseline characteristics and different outcomes of HIV-infected patients receiving HAART through clinical trials compared with routine care in Mexico.

  Journal of acquired immune deficiency syndromes (1999) 20120201

• Incidence of toxic epidermal necrolysis and Stevens-Johnson Syndrome in an HIV cohort: an observational, retrospective case series study.

  American journal of clinical dermatology 20120201

• Valacyclovir suppressive therapy reduces plasma and breast milk HIV-1 RNA levels during pregnancy and postpartum: a randomized trial.

  The Journal of infectious diseases 20120201

• HIV-1 reverse transcriptase complex with DNA and nevirapine reveals non-nucleoside inhibition mechanism.

  Nature structural & molecular biology 20120201

• Lipid profile changes in Thai HIV and tuberculosis co-infected patients receiving non-nucleoside reverse transcriptase inhibitors-based antiretroviral therapy.

  Journal of the Medical Association of Thailand = Chotmaihet thangphaet 20120201

• Extended prophylaxis with nevirapine and cotrimoxazole among HIV-exposed uninfected infants is well tolerated.

  AIDS (London, England) 20120128

• Is nevirapine atropisomeric? Experimental and computational evidence for rapid conformational inversion.

  Organic & biomolecular chemistry 20120128

• Efficacy and safety of an extended nevirapine regimen in infant children of breastfeeding mothers with HIV-1 infection for prevention of postnatal HIV-1 transmission (HPTN 046): a randomised, double-blind, placebo-controlled trial.

  Lancet (London, England) 20120121

• A comparison of 3 regimens to prevent nevirapine resistance mutations in HIV-infected pregnant women receiving a single intrapartum dose of nevirapine.

  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20120115

• kinITC: a new method for obtaining joint thermodynamic and kinetic data by isothermal titration calorimetry.

  Journal of the American Chemical Society 20120111

• Extended antenatal use of triple antiretroviral therapy for prevention of mother-to-child transmission of HIV-1 correlates with favorable pregnancy outcomes.

  AIDS (London, England) 20120102

• Dynamics and constraints of early infant diagnosis of HIV infection in Rural Kenya.

  AIDS and behavior 20120101

• Antiretroviral prophylaxis and the risk of cleft lip and palate: preliminary signal detection in the food and drug administration's adverse events reporting system database.

  The Cleft palate-craniofacial journal : official publication of the American Cleft Palate-Craniofacial Association 20120101

• Discontinuation rate of nevirapine-based highly active antiretroviral therapy.

  AIDS research and human retroviruses 20120101

• The rate of accumulation of nonnucleoside reverse transcriptase inhibitor (NNRTI) resistance in patients kept on a virologically failing regimen containing an NNRTI*.

  HIV medicine 20120101

• Hypertriglyceridemia, Metabolic Syndrome, and Cardiovascular Disease in HIV-Infected Patients: Effects of Antiretroviral Therapy and Adipose Tissue Distribution.

  International journal of vascular medicine 20120101

• Prevalence of low estimated glomerular filtration rate, proteinuria, and associated risk factors among HIV-infected black patients using Cockroft-Gault and modification of diet in renal disease study equations.

  Journal of acquired immune deficiency syndromes (1999) 20120101

• Reverse transcriptase genotypes in pediatric patients failing initial antiretroviral therapy in Gaborone, Botswana.

  Journal of the International Association of Physicians in AIDS Care (Chicago, Ill. : 2002) 20120101

• Resistance-associated mutations in HIV-1 among patients failing first-line antiretroviral therapy.

  Journal of the International Association of Physicians in AIDS Care (Chicago, Ill. : 2002) 20120101

• The impact of HIV on maternal morbidity in the Pre-HAART era in Uganda.

  Journal of pregnancy 20120101

• The antiretroviral protease inhibitors indinavir and nelfinavir stimulate Mrp1-mediated GSH export from cultured brain astrocytes.

  Journal of neurochemistry 20120101

• Nevirapine-associated hepatotoxicity and rash among HIV-infected pregnant women in Kenya.

  Journal of the International Association of Physicians in AIDS Care (Chicago, Ill. : 2002) 20120101

• F18, a novel small-molecule nonnucleoside reverse transcriptase inhibitor, inhibits HIV-1 replication using distinct binding motifs as demonstrated by resistance selection and docking analysis.

  Antimicrobial agents and chemotherapy 20120101

• Association of ABCC10 polymorphisms with nevirapine plasma concentrations in the German Competence Network for HIV/AIDS.

  Pharmacogenetics and genomics 20120101

• Reasons for and correlates of antiretroviral treatment interruptions in a cohort of patients from public and private clinics in southern India.

  AIDS care 20120101

• Exploration of CYP450 and drug transporter genotypes and correlations with nevirapine exposure in Malawians.

  Pharmacogenomics 20120101

• Tuberculosis in pregnancy: a review.

  Journal of pregnancy 20120101

• Nevirapine extended-release for the treatment of HIV-1 infection.

  Expert review of anti-infective therapy 20120101

• The pathophysiology of HIV-/HAART-related metabolic syndrome leading to cardiovascular disorders: the emerging role of adipokines.

  Experimental diabetes research 20120101

• Listening to health workers: lessons from Eastern Uganda for strengthening the programme for the prevention of mother-to-child transmission of HIV.

  BMC health services research 20120101

• Determinants of sustained viral suppression in HIV-infected patients with self-reported poor adherence to antiretroviral therapy.

  PloS one 20120101

• Interactions between prostaglandins, leukotrienes and HIV-1: possible implications for the central nervous system.

  Retrovirology 20120101

• HIV infection and HERV expression: a review.

  Retrovirology 20120101

• What will it take to eliminate pediatric HIV? Reaching WHO target rates of mother-to-child HIV transmission in Zimbabwe: a model-based analysis.

  PLoS medicine 20120101

• Incidence and correlates of HIV-1 RNA detection in the breast milk of women receiving HAART for the prevention of HIV-1 transmission.

  PloS one 20120101

• Emerging mutations and associated factors in patients displaying treatment failure on an etravirine-containing regimen.

  Antiviral therapy 20120101

• Treatment outcomes in HIV-infected adolescents attending a community-based antiretroviral therapy clinic in South Africa.

  BMC infectious diseases 20120101

• Noncirrhotic portal hypertension associated with didanosine: a case report and literature review.

  Japanese journal of infectious diseases 20120101

• Health facility characteristics and their relationship to coverage of PMTCT of HIV services across four African countries: the PEARL study.

  PloS one 20120101

• Aligning vertical interventions to health systems: a case study of the HIV monitoring and evaluation system in South Africa.

  Health research policy and systems 20120101

• HIV-free survival among nine- to 24-month-old children born to HIV-positive mothers in the Rwandan national PMTCT programme: a community-based household survey.

  Journal of the International AIDS Society 20120101

• Short-term risk of anaemia following initiation of combination antiretroviral treatment in HIV-infected patients in countries in sub-Saharan Africa, Asia-Pacific, and central and South America.

  Journal of the International AIDS Society 20120101

• Immune reconstitution inflammatory syndrome from Penicillium marneffei in an HIV-infected child: a case report and review of literature.

  BMC infectious diseases 20120101

• Short-course Combivir after single-dose nevirapine reduces but does not eliminate the emergence of nevirapine resistance in women.

  Antiviral therapy 20120101

• Low rates of nucleoside reverse transcriptase inhibitor resistance in a well-monitored cohort in South Africa on antiretroviral therapy.

  Antiviral therapy 20120101

• Prevalence of MDR1 C3435T and CYP2B6 G516T polymorphisms among HIV-1 infected South African patients.

  Disease markers 20120101

• Incidence of treatment-limiting toxicity with stavudine-based antiretroviral therapy in Cambodia: a retrospective cohort study.

  PloS one 20120101

• A clinician-nurse model to reduce early mortality and increase clinic retention among high-risk HIV-infected patients initiating combination antiretroviral treatment.

  Journal of the International AIDS Society 20120101

• The use of preexposure treatments for HIV prophylaxis.

  HIV/AIDS (Auckland, N.Z.) 20120101

• Progressive activation of CD127+132- recent thymic emigrants into terminally differentiated CD127-132+ T-cells in HIV-1 infection.

  PloS one 20120101

• Hyperhidrosis related to nevirapine therapy.

  International journal of STD & AIDS 20120101

• Gender differences in immune reconstitution: a multicentric cohort analysis in sub-Saharan Africa.

  PloS one 20120101

• Zidovudine (AZT) monotherapy selects for the A360V mutation in the connection domain of HIV-1 reverse transcriptase.

  PloS one 20120101

• Do genetic polymorphisms of nevirapine metabolic, transport and antigen recognition enzymes play a role in nevirapine toxicity risk?

  Pharmacogenomics 20120101

• Determining the prevalence of human immunodeficiency virus-associated nephropathy (HIVAN) using proteinuria and ultrasound findings in a Nigerian paediatric HIV population.

  The Pan African medical journal 20120101

• Key informant perspectives on policy- and service-level challenges and opportunities for delivering integrated sexual and reproductive health and HIV care in South Africa.

  BMC health services research 20120101

• Adverse drug reactions to antiretroviral therapy (ARVs): incidence, type and risk factors in Nigeria.

  BMC clinical pharmacology 20120101

• Children who acquire HIV infection perinatally are at higher risk of early death than those acquiring infection through breastmilk: a meta-analysis.

  PloS one 20120101

• High prevalence of hypertension and placental insufficiency, but no in utero HIV transmission, among women on HAART with stillbirths in Botswana.

  PloS one 20120101

• Emergence of minor drug-resistant HIV-1 variants after triple antiretroviral prophylaxis for prevention of vertical HIV-1 transmission.

  PloS one 20120101

• Prevalence and risk factors for cervical squamous intraepithelial lesions among women infected with HIV-1 in Makurdi, Nigeria.

  International journal of women's health 20120101

• The Reason for Regimen Change Among HIV/AIDS Patients Initiated on First Line Highly Active Antiretroviral Therapy in Southern Ethiopia.

  North American journal of medical sciences 20120101

• Switching virally suppressed, treatment-experienced patients to a raltegravir-containing regimen does not alter levels of HIV-1 DNA.

  PloS one 20120101

• Simple and sensitive stability-indicating ion chromatography method for the determination of cyclopropylamine in nevirapine and moxifloxacin hydrochloride drug substances.

  Scientia pharmaceutica 20120101

• A low proportion of HBeAg among HBsAg-positive pregnant women with known HIV status could suggest low perinatal transmission of HBV in Cameroon.

  Virology journal 20120101

• Assessment of HBV flare in a randomized clinical trial in HIV/HBV coinfected subjects initiating HBV-active antiretroviral therapy in Thailand.

  AIDS research and therapy 20120101

• Reducing mother-to-child transmission of HIV: findings from an early infant diagnosis program in south-south region of Nigeria.

  BMC public health 20120101

• Emergence of HIV-1 drug resistance mutations among antiretroviral-naïve HIV-1-infected patients after rapid scaling up of antiretroviral therapy in Thailand.

  Journal of the International AIDS Society 20120101

• Effectiveness and safety of 30 mg versus 40 mg stavudine regimens: a cohort study among HIV-infected adults initiating HAART in South Africa.

  Journal of the International AIDS Society 20120101

• Survival from XDR-TB is associated with modifiable clinical characteristics in rural South Africa.

  PloS one 20120101

• Differences in HIV natural history among African and non-African seroconverters in Europe and seroconverters in sub-Saharan Africa.

  PloS one 20120101

• Virologic failure of protease inhibitor-based second-line antiretroviral therapy without resistance in a large HIV treatment program in South Africa.

  PloS one 20120101

• Survey of methadone-drug interactions among patients of methadone maintenance treatment program in Taiwan.

  Substance abuse treatment, prevention, and policy 20120101

• An autopsy study describing causes of death and comparing clinico-pathological findings among hospitalized patients in Kampala, Uganda.

  PloS one 20120101

• Immune Reconstitution During the First Year of Antiretroviral Therapy of HIV-1-Infected Adults in Rural Burkina Faso.

  The open AIDS journal 20120101

• Low prevalence of transmitted drug resistance in patients newly diagnosed with HIV-1 infection in Sweden 2003-2010.

  PloS one 20120101

• The association between malnutrition and the incidence of malaria among young HIV-infected and -uninfected Ugandan children: a prospective study.

  Malaria journal 20120101

• Assessment of liver fibrosis and associated risk factors in HIV-infected individuals using transient elastography and serum biomarkers.

  BMC gastroenterology 20120101

• Regulation of reverse cholesterol transport - a comprehensive appraisal of available animal studies.

  Nutrition & metabolism 20120101

• Urgent liver transplantation for nevirapine-induced acute liver failure: report of a case and review of the literature.

  Annals of transplantation 20120101

• Incidence of adverse drug reactions in human immune deficiency virus-positive patients using highly active antiretroviral therapy.

  Journal of advanced pharmaceutical technology & research 20120101

• Stroke outcomes in Malawi, a country with high prevalence of HIV: a prospective follow-up study.

  PloS one 20120101

• HIV-1 phenotypic reverse transcriptase inhibitor drug resistance test interpretation is not dependent on the subtype of the virus backbone.

  PloS one 20120101

• A Prospective Study Assessing Tumour Response, Survival, and Palliative Care Outcomes in Patients with HIV-Related Kaposi's Sarcoma at Queen Elizabeth Central Hospital, Blantyre, Malawi.

  AIDS research and treatment 20120101

• Prevalence of HIV Drug Resistance Mutations in HIV Type 1 Isolates in Antiretroviral Therapy Naïve Population from Northern India.

  AIDS research and treatment 20120101

• Novel therapeutic strategies targeting HIV integrase.

  BMC medicine 20120101

• Nevirapine-Based Antiretroviral Therapy Impacts Artesunate and Dihydroartemisinin Disposition in HIV-Infected Nigerian Adults.

  AIDS research and treatment 20120101

• The impact of herbal drug use on adverse drug reaction profiles of patients on antiretroviral therapy in zimbabwe.

  AIDS research and treatment 20120101

• HIV-Antiretroviral Therapy Induced Liver, Gastrointestinal, and Pancreatic Injury.

  International journal of hepatology 20120101

• The frequency of malaria is similar among women receiving either lopinavir/ritonavir or nevirapine-based antiretroviral treatment.

  PloS one 20120101

• Infant safety during and after maternal valacyclovir therapy in conjunction with antiretroviral HIV-1 prophylaxis in a randomized clinical trial.

  PloS one 20120101

• Liver toxicity of initial antiretroviral drug regimens including two nucleoside analogs plus one non-nucleoside analog or one ritonavir-boosted protease inhibitor in HIV/HCV-coinfected patients.

  HIV clinical trials 20120101

• Pattern and determinants of antiretroviral drug adherence among Nigerian pregnant women.

  Journal of pregnancy 20120101

• Distribution of human CYP2C8*2 allele in three different African populations.

  Malaria journal 20120101

• Association of serum albumin with markers of nutritional status among HIV-infected and uninfected Rwandan women.

  PloS one 20120101

• Pharmacokinetic interactions between the hormonal emergency contraception, levonorgestrel (Plan B), and Efavirenz.

  Infectious diseases in obstetrics and gynecology 20120101

• Assessment of the impact of adherence and other predictors during HAART on various CD4 cell responses in resource-limited settings.

  Patient preference and adherence 20120101

• The impact of HIV clinical pharmacists on HIV treatment outcomes: a systematic review.

  Patient preference and adherence 20120101

• Remission of progressive multifocal leukoencephalopathy following highly active antiretroviral therapy in a man with AIDS.

  International journal of general medicine 20120101

• Impact of Novel Resistance Profiles in HIV-1 Reverse Transcriptase on Phenotypic Resistance to NVP.

  AIDS research and treatment 20120101

• Challenges in Providing Treatment and Care for Viral Hepatitis among Individuals Co-Infected with HIV in Resource-Limited Settings.

  AIDS research and treatment 20120101

• Imported Plasmodium falciparum malaria in HIV-infected patients: a report of two cases.

  Malaria journal 20120101

• An overview of the evidence and mechanisms of herb-drug interactions.

  Frontiers in pharmacology 20120101

• Integrating prevention of mother-to-child HIV transmission programs to improve uptake: a systematic review.

  PloS one 20120101

• Lignosulfonic acid exhibits broadly anti-HIV-1 activity--potential as a microbicide candidate for the prevention of HIV-1 sexual transmission.

  PloS one 20120101

• The cost-effectiveness of tuberculosis preventive therapy for HIV-infected individuals in southern India: a trial-based analysis.

  PloS one 20120101

• High incidence of unplanned pregnancy after antiretroviral therapy initiation: findings from a prospective cohort study in South Africa.

  PloS one 20120101

• Effectiveness of a prevention of mother-to-child HIV transmission programme in an urban hospital in Angola.

  PloS one 20120101

• Young HIV-infected children and their adult caregivers prefer tablets to syrup antiretroviral medications in Africa.

  PloS one 20120101

• Self-initiation of antiretroviral therapy in the developing world: the involvement of private pharmacies in an HIV program.

  Drug, healthcare and patient safety 20120101

• New option for management of HIV-1 infection in treatment-naive patients: once-daily, fixed-dose combination of rilpivirine-emtricitabine-tenofovir.

  HIV/AIDS (Auckland, N.Z.) 20120101

• Impact of low-level-viremia on HIV-1 drug-resistance evolution among antiretroviral treated-patients.

  PloS one 20120101

• A pharmacovigilance study of adults on highly active antiretroviral therapy, South Africa: 2007 - 2011.

  The Pan African medical journal 20120101

• Prevalence of Drug Resistance and Associated Mutations in a Population of HIV-1(+) Puerto Ricans: 2006-2010.

  AIDS research and treatment 20120101

• Challenges in the Management of HIV-Infected Malnourished Children in Sub-Saharan Africa.

  AIDS research and treatment 20120101

• Severe antiretroviral therapy-induced toxic epidermal necrolysis in a child.

  Case reports in dermatology 20120101

• Epidemiology of cutaneous adverse drug reactions.

  Chemical immunology and allergy 20120101

• K65R in subtype C HIV-1 isolates from patients failing on a first-line regimen including d4T or AZT: comparison of Sanger and UDP sequencing data.

  PloS one 20120101

• Isolation of HIV-1-neutralizing mucosal monoclonal antibodies from human colostrum.

  PloS one 20120101

• Contemporary role of nevirapine in HIV treatment.

  AIDS reviews 20120101

• Measuring the efficacy of antiretroviral therapy.

  International journal of trichology 20120101

• Outcomes of comprehensive care for children empirically treated for multidrug-resistant tuberculosis in a setting of high HIV prevalence.

  PloS one 20120101

• Human immunodeficiency virus and leprosy coinfection: challenges in resource-limited setups.

  Case reports in medicine 20120101

• Interplay between HIV-1 and Host Genetic Variation: A Snapshot into Its Impact on AIDS and Therapy Response.

  Advances in virology 20120101

• Second-line antiretroviral therapy in a workplace and community-based treatment programme in South Africa: determinants of virological outcome.

  PloS one 20120101

• Very early anthropometric changes after antiretroviral therapy predict subsequent survival, in karonga, Malawi.

  The open AIDS journal 20120101

• Use of service data to inform pediatric HIV-free survival following prevention of mother-to-child transmission programs in rural Malawi.

  BMC public health 20120101

• Differences in lipid measurements by antiretroviral regimen exposure in cohorts from Asia and australia.

  AIDS research and treatment 20120101

• Antiretroviral drugs: critical issues and recent advances.

  Indian journal of pharmacology 20120101

• Allopurinol-induced DRESS syndrome.

  Indian journal of pharmacology 20120101

• Longitudinal changes of peripheral blood DC subsets and regulatory T cells in Chinese chronic HIV-1-infected patients during antiretroviral therapy.

  PloS one 20120101

• Effects of valacyclovir on markers of disease progression in postpartum women co-infected with HIV-1 and herpes simplex virus-2.

  PloS one 20120101

• Effect of Formula Feeding and Breastfeeding on Child Growth, Infant Mortality, and HIV Transmission in Children Born to HIV-Infected Pregnant Women Who Received Triple Antiretroviral Therapy in a Resource-Limited Setting: Data from an HIV Cohort Study in India.

  ISRN pediatrics 20120101

• Malaria and hiv in adults: when the parasite runs into the virus.

  Mediterranean journal of hematology and infectious diseases 20120101

• Treatment outcomes among HIV-1 and HIV-2 infected children initiating antiretroviral therapy in a concentrated low prevalence setting in West Africa.

  BMC pediatrics 20120101

• Efavirenz conceptions and regimen management in a prospective cohort of women on antiretroviral therapy.

  Infectious diseases in obstetrics and gynecology 20120101

• Dosage optimization of treatments using population pharmacokinetic modeling and simulation.

  Chimia 20120101

• New strategies for lowering the costs of antiretroviral treatment and care for people with HIV/AIDS in the United Kingdom.

  ClinicoEconomics and outcomes research : CEOR 20120101

• Cost-effectiveness of tenofovir instead of zidovudine for use in first-line antiretroviral therapy in settings without virological monitoring.

  PloS one 20120101

• Virological Response in Cerebrospinal Fluid to Antiretroviral Therapy in a Large Italian Cohort of HIV-Infected Patients with Neurological Disorders.

  AIDS research and treatment 20120101

• Identification of drug resistant mutations in HIV-1 CRF07_BC variants selected by nevirapine in vitro.

  PloS one 20120101

• Hidradenitis suppurativa in a HIV-infected child.

  Journal of postgraduate medicine 20120101

• A Foilized Polyethylene Pouch for the Prevention of Transmission of HIV from Mother to Child.

  The open biomedical engineering journal 20120101

• Influence of ABCB-1 C3435T polymorphisms on plasma nevirapine and efavirenz levels and their effects on virologic and immunological outcomes in HIV/TB co-infected Thai adults under anti-retroviral therapy.

  The Southeast Asian journal of tropical medicine and public health 20120101

• First reported case of tenofovir-induced photoallergic reaction.

  Indian journal of pharmacology 20120101

• Computationally-guided optimization of a docking hit to yield catechol diethers as potent anti-HIV agents.

  Journal of medicinal chemistry 20111222

• Comparative outcomes of tenofovir-based and zidovudine-based antiretroviral therapy regimens in Lusaka, Zambia.

  Journal of acquired immune deficiency syndromes (1999) 20111215

• Should sponsors and DSMBs share interim results across trials?

  Journal of acquired immune deficiency syndromes (1999) 20111215

• Surface modified nevirapine nanosuspensions for viral reservoir targeting: In vitro and in vivo evaluation.

  International journal of pharmaceutics 20111215

• Docking analysis and resistance evaluation of clinically relevant mutations associated with the HIV-1 non-nucleoside reverse transcriptase inhibitors nevirapine, efavirenz and etravirine.

  ChemMedChem 20111209

• Serum Nevirapine and Efavirenz concentrations and effect of concomitant rifampicin in HIV infected children on antiretroviral therapy.

  Indian pediatrics 20111201

• Pharmacogenetics of toxicity, plasma trough concentration and treatment outcome with nevirapine-containing regimen in anti-retroviral-naïve HIV-infected adults: an exploratory study of the TRIANON ANRS 081 trial.

  Basic & clinical pharmacology & toxicology 20111201

• Safety and efficacy of HIV hyperimmune globulin for prevention of mother-to-child HIV transmission in HIV-1-infected pregnant women and their infants in Kampala, Uganda (HIVIGLOB/NVP STUDY).

  Journal of acquired immune deficiency syndromes (1999) 20111201

• A randomised comparison of safety and efficacy of nevirapine vs. atazanavir/ritonavir combined with tenofovir/emtricitabine in treatment-naïve patients.

  International journal of clinical practice 20111201

• Guidelines for the use of extended-release nevirapine in HIV-infected patients.

  Expert opinion on pharmacotherapy 20111201

• Design, synthesis and biological evaluation of cycloalkyl arylpyrimidines (CAPYs) as HIV-1 NNRTIs.

  Bioorganic & medicinal chemistry 20111201

• Qualitative prediction of blood-brain barrier permeability on a large and refined dataset.

  Journal of computer-aided molecular design 20111201

• Modelling the spread of HIV immune escape mutants in a vaccinated population.

  PLoS computational biology 20111201

• Emerging trends of drug-resistant HIV-1 among drug-treated patients in former blood donors in Hubei, China: a three-year surveillance from 2004 to 2006.

  Virologica Sinica 20111201

• Malaria therapy in HIV: drug interactions between nevirapine and quinine.

  International journal of STD & AIDS 20111201

• Herpes zoster as a sign of AIDS and nonadherence to antiretroviral therapy: a case report.

  Clinics (Sao Paulo, Brazil) 20111201

• Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).

  PLoS computational biology 20111201

• HIV drug resistance on HAART despite an undetectable viral load.

  Current HIV research 20111201

• Treatment challenges in co-infected HIV and TB children.

  Indian pediatrics 20111201

• 'Getting to zero': a steep path ahead.

  The Indian journal of medical research 20111201

• Genetic correlates influencing immunopathogenesis of HIV infection.

  The Indian journal of medical research 20111201

• Antiretroviral therapy in Indian setting: when & what to start with, when & what to switch to?

  The Indian journal of medical research 20111201

• Optimizing adherence to antiretroviral therapy.

  The Indian journal of medical research 20111201

• Diagnosis & treatment of tuberculosis in HIV co-infected patients.

  The Indian journal of medical research 20111201

• HIV serodiscordant relationships in India: translating science to practice.

  The Indian journal of medical research 20111201

• Paediatric HIV--trends & challenges.

  The Indian journal of medical research 20111201

• Lead optimization at C-2 and N-3 positions of thiazolidin-4-ones as HIV-1 non-nucleoside reverse transcriptase inhibitors.

  Bioorganic & medicinal chemistry 20111115

• Acetylcholinesterase-inhibiting alkaloids from Zephyranthes concolor.

  Molecules (Basel, Switzerland) 20111115

• How much do antiretroviral drugs penetrate into the central nervous system?

  Journal of medicine and life 20111114

• Role of non-nucleoside reverse transcriptase inhibitors in treating HIV-infected children.

  Drugs 20111112

• Selection of HIV resistance associated with antiretroviral therapy initiated due to pregnancy and suspended postpartum.

  Journal of acquired immune deficiency syndromes (1999) 20111101

• Integration of absorption, distribution, metabolism, and elimination genotyping data into a population pharmacokinetic analysis of nevirapine.

  Pharmacogenetics and genomics 20111101

• In vitro activity of antiretroviral drugs against Plasmodium falciparum.

  Antimicrobial agents and chemotherapy 20111101

• HIV-1 reverse transcriptase connection subdomain mutations involved in resistance to approved non-nucleoside inhibitors.

  Antiviral research 20111101

• HIV Therapy Simulator: a graphical user interface for comparing the effectiveness of novel therapy regimens.

  Bioinformatics (Oxford, England) 20111101

• Morphological and metabolic components of lipodystrophy in various nevirapine-based highly active antiretroviral therapy (HAART) regimens: a cross-sectional, observational study.

  Clinical drug investigation 20111101

• Efficacy and safety of nevirapine + Kivexa (abacavir/lamivudine) as a simplification strategy for HIV patients with undetectable viral load.

  Journal of acquired immune deficiency syndromes (1999) 20111101

• Effectiveness of fixed-dose combination stavudine, lamivudine and nevirapine (GPO-VIR) for treatment of naïve HIV patients in Thailand: a 3-year follow-up.

  The Southeast Asian journal of tropical medicine and public health 20111101

• Management of common adverse effects in the era of highly active antiretroviral therapy in south east Ethiopia.

  North American journal of medical sciences 20111101

• Bioavailability of nevirapine in rats after oral and subcutaneous administration, in vivo absorption from gastrointestinal segments and effect of bile on its absorption from duodenum.

  International journal of pharmaceutics 20111031

• Synthesis and oxidation of 2-hydroxynevirapine, a metabolite of the HIV reverse transcriptase inhibitor nevirapine.

  Organic & biomolecular chemistry 20111026

• The effects of RNase H inhibitors and nevirapine on the susceptibility of HIV-1 to AZT and 3TC.

  Virology 20111025

• Short communication: high prevalence of drug resistance in HIV type 1-infected children born in Honduras and Belize 2001 to 2004.

  AIDS research and human retroviruses 20111001

• Inhibition of HIV-1 reverse transcriptase, toxicological and chemical profile of Calophyllum brasiliense extracts from Chiapas, Mexico.

  Fitoterapia 20111001

• Bilateral microbial keratitis in highly active antiretroviral therapy-induced Stevens-Johnson syndrome and toxic epidermal necrolysis: a case series.

  Ocular immunology and inflammation 20111001

• Antiretroviral resistance patterns and factors associated with resistance in adult patients failing NNRTI-based regimens in the Western Cape, South Africa.

  Journal of medical virology 20111001

• Microanalysis of the antiretroviral nevirapine in human hair from HIV-infected patients by liquid chromatography-tandem mass spectrometry.

  Analytical and bioanalytical chemistry 20111001

• HIV-1-resistance-associated mutations after failure of first-line antiretroviral treatment among children in resource-poor regions: a systematic review.

  The Lancet. Infectious diseases 20111001

• Arylazolylthioacetanilide. Part 8: Design, synthesis and biological evaluation of novel 2-(2-(2,4-dichlorophenyl)-2H-1,2,4-triazol-3-ylthio)-N-arylacetamides as potent HIV-1 inhibitors.

  European journal of medicinal chemistry 20111001

• Efficacy and safety of once-daily nevirapine- or efavirenz-based antiretroviral therapy in HIV-associated tuberculosis: a randomized clinical trial.

  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20111001

• 1-[2-(2-Benzoyl- and 2-benzylphenoxy)ethyl]uracils as potent anti-HIV-1 agents.

  Bioorganic & medicinal chemistry 20111001

• HBV lamivudine resistance among hepatitis B and HIV coinfected patients starting lamivudine, stavudine and nevirapine in Kenya.

  Journal of viral hepatitis 20111001

• Combined oral contraceptives and antiretroviral PK/PD in Malawian women: pharmacokinetics and pharmacodynamics of a combined oral contraceptive and a generic combined formulation antiretroviral in Malawi.

  Journal of acquired immune deficiency syndromes (1999) 20111001

• Impact of internal standard addition on dried blood spot analysis in bioanalytical method development.

  Bioanalysis 20111001

• [Study of treatment adherence by patients living with HIV in 2009 at the outpatient care and treatment center of Brazzaville, Congo].

  Medecine tropicale : revue du Corps de sante colonial 20111001

• [Effect of highly active anti-retroviral therapy on prevention of mother to child transmission of HIV and on infant growth and development].

  Zhonghua yu fang yi xue za zhi [Chinese journal of preventive medicine] 20111001

• Nevirapine plasma concentrations in premature infants exposed to single-dose nevirapine for prevention of mother-to-child transmission of HIV-1.

  South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde 20110905

• Rapid development of antiretroviral drug resistance mutations in HIV-infected children less than two years of age initiating protease inhibitor-based therapy in South Africa.

  AIDS research and human retroviruses 20110901

• Factors associated with short-course antiretroviral prophylaxis (dual therapy) adherence for PMTCT in Nkangala district, South Africa.

  Acta paediatrica (Oslo, Norway : 1992) 20110901

• A retrospective study of HIV antiretroviral treatment persistence in a commercially insured population in the United States.

  AIDS care 20110901

• Improving retention in the early infant diagnosis of HIV program in rural Mozambique by better service integration.

  Journal of acquired immune deficiency syndromes (1999) 20110901

• Pregnancy in women with perinatally acquired HIV-infection: outcomes and challenges.

  AIDS care 20110901

• Comparison of abacavir/lamivudine and tenofovir/emtricitabine among treatment-naive HIV-infected patients initiating therapy.

  Journal of acquired immune deficiency syndromes (1999) 20110901

• Drug resistance profiles among HIV-1-infected children experiencing delayed switch and 12-month efficacy after using second-line antiretroviral therapy: an observational cohort study in rural China.

  Journal of acquired immune deficiency syndromes (1999) 20110901

• A description of congenital anomalies among infants in Entebbe, Uganda.

  Birth defects research. Part A, Clinical and molecular teratology 20110901

• Synthesis and structure-activity relationship of novel diarylpyrimidines with hydromethyl linker (CH(OH)-DAPYs) as HIV-1 NNRTIs.

  Bioorganic & medicinal chemistry 20110901

• A376S in the connection subdomain of HIV-1 reverse transcriptase confers increased risk of virological failure to nevirapine therapy.

  The Journal of infectious diseases 20110901

• Bioavailability of extended-release nevirapine 400 and 300 mg in HIV-1: a multicenter, open-label study.

  Clinical therapeutics 20110901

• Significant effects of antiretroviral therapy on global gene expression in brain tissues of patients with HIV-1-associated neurocognitive disorders.

  PLoS pathogens 20110901

• APOBEC3A is a specific inhibitor of the early phases of HIV-1 infection in myeloid cells.

  PLoS pathogens 20110901

• Modulation of cell differentiation, proliferation, and tumor growth by dihydrobenzyloxopyrimidine non-nucleoside reverse transcriptase inhibitors.

  Journal of medicinal chemistry 20110825

• Development of resistance to VIR-353 with cross-resistance to the natural HIV-1 entry virus inhibitory peptide (VIRIP).

  AIDS (London, England) 20110824

• Extended antenatal use of triple antiretroviral therapy for prevention of mother-to-child transmission of HIV-1 correlates with favorable pregnancy outcomes.

  AIDS (London, England) 20110824

• Effect of specific ART drugs on lipid changes and the need for lipid management in children with HIV.

  Journal of acquired immune deficiency syndromes (1999) 20110815

• Effects of cessation of breastfeeding in HIV-1-exposed, uninfected children in Malawi.

  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20110815

• DRESS syndrome associated with raltegravir.

  Dermatology online journal 20110815

• Easier said than done: World Health Organization recommendations for prevention of mother-to-child transmission of HIV-areas of concern.

  AIDS research and human retroviruses 20110801

• Slower clearance of nevirapine resistant virus in infants failing extended nevirapine prophylaxis for prevention of mother-to-child HIV transmission.

  AIDS research and human retroviruses 20110801

• Challenges faced by elderly guardians in sustaining the adherence to antiretroviral therapy in HIV-infected children in Zimbabwe.

  AIDS care 20110801

• Postexposure prophylaxis of breastfeeding HIV-exposed infants with antiretroviral drugs to age 14 weeks: updated efficacy results of the PEPI-Malawi trial.

  Journal of acquired immune deficiency syndromes (1999) 20110801

• Improved detection of incident HIV infection and uptake of PMTCT services in labor and delivery in a high HIV prevalence setting.

  Journal of acquired immune deficiency syndromes (1999) 20110801

• Limited risk of drug resistance after discontinuation of antiretroviral prophylaxis for the prevention of breastfeeding transmission of HIV.

  Journal of acquired immune deficiency syndromes (1999) 20110801

• Effects of nevirapine and efavirenz on human adipocyte differentiation, gene expression, and release of adipokines and cytokines.

  Antiviral research 20110801

• Comparative effectiveness of continuing a virologically effective first-line boosted protease inhibitor combination or of switching to a three-drug regimen containing either efavirenz, nevirapine or abacavir.

  The Journal of antimicrobial chemotherapy 20110801

• Effect of antiretroviral drugs on the quality of semen.

  Journal of medical virology 20110801

• Targeting nevirapine delivery across human brain microvascular endothelial cells using transferrin-grafted poly(lactide-co-glycolide) nanoparticles.

  Nanomedicine (London, England) 20110801

• Genome-wide association study identifies variations in 6p21.3 associated with nevirapine-induced rash.

  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20110801

• Prevalence of etravirine-associated mutations in clinical samples with genotypic resistance to nevirapine and efavirenz in Brazilian clinics.

  Journal of acquired immune deficiency syndromes (1999) 20110801

• Prevalence of antiretroviral drug resistance mutations and HIV-I subtypes among newly-diagnosed drug-naïve persons visiting a voluntary testing and counselling centre in northeastern South Africa.

  Journal of health, population, and nutrition 20110801

• Assessment of Effective Coverage of HIV Prevention of Pregnant Mother to Child Transimission Services in Jimma Zone, South West Ethiopia.

  Ethiopian journal of health sciences 20110801

• HIV-1 drug resistance at antiretroviral treatment initiation in children previously exposed to single-dose nevirapine.

  AIDS (London, England) 20110731

• Mothers and babies: widening the HIV safety net.

  South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde 20110725

• Rilpivirine: a step forward in tailored HIV treatment.

  Lancet (London, England) 20110716

• Prevention of mother-to-child transmission of HIV and the health-related Millennium Development Goals: time for a public health approach.

  Lancet (London, England) 20110716

• Effect of short term and chronic administration of Sutherlandia frutescens on pharmacokinetics of nevirapine in rats.

  International journal of pharmaceutics 20110715

• Impaired infectivity of ritonavir-resistant HIV is rescued by heat shock protein 90AB1.

  The Journal of biological chemistry 20110715

• Synthesis and biological evaluation of novel 5-alkyl-2-arylthio-6-((3,4-dihydroquinolin-1(2H)-yl)methyl)pyrimidin-4(3H)-ones as potent non-nucleoside HIV-1 reverse transcriptase inhibitors.

  Bioorganic & medicinal chemistry 20110715

• Imidazo[1,2-a]pyridin-3-amines as potential HIV-1 non-nucleoside reverse transcriptase inhibitors.

  Bioorganic & medicinal chemistry 20110715

• Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection.

  The Cochrane database of systematic reviews 20110706

• The importance of male partner involvement for women's acceptability and adherence to female-initiated HIV prevention methods in Zimbabwe.

  AIDS and behavior 20110701

• Prophylaxis and treatment of HIV-1 infection in pregnancy: Swedish recommendations 2010.

  Scandinavian journal of infectious diseases 20110701

• [Immune reconstitution inflammatory syndrome and HIV leprosy co-infection].

  Medecine et maladies infectieuses 20110701

• Combination of GSH trapping and time-dependent inhibition assays as a predictive method of drugs generating highly reactive metabolites.

  Drug metabolism and disposition: the biological fate of chemicals 20110701

• Good performance of an immunoassay based method for nevirapine measurements in human breast milk.

  Clinical chemistry and laboratory medicine 20110701

• Lipid profiles for nevirapine vs. atazanavir/ritonavir, both combined with tenofovir disoproxil fumarate and emtricitabine over 48 weeks, in treatment-naïve HIV-1-infected patients (the ARTEN study).

  HIV medicine 20110701

• Reduced HIV transmission at subsequent pregnancy in a resource-poor setting.

  Tropical doctor 20110701

• Impact of baseline HIV-1 tropism on viral response and CD4 cell count gains in HIV-infected patients receiving first-line antiretroviral therapy.

  The Journal of infectious diseases 20110701

• Usefulness of methadone plasma concentration measurement in patients receiving nevirapine or efavirenz.

  The American journal of drug and alcohol abuse 20110701

• Treatment outcomes and cost-effectiveness of shifting management of stable ART patients to nurses in South Africa: an observational cohort.

  PLoS medicine 20110701

• Nevirapine for the prevention of mother-to-child transmission of HIV: a nation-wide coverage survey in Côte d'Ivoire.

  Journal of acquired immune deficiency syndromes (1999) 20110701

• Nevirapine-based regimens in routine clinical settings: results from a large Italian cohort of HIV-1 infected adults.

  Current drug safety 20110701

• Predictive power of molecular dynamics receptor structures in virtual screening.

  Journal of chemical information and modeling 20110627

• Toxicogenomics of nevirapine-associated cutaneous and hepatic adverse events among populations of African, Asian, and European descent.

  AIDS (London, England) 20110619

• Integrating prevention of mother-to-child HIV transmission (PMTCT) programmes with other health services for preventing HIV infection and improving HIV outcomes in developing countries.

  The Cochrane database of systematic reviews 20110615

• [Occurrence of human immunodeficiency virus-1 resistance through a six-year surveillance in rural areas of Henan].

  Zhonghua yi xue za zhi 20110607

• In vitro protein adsorption studies on nevirapine nanosuspensions for HIV/AIDS chemotherapy.

  Nanomedicine : nanotechnology, biology, and medicine 20110601

• Non-nucleoside reverse transcriptase inhibitors efavirenz and nevirapine inhibit cytochrome C oxidase in mouse brain regions.

  Neurochemical research 20110601

• Factors influencing plasma nevirapine levels: a study in HIV-infected children on generic antiretroviral treatment in India.

  The Journal of antimicrobial chemotherapy 20110601

• The HIV protease inhibitor nelfinavir inhibits Kaposi's sarcoma-associated herpesvirus replication in vitro.

  Antimicrobial agents and chemotherapy 20110601

• Integration of population pharmacokinetics and pharmacogenetics: an aid to optimal nevirapine dose selection in HIV-infected individuals.

  The Journal of antimicrobial chemotherapy 20110601

• Evaluation of saliva as an alternative matrix for monitoring plasma Zidovudine, Lamivudine and nevirapine concentrations in Rwanda.

  Current HIV research 20110601

• The effect of highly active antiretroviral therapy on the survival of HIV-infected children in a resource-deprived setting: a cohort study.

  PLoS medicine 20110601

• Nevirapine nanosuspensions for HIV reservoir targeting.

  Die Pharmazie 20110601

• Pregnancy outcome among HIV positive women receiving antenatal HAART versus untreated maternal HIV infection.

  Journal of the College of Physicians and Surgeons--Pakistan : JCPSP 20110601

• 7-Chloro-5-cyclo-propyl-9-methyl-5H-4,5,6,10-tetra-aza-dibenzo[a,d]cyclo-hepten-11(10H)-one.

  Acta crystallographica. Section E, Structure reports online 20110601

• A liquid-liquid LC/MS/MS assay for the determination of artemether and DHA in malaria patient samples.

  Journal of pharmaceutical and biomedical analysis 20110515

• Selection of nonnucleoside reverse transcriptase inhibitor-associated mutations in HIV-1 subtype C: evidence of etravirine cross-resistance.

  AIDS (London, England) 20110515

• Risk of triple-class virological failure in children with HIV: a retrospective cohort study.

  Lancet (London, England) 20110507

• A comparison of the long-term durability of nevirapine, efavirenz and lopinavir in routine clinical practice in Europe: a EuroSIDA study.

  HIV medicine 20110501

• Molecular recognition of the antiretroviral drug abacavir: towards the development of a novel carbazole-based fluorosensor.

  Journal of fluorescence 20110501

• State of the art of nanocrystals--special features, production, nanotoxicology aspects and intracellular delivery.

  European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V 20110501

• Socio-demographic factors associated with loss to follow-up of HIV-infected women attending a private sector PMTCT program in Maharashtra, India.

  AIDS care 20110501

• [Characteristics of antiretroviral drugs].

  Enfermedades infecciosas y microbiologia clinica 20110501

• Effectiveness of early antiretroviral therapy initiation to improve survival among HIV-infected adults with tuberculosis: a retrospective cohort study.

  PLoS medicine 20110501

• CTL escape mediated by proteasomal destruction of an HIV-1 cryptic epitope.

  PLoS pathogens 20110501

• Inhibition of both HIV-1 reverse transcription and gene expression by a cyclic peptide that binds the Tat-transactivating response element (TAR) RNA.

  PLoS pathogens 20110501

• Hepatotoxicity in patients co-infected with tuberculosis and HIV-1 while receiving non-nucleoside reverse transcriptase inhibitor-based antiretroviral therapy and rifampicin-containing anti-tuberculosis regimen.

  The Southeast Asian journal of tropical medicine and public health 20110501

• Human immunodeficiency virus therapeutics and pharmacogenomics.

  Indian journal of human genetics 20110501

• Diarylpyrimidine-dihydrobenzyloxopyrimidine hybrids: new, wide-spectrum anti-HIV-1 agents active at (sub)-nanomolar level.

  Journal of medicinal chemistry 20110428

• Analysis of nevirapine resistance in HIV-infected infants who received extended nevirapine or nevirapine/zidovudine prophylaxis.

  AIDS (London, England) 20110424

• Hospitalization for severe malnutrition among HIV-infected children starting antiretroviral therapy.

  AIDS (London, England) 20110424

• Resistance, resistance, go away: persistence of nevirapine-resistant HIV mutations in HIV-infected infants.

  AIDS (London, England) 20110424

• Asymmetric total synthesis of (+)- and (-)-clusianone and (+)- and (-)-clusianone methyl enol ether via ACC alkylation and evaluation of their anti-HIV activity.

  Bioorganic & medicinal chemistry letters 20110415

• Cohort profile: Hlabisa HIV treatment and care programme.

  International journal of epidemiology 20110401

• Simultaneous determination of atorvastatin, amlodipine, ramipril and benazepril in human plasma by LC-MS/MS and its application to a human pharmacokinetic study.

  Biomedical chromatography : BMC 20110401

• 'Forgiving' a missed daily dose.

  AIDS research and human retroviruses 20110401

• Physicochemical properties of nevirapine-loaded solid lipid nanoparticles and nanostructured lipid carriers.

  Colloids and surfaces. B, Biointerfaces 20110401

• Rapid intrapartum or postpartum HIV testing at a midwife obstetric unit and a district hospital in South Africa.

  International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics 20110401

• Impact of the N348I mutation in HIV-1 reverse transcriptase on nonnucleoside reverse transcriptase inhibitor resistance in non-subtype B HIV-1.

  Antimicrobial agents and chemotherapy 20110401

• Synthesis of 9-substituted derivatives of berberine as anti-HIV agents.

  European journal of medicinal chemistry 20110401

• The International Interlaboratory Quality Control Program for Measurement of Antiretroviral Drugs in Plasma: a global proficiency testing program.

  Therapeutic drug monitoring 20110401

• Cardiovascular risk factors in patients on long-term treatment with nevirapine- or efavirenz-based regimens.

  The Journal of antimicrobial chemotherapy 20110401

• Phenotypic characterization of drug resistance-associated mutations in HIV-1 RT connection and RNase H domains and their correlation with thymidine analogue mutations.

  The Journal of antimicrobial chemotherapy 20110401

• Nevirapine once daily: pharmacology, metabolic profile and efficacy data of the new extended-release formulation.

  Expert opinion on drug metabolism & toxicology 20110401

• Once-a-day (QD) vs. twice-daily (BID) nevirapine as simplification in PI-treated patients after 2 mos. of BID induction.

  Current HIV research 20110401

• Trial in youngest group points to HIV treatment overhaul.

  Nature medicine 20110401

• Clinical experience with nevirapine combined with tenofovir plus emtricitabine or lamivudine-containing regimens in HIV-infected subjects.

  International journal of STD & AIDS 20110401

• Nevirapine-induced agranulocytosis.

  Journal of chemotherapy (Florence, Italy) 20110401

• Safety of single-dose nevirapine for prevention of vertical transmission of human immunodeficiency virus infection.

  Indian journal of pharmacology 20110401

• Lactic acidosis associated with severe neuromuscular weakness and stavudine therapy.

  Journal of the Medical Association of Thailand = Chotmaihet thangphaet 20110401

• First-line antiretroviral treatment of HIV-infected children. A choice largely based on adult data.

  Prescrire international 20110401

• Drug-resistant HIV-1 in Cuban children and their seropositive mothers.

  MEDICC review 20110401

• [Comparative study of two anti-antiretroviral protocols used for treatment of a cohort of HIV 1-positive patients followed at the Institute of Public Health and Hygiene in Dakar, Senegal].

  Medecine tropicale : revue du Corps de sante colonial 20110401

• Clinical management of HIV drug resistance.

  Viruses 20110401

• Clinical applications of drug desensitization in the Asia-Pacific region.

  Asia Pacific allergy 20110401

• Twelve-month follow-up of Six Week Extended Dose Nevirapine randomized controlled trials: differential impact of extended-dose nevirapine on mother-to-child transmission and infant death by maternal CD4 cell count.

  AIDS (London, England) 20110327

• Do nevirapine and efavirenz affect vitamin D homeostasis similarly?

  AIDS (London, England) 20110327

• A HPLC-MS method for the simultaneous quantification of fourteen antiretroviral agents in peripheral blood mononuclear cell of HIV infected patients optimized using medium corpuscular volume evaluation.

  Journal of pharmaceutical and biomedical analysis 20110325

• Indolylarylsulfones as HIV-1 non-nucleoside reverse transcriptase inhibitors: new cyclic substituents at indole-2-carboxamide.

  Journal of medicinal chemistry 20110324

• Detection of low-level K65R variants in nucleoside reverse transcriptase inhibitor-naive chronic and acute HIV-1 subtype C infections.

  The Journal of infectious diseases 20110315

• Antiviral activity of seed extract from Citrus bergamia towards human retroviruses.

  Bioorganic & medicinal chemistry 20110315

• Cumulative exposure to cell-free HIV in breast milk, rather than feeding pattern per se, identifies postnatally infected infants.

  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20110315

• Virologic failure and second-line antiretroviral therapy in children in South Africa--the IeDEA Southern Africa collaboration.

  Journal of acquired immune deficiency syndromes (1999) 20110301

• Birth defects among a cohort of infants born to HIV-infected women on antiretroviral medication.

  Journal of perinatal medicine 20110301

• CD4+ cell count and risk for antiretroviral drug resistance among women using peripartum nevirapine for perinatal HIV prevention.

  BJOG : an international journal of obstetrics and gynaecology 20110301

• Impact of malaria at the end of pregnancy on infant mortality and morbidity.

  The Journal of infectious diseases 20110301

• Triple antiretroviral compared with zidovudine and single-dose nevirapine prophylaxis during pregnancy and breastfeeding for prevention of mother-to-child transmission of HIV-1 (Kesho Bora study): a randomised controlled trial.

  The Lancet. Infectious diseases 20110301

• Automatic nevirapine concentration interpretation system using support vector regression.

  Computer methods and programs in biomedicine 20110301

• Effectiveness of a PMTCT programme in rural Western Kenya.

  AIDS care 20110301

• A randomized controlled trial comparing the effects of counseling and alarm device on HAART adherence and virologic outcomes.

  PLoS medicine 20110301

• Triple-antiretroviral prophylaxis to prevent mother-to-child HIV transmission through breastfeeding--the Kisumu Breastfeeding Study, Kenya: a clinical trial.

  PLoS medicine 20110301

• HIV-1 drug resistance emergence among breastfeeding infants born to HIV-infected mothers during a single-arm trial of triple-antiretroviral prophylaxis for prevention of mother-to-child transmission: a secondary analysis.

  PLoS medicine 20110301

• Hepatotoxicity from first line antiretroviral therapy: an experience from a resource limited setting.

  African health sciences 20110301

• Hepatitis B and C Viruses Infections and Their Association with Human Immunodeficiency Virus: A Cross-Sectional Study among Blood Donors in Ethiopia.

  Ethiopian journal of health sciences 20110301

• Development and validation of a normal-phase HPTLC method for the simultaneous analysis of lamivudine, stavudine and nevirapine in fixed-dose combination tablets.

  Journal of pharmaceutical and biomedical analysis 20110220

• First-line antiretroviral therapy after single-dose nevirapine exposure in South Africa: a cost-effectiveness analysis of the OCTANE trial.

  AIDS (London, England) 20110220

• Marked reduction in prevalence of malaria parasitemia and anemia in HIV-infected pregnant women taking cotrimoxazole with or without sulfadoxine-pyrimethamine intermittent preventive therapy during pregnancy in Malawi.

  The Journal of infectious diseases 20110215

• Dyslipidemia among HIV-infected Patients with tuberculosis taking once-daily nonnucleoside reverse-transcriptase inhibitor-based antiretroviral therapy in India.

  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20110215

• Induction therapy with protease-inhibitors modifies the effect of nevirapine resistance on virologic response to nevirapine-based HAART in children.

  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20110215

• Identification of a novel scaffold for allosteric inhibition of wild type and drug resistant HIV-1 reverse transcriptase by fragment library screening.

  Journal of medicinal chemistry 20110210

• Theoretical studies on the molecular basis of HIV-1RT/NNRTIs interactions.

  Journal of enzyme inhibition and medicinal chemistry 20110201

• Standard measures are inadequate to monitor pediatric adherence in a resource-limited setting.

  AIDS and behavior 20110201

• Pregnancy outcomes in women exposed to efavirenz and nevirapine: an appraisal of the IeDEA West Africa and ANRS Databases, Abidjan, Côte d'Ivoire.

  Journal of acquired immune deficiency syndromes (1999) 20110201

• Long-term effectiveness and safety of didanosine combined with lamivudine and efavirenz or nevirapine in antiretroviral-naive patients: a 9-year cohort study in Senegal.

  Tropical medicine & international health : TM & IH 20110201

• Distribution of HLA-B alleles in a Ugandan HIV-infected adult population: NORA pharmacogenetic substudy of DART.

  Tropical medicine & international health : TM & IH 20110201

• HIV-1 drug resistance testing from dried blood spots collected in rural Tanzania using the ViroSeq HIV-1 Genotyping System.

  The Journal of antimicrobial chemotherapy 20110201

• Adherence to HIV therapeutic drug monitoring guidelines in The Netherlands.

  Therapeutic drug monitoring 20110201

• Maternal tuberculosis: a risk factor for mother-to-child transmission of human immunodeficiency virus.

  The Journal of infectious diseases 20110201

• Lack of effect from a previous single dose of nevirapine on virologic and immunologic responses after 6 months of antiretroviral regimens containing either efavirenz or lopinavir-ritonavir.

  Pharmacotherapy 20110201

• Novel HIV-1 recombinant forms in antenatal cohort, Montreal, Quebec, Canada.

  Emerging infectious diseases 20110201

• Innate sensing of HIV-infected cells.

  PLoS pathogens 20110201

• Nevirapine induced Stevens-Johnson syndrome in an HIV infected patient.

  Indian journal of pharmacology 20110201

• [Mass screening for hypothyroidism in a cohort of HIV infected patients in a Bogotá hospital, Colombia].

  Revista chilena de infectologia : organo oficial de la Sociedad Chilena de Infectologia 20110201

• Clinical profile of HIV/AIDS-infected patients admitted to a new specialist unit in Dhaka, Bangladesh--a low-prevalence country for HIV.

  Journal of health, population, and nutrition 20110201

• A bird's eye view of PMTCT coverage at two regional hospitals and their referral clinics in a resource-limited setting.

  South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde 20110201

• From Clinical Presentation to the Outcome: the Natural History of PML in a Portuguese Population of HIV Infected Patients.

  Journal of clinical medicine research 20110201

• Higher efficacy of nevirapine than efavirenz to achieve HIV-1 plasma viral load below 1 copy/ml.

  AIDS (London, England) 20110128

• Rational approaches for the design of effective human immunodeficiency virus type 1 nonnucleoside reverse transcriptase inhibitors.

  Journal of chemical information and modeling 20110124

• Synthesis and biological evaluation of novel dihydro-aryl/alkylsulfanyl-cyclohexylmethyl-oxopyrimidines (S-DACOs) as high active anti-HIV agents.

  Bioorganic & medicinal chemistry letters 20110115

• Anti-HIV drugs nevirapine and efavirenz affect anxiety-related behavior and cognitive performance in mice.

  Neurotoxicity research 20110101

• Safety and effectiveness of antiretroviral drugs during pregnancy, delivery and breastfeeding for prevention of mother-to-child transmission of HIV-1: the Kesho Bora Multicentre Collaborative Study rationale, design, and implementation challenges.

  Contemporary clinical trials 20110101

• Stavudine toxicity in women is the main reason for treatment change in a 3-year prospective cohort of adult patients started on first-line antiretroviral treatment in Uganda.

  Journal of acquired immune deficiency syndromes (1999) 20110101

• Determination of the antiretroviral drug nevirapine in diluted alkaline electrolyte by adsorptive stripping voltammetry at the mercury film electrode.

  Combinatorial chemistry & high throughput screening 20110101

• Nevirapine pharmacokinetics when initiated at 200 mg or 400 mg daily in HIV-1 and tuberculosis co-infected Ugandan adults on rifampicin.

  The Journal of antimicrobial chemotherapy 20110101

• [Rate of genotypic mutations and resistance to antiretroviral drugs in a general hospital].

  Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria 20110101

• The assessment of metabolic syndrome in UK patients with HIV using two different definitions: CREATE 2 study.

  Current medical research and opinion 20110101

• Novel isatinyl thiosemicarbazones derivatives as potential molecule to combat HIV-TB co-infection.

  European journal of medicinal chemistry 20110101

• The impact of maternal highly active antiretroviral therapy and short-course combination antiretrovirals for prevention of mother-to-child transmission on early infant infection rates at the Mulago national referral hospital in Kampala, Uganda, January 2007 to May 2009.

  Journal of acquired immune deficiency syndromes (1999) 20110101

• The toxicogenetics of antiretroviral therapy: the evil inside.

  Current medicinal chemistry 20110101

• A combined sequence-structure approach for predicting resistance to the non-nucleoside HIV-1 reverse transcriptase inhibitor Nevirapine.

  Biophysical chemistry 20110101

• Postnatal infant HIV prophylaxis: a survey of U.S. practice.

  AIDS patient care and STDs 20110101

• Long-term safety from the raltegravir clinical development program.

  Current HIV research 20110101

• Project Masihambisane: a cluster randomised controlled trial with peer mentors to improve outcomes for pregnant mothers living with HIV.

  Trials 20110101

• Human Immunodeficiency Virus (HIV) types Western blot (WB) band profiles as potential surrogate markers of HIV disease progression and predictors of vertical transmission in a cohort of infected but antiretroviral therapy naïve pregnant women in Harare, Zimbabwe.

  BMC infectious diseases 20110101

• Prediction of cyclin-dependent kinase 2 inhibitor potency using the fragment molecular orbital method.

  Journal of cheminformatics 20110101

• Timing of antiretroviral therapy for HIV in the setting of TB treatment.

  Clinical & developmental immunology 20110101

• Expenditures for the care of HIV-infected patients in rural areas in China's antiretroviral therapy programs.

  BMC medicine 20110101

• An antiretroviral/zinc combination gel provides 24 hours of complete protection against vaginal SHIV infection in macaques.

  PloS one 20110101

• Taking multiple infections of cells and recombination into account leads to small within-host effective-population-size estimates of HIV-1.

  PloS one 20110101

• Quality of data collection in a large HIV observational clinic database in sub-Saharan Africa: implications for clinical research and audit of care.

  Journal of the International AIDS Society 20110101

• Culture conversion among HIV co-infected multidrug-resistant tuberculosis patients in Tugela Ferry, South Africa.

  PloS one 20110101

• New insights into HIV-1-primary skin disorders.

  Journal of the International AIDS Society 20110101

• Clinical manifestations and outcome in HIV-infected young infants presenting with acute illness in Durban, South Africa.

  Annals of tropical paediatrics 20110101

• Perinatal tuberculosis: two unusual cases.

  Annals of tropical paediatrics 20110101

• Long-term CD4+ T-cell count evolution after switching from regimens including HIV nucleoside reverse transcriptase inhibitors (NRTI) plus protease inhibitors to regimens containing NRTI plus non-NRTI or only NRTI.

  BMC infectious diseases 20110101

• A comparison of the MOS-HIV and SF-12v2 for measuring health-related quality of life of men and women living with HIV/AIDS.

  AIDS research and therapy 20110101

• Clinical use of CCR5 inhibitors in HIV and beyond.

  Journal of translational medicine 20110101

• Intensified treatment with high dose rifampicin and levofloxacin compared to standard treatment for adult patients with tuberculous meningitis (TBM-IT): protocol for a randomized controlled trial.

  Trials 20110101

• Adherence and virologic suppression during the first 24 weeks on antiretroviral therapy among women in Johannesburg, South Africa - a prospective cohort study.

  BMC public health 20110101

• A biregional survey and review of first-line treatment failure and second-line paediatric antiretroviral access and use in Asia and southern Africa.

  Journal of the International AIDS Society 20110101

• The cost-effectiveness of preventing mother-to-child transmission of HIV in low- and middle-income countries: systematic review.

  Cost effectiveness and resource allocation : C/E 20110101

• Minor drug-resistant HIV type-1 variants in breast milk and plasma of HIV type-1-infected Ugandan women after nevirapine single-dose prophylaxis.

  Antiviral therapy 20110101

• Multi-nucleoside reverse transcriptase inhibitor resistant HIV type-1 in a patient from Sierra Leone failing stavudine, lamivudine and nevirapine.

  Antiviral therapy 20110101

• Control of viral replication after cessation of HAART.

  AIDS research and therapy 20110101

• Development of Buffalo Hump in the course of antiretroviral therapy including raltegravir and unboosted atazanavir: a case report and review of the literature.

  Journal of medical case reports 20110101

• HIV-1 infected patients with suppressed plasma viremia on treatment have pro-inflammatory HDL.

  Lipids in health and disease 20110101

• KIR-HLA and maternal-infant HIV-1 transmission in sub-Saharan Africa.

  PloS one 20110101

• Management of HIV-1 associated hepatitis in patients with acquired immunodeficiency syndrome: role of a successful control of viral replication.

  AIDS research and therapy 20110101

• Weight and height z-scores improve after initiating ART among HIV-infected children in rural Zambia: a cohort study.

  BMC infectious diseases 20110101

• Timely HAART initiation may pave the way for a better viral control.

  BMC infectious diseases 20110101

• Efavirenz-based combination antiretroviral therapy after peripartum single-dose nevirapine.

  International journal of STD & AIDS 20110101

• Neurobehavioral effects in HIV-positive individuals receiving highly active antiretroviral therapy (HAART) in Gaborone, Botswana.

  PloS one 20110101

• Health system weaknesses constrain access to PMTCT and maternal HIV services in South Africa: a qualitative enquiry.

  AIDS research and therapy 20110101

• Prevalence of potential drug-drug interactions involving antiretroviral drugs in a large Kenyan cohort.

  PloS one 20110101

• Correcting for mortality among patients lost to follow up on antiretroviral therapy in South Africa: a cohort analysis.

  PloS one 20110101

• Antiretroviral therapy outcomes in HIV-infected children after adjusting protease inhibitor dosing during tuberculosis treatment.

  PloS one 20110101

• Time for gender mainstreaming in editorial policies.

  Journal of the International AIDS Society 20110101

• Is 'Opt-Out HIV Testing' a real option among pregnant women in rural districts in Kenya?

  BMC public health 20110101

• Incidence and predictors of immune reconstitution inflammatory syndrome in a rural area of Mozambique.

  PloS one 20110101

• Drug efficacy by direct and adjusted indirect comparison to placebo: An illustration by Mycobacterium avium complex prophylaxis in HIV.

  AIDS research and therapy 20110101

• 'Dynamic range' of inferred phenotypic HIV drug resistance values in clinical practice.

  PloS one 20110101

• Adherence to drug-refill is a useful early warning indicator of virologic and immunologic failure among HIV patients on first-line ART in South Africa.

  PloS one 20110101

• Research translation to inform national health policies: learning from multiple perspectives in Uganda.

  BMC international health and human rights 20110101

• A grander challenge: the case of how Makerere University College of Health Sciences (MakCHS) contributes to health outcomes in Africa.

  BMC international health and human rights 20110101

• Highly active antiretroviral therapy: Does it Sound toxic?

  Journal of pharmacy & bioallied sciences 20110101

• Nutritional status and HIV in rural South African children.

  BMC pediatrics 20110101

• High efficacy of lopinavir/r-based second-line antiretroviral treatment after 24 months of follow up at ESTHER/Calmette Hospital in Phnom Penh, Cambodia.

  Journal of the International AIDS Society 20110101

• Driving a decade of change: HIV/AIDS, patents and access to medicines for all.

  Journal of the International AIDS Society 20110101

• Machine learning on normalized protein sequences.

  BMC research notes 20110101

• HIV quasispecies dynamics during pro-active treatment switching: impact on multi-drug resistance and resistance archiving in latent reservoirs.

  PloS one 20110101

• Comparison of intima-media thickness and ophthalmic artery resistance index for assessing subclinical atherosclerosis in HIV-1-infected patients.

  Cardiovascular ultrasound 20110101

• Cost effectiveness of a pharmacy-only refill program in a large urban HIV/AIDS clinic in Uganda.

  PloS one 20110101

• Nutrition and inflammation serum biomarkers are associated with 12-week mortality among malnourished adults initiating antiretroviral therapy in Zambia.

  Journal of the International AIDS Society 20110101

• Results of antiretroviral treatment interruption and intensification in advanced multi-drug resistant HIV infection from the OPTIMA trial.

  PloS one 20110101

• Four-year treatment outcomes of adult patients enrolled in Mozambique's rapidly expanding antiretroviral therapy program.

  PloS one 20110101

• Pharmacology and metabolism of anidulafungin, caspofungin and micafungin in the treatment of invasive candidosis: review of the literature.

  European journal of medical research 20110101

• Tinea incognito Caused by Microsporum gypseum in a Patient with Advanced HIV Infection: A Case Report.

  Case reports in dermatology 20110101

• HIV Suppression among Patients on Treatment in Vietnam: A Review of HIV Viral Load Testing in a Public Urban Clinic in Ho Chi Minh City.

  AIDS research and treatment 20110101

• Monitoring Antiretroviral Therapy in HIV-Infected Children in Resource-Limited Countries: A Tale of Two Epidemics.

  AIDS research and treatment 20110101

• Long-Term Outcome of an HIV-Treatment Programme in Rural Africa: Viral Suppression despite Early Mortality.

  AIDS research and treatment 20110101

• Antiretroviral Therapy for HIV-2 Infection: Recommendations for Management in Low-Resource Settings.

  AIDS research and treatment 20110101

• Outcomes of Universal Access to Antiretroviral Therapy (ART) in Georgia.

  AIDS research and treatment 20110101

• Utilization patterns and projected demand of antiretroviral drugs in low- and middle-income countries.

  AIDS research and treatment 20110101

• A risk-factor guided approach to reducing lactic acidosis and hyperlactatemia in patients on antiretroviral therapy.

  PloS one 20110101

• Improved antiretroviral treatment outcome in a rural African setting is associated with cART initiation at higher CD4 cell counts and better general health condition.

  BMC infectious diseases 20110101

• Identification of new, emerging HIV-1 unique recombinant forms and drug resistant viruses circulating in Cameroon.

  Virology journal 20110101

• Excellent adherence to antiretrovirals in HIV+ Zambian children is compromised by disrupted routine, HIV nondisclosure, and paradoxical income effects.

  PloS one 20110101

• Association of HIV diversity and survival in HIV-infected Ugandan infants.

  PloS one 20110101

• HIV-Associated Tuberculosis in the Newborn and Young Infant.

  International journal of pediatrics 20110101

• Evaluation of WHO Criteria for Viral Failure in Patients on Antiretroviral Treatment in Resource-Limited Settings.

  AIDS research and treatment 20110101

• Effect of reverse transcriptase inhibitors on LINE-1 and Ty1 reverse transcriptase activities and on LINE-1 retrotransposition.

  BMC biochemistry 20110101

• HIV-infected children in rural Zambia achieve good immunologic and virologic outcomes two years after initiating antiretroviral therapy.

  PloS one 20110101

• Nevirapine versus atazanavir/ritonavir, each combined with tenofovir disoproxil fumarate/emtricitabine, in antiretroviral-naive HIV-1 patients: the ARTEN Trial.

  Antiviral therapy 20110101

• Targeted maximum likelihood estimation of effect modification parameters in survival analysis.

  The international journal of biostatistics 20110101

• Factors influencing retention in care after starting antiretroviral therapy in a rural South African programme.

  PloS one 20110101

• Survival of HIV-infected adolescents on antiretroviral therapy in Uganda: findings from a nationally representative cohort in Uganda.

  PloS one 20110101

• [Efficacy and safety of the substitution of zidovudine by nevirapine in treatments based on three nucleoside analogue reverse transcriptase inhibitors in HIV-1 infected patients].

  Enfermedades infecciosas y microbiologia clinica 20110101

• The evolution of HIV-1 reverse transcriptase in route to acquisition of Q151M multi-drug resistance is complex and involves mutations in multiple domains.

  Retrovirology 20110101

• CD4+ T cells spontaneously producing human immunodeficiency virus type I in breast milk from women with or without antiretroviral drugs.

  Retrovirology 20110101

• Inhibitory activity of 9-phenylcyclohepta[d]pyrimidinedione derivatives against different strains of HIV-1 as non-nucleoside reverse transcriptase inhibitors.

  Virology journal 20110101

• Retrospective analysis of stevens-johnson syndrome and toxic epidermal necrolysis over a period of 10 years.

  Indian journal of dermatology 20110101

• Knowledge and perceptions of couples' voluntary counseling and testing in urban Rwanda and Zambia: a cross-sectional household survey.

  PloS one 20110101

• The net cost of incorporating resistance testing into HIV/AIDS treatment in South Africa: a Markov model with primary data.

  Journal of the International AIDS Society 20110101

• Barriers to initiation of antiretrovirals during antituberculosis therapy in Africa.

  PloS one 20110101

• Latent Membrane Protein 1 as a molecular adjuvant for single-cycle lentiviral vaccines.

  Retrovirology 20110101

• Predicted susceptibility of etravirine in HIV patients experiencing virological failure secondary to non-nucleoside reverse transcriptase inhibitor resistance in Argentina.

  Enfermedades infecciosas y microbiologia clinica 20110101

• Early infant HIV-1 diagnosis programs in resource-limited settings: opportunities for improved outcomes and more cost-effective interventions.

  BMC medicine 20110101

• Feasibility and safety of setting up a donor breastmilk bank in a neonatal prem unit in a resource limited setting: An observational, longitudinal cohort study.

  BMC public health 20110101

• Added value of deep sequencing relative to population sequencing in heavily pre-treated HIV-1-infected subjects.

  PloS one 20110101

• Safety and tolerability of antiretrovirals during pregnancy.

  Infectious diseases in obstetrics and gynecology 20110101

• Incidence and risk factors of serious adverse events during antituberculous treatment in Rwanda: a prospective cohort study.

  PloS one 20110101

• Asking the right questions: developing evidence-based strategies for treating HIV in women and children.

  BMC public health 20110101

• Detection of HIV drug resistance mutations in pregnant women receiving single dose Nevirapine in south India.

  Indian journal of pathology & microbiology 20110101

• Presentation and outcome of tuberculous meningitis in a high HIV prevalence setting.

  PloS one 20110101

• A synthetic HIV-1 subtype C backbone generates comparable PR and RT resistance profiles to a subtype B backbone in a recombinant virus assay.

  PloS one 20110101

• Contraception in HIV-positive female adolescents.

  AIDS research and therapy 20110101

• Personalizing carbamazepine therapy.

  Genome medicine 20110101

• Uptake and outcomes of a prevention-of mother-to-child transmission (PMTCT) program in Zomba district, Malawi.

  BMC public health 20110101

• HIV and HAART-Associated Dyslipidemia.

  The open cardiovascular medicine journal 20110101

• Drug-induced Stevens-Johnson syndrome (SJS), toxic epidermal necrolysis (TEN), and SJS-TEN overlap: a multicentric retrospective study.

  Journal of postgraduate medicine 20110101

• WHO 2010 guidelines for prevention of mother-to-child HIV transmission in Zimbabwe: modeling clinical outcomes in infants and mothers.

  PloS one 20110101

• Emergence and persistence of minor drug-resistant HIV-1 variants in Ugandan women after nevirapine single-dose prophylaxis.

  PloS one 20110101

• A template-dependent dislocation mechanism potentiates K65R reverse transcriptase mutation development in subtype C variants of HIV-1.

  PloS one 20110101

• Coreceptor and cytokine concentrations may not explain differences in disease progression observed in HIV-1 clade A and D infected Ugandans.

  PloS one 20110101

• When masculinity interferes with women's treatment of HIV infection: a qualitative study about adherence to antiretroviral therapy in Zimbabwe.

  Journal of the International AIDS Society 20110101

• High prevalence of HIV-1 drug resistance among patients on first-line antiretroviral treatment in Lomé, Togo.

  Journal of the International AIDS Society 20110101

• Clinical predictors of immune reconstitution following combination antiretroviral therapy in patients from the Australian HIV Observational Database.

  PloS one 20110101

• Investing in the future: lessons learnt from communicating the results of HSV/ HIV intervention trials in South Africa.

  Health research policy and systems 20110101

• Retention in an antiretroviral therapy programme during an era of decreasing drug cost in Limbe, Cameroon.

  Journal of the International AIDS Society 20110101

• Blocking premature reverse transcription fails to rescue the HIV-1 nucleocapsid-mutant replication defect.

  Retrovirology 20110101

• Use of non-nucleoside analogues together with rifampin in HIV patients with tuberculosis.

  HIV clinical trials 20110101

• Rapid turnover of 2-LTR HIV-1 DNA during early stage of highly active antiretroviral therapy.

  PloS one 20110101

• Analyzing media coverage of the global fund diseases compared with lower funded diseases (childhood pneumonia, diarrhea and measles).

  PloS one 20110101

• Adherence to combination prophylaxis for prevention of mother-to-child-transmission of HIV in Tanzania.

  PloS one 20110101

• Surveillance of transmitted antiretroviral drug resistance among HIV-1 infected women attending antenatal clinics in Chitungwiza, Zimbabwe.

  PloS one 20110101

• Early mortality and AIDS progression despite high initial antiretroviral therapy adherence and virologic suppression in Botswana.

  PloS one 20110101

• Critical appraisal of irrational drug combinations: A call for awareness in undergraduate medical students.

  Journal of pharmacology & pharmacotherapeutics 20110101

• Rebound of residual plasma viremia after initial decrease following addition of intravenous immunoglobulin to effective antiretroviral treatment of HIV.

  AIDS research and therapy 20110101

• Immune reconstitution and inflammatory syndrome due to disseminated tuberculosis in a case of human immunodeficiency virus 2 infection.

  Indian journal of pharmacology 20110101

• Virological breakthrough: a risk factor for loss to followup in a large community-based cohort on antiretroviral therapy.

  AIDS research and treatment 20110101

• Is a HIV vaccine a viable option and at what price? An economic evaluation of adding HIV vaccination into existing prevention programs in Thailand.

  BMC public health 20110101

• Oral lesions associated with nevirapine-related Stevens Johnson syndrome: A report of four cases.

  Journal of oral and maxillofacial pathology : JOMFP 20110101

• Tuberculosis: current situation, challenges and overview of its control programs in India.

  Journal of global infectious diseases 20110101

• Minor HIV-1 variants with the K103N resistance mutation during intermittent efavirenz-containing antiretroviral therapy and virological failure.

  PloS one 20110101

• Time to and Predictors of CD4+ T-Lymphocytes Recovery in HIV-Infected Children Initiating Highly Active Antiretroviral Therapy in Ghana.

  AIDS research and treatment 20110101

• Antiretroviral treatment reverses HIV-associated anemia in rural Tanzania.

  BMC infectious diseases 20110101

• Association of age with mortality and virological and immunological response to antiretroviral therapy in rural South African adults.

  PloS one 20110101

• Realities and Challenges of a Five Year Follow Up of Mother and Child Pairs on a PMTCT Program in Zimbabwe.

  The open AIDS journal 20110101

• Non-cirrhotic portal hypertension in human immunodeficiency virus-infected patients: a new challenge in antiretroviral therapy era.

  The open AIDS journal 20110101

• High rates of all-cause and gastroenteritis-related hospitalization morbidity and mortality among HIV-exposed Indian infants.

  BMC infectious diseases 20110101

• HLA involvement in nevirapine-induced dermatological reaction in antiretroviral-treated HIV-1 patients.

  Journal of pharmacology & pharmacotherapeutics 20110101

• Predictors of Weight Change in Male HIV-Positive Injection Drug Users Initiating Antiretroviral Therapy in Hanoi, Vietnam.

  AIDS research and treatment 20110101

• Immune reconstitution inflammatory syndrome associated with acquired immunodeficiency syndrome-related gastrointestinal limited Kaposi's sarcoma presenting as acute intestinal obstruction: a case report.

  Journal of medical case reports 20110101

• Immunovirological response to combined antiretroviral therapy and drug resistance patterns in children: 1- and 2-year outcomes in rural Uganda.

  BMC pediatrics 20110101

• HIV-1 mutational pathways under multidrug therapy.

  AIDS research and therapy 20110101

• Pre-exposure prophylaxis of HIV.

  Indian journal of sexually transmitted diseases and AIDS 20110101

• Two years CD4 count follow-up of rural patients on antiretroviral therapy: A study in Government Hospital.

  Indian journal of sexually transmitted diseases and AIDS 20110101

• Measuring enzymatic HIV-1 susceptibility to two reverse transcriptase inhibitors as a rapid and simple approach to HIV-1 drug-resistance testing.

  PloS one 20110101

• Impact of small body weight on tenofovir-associated renal dysfunction in HIV-infected patients: a retrospective cohort study of Japanese patients.

  PloS one 20110101

• Outcome of HIV-exposed uninfected children undergoing surgery.

  BMC pediatrics 20110101

• Alternative antiretroviral monitoring strategies for HIV-infected patients in east Africa: opportunities to save more lives?

  Journal of the International AIDS Society 20110101

• Scaling up antiretroviral therapy in Uganda: using supply chain management to appraise health systems strengthening.

  Globalization and health 20110101

• Addressing the fear and consequences of stigmatization - a necessary step towards making HAART accessible to women in Tanzania: a qualitative study.

  AIDS research and therapy 20110101

• Induction maintenance concept for HAART as initial treatment in HIV infected infants.

  European journal of medical research 20110101

• The lopinavir/ritonavir-associated rise in lipids is not related to lopinavir or ritonavir plasma concentration.

  Antiviral therapy 20110101

• Efficacy and safety of nevirapine extended-release once daily versus nevirapine immediate-release twice-daily in treatment-naive HIV-1-infected patients.

  Antiviral therapy 20110101

• [Evidence-based therapeutic drug monitoring for nevirapine].

  Therapie 20110101

• [Modeling of antiretroviral response from taxonomy of CD4 cells count trajectories in profound immunodeficiency setting].

  Therapie 20110101

• Anemia and iron homeostasis in a cohort of HIV-infected patients in Indonesia.

  BMC infectious diseases 20110101

• Pregnancy and virologic response to antiretroviral therapy in South Africa.

  PloS one 20110101

• Birth outcomes in South African women receiving highly active antiretroviral therapy: a retrospective observational study.

  Journal of the International AIDS Society 20110101

• Treatment simplification in HIV-infected adults as a strategy to prevent toxicity, improve adherence, quality of life and decrease healthcare costs.

  Patient preference and adherence 20110101

• HIV pre-exposure prophylaxis (PrEP)--a quantitative ethics appraisal.

  PloS one 20110101

• Prevention of perinatal HIV transmission: the Perinatal HIV Hotline perspective.

  Topics in antiviral medicine 20110101

• Gender difference in 2-year mortality and immunological response to ART in an HIV-infected Chinese population, 2006-2008.

  PloS one 20110101

• A higher correlation of HCV core antigen with CD4+ T cell counts compared with HCV RNA in HCV/HIV-1 coinfected patients.

  PloS one 20110101

• Subunit-specific mutational analysis of residue N348 in HIV-1 reverse transcriptase.

  Retrovirology 20110101

• Nephrotoxicity of HAART.

  AIDS research and treatment 20110101

• HIV-Associated Venous Thromboembolism.

  Mediterranean journal of hematology and infectious diseases 20110101

• HIV drug resistance (HIVDR) in antiretroviral therapy-naïve patients in Tanzania not eligible for WHO threshold HIVDR survey is dramatically high.

  PloS one 20110101

• The magnitude and kinetics of the mucosal HIV-specific CD8+ T lymphocyte response and virus RNA load in breast milk.

  PloS one 20110101

• HIV, Hepatitis B, and Hepatitis C in Zambia.

  Journal of global infectious diseases 20110101

• Beneficial effects of physical activity in an HIV-infected woman with lipodystrophy: a case report.

  Journal of medical case reports 20110101

• Long-term virological, immunological and mortality outcomes in a cohort of HIV-infected female sex workers treated with highly active antiretroviral therapy in Africa.

  BMC public health 20110101

• A longitudinal study of stavudine-associated toxicities in a large cohort of South African HIV infected subjects.

  BMC infectious diseases 20110101

• ReishiMax, mushroom based dietary supplement, inhibits adipocyte differentiation, stimulates glucose uptake and activates AMPK.

  BMC complementary and alternative medicine 20110101

• Calculation of direct antiretroviral treatment costs and potential cost savings by using generics in the German HIV ClinSurv cohort.

  PloS one 20110101

• Developing quality indicators for the care of HIV-infected pregnant women in the Dutch Caribbean.

  AIDS research and therapy 20110101

• First-line antiretroviral therapy and dyslipidemia in people living with HIV-1 in Cameroon: a cross-sectional study.

  AIDS research and therapy 20110101

• Effect of using HIV and infant feeding counselling cards on the quality of counselling provided to HIV positive mothers: a cluster randomized controlled trial.

  International breastfeeding journal 20110101

• Evaluation of intra-host variants of the entire hepatitis B virus genome.

  PloS one 20110101

• Trends in the clinical characteristics of HIV-infected patients initiating antiretroviral therapy in Kenya, Uganda and Tanzania between 2002 and 2009.

  Journal of the International AIDS Society 20110101

• The first decade of antiretroviral therapy in Africa.

  Globalization and health 20110101

• Antiretroviral drug supply challenges in the era of scaling up ART in Malawi.

  Journal of the International AIDS Society 20110101

• Current treatment strategies, complications and considerations for the use of HIV antiretroviral therapy during pregnancy.

  AIDS reviews 20110101

• Early Infant Diagnosis: A New Tool of HIV Diagnosis in Children.

  Indian journal of community medicine : official publication of Indian Association of Preventive & Social Medicine 20110101

• Promoting male involvement to improve PMTCT uptake and reduce antenatal HIV infection: a cluster randomized controlled trial protocol.

  BMC public health 20110101

• HIV-free survival and morbidity among formula-fed infants in a prevention of mother-to-child transmission of HIV program in rural Haiti.

  AIDS research and therapy 20110101

• A win-win solution?: A critical analysis of tiered pricing to improve access to medicines in developing countries.

  Globalization and health 20110101

• Reverse transcriptase drug resistance mutations in HIV-1 subtype C infected patients on ART in Karonga District, Malawi.

  AIDS research and therapy 20110101

• High rates of adherence and treatment success in a public and public-private HIV clinic in India: potential benefits of standardized national care delivery systems.

  BMC health services research 20110101

• Current status of medication adherence and infant follow up in the prevention of mother to child HIV transmission programme in Addis Ababa: a cohort study.

  Journal of the International AIDS Society 20110101

• HAART induced adverse drug reactions: a retrospective analysis at a tertiary referral health care center in India.

  The International journal of risk & safety in medicine 20110101

• Immunological failure despite virological suppression in HIV seropositive individuals on antiretroviral therapy.

  Indian journal of sexually transmitted diseases and AIDS 20110101

• Diagnosis of HIV-1 infection in infants using dried blood spots in Tamil Nadu, South India.

  Indian journal of sexually transmitted diseases and AIDS 20110101

• Nephrotic proteinuria and renal involvement in HIV-infected children.

  Indian journal of sexually transmitted diseases and AIDS 20110101

• Glomerular dysfunction and associated risk factors over 4-5 years following antiretroviral therapy initiation in Africa.

  Antiviral therapy 20110101

• Etravirine and rilpivirine resistance in HIV-1 subtype CRF01_AE-infected adults failing non-nucleoside reverse transcriptase inhibitor-based regimens.

  Antiviral therapy 20110101

• Resistance data in the ARTEN trial.

  Antiviral therapy 20110101

• Immunologic and virologic failure after first-line NNRTI-based antiretroviral therapy in Thai HIV-infected children.

  AIDS research and therapy 20110101

• Human immunodeficiency virus endocrinopathy.

  Indian journal of endocrinology and metabolism 20110101

• Anti-retroviral treatment outcomes among older adults in Zomba district, Malawi.

  PloS one 20110101

• An effectiveness study of an integrated, community-based package for maternal, newborn, child and HIV care in South Africa: study protocol for a randomized controlled trial.

  Trials 20110101

• Increase of transmitted drug resistance among HIV-infected sub-Saharan Africans residing in Spain in contrast to the native population.

  PloS one 20110101

• A prospective study of vaginal trichomoniasis and HIV-1 shedding in women on antiretroviral therapy.

  BMC infectious diseases 20110101

• The antiretroviral efficacy of highly active antiretroviral therapy and plasma nevirapine concentrations in HIV-TB co-infected Indian patients receiving rifampicin based antituberculosis treatment.

  AIDS research and therapy 20110101

• Male gender predicts mortality in a large cohort of patients receiving antiretroviral therapy in Uganda.

  Journal of the International AIDS Society 20110101

• Molecular analysis of hepatitis B virus (HBV) in an HIV co-infected patient with reactivation of occult HBV infection following discontinuation of lamivudine-including antiretroviral therapy.

  BMC infectious diseases 20110101

• HIV and pregnancy: maternal and neonatal evolution.

  Medicina 20110101

• Complete Healing of a Giant Wart in a Severely Immune-Compromised Patient with HIV Infection Treated with Acupuncture.

  Case reports in dermatology 20110101

• Incidence and risk factors of antiretroviral treatment failure in treatment-naïve HIV-infected patients at Chiang Mai University Hospital, Thailand.

  AIDS research and therapy 20110101

• Nevirapine plasma concentrations are associated with virologic response and hepatotoxicity in Chinese patients with HIV infection.

  PloS one 20110101

• An autoimmune disease prevented by anti-retroviral drugs.

  Retrovirology 20110101

• Factors associated with elevated ALT in an international HIV/HBV co-infected cohort on long-term HAART.

  PloS one 20110101

• Optimal antiviral switching to minimize resistance risk in HIV therapy.

  PloS one 20110101

• Prevalence and factors associated with traditional herbal medicine use among patients on highly active antiretroviral therapy in Uganda.

  BMC public health 20110101

• Residual HIV-1 DNA Flap-independent nuclear import of cPPT/CTS double mutant viruses does not support spreading infection.

  Retrovirology 20110101

• Utility of routine viral load, CD4 cell count, and clinical monitoring among adults with HIV receiving antiretroviral therapy in Uganda: randomised trial.

  BMJ (Clinical research ed.) 20110101

• CD4 cell count and viral load monitoring in patients undergoing antiretroviral therapy in Uganda: cost effectiveness study.

  BMJ (Clinical research ed.) 20110101

• Effect of anemia on hepatotoxicity of HAART in HIV patients in Benin city.

  Nigerian medical journal : journal of the Nigeria Medical Association 20110101

• It is time to consider third-line options in antiretroviral-experienced paediatric patients?

  Journal of the International AIDS Society 20110101

• Undernutrition among HIV-positive children in Dar es Salaam, Tanzania: antiretroviral therapy alone is not enough.

  BMC public health 20110101

• Prevalence and predictors of kaposi sarcoma herpes virus seropositivity: a cross-sectional analysis of HIV-infected adults initiating ART in Johannesburg, South Africa.

  Infectious agents and cancer 20110101

• Intimate partner violence among women with HIV infection in rural Uganda: critical implications for policy and practice.

  BMC women's health 20110101

• Impact of comorbidities and drug therapy on development of renal impairment in a predominantly African American and Hispanic HIV clinic population.

  HIV/AIDS (Auckland, N.Z.) 20110101

• Antiretroviral therapy initiated soon after HIV diagnosis as standard care: potential to save lives?

  HIV/AIDS (Auckland, N.Z.) 20110101

• Safety, efficacy, and pharmacokinetics of rilpivirine: systematic review with an emphasis on resource-limited settings.

  HIV/AIDS (Auckland, N.Z.) 20110101

• Characteristics of foot fractures in HIV-infected patients previously treated with tenofovir versus non-tenofovir-containing highly active antiretroviral therapy.

  HIV/AIDS (Auckland, N.Z.) 20110101

• Growth hormone and tesamorelin in the management of HIV-associated lipodystrophy.

  HIV/AIDS (Auckland, N.Z.) 20110101

• Utility of clinical parameters to identify HIV infection in infants below ten weeks of age in South Africa: a prospective cohort study.

  BMC pediatrics 20110101

• National prevalence and trends of HIV transmitted drug resistance in Mexico.

  PloS one 20110101

• Using HIV transmission networks to investigate community effects in HIV prevention trials.

  PloS one 20110101

• Adherence to highly active antiretroviral treatment in HIV-infected Rwandan women.

  PloS one 20110101

• AtriplaR/anti-TB combination in TB/HIV patients. Drug in focus.

  BMC research notes 20110101

• Opportunistic infections in relation to antiretroviral status among AIDS patients from south India.

  Indian journal of medical microbiology 20110101

• HIV exposure and related newborn morbidity and mortality in the University Teaching Hospital of Yaoundé, Cameroon.

  The Pan African medical journal 20110101

• Design and development of nevirapine loaded surfactant free chitosan microemulsion.

  Acta poloniae pharmaceutica 20110101

• Mother-to-child transmission of human immunodeficiency virus in aten years period.

  Reproductive health 20110101

• Resistance patterns selected by nevirapine vs. efavirenz in HIV-infected patients failing first-line antiretroviral treatment: a bayesian analysis.

  PloS one 20110101

• Which compound to select in lead optimization? Prospectively validated proteochemometric models guide preclinical development.

  PloS one 20110101

• Optimization of a low cost and broadly sensitive genotyping assay for HIV-1 drug resistance surveillance and monitoring in resource-limited settings.

  PloS one 20110101

• Prolonged control of replication-competent dual- tropic human immunodeficiency virus-1 following cessation of highly active antiretroviral therapy.

  Retrovirology 20110101

• Nevirapine induced exfoliative dermatitis in an HIV-infected patient.

  Indian journal of pharmacology 20110101

• Under-two child mortality according to maternal HIV status in Rwanda: assessing outcomes within the National PMTCT Program.

  The Pan African medical journal 20110101

• Pharmacokinetics of antiretroviral drugs in anatomical sanctuary sites: the fetal compartment (placenta and amniotic fluid).

  Antiviral therapy 20110101

• Pharmacokinetics and safety of a new paediatric fixed-dose combination of zidovudine/lamivudine/nevirapine in HIV-infected children.

  Antiviral therapy 20110101

• Surveillance of antiretroviral drug resistance mutations in untreated young children living in the Central African Republic.

  Antiviral therapy 20110101

• Correlation between lamivudine plasma concentrations and patient self-reported adherence to antiretroviral treatment in experienced HIV patients.

  Therapeutics and clinical risk management 20110101

• Pharmacogenetic & pharmacokinetic biomarker for efavirenz based ARV and rifampicin based anti-TB drug induced liver injury in TB-HIV infected patients.

  PloS one 20110101

• Cost-effectiveness analysis of initial HIV treatment under Italian guidelines.

  ClinicoEconomics and outcomes research : CEOR 20110101

• Drug allergy.

  Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology 20110101

• Rate and determinants of treatment response to different antiretroviral combination strategies in subjects presenting at HIV-1 diagnosis with advanced disease.

  BMC infectious diseases 20110101

• Lornoxicam gastro retentive floating matrix tablets: Design and in vitro evaluation.

  Journal of advanced pharmaceutical technology & research 20110101

• [Maternal and neonatal drug resistance].

  Voprosy virusologii 20110101

• Applications of next-generation sequencing technologies to diagnostic virology.

  International journal of molecular sciences 20110101

• Intensification of antiretroviral therapy with a CCR5 antagonist in patients with chronic HIV-1 infection: effect on T cells latently infected.

  PloS one 20110101

• A workshop report on HIV mHealth synergy and strategy meeting to review emerging evidence-based mHealth interventions and develop a framework for scale-up of these interventions.

  The Pan African medical journal 20110101

• Randomized controlled trials of HIV/AIDS prevention and treatment in Africa: results from the Cochrane HIV/AIDS Specialized Register.

  PloS one 20110101

• Prevalence and impact of minority variant drug resistance mutations in primary HIV-1 infection.

  PloS one 20110101

• Emergence of HBV resistance to lamivudine (3TC) in HIV/HBV co-infected patients in The Gambia, West Africa.

  BMC research notes 20110101

• Uptake of prevention of mother to child transmission interventions in Kenya: health systems are more influential than stigma.

  Journal of the International AIDS Society 20110101

• Estimating loss to follow-up in HIV-infected patients on antiretroviral therapy: the effect of the competing risk of death in Zambia and Switzerland.

  PloS one 20110101

• Systematic drug repositioning based on clinical side-effects.

  PloS one 20110101

• Atypical presentation of visceral leishmaniasis in a HIV-positive patient from a nonendemic area.

  Journal of laboratory physicians 20110101

• Early mortality in adults initiating antiretroviral therapy (ART) in low- and middle-income countries (LMIC): a systematic review and meta-analysis.

  PloS one 20110101

• Studying PPTCT Services, Interventions, Coverage and Utilization in India.

  Journal of global infectious diseases 20110101

• Twice-daily versus once-daily antiretroviral therapy and coformulation strategies in HIV-infected adults: benefits, risks, or burden?

  Patient preference and adherence 20110101

• Lipodystrophy in HIV patients: its challenges and management approaches.

  HIV/AIDS (Auckland, N.Z.) 20110101

• Artemether-Lumefantrine Combination Therapy for Treatment of Uncomplicated Malaria: The Potential for Complex Interactions with Antiretroviral Drugs in HIV-Infected Individuals.

  Malaria research and treatment 20110101

• Dress syndrome with sepsis, acute respiratory distress syndrome and pneumomediastinum.

  Indian journal of dermatology 20110101

• Disseminated infections due to Immune Reconstitution Inflammatory Syndrome after highly active antiretroviral therapy--report of 3 cases from Nigeria.

  The Pan African medical journal 20110101

• Allergic diseases in the elderly.

  Clinical and translational allergy 20110101

• Intractable chronic vulval ulceration presenting as immune reconstitution inflammatory syndrome in a treatment-failure patient: a case observation.

  Case reports in obstetrics and gynecology 20110101

• Screening of Potential HIV-1 Inhibitors/Replication Blockers Using Secure Lentiviral in Vitro System.

  Acta naturae 20110101

• Simple, precise and accurate HPLC method of analysis for nevirapine suspension from human plasma.

  Indian journal of pharmaceutical sciences 20110101

• Effect of stavudine-based antiretroviral therapy on the severity of polyneuropathy in HIV/AIDS patients: a preliminary report from Zaria, Northern Nigeria.

  West African journal of medicine 20110101

• Patient counseling about herbal-drug interactions.

  African journal of traditional, complementary, and alternative medicines : AJTCAM 20110101

• Effects of maternal and infant co-infections, and of maternal immunisation, on the infant response to BCG and tetanus immunisation.

  Vaccine 20101216

• Evaluating patients for second-line antiretroviral therapy in India: the role of targeted viral load testing.

  Journal of acquired immune deficiency syndromes (1999) 20101215

• Antiretroviral treatment for HIV-infected infants exposed to nevirapine.

  JAMA 20101215

• Efavirenz or nevirapine in three-drug combination therapy with two nucleoside-reverse transcriptase inhibitors for initial treatment of HIV infection in antiretroviral-naïve individuals.

  The Cochrane database of systematic reviews 20101208

• The N348I mutation at the connection subdomain of HIV-1 reverse transcriptase decreases binding to nevirapine.

  The Journal of biological chemistry 20101203

• Real-time adherence monitoring for HIV antiretroviral therapy.

  AIDS and behavior 20101201

• Factors associated with abandonment of infants born to HIV-positive women: results from a Ukrainian birth cohort.

  AIDS care 20101201

• What will it take to achieve virtual elimination of mother-to-child transmission of HIV? An assessment of current progress and future needs.

  Sexually transmitted infections 20101201

• Under-5 mortality due to HIV: regional levels and 1990-2009 trends.

  Sexually transmitted infections 20101201

• Changing baseline characteristics among patients in the China National Free Antiretroviral Treatment Program, 2002-09.

  International journal of epidemiology 20101201

• Comparison of the Mechanisms of Drug Resistance among HIV, Hepatitis B, and Hepatitis C.

  Viruses 20101201

• HIV-2 goes global: an unaddressed issue in Indian anti-retroviral programmes.

  The Indian journal of medical research 20101201

• Characteristics, immunological response & treatment outcomes of HIV-2 compared with HIV-1 & dual infections (HIV 1/2) in Mumbai.

  The Indian journal of medical research 20101201

• Epidemiology of hepatitis C virus infection & liver disease among injection drug users (IDUs) in Chennai, India.

  The Indian journal of medical research 20101201

• Clinical features and serum biomarkers in HIV immune reconstitution inflammatory syndrome after cryptococcal meningitis: a prospective cohort study.

  PLoS medicine 20101201

• Relative bioavailability of two formulations of nevirapine 200-mg tablets in healthy Chinese male volunteers: a single-dose, randomized-sequence, open-label, two-way crossover study.

  Clinical therapeutics 20101201

• Study leads to revision in WHO guidelines for HIV women.

  AIDS policy & law 20101201

• Liver injury in HIV-1-infected patients receiving non-nucleosides reverse transcriptase inhibitors-based antiretroviral therapy.

  Chinese medical journal 20101201

• Extended antenatal antiretroviral use correlates with improved infant outcomes throughout the first year of life.

  AIDS (London, England) 20101127

• Adverse effects after HAART Initiation in resource-limited settings: a prospective study from Mysore, India.

  Journal of infection in developing countries 20101124

• Protein adducts as prospective biomarkers of nevirapine toxicity.

  Chemical research in toxicology 20101115

• Discovery and SAR of a series of 4,6-diamino-1,3,5-triazin-2-ol as novel non-nucleoside reverse transcriptase inhibitors of HIV-1.

  Bioorganic & medicinal chemistry letters 20101115

• Antiretroviral adherence and development of drug resistance are the strongest predictors of genital HIV-1 shedding among women initiating treatment.

  The Journal of infectious diseases 20101115

• Maternal or infant antiretroviral drugs to reduce HIV-1 transmission.

  The New England journal of medicine 20101111

• Risk factors of HIV vertical transmission in a cohort of women under a PMTCT program at three peri-urban clinics in a resource-poor setting.

  Journal of perinatology : official journal of the California Perinatal Association 20101101

• Suboptimal nevirapine steady-state pharmacokinetics during intrapartum compared with postpartum in HIV-1-seropositive Ugandan women.

  Journal of acquired immune deficiency syndromes (1999) 20101101

• Nevirapine-associated hepatotoxicity was not predicted by CD4 count ≥250 cells/μL among women in Zambia, Thailand and Kenya.

  HIV medicine 20101101

• Impact of hepatitis C and liver fibrosis on antiretroviral plasma drug concentrations in HIV-HCV co-infected patients: the HEPADOSE study.

  The Journal of antimicrobial chemotherapy 20101101

• Differential impact of the HIV-1 non-nucleoside reverse transcriptase inhibitor mutations K103N and M230L on viral replication and enzyme function.

  The Journal of antimicrobial chemotherapy 20101101

• Strategies for nevirapine initiation in HIV-infected children taking pediatric fixed-dose combination 'baby pills' in Zambia: a randomized controlled trial.

  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20101101

• Treatment outcomes of patients co-infected with HIV and tuberculosis who received a nevirapine-based antiretroviral regimen: a four-year prospective study.

  International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases 20101101

• Growth of infants born to HIV-infected women in South Africa according to maternal and infant characteristics.

  Tropical medicine & international health : TM & IH 20101101

• Emergence of drug resistant mutations after single dose nevirapine exposure in HIV-1 infected pregnant women in south India.

  The Indian journal of medical research 20101101

• Role of HIV Subtype Diversity in the Development of Resistance to Antiviral Drugs.

  Viruses 20101101

• Mechanistic interplay among the M184I HIV-1 reverse transcriptase mutant, the central polypurine tract, cellular dNTP concentrations and drug sensitivity.

  Virology 20101025

• Maternal and nenonatal tenofovir and emtricitabine to prevent vertical transmission of HIV-1: tolerance and resistance.

  AIDS (London, England) 20101023

• Acute porphyria precipitated by nevirapine.

  AIDS (London, England) 20101023

• Inhibition of HIV-1 by non-nucleoside reverse transcriptase inhibitors via an induced fit mechanism-Importance of slow dissociation and relaxation rates for antiviral efficacy.

  Biochemical pharmacology 20101015

• Safety, censoring, and intent-to-treat analysis: dangers to generalizability.

  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20101015

• Antiretroviral therapies in women after single-dose nevirapine exposure.

  The New England journal of medicine 20101014

• Antiretroviral treatment for children with peripartum nevirapine exposure.

  The New England journal of medicine 20101014

• Preventing mother-to-child transmission of HIV—protecting this generation and the next.

  The New England journal of medicine 20101014

• Tenofovir or zidovudine in three-drug combination therapy with one nucleoside reverse transcriptase inhibitor and one non-nucleoside reverse transcriptase inhibitor for initial treatment of HIV infection in antiretroviral-naïve individuals.

  The Cochrane database of systematic reviews 20101006

• Testing and interval estimation for two-sample survival comparisons with small sample sizes and unequal censoring.

  Biostatistics (Oxford, England) 20101001

• A chewable pediatric fixed-dose combination tablet of stavudine, lamivudine, and nevirapine: pharmacokinetics and safety compared with the individual liquid formulations in human immunodeficiency virus-infected children in Thailand.

  The Pediatric infectious disease journal 20101001

• Intensification of a failing regimen with zidovudine may cause sustained virologic suppression in the presence of resensitising mutations including K65R.

  The Journal of infection 20101001

• [Fate of children born to HIV positive mothers followed in the context of preventing mother-to-child transmission of HIV in Togo. Study of 1042 infants].

  Bulletin de la Societe de pathologie exotique (1990) 20101001

• CYP2B6 polymorphism and nonnucleoside reverse transcriptase inhibitor plasma concentrations in Chinese HIV-infected patients.

  Therapeutic drug monitoring 20101001

• Lersivirine, a nonnucleoside reverse transcriptase inhibitor with activity against drug-resistant human immunodeficiency virus type 1.

  Antimicrobial agents and chemotherapy 20101001

• Operational evaluation of a service for prevention of mother-to-child transmission of HIV in rural Uganda: barriers to uptake of single-dose nevirapine and the role of birth reporting.

  Tropical medicine & international health : TM & IH 20101001

• Maternal-fetal pharmacokinetics and dynamics of a single intrapartum dose of maraviroc in rhesus macaques.

  Antimicrobial agents and chemotherapy 20101001

• Population pharmacokinetic-pharmacogenetic study of nevirapine in HIV-infected Cambodian patients.

  Antimicrobial agents and chemotherapy 20101001

• Simultaneous determination of niacin and its metabolites--nicotinamide, nicotinuric acid and N-methyl-2-pyridone-5-carboxamide--in human plasma by LC-MS/MS and its application to a human pharmacokinetic study.

  Biomedical chromatography : BMC 20101001

• Recent FDA approvals and changes.

  AIDS patient care and STDs 20101001

• Indinavir resistance evolution in one human immunodeficiency virus type 1 infected patient revealed by single-genome amplification.

  Virologica Sinica 20101001

• Comparison of HPLC & spectrophotometric methods for estimation of antiretroviral drug content in pharmaceutical products.

  The Indian journal of medical research 20101001

• Reuse of nevirapine in exposed HIV-infected children after protease inhibitor-based viral suppression: a randomized controlled trial.

  JAMA 20100908

• HPLC-MS method for the quantification of nine anti-HIV drugs from dry plasma spot on glass filter and their long term stability in different conditions.

  Journal of pharmaceutical and biomedical analysis 20100905

• Simultaneous determination of lamivudine, stavudine and nevirapine in human plasma by LC-MS/MS and its application to pharmacokinetic study in clinic.

  Biomedical chromatography : BMC 20100901

• Prevalence of mutations and determinants of genotypic resistance to etravirine (TMC125) in a large Italian resistance database (ARCA).

  HIV medicine 20100901

• Abdominal tuberculosis: sonographic diagnosis and treatment response in HIV-positive adults in rural South Africa.

  International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases 20100901

• [Nevirapine and cardiovascular risk].

  Medecine et maladies infectieuses 20100901

• Prevention of mother to child transmission of HIV (PMTCT) programme in KwaZulu-Natal, South Africa: an evaluation of PMTCT implementation and integration into routine maternal, child and women's health services.

  Tropical medicine & international health : TM & IH 20100901

• Drug resistance is widespread among children who receive long-term antiretroviral treatment at a rural Tanzanian hospital.

  The Journal of antimicrobial chemotherapy 20100901

• Tricyclononene carboxamide derivatives as novel anti-HIV-1 agents.

  European journal of medicinal chemistry 20100901

• Ultrafast and high-throughput mass spectrometric assay for therapeutic drug monitoring of antiretroviral drugs in pediatric HIV-1 infection applying dried blood spots.

  Analytical and bioanalytical chemistry 20100901

• KI and WU polyomaviruses and CD4+ cell counts in HIV-1-infected patients, Italy.

  Emerging infectious diseases 20100901

• Solvated crystalline forms of nevirapine: thermoanalytical and spectroscopic studies.

  AAPS PharmSciTech 20100901

• [Genetic barrier to antiretroviral drug-resistance. Focus on raltegravir, the first integrase inhibitor].

  Medecine et maladies infectieuses 20100901

• Outcomes and challenges of scaling up comprehensive PMTCT services in rural Swaziland, Southern Africa.

  AIDS care 20100901

• [Nevirapine related hepatotoxicity: the prevalence and risk factors in a cohort of ART naive Han Chinese with AIDS].

  Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology 20100901

• 'They call our children 'Nevirapine babies?' ': A qualitative study about exclusive breastfeeding among HIV positive mothers in Malawi.

  African journal of reproductive health 20100901

• N348I in HIV-1 reverse transcriptase can counteract the nevirapine-mediated bias toward RNase H cleavage during plus-strand initiation.

  The Journal of biological chemistry 20100827

• Anti-HIV and antiplasmodial activity of original flavonoid derivatives.

  Bioorganic & medicinal chemistry 20100815

• Addition of 7 days of zidovudine plus lamivudine to peripartum single-dose nevirapine effectively reduces nevirapine resistance postpartum in HIV-infected mothers in Malawi.

  Journal of acquired immune deficiency syndromes (1999) 20100815

• Predicting virologic failure among HIV-1-infected children receiving antiretroviral therapy in Tanzania: a cross-sectional study.

  Journal of acquired immune deficiency syndromes (1999) 20100801

• Associations with virologic treatment failure in adults on antiretroviral therapy in South Africa.

  Journal of acquired immune deficiency syndromes (1999) 20100801

• A less sensitive detector does not necessarily result in a less sensitive method: fast quantification of 13 antiretroviral analytes in plasma with liquid chromatography coupled with tandem mass spectrometry.

  Clinical chemistry and laboratory medicine 20100801

• Drug resistance in human immunodeficiency virus type-1 infected Zambian children using adult fixed dose combination stavudine, lamivudine, and nevirapine.

  The Pediatric infectious disease journal 20100801

• Reducing pediatric HIV infection: estimating mother-to-child transmission rates in a program setting in Zambia.

  Journal of acquired immune deficiency syndromes (1999) 20100801

• Methadone, buprenorphine, and street drug interactions with antiretroviral medications.

  Current HIV/AIDS reports 20100801

• Eighteen-month follow-up of HIV-1-infected mothers and their children enrolled in the Kesho Bora study observational cohorts.

  Journal of acquired immune deficiency syndromes (1999) 20100801

• Switching from efavirenz to nevirapine.

  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20100801

• Hemodialysis does not significantly affect the pharmacokinetics of nevirapine in HIV-1-infected persons requiring hemodialysis: results from ACTG A5177.

  Journal of acquired immune deficiency syndromes (1999) 20100801

• Evaluation of the safety of nevirapine therapy during pregnancy.

  Journal of acquired immune deficiency syndromes (1999) 20100801

• Cardiovascular risk evaluation and antiretroviral therapy effects in an HIV cohort: implications for clinical management: the CREATE 1 study.

  International journal of clinical practice 20100801

• Using touchscreen electronic medical record systems to support and monitor national scale-up of antiretroviral therapy in Malawi.

  PLoS medicine 20100801

• Recent FDA approvals and changes.

  AIDS patient care and STDs 20100801

• Low frequency of liver enzyme elevation in HIV-infected patients attending a large urban treatment centre in Uganda.

  International journal of STD & AIDS 20100801

• Coverage of nevirapine-based services to prevent mother-to-child HIV transmission in 4 African countries.

  JAMA 20100721

• Isoniazid-associated hepatitis and antiretroviral drugs during tuberculosis prophylaxis in hiv-infected adults in Botswana.

  American journal of respiratory and critical care medicine 20100715

• Hybrid diarylbenzopyrimidine non-nucleoside reverse transcriptase inhibitors as promising new leads for improved anti-HIV-1 chemotherapy.

  Bioorganic & medicinal chemistry 20100715

• Modelling the binding of HIV-reverse transcriptase and nevirapine: an assessment of quantum mechanical and force field approaches and predictions of the effect of mutations on binding.

  Physical chemistry chemical physics : PCCP 20100714

• Vanishing bile duct syndrome in human immunodeficiency virus: nevirapine hepatotoxicity revisited.

  World journal of gastroenterology 20100714

• Diarylaniline derivatives as a distinct class of HIV-1 non-nucleoside reverse transcriptase inhibitors.

  Journal of medicinal chemistry 20100708

• A sensitive and specific liquid chromatography/tandem mass spectrometry method for quantification of nevirapine and its five metabolites and their pharmacokinetics in baboons.

  Biomedical chromatography : BMC 20100701

• Drug-resistant mutation patterns in CRF01_AE cases that failed d4T+3TC+nevirapine fixed-dosed, combination treatment: Follow-up study from the Lampang cohort.

  Antiviral research 20100701

• Pharmacokinetics of lopinavir-ritonavir with and without nonnucleoside reverse transcriptase inhibitors in Ugandan HIV-infected adults.

  Antimicrobial agents and chemotherapy 20100701

• Minor resistant variants in nevirapine-exposed infants may predict virologic failure on nevirapine-containing ART.

  Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology 20100701

• Constrained patterns of covariation and clustering of HIV-1 non-nucleoside reverse transcriptase inhibitor resistance mutations.

  The Journal of antimicrobial chemotherapy 20100701

• Peripartum nevirapine exposure and subsequent clinical outcomes among HIV-infected women receiving antiretroviral therapy for at least 12 months.

  Tropical medicine & international health : TM & IH 20100701

• Long-term outcomes of HIV-infected patients with <95% rates of adherence to nonnucleoside reverse-transcriptase inhibitors.

  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20100701

• Inhibition of mitochondrial function by efavirenz increases lipid content in hepatic cells.

  Hepatology (Baltimore, Md.) 20100701

• Drug interactions during periodontal therapy in HIV-infected subjects.

  Mini reviews in medicinal chemistry 20100701

• Synthesis and anti-HIV activity of 2-naphthyl substituted DAPY analogues as non-nucleoside reverse transcriptase inhibitors.

  Bioorganic & medicinal chemistry 20100701

• Impact of maternal HAART on the prevention of mother-to-child transmission of HIV: results of an 18-month follow-up study in Ouagadougou, Burkina Faso.

  AIDS care 20100701

• Nevirapine-induced stevens johnson-syndrome and fulminant hepatic failure requiring liver transplantation.

  American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 20100701

• Improving prevention of mother-to-child transmission of HIV care and related services in eastern Rwanda.

  PLoS medicine 20100701

• Response to first line HAART using CD4 cell counts experience in a university hospital in Kingston.

  The West Indian medical journal 20100701

• Self-reported adherence to HAART in South-Eastern Nigeria is related to patients' use of pill box.

  SAHARA J : journal of Social Aspects of HIV/AIDS Research Alliance 20100701

• Maternal or infant antiretroviral drugs to reduce HIV-1 transmission.

  The New England journal of medicine 20100617

• Antiretroviral regimens in pregnancy and breast-feeding in Botswana.

  The New England journal of medicine 20100617

• Study on the interaction between HIV reverse transcriptase and its non-nucleoside inhibitor nevirapine by capillary electrophoresis.

  Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20100615

• Extensive hypertrophic lichen planus in an HIV positive patient.

  Dermatology online journal 20100615

• Comparing couples' and individual voluntary counseling and testing for HIV at antenatal clinics in Tanzania: a randomized trial.

  AIDS and behavior 20100601

• Using electronic drug monitor feedback to improve adherence to antiretroviral therapy among HIV-positive patients in China.

  AIDS and behavior 20100601

• Successful paediatric HIV treatment in rural primary care in Africa.

  Archives of disease in childhood 20100601

• Dammarenolic acid, a secodammarane triterpenoid from Aglaia sp. shows potent anti-retroviral activity in vitro.

  Phytomedicine : international journal of phytotherapy and phytopharmacology 20100601

• Limited sampling models to predict the pharmacokinetics of nevirapine, stavudine, and lamivudine in HIV-infected children treated with pediatric fixed-dose combination tablets.

  Therapeutic drug monitoring 20100601

• Early versus delayed initiation of antiretroviral therapy for concurrent HIV infection and cryptococcal meningitis in sub-saharan Africa.

  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20100601

• Validation of a rapid and sensitive high-performance liquid chromatography-tandem mass spectrometry (HPLC-MS/MS) assay for the simultaneous determination of existing and new antiretroviral compounds.

  Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20100601

• Pharmacokinetics of the treatment switch from efavirenz to nevirapine.

  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20100601

• The benefit of supplementary feeding for wasted Malawian adults initiating ART.

  AIDS care 20100601

• Patients infected with HIV type 1 subtype CRF01_AE and failing first-line nevirapine- and efavirenz-based regimens demonstrate considerable cross-resistance to etravirine.

  AIDS research and human retroviruses 20100601

• Predictors of treatment failure in Cambodian children with human immunodeficiency virus infection.

  The Pediatric infectious disease journal 20100601

• Tetherin restricts productive HIV-1 cell-to-cell transmission.

  PLoS pathogens 20100601

• Strategies to improve patient retention on antiretroviral therapy in sub-Saharan Africa.

  Tropical medicine & international health : TM & IH 20100601

• Cost of using a patient tracer to reduce loss to follow-up and ascertain patient status in a large antiretroviral therapy program in Johannesburg, South Africa.

  Tropical medicine & international health : TM & IH 20100601

• Utilization of therapeutic intervention to prevent mother to child transmission of HIV in a teaching hospital in Kolkata, India.

  The journal of obstetrics and gynaecology research 20100601

• [Stevens-Johnson syndrome and toxic epidermal necrolysis in a teaching hospital in Lomé, Togo: retrospective study of 89 cases].

  Medecine tropicale : revue du Corps de sante colonial 20100601

• Zidovudine-induced reversible pure red cell aplasia.

  Indian journal of pharmacology 20100601

• Selective and sensitive method for the determination of metoprolol in human plasma using liquid chromatography coupled with tandem mass spectrometry.

  Acta pharmaceutica (Zagreb, Croatia) 20100601

• Adverse drug reactions to antiretroviral therapy in AIDS patients at a tertiary care hospital in India: A prospective observational study.

  Indian journal of medical sciences 20100601

• Amino acid adduct formation by the nevirapine metabolite, 12-hydroxynevirapine--a possible factor in nevirapine toxicity.

  Chemical research in toxicology 20100517

• Association between detection of HIV-1 DNA resistance mutations by a sensitive assay at initiation of antiretroviral therapy and virologic failure.

  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20100515

• Nevirapine resistance by timing of HIV type 1 infection in infants treated with single-dose nevirapine.

  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20100515

• 'Viologen' dendrimers as antiviral agents: the effect of charge number and distance.

  Journal of medicinal chemistry 20100513

• Nevirapine/zidovudine/lamivudine has superior immunological and virological responses not reflected in clinical outcomes in a 48-week randomized comparison with abacavir/zidovudine/lamivudine in HIV-infected Ugandan adults with low CD4 cell counts.

  HIV medicine 20100501

• Determinants of adherence to a single-dose nevirapine regimen for the prevention of mother-to-child HIV transmission in Gert Sibande district in South Africa.

  Acta paediatrica (Oslo, Norway : 1992) 20100501

• Detection of HIV-1 drug resistance in women following administration of a single dose of nevirapine: comparison of plasma RNA to cellular DNA by consensus sequencing and by oligonucleotide ligation assay.

  Journal of clinical microbiology 20100501

• In vitro resistance development for RO-0335, a novel diphenylether nonnucleoside reverse transcriptase inhibitor.

  Antiviral research 20100501

• A Safe Motherhood project in Kenya: assessment of antenatal attendance, service provision and implications for PMTCT.

  Tropical medicine & international health : TM & IH 20100501

• Synthesis and biological evaluation of novel 2-arylalkylthio-4-amino-6-benzyl pyrimidines as potent HIV-1 non-nucleoside reverse transcriptase inhibitors.

  Bioorganic & medicinal chemistry letters 20100501

• Synthesis and biological evaluation of novel C5 halogen-functionalized S-DABO as potent HIV-1 non-nucleoside reverse transcriptase inhibitors.

  Bioorganic & medicinal chemistry 20100501

• Design of potential reverse transcriptase inhibitor containing Isatin nucleus using molecular modeling studies.

  Bioorganic & medicinal chemistry 20100501

• The use of highly active antiretroviral therapy for the prevention of mother-to-child transmission of the human immunodeficiency virus in Nigeria.

  Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology 20100501

• Analysis of drug resistance in children receiving antiretroviral therapy for treatment of HIV-1 infection in Uganda.

  AIDS research and human retroviruses 20100501

• Nonnucleoside reverse transcriptase inhibitor concentrations during treatment interruptions and the emergence of resistance: a substudy of the ISS-PART Trial.

  AIDS research and human retroviruses 20100501

• Inhibition of HIV-1 replication by isoxazolidine and isoxazole sulfonamides.

  Chemical biology & drug design 20100501

• Identification, isolation, and characterization of potential degradation products in a triple combination lamivudine, zidovudine, and nevirapine tablet for oral suspension.

  Die Pharmazie 20100501

• Homodimerization of the p51 subunit of HIV-1 reverse transcriptase.

  Biochemistry 20100406

• Cohort profile: mamanengane or the Africa centre vertical transmission study.

  International journal of epidemiology 20100401

• Factors determining HIV viral testing of infants in the context of mother-to-child transmission.

  Acta paediatrica (Oslo, Norway : 1992) 20100401

• Antiretroviral therapy hepatotoxicity: Prevalence, risk factors, and clinical characteristics in a cohort of Han Chinese.

  Hepatology research : the official journal of the Japan Society of Hepatology 20100401

• Suboptimal etravirine activity is common during failure of nevirapine-based combination antiretroviral therapy in a cohort infected with non-B subtype HIV-1.

  Current HIV research 20100401

• Using of nevirapine is associated with intermediate and reduced response to etravirine among HIV-infected patients who experienced virologic failure in a resource-limited setting.

  Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology 20100401

• Rising mother-to-child HIV transmission in a resource-limited breastfeeding population.

  Tropical doctor 20100401

• Synthesis and biological evaluation of 4-(hydroxyimino)arylmethyl diarylpyrimidine analogues as potential non-nucleoside reverse transcriptase inhibitors against HIV.

  Bioorganic & medicinal chemistry 20100401

• Successful bosentan and nonnucleoside reverse transcriptase inhibitor-based therapy in a patient with acquired immunodeficiency syndrome and pulmonary arterial hypertension.

  Pharmacotherapy 20100401

• Report from the 17th Conference on Retroviruses and Opportunistic Infections. Randomized studies of once-daily darunavir and tenofovir/FTC + nevirapine.

  Journal watch. AIDS clinical care 20100401

• HIV-1 RT Inhibitors with a Novel Mechanism of Action: NNRTIs that Compete with the Nucleotide Substrate.

  Viruses 20100401

• HIV-1 Ribonuclease H: Structure, Catalytic Mechanism and Inhibitors.

  Viruses 20100401

• Antiretroviral therapy (ART) for treating HIV infection in ART-eligible pregnant women.

  The Cochrane database of systematic reviews 20100317

• Efficacy and safety of 1-month postpartum zidovudine-didanosine to prevent HIV-resistance mutations after intrapartum single-dose nevirapine.

  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20100315

• Another milestone in minimizing risks to mothers exposed to single-dose nevirapine for prevention of vertical transmission of HIV-1 to infants: what next?

  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20100315

• Impact of human leukocyte antigen-B*51-restricted cytotoxic T-lymphocyte pressure on mutation patterns of nonnucleoside reverse transcriptase inhibitor resistance.

  AIDS (London, England) 20100313

• Safety and efficacy of tenofovir/emtricitabine plus nevirapine in HIV-infected patients.

  AIDS (London, England) 20100313

• Total body and spinal bone mineral density across Tanner stage in perinatally HIV-infected and uninfected children and youth in PACTG 1045.

  AIDS (London, England) 20100313

• Epidemic Stevens-Johnson syndrome in HIV patients in Guinea-Bissau: a side effect of the drug-supply policy?

  AIDS (London, England) 20100313

• [Evolution of HIV-1 drug resistance in patients failing combination antiretroviral therapy].

  Zhonghua yi xue za zhi 20100309

• 17th Conference on Retroviruses and Opportunistic Infections, 16-19 February, San Francisco, CA. Limits of success.

  Science (New York, N.Y.) 20100305

• Association between cervical dysplasia and human papillomavirus in HIV seropositive women from Johannesburg South Africa.

  Cancer causes & control : CCC 20100301

• Adverse drug reactions to antiretroviral therapy (ART): an experience of spontaneous reporting and intensive monitoring from ART centre in India.

  Pharmacoepidemiology and drug safety 20100301

• Antiviral drugs in wastewater and surface waters: a new pharmaceutical class of environmental relevance?

  Environmental science & technology 20100301

• Substitution of nevirapine because of efavirenz toxicity in AIDS clinical trials group A5095.

  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20100301

• Biomimetic synthesis and anti-HIV activity of dimeric phloroglucinols.

  Bioorganic & medicinal chemistry 20100301

• HIV type 1 antiretroviral resistance mutations in subtypes B, C, and F in the City of São Paulo, Brazil.

  AIDS research and human retroviruses 20100301

• Ultrasensitive detection of minor drug-resistant variants for HIV after nevirapine exposure using allele-specific PCR: clinical significance.

  AIDS research and human retroviruses 20100301

• Analysis of RT sequences of subtype C HIV-type 1 isolates from indian patients at failure of a first-line treatment according to clinical and/or immunological WHO guidelines.

  AIDS research and human retroviruses 20100301

• [Durability and tolerability of long-term nevirapine-based HAART].

  Le infezioni in medicina : rivista periodica di eziologia, epidemiologia, diagnostica, clinica e terapia delle patologie infettive 20100301

• A novel non-radioactive assay for HIV-RT (RdDp) based on pyrosequencing for high-throughput drug screening.

  Protein & cell 20100301

• Stevens Johnson syndrome after carbamazepine and SJS/TEN overlap syndrome after amoxicillin: case reports and a review.

  Archives of medical science : AMS 20100301

• Emergence and persistence of nevirapine resistance in breast milk after single-dose nevirapine administration.

  AIDS (London, England) 20100220

• Decline in early life mortality in a high HIV prevalence rural area of South Africa: evidence of HIV prevention or treatment impact?

  AIDS (London, England) 20100220

• Novel 1,3-dihydro-benzimidazol-2-ones and their analogues as potent non-nucleoside HIV-1 reverse transcriptase inhibitors.

  Bioorganic & medicinal chemistry 20100215

• HIV-positive women's experiences of a PMTCT programme in rural Malawi.

  Midwifery 20100201

• Effect of maternal HIV status on infant mortality: evidence from a 9-month follow-up of mothers and their infants in Zimbabwe.

  Journal of perinatology : official journal of the California Perinatal Association 20100201

• Stavudine- and nevirapine-related drug toxicity while on generic fixed-dose antiretroviral treatment: incidence, timing and risk factors in a three-year cohort in Kigali, Rwanda.

  Transactions of the Royal Society of Tropical Medicine and Hygiene 20100201

• Debio-025 inhibits HIV-1 by interfering with an early event in the replication cycle.

  Antiviral research 20100201

• Insulin sensitivity in multiple pathways is differently affected during zidovudine/lamivudine-containing compared with NRTI-sparing combination antiretroviral therapy.

  Journal of acquired immune deficiency syndromes (1999) 20100201

• TMC278, a next-generation nonnucleoside reverse transcriptase inhibitor (NNRTI), active against wild-type and NNRTI-resistant HIV-1.

  Antimicrobial agents and chemotherapy 20100201

• Co-administration of fluconazole increases nevirapine concentrations in HIV-infected Ugandans.

  The Journal of antimicrobial chemotherapy 20100201

• Risk of myocardial infarction in patients with HIV infection exposed to specific individual antiretroviral drugs from the 3 major drug classes: the data collection on adverse events of anti-HIV drugs (D:A:D) study.

  The Journal of infectious diseases 20100201

• Effect of nevirapine on the steady-state trough concentrations of atazanavir in HIV-infected patients receiving atazanavir/ritonavir.

  Therapeutic drug monitoring 20100201

• Cost-effectiveness of tenofovir as first-line antiretroviral therapy in India.

  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20100201

• Pediatric HIV clinical care resources and management practices in Asia: a regional survey of the TREAT Asia pediatric network.

  AIDS patient care and STDs 20100201

• Outcomes and safety of concomitant nevirapine and rifampicin treatment under programme conditions in Malawi.

  The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease 20100201

• Prevention of mother-to-child transmission of HIV-1 using highly active antiretroviral therapy in rural Yunnan, China.

  Journal of acquired immune deficiency syndromes (1999) 20100201

• Determination of nevirapine in plasma by GC-MS.

  Journal of chromatographic science 20100201

• Causes of acute hospitalization in adolescence: burden and spectrum of HIV-related morbidity in a country with an early-onset and severe HIV epidemic: a prospective survey.

  PLoS medicine 20100201

• Impact of antiretroviral therapy on incidence of pregnancy among HIV-infected women in Sub-Saharan Africa: a cohort study.

  PLoS medicine 20100201

• Effectiveness of non-nucleoside reverse-transcriptase inhibitor-based antiretroviral therapy in women previously exposed to a single intrapartum dose of nevirapine: a multi-country, prospective cohort study.

  PLoS medicine 20100201

• Is single-dose NVP relevant in the era of more efficacious PMTCT regimens? Lessons from Zambia.

  AIDS care 20100201

• The anti-HIV activity of three 2-alkylsulfanyl-6-benzyl-3, 4-dihydropyrimidin-4 (3H)-one derivatives acting as non-nucleoside reverse transcriptase inhibitor in vitro.

  Yao xue xue bao = Acta pharmaceutica Sinica 20100201

• HIV Genetic Diversity and Drug Resistance.

  Viruses 20100201

• Simultaneous production and co-mixing of microparticles of nevirapine with excipients by supercritical antisolvent method for dissolution enhancement.

  European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences 20100131

• A cluster-randomized trial of enhanced labor ward-based PMTCT services to increase nevirapine coverage in Lusaka, Zambia.

  AIDS (London, England) 20100128

• Addition of extended zidovudine to extended nevirapine prophylaxis reduces nevirapine resistance in infants who were HIV-infected in utero.

  AIDS (London, England) 20100128

• Etravirine resistance associated mutations in HIV-infected patients failing efavirenz or nevirapine in the Spanish antiretroviral resistance database.

  AIDS (London, England) 20100128

• N348I in HIV-1 reverse transcriptase decreases susceptibility to tenofovir and etravirine in combination with other resistance mutations.

  AIDS (London, England) 20100116

• Treatment modification in human immunodeficiency virus-infected individuals starting combination antiretroviral therapy between 2005 and 2008.

  Archives of internal medicine 20100111

• Routine versus clinically driven laboratory monitoring of HIV antiretroviral therapy in Africa (DART): a randomised non-inferiority trial.

  Lancet (London, England) 20100109

• Postpartum antiretroviral drug resistance in HIV-1-infected women receiving pregnancy-limited antiretroviral therapy.

  AIDS (London, England) 20100102

• Lack of increased hepatotoxicity in HIV-infected pregnant women receiving nevirapine compared with other antiretrovirals.

  AIDS (London, England) 20100102

• Antiretroviral treatment changes in adults from Côte d'Ivoire: the roles of tuberculosis and pregnancy.

  AIDS (London, England) 20100102

• Pharmacogenetics of antiretrovirals.

  Antiviral research 20100101

• Quantifying the metabolic activation of nevirapine in patients by integrated applications of NMR and mass spectrometries.

  Drug metabolism and disposition: the biological fate of chemicals 20100101

• Frequency of gastroenteritis and gastroenteritis-associated mortality with early weaning in HIV-1-uninfected children born to HIV-infected women in Malawi.

  Journal of acquired immune deficiency syndromes (1999) 20100101

• HIV-1 viral load and phenotypic antiretroviral drug resistance assays based on reverse transcriptase activity in comparison to amplification based HIV-1 RNA and genotypic assays.

  Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology 20100101

• Viral rebound and emergence of drug resistance in the absence of viral load testing: a randomized comparison between zidovudine-lamivudine plus Nevirapine and zidovudine-lamivudine plus Abacavir.

  The Journal of infectious diseases 20100101

• Dose adjustment of the non-nucleoside reverse transcriptase inhibitors during concurrent rifampicin-containing tuberculosis therapy: one size does not fit all.

  Expert opinion on drug metabolism & toxicology 20100101

• Nevirapine-induced hepatotoxicity and pharmacogenetics: a retrospective study in a population from Mozambique.

  Pharmacogenomics 20100101

• Nevirapine hypersensitivity.

  Handbook of experimental pharmacology 20100101

• Non-nucleoside reverse transcriptase inhibitor outcomes among combination antiretroviral therapy-treated adults in Botswana.

  AIDS (London, England) 20100101

• Management of individuals requiring antiretroviral therapy and TB treatment.

  Current opinion in HIV and AIDS 20100101

• Modelling imperfect adherence to HIV induction therapy.

  BMC infectious diseases 20100101

• Successful viral suppression with subsequent efavirenz-based regimen in HIV-1-infected patients who stop nevirapine prior to discontinuation of the NRTI backbone.

  Journal of the International Association of Physicians in AIDS Care (Chicago, Ill. : 2002) 20100101

• Increasing the uptake of prevention of mother-to-child transmission of HIV services in a resource-limited setting.

  BMC health services research 20100101

• Lack of clinically significant drug interactions between nevirapine and buprenorphine.

  The American journal on addictions 20100101

• Role of QuantiFERON-TB gold, interferon gamma inducible protein-10 and tuberculin skin test in active tuberculosis diagnosis.

  PloS one 20100101

• Only slight impact of predicted replicative capacity for therapy response prediction.

  PloS one 20100101

• The tuberculosis challenge in a rural South African HIV programme.

  BMC infectious diseases 20100101

• Antiretroviral (ARV) Therapy in Resource Poor Countries: What do we Need in Real Life?

  The open AIDS journal 20100101

• Patent Pooling for Promoting Access to Antiretroviral Drugs (ARVs) - A Strategic Option for India.

  The open AIDS journal 20100101

• An observational study of the pattern of HIV infection in a specified rural area of India with special reference to migratory laborers.

  Journal of the International Association of Physicians in AIDS Care (Chicago, Ill. : 2002) 20100101

• Pharmacokinetics of generic and trade formulations of lamivudine, stavudine and nevirapine in HIV-infected Malawian children.

  Antiviral therapy 20100101

• Update on the efficacy, effectiveness and safety of artemether-lumefantrine combination therapy for treatment of uncomplicated malaria.

  Therapeutics and clinical risk management 20100101

• Profile of etravirine for the treatment of HIV infection.

  Therapeutics and clinical risk management 20100101

• Nevirapine-associated early hepatotoxicity: incidence, risk factors, and associated mortality in a primary care ART programme in South Africa.

  PloS one 20100101

• Hepatotoxicity and effectiveness of a Nevirapine-based antiretroviral therapy in HIV-infected patients with or without viral hepatitis B or C infection in Cameroon.

  BMC public health 20100101

• Designing ARVs Patent Pool Up to Trade & Policy Evolutionary Dynamics.

  The open AIDS journal 20100101

• Antiretroviral treatment adherence among HIV patients in KwaZulu-Natal, South Africa.

  BMC public health 20100101

• Impact of HIV-1 viral subtype on disease progression and response to antiretroviral therapy.

  Journal of the International AIDS Society 20100101

• Is the drug-induced hypersensitivity syndrome (DIHS) due to human herpesvirus 6 infection or to allergy-mediated viral reactivation? Report of a case and literature review.

  BMC infectious diseases 20100101

• Simplification of antiretroviral therapy with etravirine.

  AIDS reviews 20100101

• Technology Development Through Pooling ARV Drug Patents: A Vision from China.

  The open AIDS journal 20100101

• Task shifting routine inpatient pediatric HIV testing improves program outcomes in urban Malawi: a retrospective observational study.

  PloS one 20100101

• Decreased NK Cell FcRgamma in HIV-1 infected individuals receiving combination antiretroviral therapy: a cross sectional study.

  PloS one 20100101

• Couples' voluntary counselling and testing and nevirapine use in antenatal clinics in two African capitals: a prospective cohort study.

  Journal of the International AIDS Society 20100101

• Abacavir/lamivudine combination in the treatment of HIV: a review.

  Therapeutics and clinical risk management 20100101

• A cluster randomized trial of routine HIV-1 viral load monitoring in Zambia: study design, implementation, and baseline cohort characteristics.

  PloS one 20100101

• High survival and treatment success sustained after two and three years of first-line ART for children in Cambodia.

  Journal of the International AIDS Society 20100101

• The UNITAID Patent Pool Initiative: Bringing Patents Together for the Common Good.

  The open AIDS journal 20100101

• An ab initio and AIM investigation into the hydration of 2-thioxanthine.

  Chemistry Central journal 20100101

• Effects of CYP2B6 G516T polymorphisms on plasma efavirenz and nevirapine levels when co-administered with rifampicin in HIV/TB co-infected Thai adults.

  AIDS research and therapy 20100101

• 4E10-resistant HIV-1 isolated from four subjects with rare membrane-proximal external region polymorphisms.

  PloS one 20100101

• Clinical deterioration during antituberculosis treatment in Africa: incidence, causes and risk factors.

  BMC infectious diseases 20100101

• When to start antiretroviral therapy in resource-limited settings: a human rights analysis.

  BMC international health and human rights 20100101

• Evaluation of a 6-year highly active antiretroviral therapy in Chinese HIV-1-infected patients.

  Intervirology 20100101

• Aripiprazole Improves Depressive Symptoms and Immunological Response to Antiretroviral Therapy in an HIV-Infected Subject with Resistant Depression.

  Case reports in medicine 20100101

• Dipyridodiazepinone analogs as human immunodeficiency virus type 1-specific non-nucleoside reverse transcriptase inhibitors: an overview.

  Current medicinal chemistry 20100101

• Positive and negative drug selection pressures on the N348I connection domain mutation: new insights from in vivo data.

  Antiviral therapy 20100101

• Better health-related quality of life after switching from a virologically effective regimen to a regimen containing efavirenz or nevirapine.

  AIDS care 20100101

• Anti-tuberculosis activity and drug interaction with nevirapine of inhalable lipid microspheres containing rifampicin in murine model.

  Journal of microencapsulation 20100101

• Liver toxicity after switching or simplifying to nevirapine-based therapy is not related to CD4 cell counts: results of the TOSCANA study.

  HIV clinical trials 20100101

• Pharmacokinetic characterization of three doses of tipranavir boosted with ritonavir on highly active antiretroviral therapy in treatment-experienced HIV-1 patients.

  HIV clinical trials 20100101

• HIV-1 subtype C-infected individuals maintaining high viral load as potential targets for the 'test-and-treat' approach to reduce HIV transmission.

  PloS one 20100101

• Experiences in conducting multiple community-based HIV prevention trials among women in KwaZulu-Natal, South Africa.

  AIDS research and therapy 20100101

• 'I will not let my HIV status stand in the way.' Decisions on motherhood among women on ART in a slum in Kenya- a qualitative study.

  BMC women's health 20100101

• Non-adherence to the single dose nevirapine regimen for the prevention of mother-to-child transmission of HIV in Bindura town, Zimbabwe: a cross-sectional analytic study.

  BMC public health 20100101

• A randomized, controlled, trial of short cycle intermittent compared to continuous antiretroviral therapy for the treatment of HIV infection in Uganda.

  PloS one 20100101

• Determinants of survival in very low birth weight neonates in a public sector hospital in Johannesburg.

  BMC pediatrics 20100101

• A modified method for determination of lumefantrine in human plasma by HPLC-UV and combination of protein precipitation and solid-phase extraction: application to a pharmacokinetic study.

  Analytical chemistry insights 20100101

• Raltegravir, tenofovir, and emtricitabine in an HIV-infected patient with HCV chronic hepatitis, NNRTI intolerance and protease inhibitors-induced severe liver toxicity.

  European journal of medical research 20100101

• HAART and the liver: friend or foe?

  European journal of medical research 20100101

• Effectiveness of multidrug antiretroviral regimens to prevent mother-to-child transmission of HIV-1 in routine public health services in Cameroon.

  PloS one 20100101

• [Nikavir in chemoprevention regimens for vertical HIV infection transmission].

  Voprosy virusologii 20100101

• Cost-effectiveness of HIV prevention interventions in Andhra Pradesh state of India.

  BMC health services research 20100101

• Prevalence and risk factors for significant liver fibrosis among HIV-monoinfected patients.

  BMC infectious diseases 20100101

• Excluding pregnancy among women initiating antiretroviral therapy: efficacy of a family planning job aid.

  BMC public health 20100101

• Incident tuberculosis during antiretroviral therapy contributes to suboptimal immune reconstitution in a large urban HIV clinic in sub-Saharan Africa.

  PloS one 20100101

• Early adherence to antiretroviral medication as a predictor of long-term HIV virological suppression: five-year follow up of an observational cohort.

  PloS one 20100101

• Semen may harbor HIV despite effective HAART: another piece in the puzzle.

  PloS one 20100101

• Patient retention and adherence to antiretrovirals in a large antiretroviral therapy program in Nigeria: a longitudinal analysis for risk factors.

  PloS one 20100101

• Design of the anti-tuberculosis drugs induced adverse reactions in China National Tuberculosis Prevention and Control Scheme Study (ADACS).

  BMC public health 20100101

• Intervening in global markets to improve access to HIV/AIDS treatment: an analysis of international policies and the dynamics of global antiretroviral medicines markets.

  Globalization and health 20100101

• Reduced referral and case fatality rates for severe symptomatic hyperlactataemia in a South African public sector antiretroviral programme: a retrospective observational study.

  AIDS research and therapy 20100101

• Serum phosphate predicts early mortality in adults starting antiretroviral therapy in Lusaka, Zambia: a prospective cohort study.

  PloS one 20100101

• Steady-state nevirapine, lamivudine and stavudine levels in Malawian HIV-infected children on antiretroviral therapy using split Triomune 30 tablets.

  Antiviral therapy 20100101

• 5th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention: summary of key research and implications for policy and practice - clinical sciences.

  Journal of the International AIDS Society 20100101

• 5th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention: summary of key research and implications for policy and practice - operations research.

  Journal of the International AIDS Society 20100101

• Increasing support for contraception as HIV prevention: stakeholder mapping to identify influential individuals and their perceptions.

  PloS one 20100101

• High prevalence and genetic diversity of HCV among HIV-1 infected people from various high-risk groups in China.

  PloS one 20100101

• Cerebrospinal fluid neopterin: an informative biomarker of central nervous system immune activation in HIV-1 infection.

  AIDS research and therapy 20100101

• Sociocultural and epidemiological aspects of HIV/AIDS in Mozambique.

  BMC international health and human rights 20100101

• Rates and reasons for early change of first HAART in HIV-1-infected patients in 7 sites throughout the Caribbean and Latin America.

  PloS one 20100101

• Update on the clinical utility of sildenafil in the treatment of pulmonary arterial hypertension.

  Drug design, development and therapy 20100101

• Depression symptoms and cognitive function among individuals with advanced HIV infection initiating HAART in Uganda.

  BMC psychiatry 20100101

• Twelve-year experience of nevirapine use: benefits and convenience for long-term management in a French cohort of HIV-1-infected patients.

  HIV clinical trials 20100101

• Hidden drug resistant HIV to emerge in the era of universal treatment access in Southeast Asia.

  PloS one 20100101

• Provision of antiretroviral treatment in conflict settings: the experience of Médecins Sans Frontières.

  Conflict and health 20100101

• A decline in new HIV infections in South Africa: estimating HIV incidence from three national HIV surveys in 2002, 2005 and 2008.

  PloS one 20100101

• Transmission of human immunodeficiency virus I drug resistance - a case report. What are the clinical implications?

  European journal of medical research 20100101

• Introducing a multi-site program for early diagnosis of HIV infection among HIV-exposed infants in Tanzania.

  BMC pediatrics 20100101

• Prevention of mother-to-child transmission of HIV infection: views and perceptions about swallowing nevirapine in rural Lilongwe, Malawi.

  BMC public health 20100101

• Generic and low dose antiretroviral therapy in adults and children: implication for scaling up treatment in resource limited settings.

  AIDS research and therapy 20100101

• Determinants of male involvement in the prevention of mother-to-child transmission of HIV programme in Eastern Uganda: a cross-sectional survey.

  Reproductive health 20100101

• Family-centred approaches to the prevention of mother to child transmission of HIV.

  Journal of the International AIDS Society 20100101

• Incidence and risk factors of severe adverse events with nevirapine-based antiretroviral therapy in HIV-infected women. MTCT-Plus program, Abidjan, Côte d'Ivoire.

  BMC infectious diseases 20100101

• Virologic and immunologic outcomes in HIV-infected Cambodian children after 18 months of highly active antiretroviral therapy (HAART).

  The Southeast Asian journal of tropical medicine and public health 20100101

• The impact of Highly Active Antiretroviral Therapy (HAART) on the clinical features of HIV - related oral lesions in Nigeria.

  AIDS research and therapy 20100101

• Differentiating Plasmodium falciparum alleles by transforming Cartesian X,Y data to polar coordinates.

  BMC genetics 20100101

• Who is accessing public-sector anti-retroviral treatment in the Free State, South Africa? An exploratory study of the first three years of programme implementation.

  BMC public health 20100101

• Financing equitable access to antiretroviral treatment in South Africa.

  BMC health services research 20100101

• Improving the evidence base of Markov models used to estimate the costs of scaling up antiretroviral programmes in resource-limited settings.

  BMC health services research 20100101

• Differences in antiretroviral scale up in three South African provinces: the role of implementation management.

  BMC health services research 20100101

• Reviewing the evidence on effectiveness and cost-effectiveness of HIV prevention strategies in Thailand.

  BMC public health 20100101

• Making it happen, level 2.

  Global health action 20100101

• Making it happen: prevention of mother to child transmission of HIV in rural Malawi.

  Global health action 20100101

• Cost-effectiveness of Childbirth Strategies for Prevention of Mother-to-child Transmission of HIV Among Mothers Receiving Nevirapine in India.

  Indian journal of community medicine : official publication of Indian Association of Preventive & Social Medicine 20100101

• AIDS-associated Kaposi's sarcoma is linked to advanced disease and high mortality in a primary care HIV programme in South Africa.

  Journal of the International AIDS Society 20100101

• Planning for pre-exposure prophylaxis to prevent HIV transmission: challenges and opportunities.

  Journal of the International AIDS Society 20100101

• Development of a liposomal nanodelivery system for nevirapine.

  Journal of biomedical science 20100101

• Ultra-fast analysis of plasma and intracellular levels of HIV protease inhibitors in children: a clinical application of MALDI mass spectrometry.

  PloS one 20100101

• Dynamics of HIV-1 quasispecies during antiviral treatment dissected using ultra-deep pyrosequencing.

  PloS one 20100101

• Lack of association between stavudine exposure and lipoatrophy, dysglycaemia, hyperlactataemia and hypertriglyceridaemia: a prospective cross sectional study.

  AIDS research and therapy 20100101

• Linking sexual and reproductive health and HIV interventions: a systematic review.

  Journal of the International AIDS Society 20100101

• Contrasting predictors of poor antiretroviral therapy outcomes in two South African HIV programmes: a cohort study.

  BMC public health 20100101

• Low haemoglobin predicts early mortality among adults starting antiretroviral therapy in an HIV care programme in South Africa: a cohort study.

  BMC public health 20100101

• Stevens-Johnson syndrome associated with nevirapine use in an HIV-positive pregnant woman: a case report.

  West African journal of medicine 20100101

• Secular trends in pediatric antiretroviral treatment programs in rural and urban Zambia: a retrospective cohort study.

  BMC pediatrics 20100101

• Antenatal HIV-1 RNA load and timing of mother to child transmission; a nested case-control study in a resource poor setting.

  Virology journal 20100101

• Immunological response to highly active antiretroviral therapy following treatment for prevention of mother to child transmission of HIV-1: a study in Côte d'Ivoire.

  Journal of the International AIDS Society 20100101

• Growth, immune and viral responses in HIV infected African children receiving highly active antiretroviral therapy: a prospective cohort study.

  BMC pediatrics 20100101

• Discontinuation of standard first-line antiretroviral therapy in a cohort of 1434 Malawian children.

  Journal of the International AIDS Society 20100101

• Presence of the CYP2B6 516G> T polymorphism, increased plasma Efavirenz concentrations and early neuropsychiatric side effects in South African HIV-infected patients.

  AIDS research and therapy 20100101

• Lipoprotein levels and cardiovascular risk in HIV-infected and uninfected Rwandan women.

  AIDS research and therapy 20100101

• Stigmatizing attitudes and low levels of knowledge but high willingness to participate in HIV management: a community-based survey of pharmacies in Pune, India.

  BMC public health 20100101

• Susceptibility of the human retrovirus XMRV to antiretroviral inhibitors.

  Retrovirology 20100101

• Structure activity relationship of dendrimer microbicides with dual action antiviral activity.

  PloS one 20100101

• Promising outcomes of a national programme for the prevention of Mother-to-Child HIV transmission in Addis Ababa: a retrospective study.

  BMC health services research 20100101

• Towards the complete eradication of mother-to-child HIV/HBV coinfection at Saint Camille Medical Centre in Burkina Faso, Africa.

  The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases 20100101

• Higher levels of Zidovudine resistant HIV in the colon compared to blood and other gastrointestinal compartments in HIV infection.

  Retrovirology 20100101

• Adverse events in a cohort of HIV infected pregnant and non-pregnant women treated with nevirapine versus non-nevirapine antiretroviral medication.

  PloS one 20100101

• A prospective cohort study of immunologic and virologic outcomes in patients with HIV/AIDS and hepatitis virus co-infection in Jos, Nigeria.

  Nigerian journal of medicine : journal of the National Association of Resident Doctors of Nigeria 20100101

• Impact of HIV/Aids on Child Mortality before the Highly Active Antiretroviral Therapy Era: A Study in Pointe-Noire, Republic of Congo.

  Journal of tropical medicine 20100101

• Knowledge and adherence to antiretroviral therapy among adult people living with HIV/AIDS treated in the health care centers of the association 'Espoir Vie Togo' in Togo, West Africa.

  BMC clinical pharmacology 20100101

• A cluster randomised controlled trial of the community effectiveness of two interventions in rural Malawi to improve health care and to reduce maternal, newborn and infant mortality.

  Trials 20100101

• Economic outcomes of patients receiving antiretroviral therapy for HIV/AIDS in South Africa are sustained through three years on treatment.

  PloS one 20100101

• Traditional birth attendants lack basic information on HIV and safe delivery practices in rural Mysore, India.

  BMC public health 20100101

• Cost-effectiveness of HIV testing referral strategies among tuberculosis patients in India.

  PloS one 20100101

• Clinical, virological and immunological responses in Danish HIV patients receiving raltegravir as part of a salvage regimen.

  Clinical epidemiology 20100101

• Population uptake of antiretroviral treatment through primary care in rural South Africa.

  BMC public health 20100101

• Nevirapine-associated toxicity in clinical practice in Buenos Aires, Argentina.

  Journal of the International Association of Physicians in AIDS Care (Chicago, Ill. : 2002) 20100101

• Comparative biochemical analysis of recombinant reverse transcriptase enzymes of HIV-1 subtype B and subtype C.

  Retrovirology 20100101

• Renal impairment after switching from stavudine/lamivudine to tenofovir/lamivudine in NNRTI-based antiretroviral regimens.

  AIDS research and therapy 20100101

• What happens to ART-eligible patients who do not start ART? Dropout between screening and ART initiation: a cohort study in Karonga, Malawi.

  BMC public health 20100101

• Subtype-associated differences in HIV-1 reverse transcription affect the viral replication.

  Retrovirology 20100101

• Task shifting in Mozambique: cross-sectional evaluation of non-physician clinicians' performance in HIV/AIDS care.

  Human resources for health 20100101

• Pregnancy does not affect HIV incidence test results obtained using the BED capture enzyme immunoassay or an antibody avidity assay.

  PloS one 20100101

• Patients present earlier and survival has improved, but pre-ART attrition is high in a six-year HIV cohort data from Ethiopia.

  PloS one 20100101

• Prevalence of transmitted drug resistance and impact of transmitted resistance on treatment success in the German HIV-1 Seroconverter Cohort.

  PloS one 20100101

• A comparative analysis of HIV drug resistance interpretation based on short reverse transcriptase sequences versus full sequences.

  AIDS research and therapy 20100101

• Selective killing of human immunodeficiency virus infected cells by non-nucleoside reverse transcriptase inhibitor-induced activation of HIV protease.

  Retrovirology 20100101

• The global pediatric antiretroviral market: analyses of product availability and utilization reveal challenges for development of pediatric formulations and HIV/AIDS treatment in children.

  BMC pediatrics 20100101

• Genotypic evaluation of etravirine sensitivity of clinical human immunodeficiency virus type 1 (HIV-1) isolates carrying resistance mutations to nevirapine and efavirenz.

  Acta clinica Belgica 20100101

• Progress in antiretroviral drug delivery using nanotechnology.

  International journal of nanomedicine 20100101

• Population-level reduction in adult mortality after extension of free anti-retroviral therapy provision into rural areas in northern Malawi.

  PloS one 20100101

• Impact of drug stock-outs on death and retention to care among HIV-infected patients on combination antiretroviral therapy in Abidjan, Côte d'Ivoire.

  PloS one 20100101

• Poisonous milk and sinful mothers: the changing meaning of breastfeeding in the wake of the HIV epidemic in Addis Ababa, Ethiopia.

  International breastfeeding journal 20100101

• Gendered perceptions on infant feeding in Eastern Uganda: continued need for exclusive breastfeeding support.

  International breastfeeding journal 20100101

• 'On our own, we can't manage': experiences with infant feeding recommendations among Malawian mothers living with HIV.

  International breastfeeding journal 20100101

• Efficacy of HIV PCR techniques to diagnose HIV in infants born to HIV infected mothers at LASUTH.

  Nigerian quarterly journal of hospital medicine 20100101

• Predictors of adherence to antiretroviral therapy among people living with HIV/AIDS in resource-limited setting of southwest ethiopia.

  AIDS research and therapy 20100101

• Reduced dose of stavudine and lipoatrophy in HIV-infected patients in Cameroon.

  Antiviral therapy 20100101

• Determinants of survival in adult HIV patients on antiretroviral therapy in Oromiyaa, Ethiopia.

  Global health action 20100101

• Baseline severe anaemia should not preclude use of zidovudine in antiretroviral-eligible patients in resource-limited settings.

  Journal of the International AIDS Society 20100101

• The incidence of HIV among women recruited during late pregnancy and followed up for six years after childbirth in Zimbabwe.

  BMC public health 20100101

• Antiretroviral therapy optimisation without genotype resistance testing: a perspective on treatment history based models.

  PloS one 20100101

• Gender-related mortality for HIV-infected patients on highly active antiretroviral therapy (HAART) in rural Uganda.

  International journal of women's health 20100101

• Prevalence of and risk factors for pre-diabetes in HIV-1-infected patients in Bangkok, Thailand.

  Journal of the International Association of Physicians in AIDS Care (Chicago, Ill. : 2002) 20100101

• DNA suspension arrays: silencing discrete artifacts for high-sensitivity applications.

  PloS one 20100101

• Evaluating the cost-effectiveness of pre-exposure prophylaxis (PrEP) and its impact on HIV-1 transmission in South Africa.

  PloS one 20100101

• Contraceptive use and method preference among women in Soweto, South Africa: the influence of expanding access to HIV care and treatment services.

  PloS one 20100101

• Revisiting HIV-1 uncoating.

  Retrovirology 20100101

• Improving a mother to child HIV transmission programme through health system redesign: quality improvement, protocol adjustment and resource addition.

  PloS one 20100101

• Uridine metabolism in HIV-1-infected patients: effect of infection, of antiretroviral therapy and of HIV-1/ART-associated lipodystrophy syndrome.

  PloS one 20100101

• Decrease of vitamin D concentration in patients with HIV infection on a non nucleoside reverse transcriptase inhibitor-containing regimen.

  AIDS research and therapy 20100101

• Treatment and disease progression in a birth cohort of vertically HIV-1 infected children in Ukraine.

  BMC pediatrics 20100101

• Increased vulnerability of rural children on antiretroviral therapy attending public health facilities in South Africa: a retrospective cohort study.

  Journal of the International AIDS Society 20100101

• Severe course of Lyme neuroborreliosis in an HIV-1 positive patient; case report and review of the literature.

  BMC neurology 20100101

• Knowledge and practice of prevention of mother-to-child transmission of HIV among traditional birth attendants in Lagos State, Nigeria.

  The Pan African medical journal 20100101

• Comparing two service delivery models for the prevention of mother-to-child transmission (PMTCT) of HIV during transition from single-dose nevirapine to multi-drug antiretroviral regimens.

  BMC public health 20100101

• Experiencing antiretroviral adherence: helping healthcare staff better understand adherence to paediatric antiretrovirals.

  Journal of the International AIDS Society 20100101

• The importance of clinic attendance in the first six months on antiretroviral treatment: a retrospective analysis at a large public sector HIV clinic in South Africa.

  Journal of the International AIDS Society 20100101

• Experiences of women who have lost young children to AIDS in KwaZulu-Natal, South Africa: a qualitative study.

  Journal of the International AIDS Society 20100101

• Science-based health innovation in Uganda: creative strategies for applying research to development.

  BMC international health and human rights 20100101

• The reverse transcription inhibitor abacavir shows anticancer activity in prostate cancer cell lines.

  PloS one 20100101

• Early development of non-hodgkin lymphoma following initiation of newer class antiretroviral therapy among HIV-infected patients - implications for immune reconstitution.

  AIDS research and therapy 20100101

• Toxic epidermal necrolysis and Stevens-Johnson syndrome.

  Orphanet journal of rare diseases 20100101

• Immune restoration disease and changes in CD4+ T-cell count in HIV- infected patients during highly active antiretroviral therapy at Zewditu memorial hospital, Addis Ababa, Ethiopia.

  AIDS research and therapy 20100101

• Uterine epithelial cell regulation of DC-SIGN expression inhibits transmitted/founder HIV-1 trans infection by immature dendritic cells.

  PloS one 20100101

• Trends in CD4 counts in HIV-infected patients with HIV viral load monitoring while on combination antiretroviral treatment: results from The TREAT Asia HIV Observational Database.

  BMC infectious diseases 20100101

• HIV Wasting Syndrome in a Nigerian Failing Antiretroviral Therapy: A Case Report and Review of the Literature.

  Case reports in medicine 20100101

• Computational Analysis of Molecular Interaction Networks Underlying Change of HIV-1 Resistance to Selected Reverse Transcriptase Inhibitors.

  Bioinformatics and biology insights 20100101

• Effect of Maternal HIV-1 Status and Antiretroviral Drugs on Haematological Profiles of South African Infants in Early Life.

  The open AIDS journal 20100101

• Floating drug delivery of nevirapine as a gastroretentive system.

  Journal of young pharmacists : JYP 20100101

• National Response to HIV/AIDS in India.

  Indian journal of community medicine : official publication of Indian Association of Preventive & Social Medicine 20100101

• Evaluation of the prevention of parent to child transmission program in a rural tertiary care hospital of west bengal, India.

  Indian journal of community medicine : official publication of Indian Association of Preventive & Social Medicine 20100101

• An interlaboratory investigation on the use of high-performance thin layer chromatography to perform assays of lamivudine-zidovudine, metronidazole, nevirapine, and quinine composite samples.

  Journal of AOAC International 20100101

• Potential anti-HIV agents from marine resources: an overview.

  Marine drugs 20100101

• Simplified Assessment of Antiretroviral Adherence and Prediction of Virological Efficacy in HIV-Infected Patients in Cambodia.

  AIDS research and treatment 20100101

• Incidence of Severe Hepatotoxicity Related to Antiretroviral Therapy in HIV/HCV Coinfected Patients.

  AIDS research and treatment 20100101

• Clinic Attendance for Medication Refills and Medication Adherence amongst an Antiretroviral Treatment Cohort in Uganda: A Prospective Study.

  AIDS research and treatment 20100101

• Lipid Metabolism and Cardiovascular Risk in HIV-1 Infection and HAART: Present and Future Problems.

  Cholesterol 20100101

• Beyond the black box: drug- and device-associated hypersensitivity events.

  Drug, healthcare and patient safety 20100101

• Prevention of parent to child transmission services and interventions - coverage and utilization: A cohort analysis in Gujarat, India.

  Indian journal of sexually transmitted diseases and AIDS 20100101

• HIV Infection, Antiretroviral Therapy and Cardiovascular Risk.

  Mediterranean journal of hematology and infectious diseases 20100101

• Tenofovir-associated renal dysfunction in clinical practice: An observational cohort from western India.

  Indian journal of sexually transmitted diseases and AIDS 20100101

• Novel strategies in the use of lopinavir/ritonavir for the treatment of HIV infection in children.

  HIV/AIDS (Auckland, N.Z.) 20100101

• Adherence to antiretroviral therapy in Nigeria: an overview of research studies and implications for policy and practice.

  HIV/AIDS (Auckland, N.Z.) 20100101

• Role of etravirine in the management of treatment-experienced patients with human immunodeficiency virus type 1.

  HIV/AIDS (Auckland, N.Z.) 20100101

• Long-term treatment of patients with HIV-1: the role of atazanavir.

  HIV/AIDS (Auckland, N.Z.) 20100101

• New and emerging agents in the management of lipodystrophy in HIV-infected patients.

  HIV/AIDS (Auckland, N.Z.) 20100101

• Rates of virological failure in patients treated in a home-based versus a facility-based HIV-care model in Jinja, southeast Uganda: a cluster-randomised equivalence trial.

  Lancet (London, England) 20091219

• Viremia, resuppression, and time to resistance in human immunodeficiency virus (HIV) subtype C during first-line antiretroviral therapy in South Africa.

  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20091215

• Synthesis and biological evaluation of C-5 methyl substituted 4-arylthio and 4-aryloxy-3-Iodopyridin-2(1H)-one type anti-HIV agents.

  Journal of medicinal chemistry 20091210

• Two-dimensional LC-MS/MS determination of antiretroviral drugs in rat serum and urine.

  Journal of pharmaceutical and biomedical analysis 20091205

• Primiparous mothers' knowledge about mother-to-child transmission of HIV in Lusaka, Zambia.

  Midwifery 20091201

• Community, family, and partner-related stigma experienced by pregnant and postpartum women with HIV in Ho Chi Minh City, Vietnam.

  AIDS and behavior 20091201

• Solution characterization of [methyl-(13)C]methionine HIV-1 reverse transcriptase by NMR spectroscopy.

  Antiviral research 20091201

• A study of the specificity of lymphocytes in nevirapine-induced skin rash.

  The Journal of pharmacology and experimental therapeutics 20091201

• Activity and molecular modeling of a new small molecule active against NNRTI-resistant HIV-1 mutants.

  European journal of medicinal chemistry 20091201

• Low-frequency K103N strengthens the impact of transmitted drug resistance on virologic responses to first-line efavirenz or nevirapine-based highly active antiretroviral therapy.

  Journal of acquired immune deficiency syndromes (1999) 20091201

• HTS and hit finding in academia--from chemical genomics to drug discovery.

  Drug discovery today 20091201

• Assessment of nevirapine bioavailability from targeted sites in the human gastrointestinal tract.

  Journal of clinical pharmacology 20091201

• Pharmacokinetics of nevirapine in HIV-infected children with and without malnutrition receiving divided adult fixed-dose combination tablets.

  The Journal of antimicrobial chemotherapy 20091201

• Influence of CYP2B6 polymorphisms on the persistence of plasma nevirapine concentrations following a single intra-partum dose for the prevention of mother to child transmission in HIV-infected Thai women.

  The Journal of antimicrobial chemotherapy 20091201

• Herb-drug interactions with St John's wort (Hypericum perforatum): an update on clinical observations.

  The AAPS journal 20091201

• In vitro-in vivo correlation for nevirapine extended release tablets.

  Biopharmaceutics & drug disposition 20091201

• Risk of extended viral resistance in human immunodeficiency virus-1-infected Mozambican children after first-line treatment failure.

  The Pediatric infectious disease journal 20091201

• Lactic acidosis in HIV-exposed infants with perinatal exposure to antiretroviral therapy.

  Annals of tropical paediatrics 20091201

• Response to antiretroviral therapy in HIV-infected Ugandan children exposed and not exposed to single-dose nevirapine at birth.

  Journal of acquired immune deficiency syndromes (1999) 20091201

• Early and late direct costs in a Southern African antiretroviral treatment programme: a retrospective cohort analysis.

  PLoS medicine 20091201

• Temporal reduction of HIV type 1 viral load in breast milk by single-dose nevirapine during prevention of MTCT.

  AIDS research and human retroviruses 20091201

• [Chemical characteristics, mechanism of action and antiviral activity of etravirine].

  Enfermedades infecciosas y microbiologia clinica 20091201

• [Etravirine drug interactions].

  Enfermedades infecciosas y microbiologia clinica 20091201

• [Etravirine: genetic barrier and resistance development].

  Enfermedades infecciosas y microbiologia clinica 20091201

• [Treatment of chronic hepatitis C in human immunodeficiency virus infected patients].

  Acta medica Croatica : casopis Hravatske akademije medicinskih znanosti 20091201

• (S)-6-Chloro-4-cyclo-propyl-ethynyl-4-trifluoro-methyl-1H-3,1-benzoxazin-2(4H)-one.

  Acta crystallographica. Section E, Structure reports online 20091201

• Revisiting plus-strand DNA synthesis in retroviruses and long terminal repeat retrotransposons: dynamics of enzyme: substrate interactions.

  Viruses 20091201

• Increased risk of hepatotoxicity in HIV-infected pregnant women receiving antiretroviral therapy independent of nevirapine exposure.

  AIDS (London, England) 20091127

• Modeling vertical transmission of HIV: imperfect vaccines can be of benefit.

  Vaccine 20091123

• Synthesis and biological evaluation of novel 2-(substituted phenylaminocarbonylmethylthio)-6-(2,6-dichlorobenzyl)-pyrimidin-4(3H)-ones as potent HIV-1 NNRTIs.

  Bioorganic & medicinal chemistry 20091115

• Postnatal HIV-1 transmission after cessation of infant extended antiretroviral prophylaxis and effect of maternal highly active antiretroviral therapy.

  The Journal of infectious diseases 20091115

• Substituting nevirapine for efavirenz: risk factors for toxicity in nonnaive patients in a resource-constrained setting.

  AIDS (London, England) 20091113

• [Inefficacy of vitamin K antagonists in an human immunodeficiency virus seropositive patient taking nevirapine].

  Presse medicale (Paris, France : 1983) 20091101

• Is 1 alanine transaminase >200 IU enough to define an alanine transaminase flare in HIV-infected populations? A new definition derived from a large cohort study.

  Journal of acquired immune deficiency syndromes (1999) 20091101

• Synthesis and anti-HIV activity evaluation of 2-(4-(naphthalen-2-yl)-1,2,3-thiadiazol-5-ylthio)-N-acetamides as novel non-nucleoside HIV-1 reverse transcriptase inhibitors.

  European journal of medicinal chemistry 20091101

• Prevention of mother-to-child transmission of HIV-1 through breastfeeding by treating mothers with triple antiretroviral therapy in Dar es Salaam, Tanzania: the Mitra Plus study.

  Journal of acquired immune deficiency syndromes (1999) 20091101

• Intracellular accumulation of efavirenz and nevirapine is independent of P-glycoprotein activity in cultured CD4 T cells and primary human lymphocytes.

  The Journal of antimicrobial chemotherapy 20091101

• Efavirenz: a decade of clinical experience in the treatment of HIV.

  The Journal of antimicrobial chemotherapy 20091101

• Efficient synthesis of nevirapine analogs to study its metabolic profile by click fishing.

  Bioorganic & medicinal chemistry letters 20091101

• Do we still need lead-in dosing of nevirapine in HIV-infected patients who are receiving rifampicin-containing antituberculous therapy?

  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20091101

• Intrapartum tenofovir and emtricitabine reduces low-concentration drug resistance selected by single-dose nevirapine for perinatal HIV prevention.

  AIDS research and human retroviruses 20091101

• Antiretroviral drug-resistant mutations at baseline and at time of failure of antiretroviral therapy in HIV type 1-coinfected TB patients.

  AIDS research and human retroviruses 20091101

• Transplacental transfer of antiretroviral drugs and newborn birth weight in HIV-infected pregnant women.

  Current HIV research 20091101

• Drugs in traditional drug classes (nucleoside reverse transcriptase inhibitor/nonnucleoside reverse transcriptase inhibitor/protease inhibitors) with activity against drug-resistant virus (tipranavir, darunavir, etravirine).

  Current opinion in HIV and AIDS 20091101

• Metabolomics in drug intolerance.

  Current drug metabolism 20091101

• Human immunodeficiency virus type 1 subtypes prevalence in central China.

  Yonsei medical journal 20091031

• Crystallographic study of a novel subnanomolar inhibitor provides insight on the binding interactions of alkenyldiarylmethanes with human immunodeficiency virus-1 reverse transcriptase.

  Journal of medicinal chemistry 20091022

• Impact of baseline CD4(+) T cell counts on the efficacy of nevirapine-based highly active antiretroviral therapy in Chinese HIV/AIDS patients: a prospective, multicentric study.

  Chinese medical journal 20091020

• Reflections: neurology and the humanities: reflections for October.

  Neurology 20091013

• Antiretroviral compounds and cholesterol efflux from macrophages.

  Atherosclerosis 20091001

• Influence of darunavir coadministration on nevirapine pharmacokinetics in HIV-infected patients: a population approach.

  HIV medicine 20091001

• Predictors of rapid HIV testing acceptance and successful nevirapine administration in Zambian labor wards.

  Journal of acquired immune deficiency syndromes (1999) 20091001

• Dissection of regenerating T-Cell responses against tuberculosis in HIV-infected adults sensitized by Mycobacterium tuberculosis.

  American journal of respiratory and critical care medicine 20091001

• Clinical and genotypic findings in HIV-infected patients with the K65R mutation failing first-line antiretroviral therapy in Nigeria.

  Journal of acquired immune deficiency syndromes (1999) 20091001

• A comparison of HIV-1 drug susceptibility as provided by conventional phenotyping and by a phenotype prediction tool based on viral genotype.

  Journal of medical virology 20091001

• A liquid chromatography-tandem mass spectrometry assay for quantification of nevirapine, indinavir, atazanavir, amprenavir, saquinavir, ritonavir, lopinavir, efavirenz, tipranavir, darunavir and maraviroc in the plasma of patients infected with HIV.

  Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20091001

• Computational modeling of novel inhibitors targeting the Akt pleckstrin homology domain.

  Bioorganic & medicinal chemistry 20091001

• Response to nonnucleoside reverse transcriptase inhibitor-based therapy in HIV-infected children with perinatal exposure to single-dose nevirapine.

  AIDS research and human retroviruses 20091001

• Single-dose nevirapine exposure affects T cell response and cytokine levels in HIV type 1-infected women.

  AIDS research and human retroviruses 20091001

• Task shifting for scale-up of HIV care: evaluation of nurse-centered antiretroviral treatment at rural health centers in Rwanda.

  PLoS medicine 20091001

• Efficacy of short-course AZT plus 3TC to reduce nevirapine resistance in the prevention of mother-to-child HIV transmission: a randomized clinical trial.

  PLoS medicine 20091001

• Antiretroviral strategies to prevent mother-to-child transmission of HIV: striking a balance between efficacy, feasibility, and resistance.

  PLoS medicine 20091001

• UV spectrophotometric method for the identification and solubility determination of nevirapine.

  Die Pharmazie 20091001

• A prospective, observational cohort study to elicit adverse effects of antiretroviral agents in a remote resource-restricted tribal population of Chhattisgarh.

  Indian journal of pharmacology 20091001

• Report from the 5th IAS Conference on HIV Pathogenesis Treatment and Prevention. Nevirapine vs. boosted atazanavir--the ARTEN Study.

  Journal watch. AIDS clinical care 20091001

• Reply to 'kidney transplantation in a patient with HIV disease'.

  Indian journal of nephrology 20091001

• Improvement of mitochondrial toxicity in patients receiving a nucleoside reverse-transcriptase inhibitor-sparing strategy: results from the Multicenter Study with Nevirapine and Kaletra (MULTINEKA).

  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20090915

• Long-term follow-up of nevirapine-treated patients in a single-centre cohort.

  HIV medicine 20090901

• Mortality and virologic outcomes after access to antiretroviral therapy among a cohort of HIV-infected women who received single-dose nevirapine in Lusaka, Zambia.

  Journal of acquired immune deficiency syndromes (1999) 20090901

• Inhibition of HIV-1 ribonuclease H activity by novel frangula-emodine derivatives.

  Medicinal chemistry (Shariqah (United Arab Emirates)) 20090901

• Design, synthesis, and SAR of naphthyl-substituted Diarylpyrimidines as non-nucleoside inhibitors of HIV-1 reverse transcriptase.

  ChemMedChem 20090901

• Predictors of early and late mother-to-child transmission of HIV in a breastfeeding population: HIV Network for Prevention Trials 012 experience, Kampala, Uganda.

  Journal of acquired immune deficiency syndromes (1999) 20090901

• 1,2,3-Selenadiazole thioacetanilides: synthesis and anti-HIV activity evaluation.

  Bioorganic & medicinal chemistry 20090901

• Predictors of virologic failure and genotypic resistance mutation patterns in thai children receiving non-nucleoside reverse transcriptase inhibitor-based antiretroviral therapy.

  The Pediatric infectious disease journal 20090901

• Nevirapine increases high-density lipoprotein cholesterol concentration by stimulation of apolipoprotein A-I production.

  Arteriosclerosis, thrombosis, and vascular biology 20090901

• Substrate specificity, regulation, and polymorphism of human cytochrome P450 2B6.

  Current drug metabolism 20090901

• The history of antiretrovirals: key discoveries over the past 25 years.

  Reviews in medical virology 20090901

• Changes in cognition during antiretroviral therapy: comparison of 2 different ranking systems to measure antiretroviral drug efficacy on HIV-associated neurocognitive disorders.

  Journal of acquired immune deficiency syndromes (1999) 20090901

• Reversible reduction of nevirapine plasma concentrations during rifampicin treatment in patients coinfected with HIV-1 and tuberculosis.

  Journal of acquired immune deficiency syndromes (1999) 20090901

• Long-term effectiveness and safety outcomes in HIV-1-infected patients after a median time of 6 years on nevirapine.

  Current HIV research 20090901

• FDA notifications. FDA gives tentative approval for stavudine, lamivudine & nevirapine tablet.

  AIDS alert 20090901

• Risk factors for treatment-limiting toxicities in patients starting nevirapine-containing antiretroviral therapy.

  AIDS (London, England) 20090824

• Lower risk of resistance after short-course HAART compared with zidovudine/single-dose nevirapine used for prevention of HIV-1 mother-to-child transmission.

  Journal of acquired immune deficiency syndromes (1999) 20090815

• Optimal versus suboptimal treatment for HIV-infected pregnant women and HIV-exposed infants in clinical research studies.

  Journal of acquired immune deficiency syndromes (1999) 20090815

• Design, synthesis, and structure-activity relationships of 1,3-dihydrobenzimidazol-2-one analogues as anti-HIV agents.

  Bioorganic & medicinal chemistry 20090815

• Novel 1,2,3-thiadiazole derivatives as HIV-1 NNRTIs with improved potency: Synthesis and preliminary SAR studies.

  Bioorganic & medicinal chemistry 20090815

• Synthesis and biological evaluation of imidazole thioacetanilides as novel non-nucleoside HIV-1 reverse transcriptase inhibitors.

  Bioorganic & medicinal chemistry 20090815

• Tenofovir disoproxil fumarate in pregnancy and prevention of mother-to-child transmission of HIV-1: is it time to move on from zidovudine?

  HIV medicine 20090801

• Human immunodeficiency virus: 25 years of diagnostic and therapeutic strategies and their impact on hepatitis B and C virus.

  Medical microbiology and immunology 20090801

• Drug skin metabolites and allergic drug reactions.

  Current opinion in allergy and clinical immunology 20090801

• No influence of nevirapine on vitamin D deficiency in HIV-infected patients.

  AIDS research and human retroviruses 20090801

• [Therapeutic effect and safety evaluation on 6-year highly active antiretroviral therapy for Chinese HIV-1 infected patients].

  Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences 20090801

• First line zidovudine/lamivudine/lopinavir/ritonavir leads to greater bone loss compared to nevirapine/lopinavir/ritonavir.

  AIDS (London, England) 20090717

• Antiretroviral resistance patterns and HIV-1 subtype in mother-infant pairs after the administration of combination short-course zidovudine plus single-dose nevirapine for the prevention of mother-to-child transmission of HIV.

  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20090715

• Timing and determinants of mother-to-child transmission of HIV in Nigeria.

  International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics 20090701

• Metabolic activation of nevirapine in human liver microsomes: dehydrogenation and inactivation of cytochrome P450 3A4.

  Drug metabolism and disposition: the biological fate of chemicals 20090701

• Cytotoxicological analysis of a gp120 binding aptamer with cross-clade human immunodeficiency virus type 1 entry inhibition properties: comparison to conventional antiretrovirals.

  Antimicrobial agents and chemotherapy 20090701

• The effect of individual antiretroviral drugs on body composition in HIV-infected persons initiating highly active antiretroviral therapy.

  Journal of acquired immune deficiency syndromes (1999) 20090701

• Antiretroviral treatment in pregnancy: a six-year perspective on recent trends in prescription patterns, viral load suppression, and pregnancy outcomes.

  AIDS patient care and STDs 20090701

• Prevention of human immunodeficiency virus mother-to-child transmission in Israel.

  International journal of STD & AIDS 20090701

• In utero HIV infection is associated with an increased risk of nevirapine resistance in ugandan infants who were exposed to perinatal single dose nevirapine.

  AIDS research and human retroviruses 20090701

• Focusing on quality patient care in the new global subsidy for malaria medicines.

  PLoS medicine 20090701

• Comparison of laboratory methods for analysis of non-nucleoside reverse transcriptase inhibitor resistance in Ugandan infants.

  AIDS research and human retroviruses 20090701

• Confluent molluscum contagiosum covering the eyelids of an HIV-positive child.

  Clinical & experimental ophthalmology 20090701

• Pharmacokinetic interaction between nevirapine and darunavir with low-dose ritonavir in HIV-1-infected patients.

  British journal of clinical pharmacology 20090701

• Grade 3-4 liver enzyme elevation during HAART in HIV and hepatitis C co-infected adults.

  Acta medica Indonesiana 20090701

• Skin disorders in HIV-infected patients from West Java.

  Acta medica Indonesiana 20090701

• A Program on Prevention of Mother to Child Transmission of HIV at Government Hospital, Tiruchengode Taluk, Namakkal District.

  Indian journal of community medicine : official publication of Indian Association of Preventive & Social Medicine 20090701

• Renal transplantation in a HIV positive patient.

  Indian journal of nephrology 20090701

• Kidney transplantation in a patient with HIV disease.

  Indian journal of nephrology 20090701

• New pyridinone derivatives as potent HIV-1 nonnucleoside reverse transcriptase inhibitors.

  Journal of medicinal chemistry 20090625

• Acute intoxication with nevirapine in an HIV-1-infected patient: clinical and pharmacokinetic follow up.

  AIDS (London, England) 20090619

• Efavirenz and nevirapine interactions with rifampicin: resolving the dilemmas?

  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20090615

• A randomized trial comparing plasma drug concentrations and efficacies between 2 nonnucleoside reverse-transcriptase inhibitor-based regimens in HIV-infected patients receiving rifampicin: the N2R Study.

  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20090615

• Mother-to-child HIV and HHV-8 transmission in neonates at Saint Camille Medical Centre in Burkina Faso.

  Pakistan journal of biological sciences : PJBS 20090615

• Effects of nevirapine and efavirenz on HDL cholesterol levels and reverse cholesterol transport in mice.

  Atherosclerosis 20090601

• Adherence to first-line antiretroviral therapy affects non-virologic outcomes among patients on treatment for more than 12 months in Lusaka, Zambia.

  International journal of epidemiology 20090601

• Antiviral activity of MK-4965, a novel nonnucleoside reverse transcriptase inhibitor.

  Antimicrobial agents and chemotherapy 20090601

• Population pharmacokinetics of ritonavir-boosted atazanavir in HIV-infected patients and healthy volunteers.

  The Journal of antimicrobial chemotherapy 20090601

• The nucleoside backbone affects durability of efavirenz- or nevirapine-based highly active antiretroviral therapy in antiretroviral-naive individuals.

  Journal of acquired immune deficiency syndromes (1999) 20090601

• The obstetric face and challenge of HIV/AIDS.

  Clinical obstetrics and gynecology 20090601

• Clinical relevance of substitutions in the connection subdomain and RNase H domain of HIV-1 reverse transcriptase from a cohort of antiretroviral treatment-naïve patients.

  Antiviral research 20090601

• Drug resistance in the Chinese National Pediatric Highly Active Antiretroviral Therapy Cohort: implications for paediatric treatment in the developing world.

  International journal of STD & AIDS 20090601

• Nevirapine hypersensitivity reaction: will the real HLA please stand up?

  Current opinion in molecular therapeutics 20090601

• Pattern and predictors of immunologic recovery in human immunodeficiency virus-infected children receiving non-nucleoside reverse transcriptase inhibitor-based highly active antiretroviral therapy.

  The Pediatric infectious disease journal 20090601

• Risk factors for helminth, malaria, and HIV infection in pregnancy in Entebbe, Uganda.

  PLoS neglected tropical diseases 20090601

• Nevirapine restores androgen signaling in hormone-refractory human prostate carcinoma cells both in vitro and in vivo.

  The Prostate 20090515

• Elucidating the inhibition mechanism of HIV-1 non-nucleoside reverse transcriptase inhibitors through multicopy molecular dynamics simulations.

  Journal of molecular biology 20090508

• Competitive capacity of HIV-1 strains carrying M184I or Y181I drug-resistant mutations.

  Chinese medical journal 20090505

• Comment on: High rate of early virological failure with the once-daily tenofovir/lamivudine/nevirapine combination in naive HIV-1-infected patients.

  The Journal of antimicrobial chemotherapy 20090501

• The transport of anti-HIV drugs across blood-CNS interfaces: summary of current knowledge and recommendations for further research.

  Antiviral research 20090501

• Cytochrome P450 2B6 516G-->T is associated with plasma concentrations of nevirapine at both 200 mg twice daily and 400 mg once daily in an ethnically diverse population.

  HIV medicine 20090501

• Nevirapine pharmacokinetics in HIV-infected and HIV/HCV-coinfected individuals.

  The Journal of antimicrobial chemotherapy 20090501

• Response to zidovudine/didanosine-containing combination antiretroviral therapy among HIV-1 subtype C-infected adults in Botswana: two-year outcomes from a randomized clinical trial.

  Journal of acquired immune deficiency syndromes (1999) 20090501

• Peripheral and visceral fat changes following a treatment switch to a non-thymidine analogue or a nucleoside-sparing regimen in HIV-infected subjects with peripheral lipoatrophy: results of ACTG A5110.

  The Journal of antimicrobial chemotherapy 20090501

• Circulating HIV type 1 drug resistance will have limited impact on the effectiveness of preexposure prophylaxis among young women in Zimbabwe.

  The Journal of infectious diseases 20090501

• Resistance to antiretrovirals in HIV-infected pregnant women.

  Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology 20090501

• Establishment of drug-resistant HIV-1 in latent reservoirs.

  The Journal of infectious diseases 20090501

• Identification of nevirapine-resistant HIV-1 in the latent reservoir after single-dose nevirapine to prevent mother-to-child transmission of HIV-1.

  The Journal of infectious diseases 20090501

• Arthritis as the presenting feature of HIV infection in a child.

  The Journal of infection 20090501

• Synthesis and studies of new 2-(coumarin-4-yloxy)-4,6-(substituted)-S-triazine derivatives as potential anti-HIV agents.

  Archiv der Pharmazie 20090501

• Long-term CD4 cell count recovery among Thai naive HIV-infected patients initiating HAART at low CD4 cell count.

  Current HIV research 20090501

• Reducing vertical HIV transmission in Kinshasa, Democratic Republic of Congo: trends in HIV prevalence and service delivery.

  AIDS care 20090501

• Managing toxicities and optimal dosing of targeted drugs in advanced kidney cancer.

  Current oncology (Toronto, Ont.) 20090501

• High rates of regimen change due to drug toxicity among a cohort of South Indian adults with HIV infection initiated on generic, first-line antiretroviral treatment.

  The Journal of the Association of Physicians of India 20090501

• Antiretroviral drug susceptibility among drug-naive adults with recent HIV infection in Rakai, Uganda.

  AIDS (London, England) 20090427

• Women exposed to single-dose nevirapine in successive pregnancies: effectiveness and nonnucleoside reverse transcriptase inhibitor resistance.

  AIDS (London, England) 20090427

• Tolerance and viral resistance after single-dose nevirapine with tenofovir and emtricitabine to prevent vertical transmission of HIV-1.

  AIDS (London, England) 20090427

• Screening and monitoring antiretrovirals and antivirals in the serum of acquired immunodeficiency syndrome patients by micellar liquid chromatography.

  Journal of chromatography. A 20090417

• National expansion of antiretroviral treatment in Thailand, 2000-2007: program scale-up and patient outcomes.

  Journal of acquired immune deficiency syndromes (1999) 20090415

• The combined effect of modern highly active antiretroviral therapy regimens and adherence on mortality over time.

  Journal of acquired immune deficiency syndromes (1999) 20090415

• Increase in carotid artery intima-media thickness and arterial stiffness but improvement in several markers of endothelial function after initiation of antiretroviral therapy.

  The Journal of infectious diseases 20090415

• Proinflammatory cytokine changes in clinically stable, virologically suppressed, HIV-infected patients switching from protease inhibitors to abacavir.

  Journal of acquired immune deficiency syndromes (1999) 20090415

• Nonnucleoside reverse transcriptase inhibitor pharmacokinetics in a large unselected cohort of HIV-infected women.

  Journal of acquired immune deficiency syndromes (1999) 20090415

• Indolylarylsulfones bearing natural and unnatural amino acids. Discovery of potent inhibitors of HIV-1 non-nucleoside wild type and resistant mutant strains reverse transcriptase and coxsackie B4 virus.

  Journal of medicinal chemistry 20090409

• Identification of a process impurity formed during synthesis of a nevirapine analogue HIV NNRT inhibitor using LC/MS and forced degradation studies.

  Journal of pharmaceutical and biomedical analysis 20090405

• Preventing mother-to-child transmission of HIV in resource-limited settings: the Elizabeth Glaser Pediatric AIDS Foundation experience.

  American journal of public health 20090401

• Anti-HIV drugs: 25 compounds approved within 25 years after the discovery of HIV.

  International journal of antimicrobial agents 20090401

• Safety of Switching Nevirapine Twice Daily to Nevirapine Once Daily in Virologically Suppressed Patients.

  Journal of acquired immune deficiency syndromes (1999) 20090401

• Association of high T allele frequency of CYP2B6 G516T polymorphism among ethnic south Indian HIV-infected patients with elevated plasma efavirenz and nevirapine.

  The Journal of antimicrobial chemotherapy 20090401

• Effects of concurrent administration of nevirapine on the disposition of quinine in healthy volunteers.

  The Journal of pharmacy and pharmacology 20090401

• Resistance mutations in HIV-1 infected pregnant women and their infants receiving antiretrovirals to prevent HIV-1 vertical transmission in China.

  International journal of STD & AIDS 20090401

• Placental malaria and mother-to-child transmission of human immunodeficiency virus-1.

  The American journal of tropical medicine and hygiene 20090401

• The RNA polymerase dictates ORF1 requirement and timing of LINE and SINE retrotransposition.

  PLoS genetics 20090401

• Report from the 16th Conference on Retroviruses and Opportunistic Infections. Lopinavir/r is superior to nevirapine in women who previously received single-dose nevirapine.

  Journal watch. AIDS clinical care 20090401

• [Establishment of pharmacological evaluation system for non-nucleoside reverse-transcriptase inhibitors resistant HIV-1].

  Yao xue xue bao = Acta pharmaceutica Sinica 20090401

• Metabolic effects associated to the highly active antiretroviral therapy (HAART) in AIDS patients.

  The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases 20090401

• Kidney transplantation in a patient with HIV disease.

  Indian journal of nephrology 20090401

• Characterization of vaginal transmission of a simian human immunodeficiency virus (SHIV) encoding the reverse transcriptase gene from HIV-1 in Chinese rhesus macaques.

  Virology 20090330

• Associations between CYP2B6 polymorphisms and pharmacokinetics after a single dose of nevirapine or efavirenz in African americans.

  The Journal of infectious diseases 20090315

• Synthesis of alkenyldiarylmethanes (ADAMs) containing benzo[d]isoxazole and oxazolidin-2-one rings, a new series of potent non-nucleoside HIV-1 reverse transcriptase inhibitors.

  European journal of medicinal chemistry 20090301

• Computer-based design of novel HIV-1 entry inhibitors: neomycin conjugated to arginine peptides at two specific sites.

  Journal of molecular modeling 20090301

• High-throughput screening using pseudotyped lentiviral particles: a strategy for the identification of HIV-1 inhibitors in a cell-based assay.

  Antiviral research 20090301

• Ultrasensitive assessment of residual HIV viraemia in HAART-treated patients with persistently undetectable plasma HIV-RNA: a cross-sectional evaluation.

  Journal of medical virology 20090301

• Efficacy of non-nucleoside reverse transcriptase inhibitor-based highly active antiretroviral therapy in Thai HIV-infected children aged two years or less.

  The Pediatric infectious disease journal 20090301

• Does gender and nevirapine (NVP) influence abnormal liver functions in HIV disease?

  The Journal of infection 20090301

• A randomized, open-label study of a nucleoside analogue reverse transcriptase inhibitor-sparing regimen in antiretroviral-naive HIV-infected patients.

  Journal of acquired immune deficiency syndromes (1999) 20090301

• [Birth defects in a cohort of uninfected children born to HIV-infected women].

  Anales de pediatria (Barcelona, Spain : 2003) 20090301

• Etravirine and rilpivirine: nonnucleoside reverse transcriptase inhibitors with activity against human immunodeficiency virus type 1 strains resistant to previous nonnucleoside agents.

  Pharmacotherapy 20090301

• Predicting factors for unsuccessful switching from nevirapine to efavirenz in HIV-infected patients who developed nevirapine-associated skin rash.

  International journal of STD & AIDS 20090301

• Higher placental anti-inflammatory IL-10 cytokine expression in HIV-1 infected women receiving longer zidovudine prophylaxis associated with nevirapine.

  Current HIV research 20090301

• Safety and efficacy of nevirapine- and efavirenz-based antiretroviral treatment in adults treated for TB-HIV co-infection in Botswana.

  The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease 20090301

• Genetic drift of HIV populations in culture.

  PLoS genetics 20090301

• Generic combination approved.

  AIDS patient care and STDs 20090301

• Assessing missed opportunities for the prevention of mother-to-child HIV transmission in an Eastern Cape local service area.

  South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde 20090301

• Emergency obstetric patients in developing countries and prevalence of HIV infection.

  African journal of medicine and medical sciences 20090301

• Plasma lipid profile in pregnant women with HIV receiving nevirapine.

  AIDS patient care and STDs 20090301

• Specific targeting of highly conserved residues in the HIV-1 reverse transcriptase primer grip region. 2. Stereoselective interaction to overcome the effects of drug resistant mutations.

  Journal of medicinal chemistry 20090226

• Single-dose nevirapine to prevent mother-to-child transmission of HIV type 1: balancing the benefits and risks.

  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20090215

• Persistent minority K103N mutations among women exposed to single-dose nevirapine and virologic response to nonnucleoside reverse-transcriptase inhibitor-based therapy.

  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20090215

• Quantification of HIV protease inhibitors and non-nucleoside reverse transcriptase inhibitors in peripheral blood mononuclear cell lysate using liquid chromatography coupled with tandem mass spectrometry.

  Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20090215

• Discovery of chiral cyclopropyl dihydro-alkylthio-benzyl-oxopyrimidine (S-DABO) derivatives as potent HIV-1 reverse transcriptase inhibitors with high activity against clinically relevant mutants.

  Journal of medicinal chemistry 20090212

• Inhibition of human immunodeficiency virus type 1 infection by the candidate microbicide dapivirine, a nonnucleoside reverse transcriptase inhibitor.

  Antimicrobial agents and chemotherapy 20090201

• High rate of early virological failure with the once-daily tenofovir/lamivudine/nevirapine combination in naive HIV-1-infected patients.

  The Journal of antimicrobial chemotherapy 20090201

• Structural modifications of DAPY analogues with potent anti-HIV-1 activity.

  ChemMedChem 20090201

• Risk factors for early and late transmission of HIV via breast-feeding among infants born to HIV-infected women in a randomized clinical trial in Botswana.

  The Journal of infectious diseases 20090201

• HLA-B*3505 allele is a strong predictor for nevirapine-induced skin adverse drug reactions in HIV-infected Thai patients.

  Pharmacogenetics and genomics 20090201

• A prospective study evaluating clinical outcomes and costs of three NNRTI-based HAART regimens in Kerala, India.

  Journal of clinical pharmacy and therapeutics 20090201

• Determinants of nonadherence to a single-dose nevirapine regimen for the prevention of mother-to-child HIV transmission in Rwanda.

  Journal of acquired immune deficiency syndromes (1999) 20090201

• Prevention of mother-to-child HIV transmission using 3-drug combination antiretroviral treatment: observational cohort in clinical practice setting in India.

  Journal of acquired immune deficiency syndromes (1999) 20090201

• Warfarin-antiretroviral interactions.

  The Annals of pharmacotherapy 20090201

• How do courts set health policy? The case of the Colombian Constitutional Court.

  PLoS medicine 20090201

• Breastfeeding and AIDS in the developing world.

  Current opinion in pediatrics 20090201

• Interventions for preventing late postnatal mother-to-child transmission of HIV.

  The Cochrane database of systematic reviews 20090121

• Minority quasispecies of drug-resistant HIV-1 that lead to early therapy failure in treatment-naive and -adherent patients.

  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20090115

• Synthesis and anti-HIV studies of 2- and 3-adamantyl-substituted thiazolidin-4-ones.

  European journal of medicinal chemistry 20090101

• Population pharmacokinetics of nevirapine in combination with rifampicin-based short course chemotherapy in HIV- and tuberculosis-infected South African patients.

  European journal of clinical pharmacology 20090101

• Modifications of a large HIV prevention clinical trial to fit changing realities: a case study of the Breastfeeding, Antiretroviral, and Nutrition (BAN) protocol in Lilongwe, Malawi.

  Contemporary clinical trials 20090101

• Identification of human immunodeficiency virus type 1 non-B subtypes and antiretroviral drug-resistant strains in United States blood donors.

  Transfusion 20090101

• Persistence of nevirapine in breast milk and plasma of mothers and their children after single-dose administration.

  The Journal of antimicrobial chemotherapy 20090101

• Contraception and HIV infection in women.

  Human reproduction update 20090101

• Non-nucleoside HIV-1 reverse transcriptase inhibitors di-halo-indolyl aryl sulfones achieve tight binding to drug-resistant mutants by targeting the enzyme-substrate complex.

  Antiviral research 20090101

• Quantification of 8 HIV-protease inhibitors and 2 nonnucleoside reverse transcriptase inhibitors by ultra-performance liquid chromatography with diode array detection.

  Clinical chemistry 20090101

• The effects of Thiazolidinediones on metabolic complications and Lipodystrophy in HIV-infected patients.

  PPAR research 20090101

• Invasive disease caused by nontuberculous mycobacteria, Tanzania.

  Emerging infectious diseases 20090101

• Fatal HIV encephalitis in HIV-seronegative patients.

  Emerging infectious diseases 20090101

• Nevirapine resistance and breast-milk HIV transmission: effects of single and extended-dose nevirapine prophylaxis in subtype C HIV-infected infants.

  PloS one 20090101

• Antiretroviral-related adipocyte dysfunction and lipodystrophy in HIV-infected patients: Alteration of the PPARγ-dependent pathways.

  PPAR research 20090101

• Universal access: the benefits and challenges in bringing integrated HIV care to isolated and conflict affected populations in the Republic of Congo.

  Conflict and health 20090101

• Developing countries need better antiretroviral drugs.

  Journal of the International Association of Physicians in AIDS Care (Chicago, Ill. : 2002) 20090101

• Explaining adherence success in sub-Saharan Africa: an ethnographic study.

  PLoS medicine 20090101

• Survey of physician knowledge regarding antiretroviral medications in hospitalized HIV-infected patients.

  Journal of the International AIDS Society 20090101

• Prescribing and using self-injectable antiretrovirals: how concordant are physician and patient perspectives?

  AIDS research and therapy 20090101

• Outcomes of a remote, decentralized health center-based HIV/AIDS antiretroviral program in Zambia, 2003 to 2007.

  Journal of the International Association of Physicians in AIDS Care (Chicago, Ill. : 2002) 20090101

• Combination antiretroviral therapy in population affected by conflict: outcomes from large cohort in northern Uganda.

  BMJ (Clinical research ed.) 20090101

• Clinical deterioration during antitubercular treatment at a district hospital in South Africa: the importance of drug resistance and AIDS defining illnesses.

  PloS one 20090101

• Which ART regimen is best after receipt of single-dose nevirapine?

  AIDS clinical care 20090101

• Hepatotoxicity associated with long- versus short-course HIV-prophylactic nevirapine use: a systematic review and meta-analysis from the Research on Adverse Drug events And Reports (RADAR) project.

  Drug safety 20090101

• Prevalence of sexually transmitted infections among pregnant women with known HIV status in northern Tanzania.

  Reproductive health 20090101

• Acceptability of intrapartum HIV counselling and testing in Cameroon.

  BMC pregnancy and childbirth 20090101

• [Drug resistance of HIV-1 as a result of using nevirapine for chemoprophylaxis of vertical viral transmission from HIV-infected mother to infant].

  Voprosy virusologii 20090101

• Development and evaluation of a clinical algorithm to monitor patients on antiretrovirals in resource-limited settings using adherence, clinical and CD4 cell count criteria.

  Journal of the International AIDS Society 20090101

• Emergence of primary NNRTI resistance mutations without antiretroviral selective pressure in a HAART-treated child.

  PloS one 20090101

• [A fixed dose anti-HIV combination for the poor? Triomune].

  Revue medicale de Liege 20090101

• Demographic, socio-economic, behavioral and clinical factors predicting virologic failure with generic fixed-dose combination antiretroviral therapy before universal health insurance coverage in northern Thailand.

  The Southeast Asian journal of tropical medicine and public health 20090101

• Anti-inflammatory and antiarthritic effects of piperine in human interleukin 1beta-stimulated fibroblast-like synoviocytes and in rat arthritis models.

  Arthritis research & therapy 20090101

• Prevention of mother-to-child transmission of HIV in Haiti.

  Revista panamericana de salud publica = Pan American journal of public health 20090101

• Progress in prevention of mother-to-child transmission of HIV infection in Ukraine: results from a birth cohort study.

  BMC infectious diseases 20090101

• Community health workers for ART in sub-Saharan Africa: learning from experience--capitalizing on new opportunities.

  Human resources for health 20090101

• HIV care and treatment factors associated with improved survival during TB treatment in Thailand: an observational study.

  BMC infectious diseases 20090101

• Physical and emotional health outcomes after 12 months of public-sector antiretroviral treatment in the Free State Province of South Africa: a longitudinal study using structural equation modelling.

  BMC public health 20090101

• Efficacy and safety of darunavir and etravirine in an antiretroviral multi-experienced youth with vertically HIV-1 infection.

  European journal of medical research 20090101

• Comparative study of the persistence of anti-HIV activity of deoxynucleoside HIV reverse transcriptase inhibitors after removal from culture.

  AIDS research and therapy 20090101

• Quality of life and the impact of drug toxicities in a South African community-based antiretroviral programme.

  Journal of the International AIDS Society 20090101

• Survey on prevalence and risk factors on HIV-1 among pregnant women in North-Rift, Kenya: a hospital based cross-sectional study conducted between 2005 and 2006.

  BMC international health and human rights 20090101

• Bridge water mediates nevirapine binding to wild type and Y181C HIV-1 reverse transcriptase--evidence from molecular dynamics simulations and MM-PBSA calculations.

  Journal of molecular graphics & modelling 20090101

• Reducing stillbirths: prevention and management of medical disorders and infections during pregnancy.

  BMC pregnancy and childbirth 20090101

• Challenges for routine health system data management in a large public programme to prevent mother-to-child HIV transmission in South Africa.

  PloS one 20090101

• Role of atazanavir in the treatment of HIV infection.

  Therapeutics and clinical risk management 20090101

• The triple combination of tenofovir, emtricitabine and efavirenz shows synergistic anti-HIV-1 activity in vitro: a mechanism of action study.

  Retrovirology 20090101

• HIV patients presenting common adverse drug events caused by highly active antiretroviral therapy in Tanzania.

  Tanzania journal of health research 20090101

• Supplementary feeding with either ready-to-use fortified spread or corn-soy blend in wasted adults starting antiretroviral therapy in Malawi: randomised, investigator blinded, controlled trial.

  BMJ (Clinical research ed.) 20090101

• Resistance profiles after different periods of exposure to a first-line antiretroviral regimen in a Cameroonian cohort of HIV type-1-infected patients.

  Antiviral therapy 20090101

• Zidovudine/lamivudine for HIV-1 infection contributes to limb fat loss.

  PloS one 20090101

• Risk factors for virological failure and subtherapeutic antiretroviral drug concentrations in HIV-positive adults treated in rural northwestern Uganda.

  BMC infectious diseases 20090101

• Low-cost HIV-1 diagnosis and quantification in dried blood spots by real time PCR.

  PloS one 20090101

• Comparison of brachial and carotid artery ultrasound for assessing extent of subclinical atherosclerosis in HIV: a prospective cohort study.

  AIDS research and therapy 20090101

• Effectiveness of antiretroviral therapy and development of drug resistance in HIV-1 infected patients in Mombasa, Kenya.

  AIDS research and therapy 20090101

• Switch from a ZDV/3TC-based regimen to a completely once daily (QD) regimen of emtricitabine/tenofovir DF fixed dose combination plus a third QD agent (SONETT).

  European journal of medical research 20090101

• Pregnancy outcomes among HIV-infected women undergoing antiretroviral therapy.

  The open AIDS journal 20090101

• Medication diaries do not improve outcomes with highly active antiretroviral therapy in Kenyan children: a randomized clinical trial.

  Journal of the International AIDS Society 20090101

• Cross-clade recognition of HIV-1 CAp24 by CD4+ T cells in HIV-1-infected individuals in Burkina Faso and Germany.

  The open AIDS journal 20090101

• Differential effects of early weaning for HIV-free survival of children born to HIV-infected mothers by severity of maternal disease.

  PloS one 20090101

• Low-abundance HIV drug-resistant viral variants in treatment-experienced persons correlate with historical antiretroviral use.

  PloS one 20090101

• Synergistic activation of HIV-1 expression by deacetylase inhibitors and prostratin: implications for treatment of latent infection.

  PloS one 20090101

• Differences in resistance mutations among HIV-1 non-subtype B infections: a systematic review of evidence (1996-2008).

  Journal of the International AIDS Society 20090101

• Reduction of the HIV-1 reservoir in resting CD4+ T-lymphocytes by high dosage intravenous immunoglobulin treatment: a proof-of-concept study.

  AIDS research and therapy 20090101

• Virological efficacy and emergence of drug resistance in adults on antiretroviral treatment in rural Tanzania.

  BMC infectious diseases 20090101

• Characterization of the patterns of drug-resistance mutations in newly diagnosed HIV-1 infected patients naïve to the antiretroviral drugs.

  BMC infectious diseases 20090101

• Early initiation of antiretroviral therapy results in decreased morbidity and mortality among patients with TB and HIV.

  Journal of the International AIDS Society 20090101

• Lys169 of human glucokinase is a determinant for glucose phosphorylation: implication for the atomic mechanism of glucokinase catalysis.

  PloS one 20090101

• High prevalence of undiagnosed chronic kidney disease among at-risk population in Kinshasa, the Democratic Republic of Congo.

  BMC nephrology 20090101

• Host sequence motifs shared by HIV predict response to antiretroviral therapy.

  BMC medical genomics 20090101

• Clinical factors associated with plasma F2-isoprostane levels in HIV-infected adults.

  HIV clinical trials 20090101

• Novel methodology for antiretroviral quantitation in the female genital tract.

  HIV clinical trials 20090101

• A model and risk score for predicting nevirapine-associated rash among HIV-infected patients: in settings of low CD4 cell counts and resource limitation.

  The open AIDS journal 20090101

• HIV-1 resistance to first- and second-generation non-nucleoside reverse transcriptase inhibitors.

  AIDS reviews 20090101

• Selected hematologic and biochemical measurements in African HIV-infected and uninfected pregnant women and their infants: the HIV Prevention Trials Network 024 protocol.

  BMC pediatrics 20090101

• Mortality and loss-to-follow-up during the pre-treatment period in an antiretroviral therapy programme under normal health service conditions in Uganda.

  BMC public health 20090101

• Bosentan in the treatment of pulmonary arterial hypertension with the focus on the mildly symptomatic patient.

  Vascular health and risk management 20090101

• Excellent outcomes among HIV+ children on ART, but unacceptably high pre-ART mortality and losses to follow-up: a cohort study from Cambodia.

  BMC pediatrics 20090101

• Agreement between physicians and non-physician clinicians in starting antiretroviral therapy in rural Uganda.

  Human resources for health 20090101

• HIV and hepatitis C virus infections among hanka injection drug users in central Ukraine: a cross-sectional survey.

  Harm reduction journal 20090101

• Short-term randomized proof-of-principle trial of TMC278 in patients with HIV type-1 who have previously failed antiretroviral therapy.

  Antiviral therapy 20090101

• Pharmacotherapy of pediatric and adolescent HIV infection.

  Therapeutics and clinical risk management 20090101

• Managing treatment-experienced pediatric and adolescent HIV patients: role of darunavir.

  Therapeutics and clinical risk management 20090101

• Five-year follow-up of children with perinatal HIV-1 infection receiving early highly active antiretroviral therapy.

  BMC infectious diseases 20090101

• [Highly efficient chemoprophylaxis of perinatal transmission of HIV 1 infection in HIV-infected pregnant women].

  Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic] 20090101

• Prevention of mother-to-child transmission of HIV in Zambia: implementing efficacious ARV regimens in primary health centers.

  BMC public health 20090101

• Monitoring virologic responses to antiretroviral therapy in HIV-infected adults in Kenya: evaluation of a low-cost viral load assay.

  PloS one 20090101

• Renal impairment in a rural African antiretroviral programme.

  BMC infectious diseases 20090101

• Interactions between herbal medicines and prescribed drugs: an updated systematic review.

  Drugs 20090101

• Adverse drug reactions to nonnucleoside reverse transcriptase inhibitor-based antiretroviral regimen: a 24-week prospective study.

  Journal of the International Association of Physicians in AIDS Care (Chicago, Ill. : 2002) 20090101

• Antiretroviral therapy initiation before, during, or after pregnancy in HIV-1-infected women: maternal virologic, immunologic, and clinical response.

  PloS one 20090101

• A review of co-morbidity between infectious and chronic disease in Sub Saharan Africa: TB and diabetes mellitus, HIV and metabolic syndrome, and the impact of globalization.

  Globalization and health 20090101

• Comparison of 3-drug versus 4-drug and PI versus non-PI combinations as initial HAART: experience from 1998 to 2007.

  Journal of the International Association of Physicians in AIDS Care (Chicago, Ill. : 2002) 20090101

• Evidence for limited genetic compartmentalization of HIV-1 between lung and blood.

  PloS one 20090101

• Determining a cost effective intervention response to HIV/AIDS in Peru.

  BMC public health 20090101

• Perinatal acquisition of drug-resistant HIV-1 infection: mechanisms and long-term outcome.

  Retrovirology 20090101

• Need for timely paediatric HIV treatment within primary health care in rural South Africa.

  PloS one 20090101

• Paediatric HIV management at primary care level: an evaluation of the integrated management of childhood illness (IMCI) guidelines for HIV.

  BMC pediatrics 20090101

• Drugs associated with more suicidal ideations are also associated with more suicide attempts.

  PloS one 20090101

• Antiretroviral treatment adherence and its determinants in Sub-Saharan Africa: a prospective study at Yaounde Central Hospital, Cameroon.

  AIDS research and therapy 20090101

• Influence of non-nucleoside reverse transcriptase inhibitors (efavirenz and nevirapine) on the pharmacodynamic activity of gliclazide in animal models.

  Diabetology & metabolic syndrome 20090101

• Vertebral compression fractures in an HIV-positive patient with steroid-induced Cushing syndrome: a case report.

  Cases journal 20090101

• Duration, pattern of breastfeeding and postnatal transmission of HIV: pooled analysis of individual data from West and South African cohorts.

  PloS one 20090101

• Barriers to the care of HIV-infected children in rural Zambia: a cross-sectional analysis.

  BMC infectious diseases 20090101

• Immune control of HIV-1 infection after therapy interruption: immediate versus deferred antiretroviral therapy.

  BMC infectious diseases 20090101

• HLA-Cw*04 allele associated with nevirapine-induced rash in HIV-infected Thai patients.

  AIDS research and therapy 20090101

• Five-year follow up of genotypic resistance patterns in HIV-1 subtype C infected patients in Botswana after failure of thymidine analogue-based regimens.

  Journal of the International AIDS Society 20090101

• Male perspectives on incorporating men into antenatal HIV counseling and testing.

  PloS one 20090101

• Oxidative imbalance in HIV-1 infected patients treated with antiretroviral therapy.

  Journal of biomedicine & biotechnology 20090101

• The contribution of family planning towards the prevention of vertical HIV transmission in Uganda.

  PloS one 20090101

• RT-SHIV subpopulation dynamics in infected macaques during anti-HIV therapy.

  Retrovirology 20090101

• Improving the coverage of the PMTCT programme through a participatory quality improvement intervention in South Africa.

  BMC public health 20090101

• RT-SHIV, an infectious CCR5-tropic chimeric virus suitable for evaluating HIV reverse transcriptase inhibitors in macaque models.

  AIDS research and therapy 20090101

• Treatment interruption after pregnancy: effects on disease progression and laboratory findings.

  Infectious diseases in obstetrics and gynecology 20090101

• The cost effectiveness of home-based provision of antiretroviral therapy in rural Uganda.

  Applied health economics and health policy 20090101

• Viral load decay in antiretroviral-naïve patients receiving once-daily tenofovir and emtricitabine plus twice-daily nevirapine.

  HIV clinical trials 20090101

• The prognosis of late presenters in the era of highly active antiretroviral therapy in serbia.

  The open virology journal 20090101

• Safety and efficacy of once-daily nevirapine dosing: a multicohort study.

  Antiviral therapy 20090101

• HIV prevention cost-effectiveness: a systematic review.

  BMC public health 20090101

• Factors influencing global antiretroviral procurement prices.

  BMC public health 20090101

• Addressing the migration of health professionals: the role of working conditions and educational placements.

  BMC public health 20090101

• Determination of lamivudine, zidovudine, and nevirapine in capillary blood sampled on filter paper by LC.

  Journal of chromatographic science 20090101

• Acceptability and effectiveness of chickpea sesame-based ready-to-use therapeutic food in malnourished HIV-positive adults.

  Patient preference and adherence 20090101

• Safety and tolerability of artemether-lumefantrine versus dihydroartemisinin-piperaquine for malaria in young HIV-infected and uninfected children.

  Malaria journal 20090101

• German-Austrian recommendations for HIV1-therapy in pregnancy and in HIV1-exposed newborn, update 2008.

  European journal of medical research 20090101

• Two standards of care for HIV: why are Africans being short-changed?

  Retrovirology 20090101

• Plasmodium falciparum infection significantly impairs placental cytokine profile in HIV infected Cameroonian women.

  PloS one 20090101

• The association between alcohol use, alcohol use disorders and tuberculosis (TB). A systematic review.

  BMC public health 20090101

• Hepatic profile analyses of tipranavir in Phase II and III clinical trials.

  BMC infectious diseases 20090101

• Early severe morbidity and resource utilization in South African adults on antiretroviral therapy.

  BMC infectious diseases 20090101

• HIV reverse transcriptase: structural interpretation of drug resistant genetic variants from India.

  Bioinformation 20090101

• HIV prevention is not enough: child survival in the context of prevention of mother to child HIV transmission.

  Journal of the International AIDS Society 20090101

• The adequacy of policy responses to the treatment needs of South Africans living with HIV (1999-2008): a case study.

  Journal of the International AIDS Society 20090101

• Long term outcomes of antiretroviral therapy in a large HIV/AIDS care clinic in urban South Africa: a prospective cohort study.

  Journal of the International AIDS Society 20090101

• The implications of policy changes on the uptake of a PMTCT programme in rural Malawi: first three years of experience.

  Global health action 20090101

• [Nevirapine as an important component of therapy for HIV infection].

  Voprosy virusologii 20090101

• Treatment outcomes and plasma level of ritonavir-boosted lopinavir monotherapy among HIV-infected patients who had NRTI and NNRTI failure.

  AIDS research and therapy 20090101

• Effectiveness and safety of antiretrovirals with rifampicin: crucial issues for high-burden countries.

  Antiviral therapy 20090101

• Evaluation of minority populations of HIV type-1 with K103N and M184V drug resistance mutations among children in Argentina.

  Antiviral therapy 20090101

• Progressive Multifocal Leukoencephalopathy in HIV-Infected Children: A Case Report and Literature Review.

  International journal of pediatrics 20090101

• Efficacy of first-line, WHO recommended generic HAART regimens in Indian children.

  Kathmandu University medical journal (KUMJ) 20090101

• Disfiguring molluscum contagiosum in a HIV-positive patient responding to antiretroviral therapy.

  Indian journal of dermatology 20090101

• Zidovudine induced pure red cell aplasia: a case report.

  Nigerian journal of medicine : journal of the National Association of Resident Doctors of Nigeria 20090101

• Kinetics and determining factors of the virologic response to antiretrovirals during pregnancy.

  Infectious diseases in obstetrics and gynecology 20090101

• Effect of HCV infection on glucose metabolism in pregnant women with HIV receiving HAART.

  HIV clinical trials 20090101

• A Rough Set-Based Model of HIV-1 Reverse Transcriptase Resistome.

  Bioinformatics and biology insights 20090101

• Flail arm-like syndrome associated with HIV-1 infection.

  Annals of Indian Academy of Neurology 20090101

• Long-term efficacy and safety of once-daily nevirapine in combination with tenofovir and emtricitabine in the treatment of HIV-infected patients: a 72-week prospective multicenter study (TENOR-trial).

  European journal of medical research 20090101

• Incidence and predictors of death, retention, and switch to second-line regimens in antiretroviral- treated patients in sub-Saharan African Sites with comprehensive monitoring availability.

  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20090101

• A young nonsmoker male patient with breathlessness.

  Lung India : official organ of Indian Chest Society 20090101

• Raltegravir: The evidence of its therapeutic value in HIV-1 infection.

  Core evidence 20090101

• Etravirine (TMC-125): The evidence for its place in the treatment of HIV-1 infection.

  Core evidence 20090101

• Cardiovascular, renal and liver events associated with human immunodeficiency virus type 1 infection and antiretroviral therapy.

  F1000 medicine reports 20090101

• Rapid and persistent selection of the K103N mutation as a majority quasispecies in a HIV1-patient exposed to efavirenz for three weeks: a case report and review of the literature.

  Journal of medical case reports 20090101

• Pharmacotherapeutic options for visceral leishmaniasis-current scenario.

  Clinical medicine. Pathology 20090101

• Persistent high nevirapine blood level with DRESS syndrome 12 days after interruption of antiretroviral therapy.

  BMJ case reports 20090101

• CCR5 inhibitors: Emerging promising HIV therapeutic strategy.

  Indian journal of sexually transmitted diseases and AIDS 20090101

• Clinico-epidemiological profile of HIV/TB coinfected patients in Vadodara, Gujarat.

  Indian journal of sexually transmitted diseases and AIDS 20090101

• Progressive varicella syndrome in the setting of pediatric AIDS: An eye opener.

  Indian journal of sexually transmitted diseases and AIDS 20090101

• Pregnancy and sexually transmitted viral infections.

  Indian journal of sexually transmitted diseases and AIDS 20090101

• Papular pruritic eruptions: A marker of progressive HIV disease in children: Experience from eastern India.

  Indian journal of sexually transmitted diseases and AIDS 20090101

• Pharmacologic and nonpharmacologic options for the management of HIV infection during pregnancy.

  HIV/AIDS (Auckland, N.Z.) 20090101

• Limited-sampling strategies for anti-infective agents: systematic review.

  The Canadian journal of hospital pharmacy 20090101

• Development and preclinical studies of broad-spectrum anti-HIV agent (3'R,4'R)-3-cyanomethyl-4-methyl-3',4'-di-O-(S)-camphanoyl-(+)-cis-khellactone (3-cyanomethyl-4-methyl-DCK).

  Journal of medicinal chemistry 20081225

• Development of phenotypic HIV-1 drug resistance after exposure to single-dose nevirapine.

  Journal of acquired immune deficiency syndromes (1999) 20081215

• Effects of the HIV treatment drugs nevirapine and efavirenz on brain creatine kinase activity.

  Metabolic brain disease 20081201

• An HPLC-PDA method for the simultaneous quantification of the HIV integrase inhibitor raltegravir, the new nonnucleoside reverse transcriptase inhibitor etravirine, and 11 other antiretroviral agents in the plasma of HIV-infected patients.

  Therapeutic drug monitoring 20081201

• Substitution of the myristoylation signal of human immunodeficiency virus type 1 Pr55Gag with the phospholipase C-delta1 pleckstrin homology domain results in infectious pseudovirion production.

  The Journal of general virology 20081201

• Infant-feeding practices among HIV-infected mothers in an HIV-treatment programme.

  Journal of health, population, and nutrition 20081201

• Prevalence of nevirapine-associated resistance mutations after single dose prophylactic treatment among antenatal clinic attendees in north rift Kenya.

  AIDS research and human retroviruses 20081201

• Estimating the lost benefits of antiretroviral drug use in South Africa.

  Journal of acquired immune deficiency syndromes (1999) 20081201

• [Clinical safety of a generic fixed-dose combination of stavudine/lamivudine/névirapine (Triomune). Study of 297 cases in Togo].

  Bulletin de la Societe de pathologie exotique (1990) 20081201

• Switch to Viramune safe for some who can't tolerate Sustiva.

  Project Inform perspective 20081201

• Effect of highly active antiretroviral therapy on CD4 count and weight in AIDS patients seen at the UITH, Ilorin.

  Nigerian journal of clinical practice 20081201

• Increase of R-/S-methadone enantiomer concentration ratio in serum of patients treated with either nevirapine or efavirenz.

  Drug metabolism letters 20081201

• Therapeutic drug monitoring of nevirapine in resource-limited settings.

  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20081115

• Biochemistry. RT slides home..

  Science (New York, N.Y.) 20081114

• Slide into action: dynamic shuttling of HIV reverse transcriptase on nucleic acid substrates.

  Science (New York, N.Y.) 20081114

• Determining an optimal testing strategy for infants at risk for mother-to-child transmission of HIV-1 during the late postnatal period.

  AIDS (London, England) 20081112

• Efficacy and tolerability of nevirapine- versus efavirenz-containing regimens in HIV-infected Thai children.

  International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases 20081101

• Steady-state pharmacokinetic comparison of generic and branded formulations of stavudine, lamivudine and nevirapine in HIV-infected Ugandan adults.

  The Journal of antimicrobial chemotherapy 20081101

• Prevalence of etravirine-associated mutations in clinical samples with resistance to nevirapine and efavirenz.

  The Journal of antimicrobial chemotherapy 20081101

• Nevirapine induces growth arrest and premature senescence in human cervical carcinoma cells.

  Gynecologic oncology 20081101

• Human immunodeficiency virus-infected boy with Stevens-Johnson syndrome caused by nevirapine.

  The Pediatric infectious disease journal 20081101

• Inhibition of the CRM1-mediated nucleocytoplasmic transport by N-azolylacrylates: structure-activity relationship and mechanism of action.

  Bioorganic & medicinal chemistry 20081101

• Towards novel S-DABOC inhibitors: synthesis, biological investigation, and molecular modeling studies.

  Bioorganic & medicinal chemistry letters 20081101

• Safety and efficacy of initiating highly active antiretroviral therapy in an integrated antenatal and HIV clinic in Johannesburg, South Africa.

  Journal of acquired immune deficiency syndromes (1999) 20081101

• Infant feeding, HIV transmission and mortality at 18 months: the need for appropriate choices by mothers and prioritization within programmes.

  AIDS (London, England) 20081101

• HIV pharmacogenetics in clinical practice: recent achievements and future challenges.

  Current HIV research 20081101

• HIV type 1 subtype C drug resistance among pediatric and adult South African patients failing antiretroviral therapy.

  AIDS research and human retroviruses 20081101

• Does short-term virologic failure translate to clinical events in antiretroviral-naïve patients initiating antiretroviral therapy in clinical practice?

  AIDS (London, England) 20081101

• [Role of the new molecules in antiretroviral therapy. Position of raltegravir].

  Enfermedades infecciosas y microbiologia clinica 20081101

• Impact of traditional medicinal plant extracts on antiretroviral drug absorption.

  Journal of ethnopharmacology 20081028

• Antiretroviral prophylaxis to reduce breast-milk HIV-1 transmission.

  The New England journal of medicine 20081023

• Bayesian network analyses of resistance pathways against efavirenz and nevirapine.

  AIDS (London, England) 20081018

• Efavirenz versus nevirapine-based initial treatment of HIV infection: clinical and virological outcomes in Southern African adults.

  AIDS (London, England) 20081018

• 1,2,3-Thiadiazole thioacetanilides as a novel class of potent HIV-1 non-nucleoside reverse transcriptase inhibitors.

  Bioorganic & medicinal chemistry letters 20081015

• Validity and comparison of two measures of days supply in Medicaid claims data.

  Pharmacoepidemiology and drug safety 20081001

• Once- or twice-daily dosing of nevirapine in HIV-infected adults: a population pharmacokinetics approach.

  The Journal of antimicrobial chemotherapy 20081001

• Effect of haematological alterations on thalassaemia investigation in HIV-1-infected Thai patients receiving antiretroviral therapy.

  HIV medicine 20081001

• Secure antiretroviral therapy delivery in a resource-limited setting: streamlined to minimize drug resistance and expense.

  HIV medicine 20081001

• Switching from suppressive protease inhibitor-based regimens to nevirapine-based regimens: a meta-analysis of randomized controlled trials.

  HIV medicine 20081001

• Mother-to-child transmission of HIV-1: association with malaria prevention, anaemia and placental malaria.

  HIV medicine 20081001

• Analysis of nevirapine (NVP) resistance in Ugandan infants who were HIV infected despite receiving single-Dose (SD) NVP versus SD NVP plus daily NVP up to 6 weeks of age to prevent HIV vertical transmission.

  The Journal of infectious diseases 20081001

• Trough concentrations of lopinavir, nelfinavir, and nevirapine with standard dosing in human immunodeficiency virus-infected pregnant women receiving 3-drug combination regimens.

  Therapeutic drug monitoring 20081001

• Studies on antiretroviral drug concentrations in breast milk: validation of a liquid chromatography-tandem mass spectrometric method for the determination of 7 anti-human immunodeficiency virus medications.

  Therapeutic drug monitoring 20081001

• Combination antiretroviral therapy with tenofovir, emtricitabine or lamivudine, and nevirapine.

  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20081001

• Liver enzymes improve over twenty-four months of first-line non-nucleoside reverse transcriptase inhibitor-based therapy in rural Uganda.

  AIDS patient care and STDs 20081001

• Two for the price of one.

  International journal of STD & AIDS 20081001

• Bullous skin eruption in an HIV patient during antiretroviral drugs therapy.

  Dermatologic therapy 20081001

• Lopinavir/ritonavir in the treatment of HIV-1 infection: a review.

  Therapeutics and clinical risk management 20081001

• Miscellaneous.

  Indian journal of pharmacology 20081001

• Clinical pharmacology.

  Indian journal of pharmacology 20081001

• Pharmacovigilance and pharmacoepidemiology.

  Indian journal of pharmacology 20081001

• Antiretroviral therapy in pregnant women with advanced HIV disease and pregnancy outcomes in Abidjan, Côte d'Ivoire.

  AIDS (London, England) 20080912

• Validation of the Accutrend lactate meter for hyperlactatemia screening during antiretroviral therapy in a resource-poor setting.

  International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases 20080901

• A survey of the syntheses of active pharmaceutical ingredients for antiretroviral drug combinations critical to access in emerging nations.

  Antiviral research 20080901

• Serious toxicity associated with continuous nevirapine-based HAART in pregnancy.

  BJOG : an international journal of obstetrics and gynaecology 20080901

• Fatal outcome of nevirapine-associated toxic epidermal necrolysis.

  International journal of STD & AIDS 20080901

• Demonstration of the metabolic pathway responsible for nevirapine-induced skin rash.

  Chemical research in toxicology 20080901

• Analysis of nevirapine resistance mutations in cloned HIV type 1 variants from HIV-infected Ugandan infants using a single-step amplification-sequencing method (AmpliSeq).

  AIDS research and human retroviruses 20080901

• Dominican Children with HIV not Receiving Antiretrovirals: Massage Therapy Influences their Behavior and Development.

  Evidence-based complementary and alternative medicine : eCAM 20080901

• Correlation between HIV-1 RNA load in blood and seminal plasma depending on antiretroviral treatment status, regimen and penetration of semen by antiretroviral drugs.

  Current HIV research 20080901

• HIV infection in the elderly.

  Clinical interventions in aging 20080901

• Torsade de pointes caused by polypharmacy and substance abuse in a patient with human immunodeficiency virus.

  International journal of emergency medicine 20080901

• Structural basis for the improved drug resistance profile of new generation benzophenone non-nucleoside HIV-1 reverse transcriptase inhibitors.

  Journal of medicinal chemistry 20080828

• Hematologic and hepatic toxicities associated with antenatal and postnatal exposure to maternal highly active antiretroviral therapy among infants.

  AIDS (London, England) 20080820

• Nevirapine resistance in women and infants after first versus repeated use of single-dose nevirapine for prevention of HIV-1 vertical transmission.

  The Journal of infectious diseases 20080815

• 5-Alkyl-6-benzyl-2-(2-oxo-2-phenylethylsulfanyl)pyrimidin-4(3H)-ones, a series of anti-HIV-1 agents of the dihydro-alkoxy-benzyl-oxopyrimidine family with peculiar structure-activity relationship profile.

  Journal of medicinal chemistry 20080814

• Outcomes of nevirapine- and efavirenz-based antiretroviral therapy when coadministered with rifampicin-based antitubercular therapy.

  JAMA 20080806

• Triple antiretroviral therapy improves psoriasis associated with human immunodeficiency virus infection: a clinico-therapeutic experience.

  Journal of the European Academy of Dermatology and Venereology : JEADV 20080801

• Neutralizing antibody and anti-retroviral drug sensitivities of HIV-1 isolates resistant to small molecule CCR5 inhibitors.

  Virology 20080801

• Pharmacokinetics and therapeutic drug monitoring of antiretrovirals in pregnant women.

  British journal of clinical pharmacology 20080801

• Efavirenz replacement by immediate full-dose nevirapine is safe in HIV-1-infected patients in Cambodia.

  HIV medicine 20080801

• Quality of antenatal and delivery care before and after the implementation of a prevention of mother-to-child HIV transmission programme in Côte d'Ivoire.

  Tropical medicine & international health : TM & IH 20080801

• Novel N1-substituted 1,3-dihydro-2H-benzimidazol-2-ones as potent non-nucleoside reverse transcriptase inhibitors.

  Bioorganic & medicinal chemistry 20080801

• Efavirenz in human breast milk, mothers', and newborns' plasma.

  Journal of acquired immune deficiency syndromes (1999) 20080801

• Lymphocyte mitochondrial depolarization and apoptosis in HIV-1-infected HAART patients.

  Journal of acquired immune deficiency syndromes (1999) 20080801

• Determination of unbound antiretroviral drug concentrations by a modified ultrafiltration method reveals high variability in the free fraction.

  Therapeutic drug monitoring 20080801

• The Spectrum projection package: improvements in estimating mortality, ART needs, PMTCT impact and uncertainty bounds.

  Sexually transmitted infections 20080801

• Estimating the number of HIV infections averted: an approach and its issues.

  Sexually transmitted infections 20080801

• FDA notifications. FDA approves label change for nevirapine.

  AIDS alert 20080801

• [Study on anti-HIV-1 activities of composite extract from salvia yunnanensis].

  Zhongguo Zhong xi yi jie he za zhi Zhongguo Zhongxiyi jiehe zazhi = Chinese journal of integrated traditional and Western medicine 20080801

• The Relationship Between HIV Infection and Cardiovascular Disease.

  Current cardiology reviews 20080801

• HIV-1 persists in breast milk cells despite antiretroviral treatment to prevent mother-to-child transmission.

  AIDS (London, England) 20080731

• Hepatotoxicity in patients prescribed efavirenz or nevirapine.

  European journal of medical research 20080728

• Extended nevirapine prophylaxis to prevent HIV transmission.

  Lancet (London, England) 20080726

• SWEN--when authors disagree.

  Lancet (London, England) 20080726

• Nevirapine to prevent HIV transmission via breastfeeding.

  Lancet (London, England) 20080726

• Extended-dose nevirapine to 6 weeks of age for infants to prevent HIV transmission via breastfeeding in Ethiopia, India, and Uganda: an analysis of three randomised controlled trials.

  Lancet (London, England) 20080726

• Selective targeting of the HIV-1 reverse transcriptase catalytic complex through interaction with the 'primer grip' region by pyrrolobenzoxazepinone non-nucleoside inhibitors correlates with increased activity towards drug-resistant mutants.

  Biochemical pharmacology 20080715

• Early virological suppression with three-class antiretroviral therapy in HIV-infected African infants.

  AIDS (London, England) 20080711

• Extended antiretroviral prophylaxis to reduce breast-milk HIV-1 transmission.

  The New England journal of medicine 20080710

• Breast-feeding, antiretroviral prophylaxis, and HIV.

  The New England journal of medicine 20080710

• Prevalence and predictors of metabolic syndrome among HIV-infected and HIV-uninfected women in the Women's Interagency HIV Study.

  Journal of acquired immune deficiency syndromes (1999) 20080701

• Prevalence of infection with hepatitis B and C virus and coinfection with HIV in medical inpatients in Malawi.

  The Journal of infection 20080701

• Low male partner participation in antenatal HIV counselling and testing in northern Tanzania: implications for preventive programs.

  AIDS care 20080701

• A multimodal, evidence-based approach to achieve lipid targets in the treatment of antiretroviral-associated dyslipidemia: case report and review of the literature.

  Pharmacotherapy 20080701

• Possible antiretroviral therapy-warfarin drug interaction.

  Pharmacotherapy 20080701

• Synthesis and characterization of DNA adducts from the HIV reverse transcriptase inhibitor nevirapine.

  Chemical research in toxicology 20080701

• Extra drugs and slower weaning lowers HIV risk for newborns.

  Nature medicine 20080701

• Public-health and individual approaches to antiretroviral therapy: township South Africa and Switzerland compared.

  PLoS medicine 20080701

• HIV and obstetric complications and fetal outcomes in Vellore, India.

  Tropical doctor 20080701

• Outlook on Thailand's genomics and computational biology research and development.

  PLoS computational biology 20080701

• Labeling changes for Viramune.

  AIDS patient care and STDs 20080701

• Minority HIV-1 drug resistance mutations are present in antiretroviral treatment-naïve populations and associate with reduced treatment efficacy.

  PLoS medicine 20080701

• Transmitted minority drug-resistant HIV variants: a new epidemic?

  PLoS medicine 20080701

• Concomitant use of nonnucleoside analogue reverse transcriptase inhibitors and rifampicin in TB/HIV type 1-coinfected patients.

  AIDS research and human retroviruses 20080701

• FDA notifications. FDA: tentative approval of generic nevirapine.

  AIDS alert 20080701

• Clinical manifestations and antiretroviral management of HIV/AIDS patients with tuberculosis co-infection in Kramat 128 Hospital.

  Acta medica Indonesiana 20080701

• [Prevention of mother-to-child transmission with single dose nevirapine and human immunodeficiency virus drug resistance].

  Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi 20080701

• Reverse transcriptase inhibitors induce cell differentiation and enhance the immunogenic phenotype in human renal clear-cell carcinoma.

  International journal of cancer 20080615

• Durability and outcome of initial antiretroviral treatments received during 2000--2005 by patients in the Swiss HIV Cohort Study.

  The Journal of infectious diseases 20080615

• Prediction and identification of drug interactions with the human ATP-binding cassette transporter multidrug-resistance associated protein 2 (MRP2; ABCC2).

  Journal of medicinal chemistry 20080612

• Uncomplicated outcome after an accidental overdose of nevirapine in a newborn.

  European journal of pediatrics 20080601

• Non-nucleoside HIV-1 reverse transcriptase inhibitors. Part 11: structural modulations of diaryltriazines with potent anti-HIV activity.

  European journal of medicinal chemistry 20080601

• Structural basis for drug resistance mechanisms for non-nucleoside inhibitors of HIV reverse transcriptase.

  Virus research 20080601

• Potent synergistic anti-human immunodeficiency virus (HIV) effects using combinations of the CCR5 inhibitor aplaviroc with other anti-HIV drugs.

  Antimicrobial agents and chemotherapy 20080601

• Zidovudine with nevirapine for the prevention of HIV mother-to-child transmission reduces nevirapine resistance in mothers from the Western Cape, South Africa.

  Journal of medical virology 20080601

• Human immunodeficiency virus-infected boy with Stevens-Johnson syndrome caused by nevirapine.

  The Pediatric infectious disease journal 20080601

• Effects of HIV antiretrovirals on the pharmacokinetics of hormonal contraceptives.

  The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception 20080601

• Long-term efficacy and tolerance of efavirenz- and nevirapine-containing regimens in adult HIV type 1 Senegalese patients.

  AIDS research and human retroviruses 20080601

• Study of the genotypic resistant pattern in HIV-infected women and children from rural west Cameroon.

  AIDS research and human retroviruses 20080601

• Adherence to antiretroviral therapy assessed by drug level monitoring and self-report in cameroon.

  Journal of acquired immune deficiency syndromes (1999) 20080601

• Addition of single-dose tenofovir and emtricitabine to intrapartum nevirapine to reduce perinatal HIV transmission.

  Journal of acquired immune deficiency syndromes (1999) 20080601

• Pharmacogenomics of antiretrovirals.

  Recent patents on anti-infective drug discovery 20080601

• A review of the prevention of mother-to-child transmission programme of the Western Cape provincial government, 2003 - 2004.

  South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde 20080601

• Prevention of mother-to-child transmission of HIV programme: low vertical transmission in KwaZulu-Natal, South Africa.

  South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde 20080601

• The cost-effectiveness analysis of initiating HIV/AIDS treatment with efavirenz-based regimens compared with nevirapine-based regimens in Thailand.

  Journal of the Medical Association of Thailand = Chotmaihet thangphaet 20080601

• Paediatric and perinatal HIV/AIDS in Jamaica an international leadership initiative, 2002-2007.

  The West Indian medical journal 20080601

• Evolving care of HIV-infected pregnant women in Jamaica--from nevirapine to HAART.

  The West Indian medical journal 20080601

• Adherence to antiretroviral drug therapy in children with HIV/AIDS in Jamaica.

  The West Indian medical journal 20080601

• A review of drug patch testing and implications for HIV clinicians.

  AIDS (London, England) 20080531

• Plasma drug concentrations and virologic evaluations after stopping treatment with nonnucleoside reverse-transcriptase inhibitors in HIV type 1-infected children.

  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20080515

• Quantification of protease inhibitors and non-nucleoside reverse transcriptase inhibitors in dried blood spots by liquid chromatography-triple quadrupole mass spectrometry.

  Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20080515

• Population-level effect of HIV on adult mortality and early evidence of reversal after introduction of antiretroviral therapy in Malawi.

  Lancet (London, England) 20080510

• Estimating vertically acquired HIV infections and the impact of the prevention of mother-to-child transmission program in Zimbabwe: insights from decision analysis models.

  Journal of acquired immune deficiency syndromes (1999) 20080501

• Uptake of HIV and syphilis testing of pregnant women and their male partners in a programme for prevention of mother-to-child HIV transmission in Uganda.

  Tropical medicine & international health : TM & IH 20080501

• Haematological changes after switching from stavudine to zidovudine in HIV-infected children receiving highly active antiretroviral therapy.

  HIV medicine 20080501

• Feasibility of prevention of perinatal HIV infection by nevirapine in rural areas of the northeast Democratic Republic of Congo, 2002-2004.

  Journal of medical virology 20080501

• Standard-dose efavirenz vs. standard-dose nevirapine in antiretroviral regimens among HIV-1 and tuberculosis co-infected patients who received rifampicin.

  HIV medicine 20080501

• Antiretroviral drug resistance among antiretroviral-naïve persons with recent HIV infection in Thailand.

  HIV medicine 20080501

• Impact of round-the-clock, rapid oral fluid HIV testing of women in labor in rural India.

  PLoS medicine 20080501

• The compound 6-chloro-1,4-dihydro-4-oxo-1-(beta-D-ribofuranosyl) quinoline-3-carboxylic acid inhibits HIV-1 replication by targeting the enzyme reverse transcriptase.

  Current HIV research 20080501

• The ancillary-care obligations of medical researchers working in developing countries.

  PLoS medicine 20080501

• Pharmacy refill adherence compared with CD4 count changes for monitoring HIV-infected adults on antiretroviral therapy.

  PLoS medicine 20080501

• A paradigm shift to prevent HIV drug resistance.

  PLoS medicine 20080501

• [Toxicogenetics of antiretroviral treatment (II): neurotoxicity, hepatotoxicity, lactic acidosis, kidney damage, and other adverse effects of antiretroviral drugs].

  Enfermedades infecciosas y microbiologia clinica 20080501

• [Applicability of pharmacogenetic studies in daily clinical practice].

  Enfermedades infecciosas y microbiologia clinica 20080501

• Interactions between antiretroviral agents and those used to treat tuberculosis.

  Current opinion in HIV and AIDS 20080501

• [Reliable effectiveness for years with good long-term tolerance: 10 years nevirapine--a summary].

  MMW Fortschritte der Medizin 20080428

• Outcomes from monitoring of patients on antiretroviral therapy in resource-limited settings with viral load, CD4 cell count, or clinical observation alone: a computer simulation model.

  Lancet (London, England) 20080426

• Rapid scaling-up of antiretroviral therapy in 10,000 adults in Côte d'Ivoire: 2-year outcomes and determinants.

  AIDS (London, England) 20080423

• Severe renal dysfunction and risk factors associated with renal impairment in HIV-infected adults in Africa initiating antiretroviral therapy.

  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20080415

• Factors associated with the emergence of K65R in patients with HIV-1 infection treated with combination antiretroviral therapy containing tenofovir.

  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20080415

• Anti-HIV activity and resistance profile of the CXC chemokine receptor 4 antagonist POL3026.

  Molecular pharmacology 20080401

• Diagnosis and management of HIV drug hypersensitivity.

  The Journal of allergy and clinical immunology 20080401

• Synthesis and anti-HIV activity evaluation of novel 2,4-disubstituted 7-methyl-1,1,3-trioxo-2,4-dihydro-pyrazolo-[4,5-e][1,2]thiadiazines.

  Archiv der Pharmazie 20080401

• Impact of CYP2B6 983T>C polymorphism on non-nucleoside reverse transcriptase inhibitor plasma concentrations in HIV-infected patients.

  The Journal of antimicrobial chemotherapy 20080401

• Recent availability of two novel, fixed formulations of antiretroviral nucleoside analogues: a 12-month prospective, open-label survey of their practical use and therapeutic perspectives in antiretroviral-naive and -experienced patients.

  AIDS patient care and STDs 20080401

• Improvement in allele-specific PCR assay with the use of polymorphism-specific primers for the analysis of minor variant drug resistance in HIV-1 subtype C.

  Journal of virological methods 20080401

• From PMTCT to a more comprehensive AIDS response for women: a much-needed shift.

  Developing world bioethics 20080401

• Prevalence and risk factors for developing K65R mutations among HIV-1 infected patients who fail an initial regimen of fixed-dose combination of stavudine, lamivudine, and nevirapine.

  Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology 20080401

• Skin prick test reactivity to common allergens among women in Entebbe, Uganda.

  Transactions of the Royal Society of Tropical Medicine and Hygiene 20080401

• A novel probe drug interaction study to investigate the effect of selected antiretroviral combinations on the pharmacokinetics of a single oral dose of maraviroc in HIV-positive subjects.

  British journal of clinical pharmacology 20080401

• Nevirapine-induced Stevens-Johnson syndrome in an HIV patient.

  Cornea 20080401

• Chronic administration of nevirapine during pregnancy: impact of pregnancy on pharmacokinetics.

  HIV medicine 20080401

• Hepatotoxicity of nevirapine in virologically suppressed patients according to gender and CD4 cell counts.

  HIV medicine 20080401

• Steady-state nevirapine plasma concentrations are influenced by pregnancy.

  HIV medicine 20080401

• Comparison of LigAmp and an ASPCR assay for detection and quantification of K103N-containing HIV variants.

  AIDS research and human retroviruses 20080401

• Spectrum of adverse events after generic HAART in southern Indian HIV-infected patients.

  AIDS patient care and STDs 20080401

• Risk of early virological failure of once-daily tenofovir-emtricitabine plus twice-daily nevirapine in antiretroviral therapy-naive HIV-infected patients.

  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20080401

• Inhibition of HIV-1 protease and RNase H of HIV-1 reverse transcriptase activities by long chain phenols from the sarcotestas of Ginkgo biloba.

  Planta medica 20080401

• [Evaluation of antiretroviral therapy in HIV-infected adults in the Department of Haematology, University Hospital of Brazzavllle, Congo].

  Bulletin de la Societe de pathologie exotique (1990) 20080401

• Voluntary counselling and testing (VCT) uptake, nevirapine use and infant feeding options at the University of Nigeria Teaching Hospital.

  Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology 20080401

• Infant feeding practices among HIV infected women receiving prevention of mother-to-child transmission services at Kitale District Hospital, Kenya.

  East African medical journal 20080401

• 'One pill, once daily': what clinicians need to know about Atriplatrade mark.

  Therapeutics and clinical risk management 20080401

• Association of antiretroviral therapy with fibrinogen levels in HIV-infection.

  AIDS (London, England) 20080330

• Discontinuation of nevirapine because of hypersensitivity reactions in patients with prior treatment experience, compared with treatment-naive patients: the ATHENA cohort study.

  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20080315

• Nevirapine, stavudine and lamivudine pharmacokinetics in African children on paediatric fixed-dose combination tablets.

  AIDS (London, England) 20080312

• Monitoring the development of non-nucleoside reverse transcriptase inhibitor-associated resistant HIV-1 using an electrochemiluminescence-based reverse transcriptase polymerase assay.

  Analytical biochemistry 20080301

• Lipodystrophy and weight changes: data from the Swiss HIV Cohort Study, 2000-2006.

  HIV medicine 20080301

• Determination of abacavir, amprenavir, didanosine, efavirenz, nevirapine, and stavudine concentration in human plasma by MALDI-TOF/TOF.

  Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20080301

• Response to Birbeck et al.

  Epilepsia 20080301

• Mortality in HIV-infected Ugandan adults receiving antiretroviral treatment and survival of their HIV-uninfected children: a prospective cohort study.

  Lancet (London, England) 20080301

• Tolerability and effectiveness of first-line regimens combining nevirapine and lamivudine plus zidovudine or stavudine in Cameroon.

  AIDS research and human retroviruses 20080301

• Emergence of an NNRTI resistance mutation Y181C in an HIV-infected NNRTI-naive patient.

  AIDS research and human retroviruses 20080301

• The impact of monitoring HIV patients prior to treatment in resource-poor settings: insights from mathematical modelling.

  PLoS medicine 20080301

• Trial studies extended release Viramune.

  AIDS patient care and STDs 20080301

• Syncope as a probable side effect to combination antiretroviral therapy initiated during primary HIV-1 infection.

  Sexual health 20080301

• Changes in lipid profile over 24 months among adults on first-line highly active antiretroviral therapy in the home-based AIDS care program in rural Uganda.

  Journal of acquired immune deficiency syndromes (1999) 20080301

• Temporal and lateral dynamics of HIV shedding and elevated sodium in breast milk among HIV-positive mothers during the first 4 months of breast-feeding.

  Journal of acquired immune deficiency syndromes (1999) 20080301

• Nevirapine concentrations in newborns receiving an extended prophylactic regimen.

  Journal of acquired immune deficiency syndromes (1999) 20080301

• Impact of placental Plasmodium falciparum malaria on pregnancy and perinatal outcome in sub-Saharan Africa: part III: placental malaria, maternal health, and public health.

  The Yale journal of biology and medicine 20080301

• The spectrum of liver diseases in HIV infected individuals at an HIV treatment clinic in Kampala, Uganda.

  African health sciences 20080301

• Prevention of mother-to-child transmission, drug resistance, and implications for response to therapy.

  Current opinion in HIV and AIDS 20080301

• The estimated burden of HIV/AIDS in Uganda, 2005-2010.

  AIDS (London, England) 20080219

• HLA-DRB1*01 associated with cutaneous hypersensitivity induced by nevirapine and efavirenz.

  AIDS (London, England) 20080219

• Is nevirapine-based therapy discontinuation in hepatitis C co-infected patients a more important mortality determinant than hypersensitivity: authors' reply.

  AIDS (London, England) 20080219

• Maternal 12-month response to antiretroviral therapy following prevention of mother-to-child transmission of HIV type 1, Ivory Coast, 2003-2006.

  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20080215

• Investigation of the alkenyldiarylmethane non-nucleoside reverse transcriptase inhibitors as potential cAMP phosphodiesterase-4B2 inhibitors.

  Bioorganic & medicinal chemistry letters 20080215

• A grave delay for South Africa's mothers and infants.

  Lancet (London, England) 20080202

• Effect of rifampicin-based antitubercular therapy on nevirapine plasma concentrations in South African adults with HIV-associated tuberculosis.

  The Journal of antimicrobial chemotherapy 20080201

• 3D-QSAR models on clinically relevant K103N mutant HIV-1 reverse transcriptase obtained from two strategic considerations.

  Bioorganic & medicinal chemistry letters 20080201

• Energetic effects for observed and unobserved HIV-1 reverse transcriptase mutations of residues L100, V106, and Y181 in the presence of nevirapine and efavirenz.

  Bioorganic & medicinal chemistry letters 20080201

• Pharmacogenetics and the potential for the individualization of antiretroviral therapy.

  Current opinion in infectious diseases 20080201

• A European study of HLA-B in Stevens-Johnson syndrome and toxic epidermal necrolysis related to five high-risk drugs.

  Pharmacogenetics and genomics 20080201

• Safety and tolerability of depot medroxyprogesterone acetate among HIV-infected women on antiretroviral therapy: ACTG A5093.

  Contraception 20080201

• Impact of nevirapine or efavirenz co-administration on ritonavir-boosted amprenavir pharmacokinetics in HIV-infected patients.

  Fundamental & clinical pharmacology 20080201

• A radiolabeled oligonucleotide ligation assay demonstrates the high frequency of nevirapine resistance mutations in HIV type 1 quasispecies of NVP-treated and untreated mother-infant pairs from Uganda.

  AIDS research and human retroviruses 20080201

• Incidence of nevirapine-associated hepatitis in an antenatal clinic.

  South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde 20080201

• Pharmacogenetic information derived from analysis of HLA alleles.

  Pharmacogenomics 20080201

• Characteristics of pregnancy with human immuno-deficiency virus (HIV) and perinatal transmission in Nakornping Hospital.

  Journal of the Medical Association of Thailand = Chotmaihet thangphaet 20080201

• Incidence and risk factors of nevirapine-associated severe hepatitis among HIV-infected patients with CD4 cell counts less than 250 cells/microL.

  Journal of the Medical Association of Thailand = Chotmaihet thangphaet 20080201

• [Disseminated cutaneous histoplasmosis due to Histoplasma capsulatum var. duboisii associated with AIDS. A case report in Abidjan, Côte d'Ivoire].

  Bulletin de la Societe de pathologie exotique (1990) 20080201

• [Polyneuropathies in patients treated with HAART in Bobo-Dioulasso hospital, Burkina Faso].

  Bulletin de la Societe de pathologie exotique (1990) 20080201

• Comparison of genotypic resistance profiles and virological response between patients starting nevirapine and efavirenz in EuroSIDA.

  AIDS (London, England) 20080130

• Is nevirapine-based therapy discontinuation in hepatitis C co-infected patients a more important mortality determinant than hypersensitivity.

  AIDS (London, England) 20080130

• Zidovudine/lamivudine contributes to insulin resistance within 3 months of starting combination antiretroviral therapy.

  AIDS (London, England) 20080111

• Mechanism of inhibition of HIV-1 reverse transcriptase by the novel broad-range DNA polymerase inhibitor N-{2-[4-(aminosulfonyl)phenyl]ethyl}-2-(2-thienyl)acetamide.

  Biochemistry 20080108

• Stevens-Johnson syndrome and toxic epidermal necrolysis: assessment of medication risks with emphasis on recently marketed drugs. The EuroSCAR-study.

  The Journal of investigative dermatology 20080101

• Synthesis and anti-HIV evaluation of novel 1,3-disubstituted thieno[3,2-c][1,2,6]thiadiazin-4(3H)-one 2,2-dioxides(TTDDs).

  Bioorganic & medicinal chemistry 20080101

• Once-daily dosing of nevirapine in HAART.

  The Journal of antimicrobial chemotherapy 20080101

• Pattern recognition based on color-coded quantum mechanical surfaces for molecular alignment.

  Journal of molecular modeling 20080101

• A rapid and validated HPLC method to quantify racecadotril metabolite, thiorphan, in human plasma using solid-phase extraction.

  Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20080101

• Bilateral renal aspergillosis in a patient with AIDS: a case report and review of reported cases.

  AIDS patient care and STDs 20080101

• Association between exposure to nevirapine and reduced liver fibrosis progression in patients with HIV and hepatitis C virus coinfection.

  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20080101

• Extensive hypopigmentation after starting antiretroviral treatment in an human immunodeficiency virus (HIV)-seropositive African woman.

  International journal of dermatology 20080101

• Oral adverse effects due to the use of Nevirapine.

  The journal of contemporary dental practice 20080101

• Antiretroviral therapy in the Malawi defence force: access, treatment outcomes and impact on mortality.

  PloS one 20080101

• Antiretroviral pre-exposure prophylaxis prevents vaginal transmission of HIV-1 in humanized BLT mice.

  PLoS medicine 20080101

• Risk of side effects associated with the use of nevirapine in treatment-naïve patients, with respect to gender and CD4 cell count.

  HIV medicine 20080101

• Patterns and predictors of the use of different antiretroviral drug regimens at treatment initiation in the UK.

  HIV medicine 20080101

• Nevirapine-associated toxicity in Niger.

  HIV medicine 20080101

• Going beyond efficacy: strategies for cancer pain management.

  Current oncology (Toronto, Ont.) 20080101

• Outputs, cost and efficiency of public sector centres for prevention of mother to child transmission of HIV in Andhra Pradesh, India.

  BMC health services research 20080101

• Highly active antiretroviral therapy does not affect mitochondrial beta-oxidation of fatty acids: an in vitro study in fibroblasts.

  Pediatric and developmental pathology : the official journal of the Society for Pediatric Pathology and the Paediatric Pathology Society 20080101

• The incidence of multidrug and full class resistance in HIV-1 infected patients is decreasing over time (2001-2006) in Portugal.

  Retrovirology 20080101

• Nucleoside analogue reverse transcriptase inhibitors differentially inhibit human LINE-1 retrotransposition.

  PloS one 20080101

• Implementation and effectiveness of antiretroviral therapy in Greenland.

  Emerging infectious diseases 20080101

• The cost of antiretroviral therapy in Haiti.

  Cost effectiveness and resource allocation : C/E 20080101

• Anaemia in acute HIV-1 subtype C infection.

  PloS one 20080101

• 18-month effectiveness of short-course antiretroviral regimens combined with alternatives to breastfeeding to prevent HIV mother-to-child transmission.

  PloS one 20080101

• Risk factors for nevirapine-associated rash among HIV-infected patients with low CD4 cell counts in resource-limited settings.

  Current HIV research 20080101

• Twenty-four-week safety and tolerability of nevirapine vs. abacavir in combination with zidovudine/lamivudine as first-line antiretroviral therapy: a randomized double-blind trial (NORA).

  Tropical medicine & international health : TM & IH 20080101

• Adaptation of antiretroviral therapy in human immunodeficiency virus infection with central nervous system involvement.

  Journal of neurovirology 20080101

• Nevirapine-induced Stevens-Johnson syndrome in a pediatric patient.

  Pediatric dermatology 20080101

• Longitudinal microarray analysis of cell surface antigens on peripheral blood mononuclear cells from HIV+ individuals on highly active antiretroviral therapy.

  Retrovirology 20080101

• Overestimates of survival after HAART: implications for global scale-up efforts.

  PloS one 20080101

• Computed CD4 percentage as a low-cost method for determining pediatric antiretroviral treatment eligibility.

  BMC infectious diseases 20080101

• Bullous eruption in a patient infected with the human immunodeficiency virus.

  Skinmed 20080101

• Increase coverage of HIV and AIDS services in Myanmar.

  Conflict and health 20080101

• S4HARA: System for HIV/AIDS resource allocation.

  Cost effectiveness and resource allocation : C/E 20080101

• Distinct efficacy of HIV-1 entry inhibitors to prevent cell-to-cell transfer of R5 and X4 viruses across a human placental trophoblast barrier in a reconstitution model in vitro.

  Retrovirology 20080101

• Low rate of emergence of nevirapine and lamivudine resistance after post-partum interruption of a triple-drug regimen.

  Antiviral therapy 20080101

• Characterization of drug resistance in antiretroviral-treated patients infected with HIV-1 CRF02_AG and AGK subtypes in Mali and Burkina Faso.

  Antiviral therapy 20080101

• A randomized placebo-controlled trial of intermittent preventive treatment in pregnant women in the context of insecticide treated nets delivered through the antenatal clinic.

  PloS one 20080101

• Barriers to access prevention of mother-to-child transmission for HIV positive women in a well-resourced setting in Vietnam.

  AIDS research and therapy 20080101

• Predictors of mortality in HIV-infected patients starting antiretroviral therapy in a rural hospital in Tanzania.

  BMC infectious diseases 20080101

• Streamlining tasks and roles to expand treatment and care for HIV: randomised controlled trial protocol.

  Trials 20080101

• Estimate of infant HIV-free survival at 6 to 8 weeks of age due to maternal antiretroviral prophylaxis in Sub-Saharan Africa, 2004-2005.

  Journal of the International Association of Physicians in AIDS Care (Chicago, Ill. : 2002) 20080101

• The impact of pre-exposure prophylaxis (PrEP) on HIV epidemics in Africa and India: a simulation study.

  PloS one 20080101

• Three new derivatives of anti-HIV-1 polyphenols isolated from Salvia yunnanensis.

  Journal of Asian natural products research 20080101

• 18-month occurrence of severe events among early diagnosed HIV-infected children before antiretroviral therapy in Abidjan, Côte d'Ivoire: a cohort study.

  BMC public health 20080101

• Partial immunological and mitochondrial recovery after reducing didanosine doses in patients on didanosine and tenofovir-based regimens.

  Antiviral therapy 20080101

• Prevalence of dyslipidemia and dysglycaemia in HIV infected patients.

  East African medical journal 20080101

• HuR interacts with human immunodeficiency virus type 1 reverse transcriptase, and modulates reverse transcription in infected cells.

  Retrovirology 20080101

• Scaling-up exclusive breastfeeding support programmes: the example of KwaZulu-Natal.

  PloS one 20080101

• Prevalence of reverse transcriptase and protease mutations associated with antiretroviral drug resistance among drug-naïve HIV-1 infected pregnant women in Kagera and Kilimanjaro regions, Tanzania.

  AIDS research and therapy 20080101

• HIV drug resistance transmission threshold survey in Bangkok, Thailand.

  Antiviral therapy 20080101

• Adverse effects of antiretroviral treatment.

  Indian journal of dermatology, venereology and leprology 20080101

• Type 1 lepra reaction presenting as immune reconstitution inflammatory syndrome.

  Indian journal of dermatology, venereology and leprology 20080101

• Resolution of giant Molluscum contagiosum with antiretroviral therapy.

  Indian journal of dermatology, venereology and leprology 20080101

• Utility of CD4 cell counts for early prediction of virological failure during antiretroviral therapy in a resource-limited setting.

  BMC infectious diseases 20080101

• Risk for immune-mediated liver reactions by nevirapine revisited.

  AIDS reviews 20080101

• A coarsened multinomial regression model for perinatal mother to child transmission of HIV.

  BMC medical research methodology 20080101

• Risk factors for poor virological outcome at 12 months in a workplace-based antiretroviral therapy programme in South Africa: a cohort study.

  BMC infectious diseases 20080101

• Childhood TB epidemiology and treatment outcomes in Thailand: a TB active surveillance network, 2004 to 2006.

  BMC infectious diseases 20080101

• Viral hepatitis and HIV-associated tuberculosis: risk factors and TB treatment outcomes in Thailand.

  BMC public health 20080101

• Coprocessing of nevirapine and stavudine by spray drying.

  Pharmaceutical development and technology 20080101

• Not all missed doses are the same: sustained NNRTI treatment interruptions predict HIV rebound at low-to-moderate adherence levels.

  PloS one 20080101

• Pharmacokinetics and 48-week efficacy of nevirapine: 400 mg versus 600 mg per day in HIV-tuberculosis coinfection receiving rifampicin.

  Antiviral therapy 20080101

• Prevalence and risk factors for etravirine resistance among patients failing on non-nucleoside reverse transcriptase inhibitors.

  Antiviral therapy 20080101

• Clinical drugs that interact with St. John's wort and implication in drug development.

  Current pharmaceutical design 20080101

• The feasibility of preventing mother-to-child transmission of HIV using peer counselors in Zimbabwe.

  AIDS research and therapy 20080101

• Species distribution and in vitro antifungal susceptibility of oral yeast isolates from Tanzanian HIV-infected patients with primary and recurrent oropharyngeal candidiasis.

  BMC microbiology 20080101

• [Mother to child prevention against HIV in the Health District of Kossodo (Burkina Faso)].

  Revue medicale de Bruxelles 20080101

• Hepatic steatosis in patients with HIV-Hepatitis C Virus coinfection: is it associated with antiretroviral therapy and more advanced hepatic fibrosis?

  BMC research notes 20080101

• Anterior segment manifestations of human immunodeficiency virus/acquired immune deficiency syndrome.

  Indian journal of ophthalmology 20080101

• Medical management of human immunodeficiency virus infection.

  Indian journal of ophthalmology 20080101

• Correlation between CD4 counts of HIV patients and enteric protozoan in different seasons - an experience of a tertiary care hospital in Varanasi (India).

  BMC gastroenterology 20080101

• Factors influencing efavirenz and nevirapine plasma concentration: effect of ethnicity, weight and co-medication.

  Antiviral therapy 20080101

• In vitro evidence for a new therapeutic approach in renal cell carcinoma.

  International braz j urol : official journal of the Brazilian Society of Urology 20080101

• Progressive hypertrophic genital herpes in an HIV-infected woman despite immune recovery on antiretroviral therapy.

  Infectious diseases in obstetrics and gynecology 20080101

• HIV, visceral leishmaniasis and Parkinsonism combined with diabetes mellitus and hyperuricaemia: A case report.

  Cases journal 20080101

• Resting regulatory CD4 T cells: a site of HIV persistence in patients on long-term effective antiretroviral therapy.

  PloS one 20080101

• Success with antiretroviral treatment for children in Kigali, Rwanda: experience with health center/nurse-based care.

  BMC pediatrics 20080101

• Nevirapine toxicity in non-HIV cancer patients.

  Chemotherapy 20080101

• Highly active antiretroviral therapy versus zidovudine/nevirapine effects on early breast milk HIV type-1 Rna: a phase II randomized clinical trial.

  Antiviral therapy 20080101

• Durability of stavudine, lamivudine and nevirapine among advanced HIV-1 infected patients with/without prior co-administration of rifampicin: a 144-week prospective study.

  BMC infectious diseases 20080101

• Impending flop for brand antiretrovirals in the emerging markets?

  The open AIDS journal 20080101

• Dyslipidemia and cardiovascular disease risk factor management in HIV-1-infected subjects treated with HAART in the Spanish VACH cohort.

  The open AIDS journal 20080101

• Single-measurement therapeutic drug monitoring of the HIV/AIDS drugs abacavir, zidovudine, lamivudine, efavirenz, nevirapine, lopinavir and nelfinavir.

  Pharmacology 20080101

• Outcome of protease inhibitor substitution with nevirapine in HIV-1 infected children.

  BMC infectious diseases 20080101

• Rapid testing may not improve uptake of HIV testing and same day results in a rural South African community: a cohort study of 12,000 women.

  PloS one 20080101

• A feasibility study of immediate versus deferred antiretroviral therapy in children with HIV infection.

  AIDS research and therapy 20080101

• Successful treatment with azithromycin and rifampicin of penicillin and cephalosporin insensitive pneumococcal osteomyelitis in a child with HIV infection: a case report.

  Cases journal 20080101

• High rate of mutation K103N causing resistance to nevirapine in Indian children with acquired immunodeficiency syndrome.

  Indian journal of medical microbiology 20080101

• Virologic, immunologic, clinical, safety, and resistance outcomes from a long-term comparison of efavirenz-based versus nevirapine-based antiretroviral regimens as initial therapy in HIV-1-infected persons.

  HIV clinical trials 20080101

• The influence of lamivudine, stavudine and nevirapine on the pharmacokinetics of chlorpropamide in human subjects.

  European journal of drug metabolism and pharmacokinetics 20080101

• Follow-up survey of women who have undergone a prevention of mother-to-child transmission program in a resource-poor setting in South Africa.

  The Journal of the Association of Nurses in AIDS Care : JANAC 20080101

• Estimated HIV trends and program effects in Botswana.

  PloS one 20080101

• Transient antiretroviral therapy selecting for common HIV-1 mutations substantially accelerates the appearance of rare mutations.

  Theoretical biology & medical modelling 20080101

• Docking-MM-GB/SA and ADME screening of HIV-1 NNRTI inhibitor: nevirapine and its analogues.

  In silico biology 20080101

• Immune reconstitution inflammatory syndrome manifesting as disseminated tuberculosis, deep venous thrombosis, encephalopathy and myelopathy.

  The Indian journal of chest diseases & allied sciences 20080101

• Variability in the plasma concentration of efavirenz and nevirapine is associated with genotypic resistance after treatment interruption.

  Antiviral therapy 20080101

• Human immunodeficiency virus seroconversion presenting with acute inflammatory demyelinating polyneuropathy: a case report.

  Journal of medical case reports 20080101

• Participation of traditional birth attendants in prevention of mother-to-child transmission of HIV services in two rural districts in Zimbabwe: a feasibility study.

  BMC public health 20080101

• Adherence to highly active antiretroviral therapy and its correlates among HIV infected pediatric patients in Ethiopia.

  BMC pediatrics 20080101

• Survival of infants born to HIV-positive mothers, by feeding modality, in Rakai, Uganda.

  PloS one 20080101

• Three generic nevirapine-based antiretroviral treatments in Chinese HIV/AIDS patients: multicentric observation cohort.

  PloS one 20080101

• Steady state bioequivalence of generic and innovator formulations of stavudine, lamivudine, and nevirapine in HIV-infected Ugandan adults.

  PloS one 20080101

• Hepatitis A, B and C viral co-infections among HIV-infected adults presenting for care and treatment at Muhimbili National Hospital in Dar es Salaam, Tanzania.

  BMC public health 20080101

• Reuse of single-dose nevirapine in subsequent pregnancies for the prevention of mother-to-child HIV transmission in Lusaka, Zambia: a cohort study.

  BMC infectious diseases 20080101

• [Evaluation of the adverse effects of nevirapine in HIV-infected pregnant women in a South Brazilian University Hospital].

  Revista brasileira de ginecologia e obstetricia : revista da Federacao Brasileira das Sociedades de Ginecologia e Obstetricia 20080101

• Infection with hepatitis C virus among HIV-infected pregnant women in Thailand.

  Infectious diseases in obstetrics and gynecology 20080101

• Broad advances in understanding HIV resistance to antiretrovirals: report on the XVII International HIV Drug Resistance Workshop.

  Antiviral therapy 20080101

• High treatment success rates when switching to once daily nevirapine containing antiretroviral therapy.

  The open AIDS journal 20080101

• Awareness and attitudes about HIV among pregnant women in Aksu, northwest China.

  The open AIDS journal 20080101

• Prevention of mother-to-child transmission of HIV in a refugee camp setting in Tanzania.

  Global public health 20080101

• Abstracts of papers presented at the 2008 pittsburgh conference.

  Journal of automated methods & management in chemistry 20080101

• Supersensitive Viral Load Assay in Predicting CD4-Guided Treatment Failure.

  The open virology journal 20080101

• Determinants of Treatment Access in a Population-based Cohort of HIV-positive Men and Women Living in Argentina.

  Journal of the International AIDS Society 20080101

• Effectiveness and Safety of Generic Fixed-Dose Combination of Tenofovir/Emtricitabine/Efavirenz in HIV-1-Infected Patients in Western India.

  Journal of the International AIDS Society 20080101

• Meningitis caused by Rhodotorula mucilaginosa in human immunodeficiency virus seropositive patient.

  Annals of Indian Academy of Neurology 20080101

• Raltegravir in the management of HIV-infected patients.

  Drug design, development and therapy 20080101

• Low-temperature study of a new nevirapine pseudopolymorph.

  Acta crystallographica. Section E, Structure reports online 20080101

• Solid-state characterization of nevirapine.

  Indian journal of pharmaceutical sciences 20080101

• Determinants of retention in care in an antiretroviral therapy (ART) program in urban Cameroon, 2003-2005.

  The Pan African medical journal 20080101

• Antiretroviral prophylaxis to prevent post-natal transmission of HIV through breastfeeding.

  The Pan African medical journal 20080101

• Dihydro-alkylthio-benzyl-oxopyrimidines as inhibitors of reverse transcriptase: synthesis and rationalization of the biological data on both wild-type enzyme and relevant clinical mutants.

  Journal of medicinal chemistry 20071227

• Chinese pediatric highly active antiretroviral therapy observational cohort: a 1-year analysis of clinical, immunologic, and virologic outcomes.

  Journal of acquired immune deficiency syndromes (1999) 20071215

• [HIV-1 genotypic resistance profiles in children failing highly active antiretroviral therapy].

  Zhonghua yi xue za zhi 20071211

• Modeling Maternal-Infant HIV Transmission in the Presence of Breastfeeding with an Imperfect Test.

  Biometrics 20071201

• The design and synthesis of N-1-alkylated-5-aminoarylalkylsubstituted-6-methyluracils as potential non-nucleoside HIV-1 RT inhibitors.

  Bioorganic & medicinal chemistry 20071201

• Adherence to HAART therapy measured by electronic monitoring in newly diagnosed HIV patients in Botswana.

  European journal of clinical pharmacology 20071201

• Improved interpretation of genotypic changes in the HIV-1 reverse transcriptase coding region that determine the virological response to didanosine.

  The Journal of infectious diseases 20071201

• N348I in the connection domain of HIV-1 reverse transcriptase confers zidovudine and nevirapine resistance.

  PLoS medicine 20071201

• Should we include connection domain mutations of HIV-1 reverse transcriptase in HIV resistance testing.

  PLoS medicine 20071201

• HIV treatment proceeds as prevention research confounds.

  PLoS medicine 20071201

• Metabolic function and the prevalence of lipodystrophy in a population of HIV-infected African subjects receiving highly active antiretroviral therapy.

  Journal of acquired immune deficiency syndromes (1999) 20071201

• Independent effects of nevirapine prophylaxis and HIV-1 RNA suppression in breast milk on early perinatal HIV-1 transmission.

  Journal of acquired immune deficiency syndromes (1999) 20071201

• Initiating highly active antiretroviral therapy with newer protease inhibitors is associated with better survival compared to first-generation protease inhibitors or nevirapine.

  AIDS patient care and STDs 20071201

• An efficient tool for surveying CRF01_AE HIV type 1 resistance in Thailand to combined stavudine-lamivudine-nevirapine treatment: mutagenically separated PCR targeting M184I/V.

  AIDS research and human retroviruses 20071201

• Variation of CD4 count and percentage during pregnancy and after delivery: implications for HAART initiation in resource-limited settings.

  AIDS research and human retroviruses 20071201

• Reverse transcriptase mutations in Cambodian CRF01_AE isolates after antiretroviral prophylaxis against HIV Type 1 perinatal transmission.

  AIDS research and human retroviruses 20071201

• Characterization of HIV type 1 reverse transcriptase mutations in infants infected by mothers who received peripartum nevirapine prophylaxis in Jos, Nigeria.

  AIDS research and human retroviruses 20071201

• Characterization of HIV-1 subtypes and viral antiretroviral drug resistance in men who have sex with men in Beijing, China.

  AIDS (London, England) 20071201

• [Side effects of antiretroviral treatment for transmission prophylaxis in preterm and near-term infants].

  Zeitschrift fur Geburtshilfe und Neonatologie 20071201

• [The HIV pandemic in the year 2007, an overview].

  Nederlands tijdschrift voor geneeskunde 20071201

• A single-dose, randomized, open-label, two-period crossover bioequivalence study of a fixed-dose pediatric combination of lamivudine 40-mg, nevirapine 70-mg, and stavudine 10-mg tablet for oral suspension with individual liquid formulations in healthy adult male volunteers.

  Clinical therapeutics 20071201

• Steady-State Pharmacokinetics of Nevirapine in HIV-1 Infected Adults in India.

  Journal of the International Association of Physicians in AIDS Care (Chicago, Ill. : 2002) 20071201

• Therapeutic options and challenges for substances of abuse.

  Dialogues in clinical neuroscience 20071201

• Nevirapine-induced side effects in pregnant women: experience of a Brazilian university hospital.

  The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases 20071201

• Self-reported adherence to single dose nevirapine in the prevention of mother to child transmission of HIV at Kitale District Hospital.

  East African medical journal 20071201

• Review of tenofovir-emtricitabine.

  Therapeutics and clinical risk management 20071201

• Single-dose tenofovir and emtricitabine for reduction of viral resistance to non-nucleoside reverse transcriptase inhibitor drugs in women given intrapartum nevirapine for perinatal HIV prevention: an open-label randomised trial.

  Lancet (London, England) 20071117

• Reduction of HIV-1 drug resistance after intrapartum single-dose nevirapine.

  Lancet (London, England) 20071117

• [Evaluation for two-year highly active antiretroviral therapy in Chinese HIV-1 infection patients].

  Zhonghua yi xue za zhi 20071113

• HIV drug resistance after the use of generic fixed-dose combination stavudine/lamivudine/nevirapine as standard first-line regimen.

  AIDS (London, England) 20071112

• NNRTI-selected mutations at codon 190 of human immunodeficiency virus type 1 reverse transcriptase decrease susceptibility to stavudine and zidovudine.

  Antiviral research 20071101

• Synthesis and biological properties of novel 2-aminopyrimidin-4(3H)-ones highly potent against HIV-1 mutant strains.

  Journal of medicinal chemistry 20071101

• From docking false-positive to active anti-HIV agent.

  Journal of medicinal chemistry 20071101

• Effectiveness of highly active antiretroviral therapy in HIV-positive children: evaluation at 12 months in a routine program in Cambodia.

  Pediatrics 20071101

• Is it safe to switch between efavirenz and nevirapine in the event of toxicity?

  The Lancet. Infectious diseases 20071101

• Pharmacokinetics of lamivudine, zidovudine, and nevirapine administered as a fixed-dose combination formulation versus coadministration of the individual products.

  Journal of clinical pharmacology 20071101

• Nevirapine-associated rash with eosinophilia and systemic symptoms in a child with human immunodeficiency virus infection.

  The Pediatric infectious disease journal 20071101

• Evolution of antiretroviral drug costs in Brazil in the context of free and universal access to AIDS treatment.

  PLoS medicine 20071101

• Incidence and risk factors of nevirapine-associated skin rashes among HIV-infected patients with CD4 cell counts <250 cells/microL.

  International journal of STD & AIDS 20071101

• Effectiveness of repeat single-dose nevirapine for prevention of mother-to-child transmission of HIV-1 in repeat pregnancies in Uganda.

  Journal of acquired immune deficiency syndromes (1999) 20071101

• Outcomes in HIV-infected patients on antiretroviral therapy with tuberculosis.

  The Southeast Asian journal of tropical medicine and public health 20071101

• Cryptococcal meningoradiculitis: an atypical presentation after initiation of antiretroviral therapy.

  Journal of the Medical Association of Thailand = Chotmaihet thangphaet 20071101

• Clinical outcomes and CD4 cell response in children receiving antiretroviral therapy at primary health care facilities in Zambia.

  JAMA 20071024

• CYP2B6 genetic variants are associated with nevirapine pharmacokinetics and clinical response in HIV-1-infected children.

  AIDS (London, England) 20071018

• Effect of twice-daily nevirapine on adherence in HIV-1-infected patients: a randomized controlled study.

  AIDS (London, England) 20071018

• Indolyl aryl sulfones as HIV-1 non-nucleoside reverse transcriptase inhibitors: role of two halogen atoms at the indole ring in developing new analogues with improved antiviral activity.

  Journal of medicinal chemistry 20071004

• Prevalence of resistance to nevirapine in mothers and children after single-dose exposure to prevent vertical transmission of HIV-1: a meta-analysis.

  International journal of epidemiology 20071001

• N2-benzyloxycarbonylguan-9-yl acetic acid derivatives as HIV-1 reverse transcriptase non-nucleoside inhibitors with decreased loss of potency against common drug-resistance mutations.

  ChemMedChem 20071001

• Predictors of long-term viral failure among ugandan children and adults treated with antiretroviral therapy.

  Journal of acquired immune deficiency syndromes (1999) 20071001

• Polymorphism and drug selected mutations of reverse transcriptase gene in 102 HIV-1 infected patients living in China.

  Journal of medical virology 20071001

• Efficacy of highly active antiretroviral therapy in HIV-1 infected children in Kenya.

  Pediatrics 20071001

• Detection of K103N in Ugandan women after repeated exposure to single dose nevirapine.

  AIDS (London, England) 20071001

• Effect of anticoagulants on plasma nevirapine and efavirenz concentrations.

  Therapeutic drug monitoring 20071001

• A randomized trial comparing the efficacy and tolerability of two HAART strategies at two years in antiretroviral naive patients.

  Revista clinica espanola 20071001

• Tenofovir resistance among HIV-infected patients failing a fixed-dose combination of stavudine, lamivudine, and nevirapine in a resource-limited setting.

  AIDS patient care and STDs 20071001

• Evidence for direct involvement of the capsid protein in HIV infection of nondividing cells.

  PLoS pathogens 20071001

• [Treatment of children born of AIDS mothers in Tsevie hospital regional center, Togo].

  Bulletin de la Societe de pathologie exotique (1990) 20071001

• Dandy-Walker variant in an infant prenatally exposed to antiretroviral medication.

  South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde 20071001

• Prevalence of antiretroviral drug resistance in treated HIV-1 infected patients: under the initiative of access to the NNRTI-based regimen in Thailand.

  Journal of chemotherapy (Florence, Italy) 20071001

• Prevention of parent-to-child transmission of HIV: an experience in rural population.

  Indian journal of medical microbiology 20071001

• FDA notifications. Tentative approval for generic nevirapine tablets.

  AIDS alert 20071001

• Potent inhibition of HIV-1 replication by novel non-peptidyl small molecule inhibitors of protease dimerization.

  The Journal of biological chemistry 20070928

• Diffuse interstitial pulmonary opacities induced by nevirapine.

  AIDS (London, England) 20070912

• Anti-adenoviral effect of anti-HIV agents in vitro in serotypes inducing keratoconjunctivitis.

  Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie 20070901

• Associations between mild-to-moderate anaemia in pregnancy and helminth, malaria and HIV infection in Entebbe, Uganda.

  Transactions of the Royal Society of Tropical Medicine and Hygiene 20070901

• Quantitation of five nevirapine oxidative metabolites in human plasma using liquid chromatography-tandem mass spectrometry.

  Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20070901

• Nevirapine-associated toxicity in HIV-infected Thai men and women, including pregnant women.

  HIV medicine 20070901

• Hepatotoxicity of antiretroviral drugs is reduced after successful treatment of chronic hepatitis C in HIV-infected patients.

  The Journal of infectious diseases 20070901

• Modulation of heme and myristate binding to human serum albumin by anti-HIV drugs. An optical and NMR spectroscopic study.

  The FEBS journal 20070901

• International recommendations on antiretroviral drugs for treatment of HIV-infected women and prevention of mother-to-child HIV transmission in resource-limited settings: 2006 update.

  American journal of obstetrics and gynecology 20070901

• Use of single-dose nevirapine for the prevention of mother-to-child transmission of HIV-1: does development of resistance matter?

  American journal of obstetrics and gynecology 20070901

• Grand challenges in global health: engaging civil society organizations in biomedical research in developing countries.

  PLoS medicine 20070901

• Regression of a cervical spinal mass following highly active antiretroviral therapy (HAART) in child with advanced human immunodeficiency virus (HIV) disease.

  Journal of the Medical Association of Thailand = Chotmaihet thangphaet 20070901

• Antiretroviral (ARV) drug resistance in the developing world.

  Evidence report/technology assessment 20070901

• FDA notifications. Tentative approval granted of generic nevirapine.

  AIDS alert 20070901

• Children with HIV are not small adults: what is different in pharmacology?

  Current opinion in HIV and AIDS 20070901

• Synthesis, biological activity, and crystal structure of potent nonnucleoside inhibitors of HIV-1 reverse transcriptase that retain activity against mutant forms of the enzyme.

  Journal of medicinal chemistry 20070823

• African infants' CCL3 gene copies influence perinatal HIV transmission in the absence of maternal nevirapine.

  AIDS (London, England) 20070820

• Considerations on the effectiveness of nevirapine in protease inhibitor-based regimen simplification.

  AIDS (London, England) 20070820

• Symptomatic hyperlactatemia associated with nucleoside analogue reverse-transcriptase inhibitor use in HIV-infected patients: a report of 24 cases in a resource-limited setting (Uganda).

  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20070815

• Safety of switching to nevirapine-based highly active antiretroviral therapy at elevated CD4 cell counts in a resource-constrained setting.

  Journal of acquired immune deficiency syndromes (1999) 20070815

• Persistence of nevirapine in breast milk after discontinuation of treatment.

  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20070801

• Drug hypersensitivity in HIV.

  Current opinion in allergy and clinical immunology 20070801

• Hair loss induced by lopinavir-ritonavir.

  Pharmacotherapy 20070801

• Probing nonnucleoside inhibitor-induced active-site distortion in HIV-1 reverse transcriptase by transient kinetic analyses.

  Protein science : a publication of the Protein Society 20070801

• Development of a highly efficient extraction technique and specific multiplex assay for measuring antiretroviral drug concentrations in breast milk.

  Therapeutic drug monitoring 20070801

• Translating pharmacogenomics: challenges on the road to the clinic.

  PLoS medicine 20070801

• Data shows long-term nevirapine efficacy and increases in good cholesterol.

  AIDS patient care and STDs 20070801

• Antiretroviral treatment and prevention of peripartum and postnatal HIV transmission in West Africa: evaluation of a two-tiered approach.

  PLoS medicine 20070801

• Drug resistance in plasma and breast milk after single-dose nevirapine in subtype C HIV type 1: population and clonal sequence analysis.

  AIDS research and human retroviruses 20070801

• Mother-to-child transmission of HIV among women who chose not to exclusively breastfeed their infants in Pune, India.

  The Indian journal of medical research 20070801

• Review of tipranavir in the treatment of drug-resistant HIV.

  Therapeutics and clinical risk management 20070801

• Determinants of nevirapine hypersensitivity and its effect on the association between hepatitis C status and mortality in antiretroviral drug-naive HIV-positive patients.

  AIDS (London, England) 20070731

• Adherence, virological and immunological outcomes for HIV-infected veterans starting combination antiretroviral therapies.

  AIDS (London, England) 20070731

• Postpartum tuberculosis incidence and mortality among HIV-infected women and their infants in Pune, India, 2002-2005.

  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20070715

• Efavirenz to nevirapine switch in HIV-1-infected patients with dyslipidemia: a randomized, controlled study.

  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20070715

• Nodular regenerative hyperplasia: a new serious antiretroviral drugs side effect?

  AIDS (London, England) 20070711

• A new methodology for the simulation of flexible protein-ligand interactions.

  Journal of molecular graphics & modelling 20070701

• Synthesis and anti-HIV studies of 2-adamantyl-substituted thiazolidin-4-ones.

  European journal of medicinal chemistry 20070701

• Early response to highly active antiretroviral therapy in HIV-1-infected Kenyan children.

  Journal of acquired immune deficiency syndromes (1999) 20070701

• Antiretroviral durability and tolerability in HIV-infected adults living in urban Kenya.

  Journal of acquired immune deficiency syndromes (1999) 20070701

• Methadone dosing strategies in HIV-infected injection drug users enrolled in a directly observed therapy program.

  Journal of acquired immune deficiency syndromes (1999) 20070701

• Pharmacokinetics of methadone in human-immunodeficiency-virus-infected patients receiving nevirapine once daily.

  European journal of clinical pharmacology 20070701

• Effective program against mother-to-child transmission of HIV at Saint Camille Medical Centre in Burkina Faso.

  Journal of medical virology 20070701

• Late postnatal transmission of HIV-1 and associated factors.

  The Journal of infectious diseases 20070701

• Effects of nevirapine, compared with lamivudine, on lipids and lipoproteins in HIV-1-uninfected newborns: the stopping infection from mother-to-child via breast-feeding in Africa lipid substudy.

  The Journal of infectious diseases 20070701

• Dynamics of 103K/N and 184M/V HIV-1 drug resistant populations: relative comparison in plasma virus RNA versus CD45RO+T cell proviral DNA.

  Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology 20070701

• Performance of a World Health Organization first-line regimen (stavudine/lamivudine/nevirapine) in antiretroviral-naïve individuals in a Western setting.

  HIV medicine 20070701

• Safety issues about nevirapine administration in HIV-infected pregnant women.

  Journal of acquired immune deficiency syndromes (1999) 20070701

• Influence of body mass index on pregnancy outcomes among HIV-infected and HIV-uninfected Zambian women.

  Tropical medicine & international health : TM & IH 20070701

• Forecast of demand for antiretroviral drugs in low and middle-income countries: 2007-2008.

  AIDS (London, England) 20070701

• Synthesis and biological evaluation of 2,3-diaryl substituted-1,3-thiazolidin-4-ones as anti-HIV agents.

  Medicinal chemistry (Shariqah (United Arab Emirates)) 20070701

• Polymorphic CYP2B6: molecular mechanisms and emerging clinical significance.

  Pharmacogenomics 20070701

• Fixed dose combination of lamivudine, stavudine and nevirapine in the treatment of pediatric HIV infection: a preliminary report.

  Indian pediatrics 20070701

• Pathology of placenta in HIV infection.

  Indian journal of pathology & microbiology 20070701

• Antiretroviral therapy during tuberculosis treatment and marked reduction in death rate of HIV-infected patients, Thailand.

  Emerging infectious diseases 20070701

• Antiretroviral therapy-induced liver alterations.

  Current opinion in HIV and AIDS 20070701

• Hepatotoxicity and liver disease in the context of HIV therapy.

  Current opinion in HIV and AIDS 20070701

• High frequency of rapid immunological progression in African infants infected in the era of perinatal HIV prophylaxis.

  AIDS (London, England) 20070619

• Surveillance of mother-to-child transmission prevention programmes at immunization clinics: the case for universal screening.

  AIDS (London, England) 20070619

• High throughput LC-MS/MS method for simultaneous quantification of lamivudine, stavudine and nevirapine in human plasma.

  Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20070615

• Time to undetectable viral load after highly active antiretroviral therapy initiation among HIV-infected pregnant women.

  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20070615

• Variability in non-nucleoside reverse transcriptase and protease inhibitors concentrations among HIV-infected adults in routine clinical practice.

  British journal of clinical pharmacology 20070601

• Transmission rates in consecutive pregnancies exposed to single-dose nevirapine in Soweto, South Africa and Abidjan, Côte d'Ivoire.

  Journal of acquired immune deficiency syndromes (1999) 20070601

• Estimating the number of vertically HIV-infected children eligible for antiretroviral treatment in resource-limited settings.

  International journal of epidemiology 20070601

• Systematic review of the efficacy of antiretroviral therapies for reducing the risk of mother-to-child transmission of HIV infection.

  Journal of clinical pharmacy and therapeutics 20070601

• Therapeutic issues in HIV/HCV-coinfected patients.

  Journal of viral hepatitis 20070601

• Hepatotoxicity during nevirapine-based fixed-dose combination antiretroviral therapy in kampala, Uganda.

  Journal of the International Association of Physicians in AIDS Care (Chicago, Ill. : 2002) 20070601

• Safety of HIV-1 Perinatal Transmission Prophylaxis With Zidovudine and Nevirapine in Rural South India.

  Journal of the International Association of Physicians in AIDS Care (Chicago, Ill. : 2002) 20070601

• HIV prevention, care, and treatment in two prisons in Thailand.

  PLoS medicine 20070601

• Expansion of HIV-1 screening and anti-retroviral treatment programs in a resource-poor setting: results from a faith-based organization in Jos, Plateau State, Nigeria.

  African health sciences 20070601

• HIV type 1 variants with nevirapine resistance mutations are rarely detected in antiretroviral drug-naive African women with subtypes A, C, and D.

  AIDS research and human retroviruses 20070601

• HIV variants of low frequency may have a big impact.

  The AIDS reader 20070601

• Operational effectiveness of single-dose nevirapine in preventing mother-to-child transmission of HIV.

  Bulletin of the World Health Organization 20070601

• Antiretroviral pharmacokinetic profile: a review of sex differences.

  Gender medicine 20070601

• Impact of placental Plasmodium falciparum malaria on pregnancy and perinatal outcome in sub-Saharan Africa: I: introduction to placental malaria.

  The Yale journal of biology and medicine 20070601

• Biological targets for isatin and its analogues: Implications for therapy.

  Biologics : targets & therapy 20070601

• Relationship of potency and resilience to drug resistant mutations for GW420867X revealed by crystal structures of inhibitor complexes for wild-type, Leu100Ile, Lys101Glu, and Tyr188Cys mutant HIV-1 reverse transcriptases.

  Journal of medicinal chemistry 20070517

• De novo parallel design, synthesis and evaluation of inhibitors against the reverse transcriptase of human immunodeficiency virus type-1 and drug-resistant variants.

  Journal of medicinal chemistry 20070517

• Characterization of novel non-nucleoside reverse transcriptase (RT) inhibitor resistance mutations at residues 132 and 135 in the 51 kDa subunit of HIV-1 RT.

  The Biochemical journal 20070515

• Early archiving and predominance of nonnucleoside reverse transcriptase inhibitor-resistant HIV-1 among recently infected infants born in the United States.

  The Journal of infectious diseases 20070515

• Early clinical and immune response to NNRTI-based antiretroviral therapy among women with prior exposure to single-dose nevirapine.

  AIDS (London, England) 20070511

• Determination of 19 antiretroviral agents in pharmaceuticals or suspected products with two methods using high-performance liquid chromatography.

  Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20070501

• Synthesis of novel diarylpyrimidine analogues of TMC278 and their antiviral activity against HIV-1 wild-type and mutant strains.

  European journal of medicinal chemistry 20070501

• Pharmacokinetic study of the interaction between itraconazole and nevirapine.

  European journal of clinical pharmacology 20070501

• Association of serum lipid levels with HIV serostatus, specific antiretroviral agents, and treatment regimens.

  Journal of acquired immune deficiency syndromes (1999) 20070501

• Expanded services for the prevention of mother-to-child HIV transmission: field acceptability of a pilot program in Lusaka, Zambia.

  Journal of acquired immune deficiency syndromes (1999) 20070501

• Home deliveries: implications for adherence to nevirapine in a PMTCT programme in rural Malawi.

  AIDS care 20070501

• Discontinuation of non-nucleoside reverse transcriptase inhibitor-based highly active antiretroviral therapy due to nucleoside analogue reverse transcriptase inhibitor-related metabolic toxicity.

  International journal of STD & AIDS 20070501

• Emergence of NNRTI drug resistance mutations after single-dose nevirapine exposure in HIV type 1 subtype C-infected infants in India.

  AIDS research and human retroviruses 20070501

• HIV treatment in a conflict setting: outcomes and experiences from Bukavu, Democratic Republic of the Congo.

  PLoS medicine 20070501

• Cost-effectiveness of rapid syphilis screening in prenatal HIV testing programs in Haiti.

  PLoS medicine 20070501

• Antiretroviral therapy in children: Indian experience.

  Indian pediatrics 20070501

• [First case of Stevens-Johnson syndrome in a patient treated by Triomune in Abidjan, Côte d'lvoire].

  Bulletin de la Societe de pathologie exotique (1990) 20070501

• Synthesis and anti-HIV-1 activity evaluation of 5-alkyl-2-alkylthio-6-(arylcarbonyl or alpha-cyanoarylmethyl)-3,4-dihydropyrimidin-4(3H)-ones as novel non-nucleoside HIV-1 reverse transcriptase inhibitors.

  Journal of medicinal chemistry 20070419

• Intrapartum transmission after mucosal exposure to HIV was not observed with single-dose nevirapine for mother and child.

  Journal of acquired immune deficiency syndromes (1999) 20070415

• An isocratic liquid chromatography method for determining HIV non-nucleoside reverse transcriptase inhibitor and protease inhibitor concentrations in human plasma.

  Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20070401

• Antiretroviral-associated toxicity among HIV-1-seropositive pregnant women in Mozambique receiving nevirapine-based regimens.

  Journal of acquired immune deficiency syndromes (1999) 20070401

• A model of directional selection applied to the evolution of drug resistance in HIV-1.

  Molecular biology and evolution 20070401

• Discovery of novel benzimidazolones as potent non-nucleoside reverse transcriptase inhibitors active against wild-type and mutant HIV-1 strains.

  Bioorganic & medicinal chemistry letters 20070401

• Clinical toxicity of highly active antiretroviral therapy in a home-based AIDS care program in rural Uganda.

  Journal of acquired immune deficiency syndromes (1999) 20070401

• HLA-B*5701 screening for susceptibility to abacavir hypersensitivity.

  The Journal of antimicrobial chemotherapy 20070401

• Slow-, tight-binding HIV-1 reverse transcriptase non-nucleoside inhibitors highly active against drug-resistant mutants.

  ChemMedChem 20070401

• Influence of liver fibrosis stage on plasma levels of antiretroviral drugs in HIV-infected patients with chronic hepatitis C.

  The Journal of infectious diseases 20070401

• Surveillance of genotypic resistance mutations in chronic HIV-1 treated individuals after completion of the National Access to Antiretroviral Program in Thailand.

  Infection 20070401

• ART suppresses plasma HIV-1 RNA to a stable set point predicted by pretherapy viremia.

  PLoS pathogens 20070401

• Effectiveness of early initiation of protease inhibitor-sparing antiretroviral regimen in human immunodeficiency virus-1 vertically infected infants.

  The Pediatric infectious disease journal 20070401

• Molecular epidemiology of HIV type 1 in treatment-naive patients in north Ethiopia.

  AIDS research and human retroviruses 20070401

• Reinduction of cell differentiation and 131I uptake in a poorly differentiated thyroid tumor in response to the reverse transcriptase (RT) inhibitor nevirapine.

  Cancer biotherapy & radiopharmaceuticals 20070401

• Human immunodeficiency virus infection in a child presenting as herpes zoster ophthalmicus.

  Journal of the Indian Medical Association 20070401

• Nevirapine clearance from plasma in African adults stopping therapy: a pharmacokinetic substudy.

  AIDS (London, England) 20070330

• Long-term safety, effectiveness and quality of a generic fixed-dose combination of nevirapine, stavudine and lamivudine.

  AIDS (London, England) 20070330

• HIV-1 reverse transcriptase plus-strand initiation exhibits preferential sensitivity to non-nucleoside reverse transcriptase inhibitors in vitro.

  The Journal of biological chemistry 20070316

• Survival in women exposed to single-dose nevirapine for prevention of mother-to-child transmission of HIV: a stochastic model.

  The Journal of infectious diseases 20070315

• High-performance liquid chromatography assay for the determination of the HIV-protease inhibitor tipranavir in human plasma in combination with nine other antiretroviral medications.

  Journal of pharmaceutical and biomedical analysis 20070312

• Triple antiretroviral prophylaxis administered during pregnancy and after delivery significantly reduces breast milk viral load: a study within the Drug Resource Enhancement Against AIDS and Malnutrition Program.

  Journal of acquired immune deficiency syndromes (1999) 20070301

• Inhibition of MRP1/ABCC1, MRP2/ABCC2, and MRP3/ABCC3 by nucleoside, nucleotide, and non-nucleoside reverse transcriptase inhibitors.

  Drug metabolism and disposition: the biological fate of chemicals 20070301

• Helices F-G are important for the substrate specificities of CYP3A7.

  Drug metabolism and disposition: the biological fate of chemicals 20070301

• Reasons for discontinuation of nevirapine-containing HAART: results from an unselected population of a large clinical cohort.

  The Journal of antimicrobial chemotherapy 20070301

• Liver toxicity induced by non-nucleoside reverse transcriptase inhibitors.

  The Journal of antimicrobial chemotherapy 20070301

• Persistence of K103N-containing HIV-1 variants after single-dose nevirapine for prevention of HIV-1 mother-to-child transmission.

  The Journal of infectious diseases 20070301

• Cytochrome P450 2B6 (CYP2B6) G516T influences nevirapine plasma concentrations in HIV-infected patients in Uganda.

  HIV medicine 20070301

• Neuropsychiatric side effects of efavirenz therapy.

  Expert opinion on drug safety 20070301

• Evaluating drug prices, availability, affordability, and price components: implications for access to drugs in Malaysia.

  PLoS medicine 20070301

• [Vitiligo in a black patient associated with HIV infection and repigmentation under antiretroviral therapy].

  Annales de dermatologie et de venereologie 20070301

• Factors in AIDS dementia complex trial design: results and lessons from the abacavir trial.

  PLoS clinical trials 20070301

• Most common prescribing error in postexposure prophylaxis of HIV/AIDS.

  The Journal of the Association of Physicians of India 20070301

• Comparison of echinocandin antifungals.

  Therapeutics and clinical risk management 20070301

• Initiation of antiretroviral therapy leads to a rapid decline in cervical and vaginal HIV-1 shedding.

  AIDS (London, England) 20070219

• A novel nonnucleoside analogue that inhibits human immunodeficiency virus type 1 isolates resistant to current nonnucleoside reverse transcriptase inhibitors.

  Antimicrobial agents and chemotherapy 20070201

• Selection and persistence of viral resistance in HIV-infected children after exposure to single-dose nevirapine.

  Journal of acquired immune deficiency syndromes (1999) 20070201

• Depo-medroxyprogesterone in women on antiretroviral therapy: effective contraception and lack of clinically significant interactions.

  Clinical pharmacology and therapeutics 20070201

• Modulation of human BCRP (ABCG2) activity by anti-HIV drugs.

  The Journal of antimicrobial chemotherapy 20070201

• Options for a second-line antiretroviral regimen for HIV type 1-infected patients whose initial regimen of a fixed-dose combination of stavudine, lamivudine, and nevirapine fails.

  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20070201

• Drug resistance after failure of initial antiretroviral therapy in resource-limited countries.

  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20070201

• Nevirapine concentration in nonstimulated saliva: an alternative to plasma sampling in children with human immunodeficiency virus infection.

  Therapeutic drug monitoring 20070201

• Malawi's contribution to '3 by 5': achievements and challenges.

  Bulletin of the World Health Organization 20070201

• Update in HIV care.

  Journal of general internal medicine 20070201

• [Severe thrombocytopenia and human immunodeficiency virus infection. Report of two cases and review].

  Revista chilena de infectologia : organo oficial de la Sociedad Chilena de Infectologia 20070201

• Efficacy of a generic fixed-dose combination of stavudine, lamivudine and nevirapine (GPO-VIR) in Thai HIV-infected patients.

  Journal of the Medical Association of Thailand = Chotmaihet thangphaet 20070201

• Plasma nevirapine levels and 24-week efficacy of a fixed-dose combination of stavudine, lamivudine and nevirapine (GPO-VIR) among Thai HIV-infected patients.

  Journal of the Medical Association of Thailand = Chotmaihet thangphaet 20070201

• The value of highly active antiretroviral therapy in the prevention of mother-to-child transmission of HIV.

  Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology 20070201

• Three-year follow-up of protease inhibitor-based regimen simplification in HIV-infected patients.

  AIDS (London, England) 20070130

• Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection.

  The Cochrane database of systematic reviews 20070124

• Weight and body shape changes in a treatment-naive population after 6 months of nevirapine-based generic highly active antiretroviral therapy in South India.

  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20070115

• Development of a one-step immunochromatographic strip test for the rapid detection of nevirapine (NVP), a commonly used antiretroviral drug for the treatment of HIV/AIDS.

  Talanta 20070115

• Substrate-dependent inhibition or stimulation of HIV RNase H activity by non-nucleoside reverse transcriptase inhibitors (NNRTIs).

  Biochemical and biophysical research communications 20070112

• Reduction in mother-to-child transmission of HIV in Thailand, 2001-2003: Results from population-based surveillance in six provinces.

  AIDS (London, England) 20070111

• HLA-Cw8 primarily associated with hypersensitivity to nevirapine.

  AIDS (London, England) 20070111

• Response to antiretroviral therapy after a single, peripartum dose of nevirapine.

  The New England journal of medicine 20070111

• Pharmacokinetic comparison of generic and trade formulations of lamivudine, stavudine and nevirapine in HIV-infected Malawian adults.

  AIDS (London, England) 20070102

• Unrecognized near-fatal hyperlactatemia in an HIV-infected infant exposed to nucleoside reverse transcriptase inhibitors.

  International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases 20070101

• 4-Aminopyrimidines as novel HIV-1 inhibitors.

  Bioorganic & medicinal chemistry letters 20070101

• Relative activation of human pregnane X receptor versus constitutive androstane receptor defines distinct classes of CYP2B6 and CYP3A4 inducers.

  The Journal of pharmacology and experimental therapeutics 20070101

• Pradimicin A, a carbohydrate-binding nonpeptidic lead compound for treatment of infections with viruses with highly glycosylated envelopes, such as human immunodeficiency virus.

  Journal of virology 20070101

• Pharmacokinetics of two generic fixed-dose combinations for HIV-infected children (Pedimune Baby & Pedimune Junior) are similar to the branded products in healthy adults.

  The Journal of antimicrobial chemotherapy 20070101

• A randomized, double-blind, placebo-controlled trial of combined nevirapine and zidovudine compared with nevirapine alone in the prevention of perinatal transmission of HIV in Zimbabwe.

  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20070101

• Comparative biological and clinical outcomes after a switch from a virologically unsuccessful first protease inhibitor-containing antiretroviral combination to a 3-drug regimen containing efavirenz, nevirapine, or abacavir.

  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20070101

• Nevirapine levels after discontinuation of rifampicin therapy and 60-week efficacy of nevirapine-based antiretroviral therapy in HIV-infected patients with tuberculosis.

  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20070101

• SIVSM/HIV-2 Vpx proteins promote retroviral escape from a proteasome-dependent restriction pathway present in human dendritic cells.

  Retrovirology 20070101

• The emergence of HIV transmitted resistance in Botswana: 'when will the WHO detection threshold be exceeded?'.

  PloS one 20070101

• Two-year morbidity-mortality and alternatives to prolonged breast-feeding among children born to HIV-infected mothers in Côte d'Ivoire.

  PLoS medicine 20070101

• A novel substrate-based HIV-1 protease inhibitor drug resistance mechanism.

  PLoS medicine 20070101

• Non-nucleoside reverse transcriptase inhibitors: a review.

  International journal of clinical practice 20070101

• Cost-effectiveness of genotypic antiretroviral resistance testing in HIV-infected patients with treatment failure.

  PloS one 20070101

• Efavirenz and nevirapine in HIV-1 infection : is there a role for clinical pharmacokinetic monitoring?

  Clinical pharmacokinetics 20070101

• Baseline resistance to nucleoside reverse transcriptase inhibitors fails to predict virologic response to combination therapy in children (PACTG 338).

  AIDS research and therapy 20070101

• Once-daily nevirapine dosing: a pharmacokinetics, efficacy and safety review.

  HIV medicine 20070101

• Experience with the use of a first-line regimen of stavudine, lamivudine and nevirapine in patients in the TREAT Asia HIV Observational Database.

  HIV medicine 20070101

• Safety of nevirapine in pregnancy.

  HIV medicine 20070101

• Intermittent preventive treatment for malaria in pregnancy in Africa: what's new, what's needed?

  Malaria journal 20070101

• Public health the leading force of the Indonesian response to the HIV/AIDS crisis among people who inject drugs.

  Harm reduction journal 20070101

• Cost-effectiveness of medical interventions to prevent cardiovascular disease in a sub-Saharan African country--the case of Tanzania.

  Cost effectiveness and resource allocation : C/E 20070101

• The impact of helminths on the response to immunization and on the incidence of infection and disease in childhood in Uganda: design of a randomized, double-blind, placebo-controlled, factorial trial of deworming interventions delivered in pregnancy and early childhood [ISRCTN32849447].

  Clinical trials (London, England) 20070101

• Methodological standards in non-inferiority AIDS trials: moving from adherence to compliance: response.

  BMC medical research methodology 20070101

• Trends in the HIV related hospital admissions in the HAART era in Barbados, 2004-2006.

  AIDS research and therapy 20070101

• Plasma nevirapine levels, adverse events and efficacy of antiretroviral therapy among HIV-infected patients concurrently receiving nevirapine-based antiretroviral therapy and fluconazole.

  BMC infectious diseases 20070101

• Safety and efficacy of a generic fixed-dose combination of stavudine, lamivudine and nevirapine antiretroviral therapy between HIV-infected patients with baseline CD4 <50 versus CD4 > or = 50 cells/mm3.

  AIDS research and therapy 20070101

• HIV/AIDS drugs for Sub-Saharan Africa: how do brand and generic supply compare?

  PloS one 20070101

• Sequential emergence and clinical implications of viral mutants with K70E and K65R mutation in reverse transcriptase during prolonged tenofovir monotherapy in rhesus macaques with chronic RT-SHIV infection.

  Retrovirology 20070101

• Immunologic, virologic, and neuropsychologic responses in human immunodeficiency virus-infected children receiving their first highly active antiretroviral therapy regimen.

  Viral immunology 20070101

• Evaluation of human immunodeficiency virus type 1-infected Chinese patients treated with highly active antiretroviral therapy for two years.

  Viral immunology 20070101

• How labour intensive is a doctor-based delivery model for antiretroviral treatment (ART)? Evidence from an observational study in Siem Reap, Cambodia.

  Human resources for health 20070101

• The NEFA study: results at three years.

  AIDS reviews 20070101

• Interpreting cerebrospinal fluid pleocytosis in HIV in the era of potent antiretroviral therapy.

  BMC infectious diseases 20070101

• Low CD4 count plus coma predicts cryptococcal meningitis in Tanzania.

  BMC infectious diseases 20070101

• Predictors of disease progression in HIV infection: a review.

  AIDS research and therapy 20070101

• Nevirapine concentrations in HIV-infected children treated with divided fixed-dose combination antiretroviral tablets in Malawi and Zambia.

  Antiviral therapy 20070101

• A virological benefit from an induction/maintenance strategy: the Forte trial.

  Antiviral therapy 20070101

• Plasma levels of soluble urokinase-type plasminogen activator receptor (suPAR) and early mortality risk among patients enrolling for antiretroviral treatment in South Africa.

  BMC infectious diseases 20070101

• Delaying maternal NVP-based ART more effective.

  IAPAC monthly 20070101

• AIDS in the Third World: how to stop the HIV infection?

  Verhandelingen - Koninklijke Academie voor Geneeskunde van Belgie 20070101

• Anti-HIV drugs.

  Verhandelingen - Koninklijke Academie voor Geneeskunde van Belgie 20070101

• Healthcare utilization of patients accessing an African national treatment program.

  BMC health services research 20070101

• Outcome of delivery among HIV positive mothers at Aminu Kano Teaching Hospital, Kano.

  Nigerian journal of medicine : journal of the National Association of Resident Doctors of Nigeria 20070101

• Characteristics and management of HIV-1-infected pregnant women enrolled in a randomised trial: differences between Europe and the USA.

  BMC infectious diseases 20070101

• First-line highly active antiretroviral regimens in 2001-2002 in the French Hospital Database on HIV: combination prescribed and biological outcomes.

  Antiviral therapy 20070101

• Risk of discontinuation of nevirapine due to toxicities in antiretroviral-naive and -experienced HIV-infected patients with high and low CD4+ T-cell counts.

  Antiviral therapy 20070101

• N'-[2-(2-thiophene) ethyl]-N'-[2-(5-bromopyridyl)]thiourea (HI-443), a rationally designed non-nucleoside reverse transcriptase inhibitor compound with potent anti-HIV activity.

  Arzneimittel-Forschung 20070101

• Didanosine enteric-coated capsule: current role in patients with HIV-1 infection.

  Drugs 20070101

• Birth attendants trained in 'Prevention of Mother-To-Child HIV Transmission' provide care in rural Cameroon, Africa.

  Journal of midwifery & women's health 20070101

• Fast and simultaneous determination of darunavir and eleven other antiretroviral drugs for therapeutic drug monitoring: method development and validation for the determination of all currently approved HIV protease inhibitors and non-nucleoside reverse transcriptase inhibitors in human plasma by liquid chromatography coupled with electrospray ionization tandem mass spectrometry.

  Rapid communications in mass spectrometry : RCM 20070101

• Polymorphisms and drug resistance analysis of HIV-1 CRF01_AE strains circulating in Fujian Province, China.

  Archives of virology 20070101

• Protease inhibitor associated mutations compromise the efficacy of therapy in human immunodeficiency virus-1 (HIV-1) infected pediatric patients: a cross-sectional study.

  AIDS research and therapy 20070101

• HIV prevention costs and program scale: data from the PANCEA project in five low and middle-income countries.

  BMC health services research 20070101

• Phenotype and envelope gene diversity of nef-deleted HIV-1 isolated from long-term survivors infected from a single source.

  Virology journal 20070101

• A national survey of teachers on antiretroviral therapy in Malawi: access, retention in therapy and survival.

  PloS one 20070101

• Electrospray tandem mass spectroscopic characterisation of 18 antiretroviral drugs and simultaneous quantification of 12 antiretrovirals in plasma.

  Rapid communications in mass spectrometry : RCM 20070101

• Simple PCR assays improve the sensitivity of HIV-1 subtype B drug resistance testing and allow linking of resistance mutations.

  PloS one 20070101

• A liquid chromatography/atmospheric pressure ionization tandem mass spectrometry quantitation method for nevirapine and its two oxidative metabolites, 2-hydroxynevirapine and nevirapine 4-carboxylic acid, and pharmacokinetics in baboons.

  Rapid communications in mass spectrometry : RCM 20070101

• Validation of the SCID-hu Thy/Liv mouse model with four classes of licensed antiretrovirals.

  PloS one 20070101

• Nevirapine-based antiretroviral therapy started early in the course of tuberculosis treatment in adult Malawians.

  Antiviral therapy 20070101

• Substitutions due to antiretroviral toxicity or contraindication in the first 3 years of antiretroviral therapy in a large South African cohort.

  Antiviral therapy 20070101

• Durable suppression possible with FOTO treatment schedule in subjects on nevirapine-based regimens.

  HIV clinical trials 20070101

• Widespread vitiligo after erythroderma caused by nevirapine in a patient with AIDS.

  Acta dermato-venereologica 20070101

• CCR5 haplotypes and mother-to-child HIV transmission in Malawi.

  PloS one 20070101

• Impact of drug classes and treatment availability on the rate of antiretroviral treatment change in the TREAT Asia HIV Observational Database (TAHOD).

  AIDS research and therapy 20070101

• Assessment of quality of life in HAART-treated HIV-positive subjects with body fat redistribution in Rwanda.

  AIDS research and therapy 20070101

• Pulmonary cystic disease in HIV positive individuals in the Democratic Republic of Congo: three case reports.

  Journal of medical case reports 20070101

• Pathogenicity and immunogenicity of attenuated, nef-deleted HIV-1 strains in vivo.

  Retrovirology 20070101

• Combining evidence and values in priority setting: testing the balance sheet method in a low-income country.

  BMC health services research 20070101

• Both TRIM5alpha and TRIMCyp have only weak antiviral activity in canine D17 cells.

  Retrovirology 20070101

• Immune restoration syndrome with disseminated Penicillium marneffei and cytomegalovirus co-infections in an AIDS patient.

  AIDS research and therapy 20070101

• Utilization and spending trends for antiretroviral medications in the U.S. Medicaid program from 1991 to 2005.

  AIDS research and therapy 20070101

• Bioequivalence study of two nevirapine tablet formulations in human-immunodeficiency-virus-infected patients.

  Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria 20070101

• Stavudine but not didanosine as part of HAART contributes to peripheral lipoatrophy: a substudy from the Antiretroviral Regimen Evaluation Study (ARES).

  HIV clinical trials 20070101

• Poor follow-up rates at a self-pay northern Indian tertiary AIDS clinic.

  International journal for equity in health 20070101

• [Feasibility of HIV prophylaxis with nevirapine in a northeastern rural area of the Democratic Republic of the Congo].

  Sante (Montrouge, France) 20070101

• Influence of piperine on the pharmacokinetics of nevirapine under fasting conditions: a randomised, crossover, placebo-controlled study.

  Drugs in R&D 20070101

• Contraception use and pregnancy among 15-24 year old South African women: a nationally representative cross-sectional survey.

  BMC medicine 20070101

• A randomized controlled pilot trial of azithromycin or artesunate added to sulfadoxine-pyrimethamine as treatment for malaria in pregnant women.

  PloS one 20070101

• Rapid CD4 decline after interruption of non-nucleoside reverse transcriptase inhibitor-based antiretroviral therapy in a resource-limited setting.

  AIDS research and therapy 20070101

• Seroprevalence of hepatitis B and C viral co-infections among children infected with human immunodeficiency virus attending the paediatric HIV care and treatment center at Muhimbili National Hospital in Dar-es-Salaam, Tanzania.

  BMC public health 20070101

• Missed opportunities for participation in prevention of mother to child transmission programmes: simplicity of nevirapine does not necessarily lead to optimal uptake, a qualitative study.

  AIDS research and therapy 20070101

• Predisposing factors for nevirapine toxicity among AIDS patients with low baseline CD4 count.

  Asian Pacific journal of allergy and immunology 20070101

• Analysis of severe hepatic events associated with nevirapine-containing regimens: CD4+ T-cell count and gender in hepatitis C seropositive and seronegative patients.

  Drug safety 20070101

• Case-control exploration of relationships between early rash or liver toxicity and plasma concentrations of nevirapine and primary metabolites.

  HIV clinical trials 20070101

• Isothiazole derivatives as antiviral agents.

  Antiviral chemistry & chemotherapy 20070101

• Geographical information system and access to HIV testing, treatment and prevention of mother-to-child transmission in conflict affected Northern Uganda.

  Conflict and health 20070101

• Promotion of couples' voluntary counselling and testing for HIV through influential networks in two African capital cities.

  BMC public health 20070101

• High uptake of exclusive breastfeeding and reduced early post-natal HIV transmission.

  PloS one 20070101

• Lipodystrophy and metabolic changes in HIV-infected children on non-nucleoside reverse transcriptase inhibitor-based antiretroviral therapy.

  Antiviral therapy 20070101

• [Pilot study of antiretroviral therapy in Djibouti].

  Eastern Mediterranean health journal = La revue de sante de la Mediterranee orientale = al-Majallah al-sihhiyah li-sharq al-mutawassit 20070101

• A cluster-randomised trial to compare home-based with health facility-based antiretroviral treatment in Uganda: study design and baseline findings.

  The open AIDS journal 20070101

• Macrophage Tropism and Cytopathicity of HIV-1 Variants Isolated Sequentially from a Long-Term Survivor Infected with nef-Deleted Virus.

  The open microbiology journal 20070101

• [The clinical and biological tolerance of nevirapine among patients with AIDS under treatment at the Hospital of the Point G].

  Le Mali medical 20070101

• Clinical implications of mutations at reverse transcriptase codon 135 on response to NNRTI-based therapy.

  The open virology journal 20070101

• [Cutaneous side effects of antiretroviral drugs].

  Le Mali medical 20070101

• [Factors associated with antiretroviaral treatment observance at Point 'G' hospital].

  Le Mali medical 20070101

• Poor Efficacy and Tolerability of Stavudine, Didanosine, and Efavirenz-based Regimen in Treatment-Naive Patients in Senegal.

  Journal of the International AIDS Society 20070101

• Hyperlactatemia due to nevirapine.

  Annals of internal medicine 20061205

• Phenotypic resistance of resistant strains of HIV type-1 subtype B in China.

  Chinese medical journal 20061205

• Validation by simulation of a clinical trial model using the standardized mean and variance criteria.

  Journal of biomedical informatics 20061201

• Arylthiopyrrole (AThP) derivatives as non-nucleoside HIV-1 reverse transcriptase inhibitors: synthesis, structure-activity relationships, and docking studies (part 1).

  ChemMedChem 20061201

• Arylthiopyrrole (AThP) derivatives as non-nucleoside HIV-1 reverse transcriptase inhibitors: synthesis, structure-activity relationships, and docking studies (part 2).

  ChemMedChem 20061201

• Highly active antiretroviral treatment containing efavirenz or nevirapine and related toxicity in the TREAT Asia HIV Observational Database.

  Journal of acquired immune deficiency syndromes (1999) 20061201

• Liver transplantation for fulminant hepatitis related to nevirapine therapy.

  Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 20061201

• Resistance mutational analysis of HIV type 1 subtype C among rural South African drug-naive patients prior to large-scale availability of antiretrovirals.

  AIDS research and human retroviruses 20061201

• The effects of highly active antiretroviral therapy (HAART) of stavudine, lamivudine and nevirapine on the CD4 lymphocyte count of HIV-infected Africans: the Nigerian experience.

  Nigerian journal of clinical practice 20061201

• Nevirapine versus efavirenz based antiretroviral treatment in naive Indian patients: comparison of effectiveness in clinical cohort.

  The Journal of the Association of Physicians of India 20061201

• Nevirapine-induced fulminant hepatitis.

  The Journal of the Association of Physicians of India 20061201

• Nevirapine versus efavirenz in 742 patients: no link of liver toxicity with female sex, and a baseline CD4 cell count greater than 250 cells/microl.

  AIDS (London, England) 20061114

• A simple and rapid liquid chromatography method for simultaneous determination of zidovudine and nevirapine in plasma.

  Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20061107

• Optimization of pyrimidinyl- and triazinyl-amines as non-nucleoside inhibitors of HIV-1 reverse transcriptase.

  Bioorganic & medicinal chemistry letters 20061101

• Characterization of drug-resistance mutations in HIV-1 isolates from non-HAART and HAART treated patients in Burkina Faso.

  Journal of medical virology 20061101

• Stability of nevirapine suspension in prefilled oral syringes used for reduction of mother-to-child HIV transmission.

  Journal of acquired immune deficiency syndromes (1999) 20061101

• A comparison of the steady-state pharmacokinetics of nevirapine in men, nonpregnant women and women in late pregnancy.

  British journal of clinical pharmacology 20061101

• Variability in non-nucleoside reverse transcriptase and protease inhibitor concentrations among HIV-infected adults in routine clinical practice.

  British journal of clinical pharmacology 20061101

• Criteria for drugs used in pre-exposure prophylaxis trials against HIV infection.

  PLoS medicine 20061101

• Potent nonnucleoside reverse transcriptase inhibitors target HIV-1 Gag-Pol.

  PLoS pathogens 20061101

• Evaluation of nevirapine-switch strategies for HIV treatment.

  HIV medicine 20061101

• Synthesis and anti-HIV evaluation of the novel 2-(m-chlorobenzyl)-4-substituted-7-methyl-1, 1, 3-trioxo-pyrazolo[4, 5-e] [1, 2, 4]thiadiazines.

  Archives of pharmacal research 20061101

• Synthesis and anti-HIV activity of nevirapine prodrugs.

  Die Pharmazie 20061101

• European Academy of Paediatrics, Barcelona, Spain, October 7-10, 2006. Abstracts.

  European journal of pediatrics 20061101

• Switch from a first virologically effective protease inhibitor-containing regimen to a regimen containing efavirenz, nevirapine or abacavir.

  AIDS (London, England) 20061024

• HPTN 024 study: histologic chorioamnionitis, antibiotics and adverse infant outcomes in a predominantly HIV-1-infected African population.

  American journal of obstetrics and gynecology 20061001

• A computer-based, image-analysis method to quantify HIV-1 infection in a single-cycle infectious center assay.

  Journal of virological methods 20061001

• Long-term assessment of nevirapine-containing highly active antiretroviral therapy in antiretroviral-naive HIV-infected patients: 3-year follow-up of the VIRGO study.

  HIV medicine 20061001

• Brief report: enzyme inducers reduce elimination half-life after a single dose of nevirapine in healthy women.

  Journal of acquired immune deficiency syndromes (1999) 20061001

• Serum lactate levels in infants exposed peripartum to antiretroviral agents to prevent mother-to-child transmission of HIV: Agence Nationale de Recherches Sur le SIDA et les Hépatites Virales 1209 study, Abidjan, Ivory Coast.

  Pediatrics 20061001

• Pharmacogenetics of HIV therapy.

  Pharmacogenetics and genomics 20061001

• Potent antiviral synergy between monoclonal antibody and small-molecule CCR5 inhibitors of human immunodeficiency virus type 1.

  Antimicrobial agents and chemotherapy 20061001

• Cell differentiation and iodine-131 uptake in poorly differentiated thyroid tumour in response to nevirapine.

  The Lancet. Oncology 20061001

• A randomized controlled trial of folate supplementation when treating malaria in pregnancy with sulfadoxine-pyrimethamine.

  PLoS clinical trials 20061001

• Inhibition of endogenous reverse transcription of human and nonhuman primate lentiviruses: potential for development of lentivirucides.

  Virology 20060930

• Drug transporter and metabolizing enzyme gene variants and nonnucleoside reverse-transcriptase inhibitor hepatotoxicity.

  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20060915

• Pharmacogenetics of nevirapine-associated hepatotoxicity: an Adult AIDS Clinical Trials Group collaboration.

  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20060915

• Maternal syphilis infection is associated with increased risk of mother-to-child transmission of HIV in Malawi.

  AIDS (London, England) 20060911

• The design and synthesis of 9-phenylcyclohepta[d]pyrimidine-2,4-dione derivatives as potent non-nucleoside inhibitors of HIV reverse transcriptase.

  Organic & biomolecular chemistry 20060907

• Risk of breast, ovary, and uterine corpus cancers among 85,268 women with AIDS.

  British journal of cancer 20060904

• Ritonavir, saquinavir, and efavirenz, but not nevirapine, inhibit bile acid transport in human and rat hepatocytes.

  The Journal of pharmacology and experimental therapeutics 20060901

• Differential susceptibility of HIV-1 reverse transcriptase to inhibition by RNA aptamers in enzymatic reactions monitoring specific steps during genome replication.

  The Journal of biological chemistry 20060901

• Gag-Pol bearing a reverse transcriptase drug-resistant mutation influences viral genomic RNA incorporation into human immunodeficiency virus type 1 particles.

  The Journal of general virology 20060901

• Rates of disease progression according to initial highly active antiretroviral therapy regimen: a collaborative analysis of 12 prospective cohort studies.

  The Journal of infectious diseases 20060901

• Which topical microbicides for blocking HIV-1 transmission will work in the real world?

  PLoS medicine 20060901

• Plasma lipid concentrations after 1.5 years of exposure to nevirapine or efavirenz together with stavudine and lamivudine.

  HIV medicine 20060901

• The value of serum albumin in pretreatment assessment and monitoring of therapy in HIV/AIDS patients.

  HIV medicine 20060901

• Incidence and risk factors of rash associated with efavirenz in HIV-infected patients with preceding nevirapine-associated rash.

  HIV medicine 20060901

• Lessons learned from a paying antiretroviral therapy service in the public health sector at Kamuzu Central Hospital, Malawi: 1-year experience.

  Journal of the International Association of Physicians in AIDS Care (Chicago, Ill. : 2002) 20060901

• Sensitivity of the ViroSeq HIV-1 genotyping system for detection of the K103N resistance mutation in HIV-1 subtypes A, C, and D.

  The Journal of molecular diagnostics : JMD 20060901

• Study of the sequence of events involved in nevirapine-induced skin rash in Brown Norway rats.

  Chemical research in toxicology 20060901

• RAT CYP3A and CYP2B1/2 were not associated with nevirapine-induced hepatotoxicity.

  Methods and findings in experimental and clinical pharmacology 20060901

• [Observance of antiretroviral treatments: African specificities].

  Medecine et maladies infectieuses 20060901

• Efficacy and safety of generic fixed-dose combination of stavudine, lamivudine and nevirapine (GPO-vir) in advanced HIV infection.

  Journal of the Medical Association of Thailand = Chotmaihet thangphaet 20060901

• Management of antiretroviral drug toxicity.

  Current opinion in HIV and AIDS 20060901

• Placental transfer and pharmacokinetics of lopinavir and other protease inhibitors in combination with nevirapine at delivery.

  AIDS (London, England) 20060822

• Domestic violence and prevention of mother-to-child transmission of HIV-1.

  AIDS (London, England) 20060822

• Breastfeeding plus infant zidovudine prophylaxis for 6 months vs formula feeding plus infant zidovudine for 1 month to reduce mother-to-child HIV transmission in Botswana: a randomized trial: the Mashi Study.

  JAMA 20060816

• Quantitative analysis of HIV-1 variants with the K103N resistance mutation after single-dose nevirapine in women with HIV-1 subtypes A, C, and D.

  Journal of acquired immune deficiency syndromes (1999) 20060815

• Synthesis and biological evaluations of sulfanyltriazoles as novel HIV-1 non-nucleoside reverse transcriptase inhibitors.

  Bioorganic & medicinal chemistry letters 20060815

• Design, synthesis, and biological evaluations of novel quinolones as HIV-1 non-nucleoside reverse transcriptase inhibitors.

  Bioorganic & medicinal chemistry letters 20060815

• In vivo effects of HIV-1 exposure in the presence and absence of single-dose nevirapine on cellular plasma activation markers of infants born to HIV-1-seropositive mothers.

  Journal of acquired immune deficiency syndromes (1999) 20060815

• [The use of the non-nucleoside reverse transcriptase inhibitors nevirapine and efavirenz in the treatment of patients with a chronic HIV-I infection].

  Nederlands tijdschrift voor geneeskunde 20060805

• Adverse effects of antiretroviral therapy in HIV-1 infected children.

  Journal of tropical pediatrics 20060801

• Discovery of TSAO derivatives with an unusual HIV-1 activity/resistance profile.

  Antiviral research 20060801

• Inhibitory activity on HIV-1 reverse transcriptase and integrase of a carmalol derivative from a brown Alga, Ishige okamurae.

  Phytotherapy research : PTR 20060801

• Range of normal neutrophil counts in healthy zimbabwean infants: implications for monitoring antiretroviral drug toxicity.

  Journal of acquired immune deficiency syndromes (1999) 20060801

• Comparison of HIV-1 mother-to-child transmission after single-dose nevirapine prophylaxis among African women with subtypes A, C, and D.

  Journal of acquired immune deficiency syndromes (1999) 20060801

• Effect of widely used combinations of antiretroviral therapy on liver CYP3A4 activity in HIV-infected patients.

  British journal of clinical pharmacology 20060801

• HLA-dependent hypersensitivity to nevirapine in Sardinian HIV patients.

  AIDS (London, England) 20060801

• Evidence behind the WHO guidelines: hospital care for children: what antiretroviral agents and regimens are effective in the prevention of mother-to-child transmission of HIV?

  Journal of tropical pediatrics 20060801

• How do intellectual property law and international trade agreements affect access to antiretroviral therapy?

  PLoS medicine 20060801

• Variability in the clinical pattern of cutaneous side-effects of drugs with systemic symptoms: does a DRESS syndrome really exist?

  The British journal of dermatology 20060801

• Full validation of an analytical method for the HIV-protease inhibitor atazanavir in combination with 8 other antiretroviral agents and its applicability to therapeutic drug monitoring.

  Therapeutic drug monitoring 20060801

• Switch from efavirenz to nevirapine associated with resolution of efavirenz-related neuropsychiatric adverse events and improvement in lipid profiles.

  AIDS patient care and STDs 20060801

• Structural insights into mechanisms of non-nucleoside drug resistance for HIV-1 reverse transcriptases mutated at codons 101 or 138.

  The FEBS journal 20060801

• Implementation of single-dose nevirapine for prevention of MTCT of HIV--lessons from Cape Town.

  South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde 20060801

• Characteristics of HIV infected patients cared for at 'academic model for the prevention and treatment of HIV/AIDS' clinics in western Kenya.

  East African medical journal 20060801

• Plasma nevirapine levels and 24-week efficacy in HIV-infected patients receiving nevirapine-based highly active antiretroviral therapy with or without rifampicin.

  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20060715

• Flow-injection spectrophotometric determination of reverse transcriptase inhibitors used for acquired immuno deficiency syndrome (AIDS) treatment: focus on strategies for dealing with the background components.

  Analytica chimica acta 20060714

• National adult antiretroviral therapy guidelines in resource-limited countries: concordance with 2003 WHO guidelines?

  AIDS (London, England) 20060713

• Synthesis and biological investigation of S-aryl-S-DABO derivatives as HIV-1 inhibitors.

  Bioorganic & medicinal chemistry letters 20060701

• Synthesis and evaluation of N-aryl pyrrolidinones as novel anti-HIV-1 agents. Part 1.

  Bioorganic & medicinal chemistry letters 20060701

• Incidence of and risk factors for severe hepatotoxicity of nelfinavir-containing regimens among HIV-infected patients with chronic hepatitis C.

  The Journal of antimicrobial chemotherapy 20060701

• Influence of tenofovir, nevirapine and efavirenz on ritonavir-boosted atazanavir pharmacokinetics in HIV-infected patients.

  European journal of clinical pharmacology 20060701

• Insulin resistance is not associated with liver fibrosis progression in HIV/hepatitis C virus-coinfected patients.

  Journal of viral hepatitis 20060701

• Dihydroxythiophenes are novel potent inhibitors of human immunodeficiency virus integrase with a diketo acid-like pharmacophore.

  Journal of virology 20060701

• Immunoprophylaxis against mother-to-child transmission of HIV-1.

  PLoS medicine 20060701

• Novel broad-spectrum thiourea non-nucleoside inhibitors for the prevention of mucosal HIV transmission.

  Current HIV research 20060701

• Safety of nevirapine-containing antiretroviral triple therapy regimens to prevent vertical transmission in an African cohort of HIV-1-infected pregnant women.

  HIV medicine 20060701

• Scrutinized: the TRIPS agreement and public health.

  McGill journal of medicine : MJM : an international forum for the advancement of medical sciences by students 20060701

• The mother-to-child HIV transmission epidemic in Europe: evolving in the East and established in the West.

  AIDS (London, England) 20060626

• Optimizing treatment for HIV-infected South African women exposed to single-dose nevirapine: balancing efficacy and cost.

  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20060615

• Modulation of human immunodeficiency virus type 1 synergistic inhibition by reverse transcriptase mutations.

  Biochemistry 20060613

• Maternal single-dose nevirapine versus placebo as part of an antiretroviral strategy to prevent mother-to-child HIV transmission in Botswana.

  AIDS (London, England) 20060612

• The value of contraception to prevent perinatal HIV transmission.

  Sexually transmitted diseases 20060601

• New HIV-1 reverse transcriptase inhibitors based on a tricyclic benzothiophene scaffold: synthesis, resolution, and inhibitory activity.

  Bioorganic & medicinal chemistry letters 20060601

• Hepatotoxicity and antiretroviral therapy with protease inhibitors: A review.

  Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 20060601

• Cost-effectiveness of HIV rescreening during late pregnancy to prevent mother-to-child HIV transmission in South Africa and other resource-limited settings.

  Journal of acquired immune deficiency syndromes (1999) 20060601

• Association between the replication capacity and mother-to-child transmission of HIV-1, in antiretroviral drug-naive Malawian women.

  The Journal of infectious diseases 20060601

• Severe liver disease associated with prolonged exposure to antiretroviral drugs.

  Journal of acquired immune deficiency syndromes (1999) 20060601

• Antiretroviral drug resistance and routine therapy, Cameroon.

  Emerging infectious diseases 20060601

• Design, molecular modeling, synthesis, and anti-HIV-1 activity of new indolyl aryl sulfones. Novel derivatives of the indole-2-carboxamide.

  Journal of medicinal chemistry 20060601

• Nevirapine toxicity.

  International journal of STD & AIDS 20060601

• Routine intrapartum HIV counseling and testing for prevention of mother-to-child transmission of HIV in a rural Ugandan hospital.

  Journal of acquired immune deficiency syndromes (1999) 20060601

• Nevirapine resistance viral mutations after repeat use of nevirapine for prevention of perinatal HIV transmission.

  Journal of acquired immune deficiency syndromes (1999) 20060601

• Are plasma levels valid surrogates for cellular concentrations of antiretroviral drugs in HIV-infected patients?

  Therapeutic drug monitoring 20060601

• Nevirapine/lamivudine/stavudine as a combined-formulation tablet: bioequivalence study compared with each component administered concurrently under fasting condition.

  International journal of clinical pharmacology and therapeutics 20060601

• HIV infection.

  Clinical evidence 20060601

• Socio-economic and demographic factors associated with prevalence of HIV infection among pregnant women in Dar es Salaam, Tanzania.

  East African medical journal 20060601

• Estimation of the rate of mother to child transmission of HIV in Nigeria.

  African journal of medicine and medical sciences 20060601

• HIV denialists ignore large gap in the study they cite.

  Nature 20060525

• Generic fixed-dose combination antiretroviral treatment in resource-poor settings: multicentric observational cohort.

  AIDS (London, England) 20060512

• Nevirapine uptake into the central nervous system of the Guinea pig: an in situ brain perfusion study.

  The Journal of pharmacology and experimental therapeutics 20060501

• Natural polymorphism in protease and reverse transcriptase genes and in vitro antiretroviral drug susceptibilities of non-B HIV-1 strains from treatment-naive patients.

  Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology 20060501

• Frequency and treatment-related predictors of thymidine-analogue mutation patterns in HIV-1 isolates after unsuccessful antiretroviral therapy.

  The Journal of infectious diseases 20060501

• Microsphere-based protease assays and screening application for lethal factor and factor Xa.

  Cytometry. Part A : the journal of the International Society for Analytical Cytology 20060501

• Maternal hepatotoxicity with nevirapine as part of combination antiretroviral therapy in pregnancy.

  HIV medicine 20060501

• Increasing nevirapine dose can overcome reduced bioavailability due to rifampicin coadministration.

  Journal of acquired immune deficiency syndromes (1999) 20060501

• Selection of resistance mutations in children receiving prophylaxis with lamivudine or nevirapine for the prevention of postnatal transmission of HIV.

  Journal of acquired immune deficiency syndromes (1999) 20060501

• [Evolution of mortality and current status of an HIV-infected population cared for at a comprehensive HIV/AIDS center in Chile].

  Revista medica de Chile 20060501

• Effect of exposure to clinic-based health education interventions on behavioural intention to prevent mother-to-child transmission of HIV infection.

  SAHARA J : journal of Social Aspects of HIV/AIDS Research Alliance 20060501

• Reverse transcriptase mutations 118I, 208Y, and 215Y cause HIV-1 hypersusceptibility to non-nucleoside reverse transcriptase inhibitors.

  AIDS (London, England) 20060424

• Decay of K103N mutants in cellular DNA and plasma RNA after single-dose nevirapine to reduce mother-to-child HIV transmission.

  AIDS (London, England) 20060424

• This is no time to stop use of nevarapine to prevent mother-to-child transmission of HIV.

  AIDS (London, England) 20060424

• Exposure to HIV and antiretroviral medication as a potential cause of necrotizing enterocolitis in term neonates.

  AIDS (London, England) 20060424

• Scaling up of highly active antiretroviral therapy in a rural district of Malawi: an effectiveness assessment.

  Lancet (London, England) 20060422

• Biosensor-based kinetic characterization of the interaction between HIV-1 reverse transcriptase and non-nucleoside inhibitors.

  Journal of medicinal chemistry 20060420

• Stavudine, lamivudine and nevirapine combination therapy for treatment of HIV infection and AIDS in adults.

  The Cochrane database of systematic reviews 20060419

• Design, synthesis, and biological evaluations of novel oxindoles as HIV-1 non-nucleoside reverse transcriptase inhibitors. Part 2.

  Bioorganic & medicinal chemistry letters 20060415

• Design, synthesis and biological evaluations of novel oxindoles as HIV-1 non-nucleoside reverse transcriptase inhibitors. Part I.

  Bioorganic & medicinal chemistry letters 20060415

• Marked intraindividual variability in antiretroviral concentrations may limit the utility of therapeutic drug monitoring.

  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20060415

• Effect of co-trimoxazole prophylaxis, antiretroviral therapy, and insecticide-treated bednets on the frequency of malaria in HIV-1-infected adults in Uganda: a prospective cohort study.

  Lancet (London, England) 20060415

• Remission from Kaposi's sarcoma on HAART is associated with suppression of HIV replication and is independent of protease inhibitor therapy.

  British journal of cancer 20060410

• Synthesis and anti-HIV activity of new alkenyldiarylmethane (ADAM) non-nucleoside reverse transcriptase inhibitors (NNRTIs) incorporating benzoxazolone and benzisoxazole rings.

  Bioorganic & medicinal chemistry 20060401

• The contribution of HIV fitness to the evolution pattern of reverse transcriptase inhibitor resistance.

  Journal of medical virology 20060401

• Modelling the impact of antiretroviral use in resource-poor settings.

  PLoS medicine 20060401

• Controversies in the use of nevirapine for prevention of mother-to-child transmission of HIV.

  Expert opinion on pharmacotherapy 20060401

• High incidence of adverse reactions to initial antiretroviral therapy in Brazil.

  Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas 20060401

• Long-term safety and efficacy of nevirapine-based approaches in HIV type 1-infected patients.

  AIDS research and human retroviruses 20060401

• Nonnucleoside reverse transcriptase inhibitor fold change or plasma concentration as a predictor of virological response over 48 weeks in highly treatment experienced HIV-positive individuals.

  AIDS research and human retroviruses 20060401

• Successful miltefosine treatment of post-kala-azar dermal leishmaniasis occurring during antiretroviral therapy.

  Annals of tropical medicine and parasitology 20060401

• Design of nevirapine derivatives insensitive to the K103N and Y181C HIV-1 reverse transcriptase mutants.

  SAR and QSAR in environmental research 20060401

• Pharmacologic optimization of protease inhibitors and nonnucleoside reverse transcriptase inhibitors (POPIN)--a randomized controlled trial of therapeutic drug monitoring and adherence support.

  Journal of acquired immune deficiency syndromes (1999) 20060401

• Prevention of mother-to-child transmission of HIV in Cameroon: experiences from the University Teaching Hospital in Yaounde (Cameroon).

  Zentralblatt fur Gynakologie 20060401

• Urine nevirapine as a predictor of antiretroviral adherence.

  The Indian journal of medical research 20060401

• Rapid HIV testing and counselling in labour in a northern Nigerian setting.

  African journal of reproductive health 20060401

• [Codevelopment and health. Prevention of HIV transmission in Ghana: the Brothers in Work Programme].

  Atencion primaria 20060331

• Initiation of antiretroviral therapy in advanced AIDS with active tuberculosis: clinical experiences from Thailand.

  The Journal of infection 20060301

• Expression of LINE-1 retroposons is essential for murine preimplantation development.

  Molecular reproduction and development 20060301

• Antiretroviral therapy and dyslipidaemia: unlocking the code.

  PLoS medicine 20060301

• A prospective, 96-week study of the impact of Trizivir, Combivir/nelfinavir, and lamivudine/stavudine/nelfinavir on lipids, metabolic parameters and efficacy in antiretroviral-naive patients: effect of sex and ethnicity.

  HIV medicine 20060301

• Life-threatening interaction between antiretroviral therapy and vinblastine in HIV-associated multicentric Castleman's disease.

  European journal of haematology 20060301

• Transmission of human immunodeficiency virus type 1 nevirapine resistance mutation K103N from a treatment-naive mother to her child.

  The Pediatric infectious disease journal 20060301

• Pharmacokinetic parameters of nevirapine and efavirenz in relation to antiretroviral efficacy.

  AIDS research and human retroviruses 20060301

• Phenotypic drug resistance patterns in subtype A HIV-1 clones with nonnucleoside reverse transcriptase resistance mutations.

  AIDS research and human retroviruses 20060301

• Clinical profile and natural history of children with HIV infection.

  Indian journal of pediatrics 20060301

• How to Take HIV antiretroviral medications on time without a watch in rural Uganda.

  PLoS medicine 20060301

• Viral latency and reservoirs: relevance for mother-to-child transmission and resistance.

  Current opinion in HIV and AIDS 20060301

• Concerns regarding a randomized trial of two postexposure prophylaxis regimens.

  AIDS (London, England) 20060227

• Determination of the novel non-peptidic HIV-protease inhibitor tipranavir by HPLC-UV after solid-phase extraction.

  Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20060217

• Development of nevirapine resistance in infants is reduced by use of infant-only single-dose nevirapine plus zidovudine postexposure prophylaxis for the prevention of mother-to-child transmission of HIV-1.

  The Journal of infectious diseases 20060215

• Low risk of nevirapine resistance mutations in the prevention of mother-to-child transmission of HIV-1: Agence Nationale de Recherches sur le SIDA Ditrame Plus, Abidjan, Cote d'Ivoire.

  The Journal of infectious diseases 20060215

• Simultaneous determination of 16 anti-HIV drugs in human plasma by high-performance liquid chromatography.

  Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20060202

• Optimization of diarylamines as non-nucleoside inhibitors of HIV-1 reverse transcriptase.

  Bioorganic & medicinal chemistry letters 20060201

• Reduction of mother-to-child transmission of HIV at Saint Camille Medical Centre in Burkina Faso.

  Journal of medical virology 20060201

• Strategies to prevent mother-to-child transmission of HIV.

  Current opinion in infectious diseases 20060201

• A randomized crossover study to determine bioequivalence of generic and brand name nevirapine, zidovudine, and lamivudine in HIV-negative women in India.

  Journal of acquired immune deficiency syndromes (1999) 20060201

• HIV-1 reverse transcriptase gene 103K/N and 184M/V combinations in tandem: detection and quantification of HIV-1 populations in the CD45RO+ T-cell compartment by a double-ARMS real-time PCR assay.

  Journal of acquired immune deficiency syndromes (1999) 20060201

• Challenges in the concurrent management of malaria and HIV in pregnancy in sub-Saharan Africa.

  The Lancet. Infectious diseases 20060201

• Short communication: low prevalence of genotypic drug resistance mutations among antiretroviral-naive HIV type 1 patients in Malaysia.

  AIDS research and human retroviruses 20060201

• HIV drug-resistant strains as epidemiologic sentinels.

  Emerging infectious diseases 20060201

• FDA notifications. FDA grants tentative approval to generic Nevirapine.

  AIDS alert 20060201

• Structure-activity relationship studies of novel benzophenones leading to the discovery of a potent, next generation HIV nonnucleoside reverse transcriptase inhibitor.

  Journal of medicinal chemistry 20060126

• Mutations other than 103N in human immunodeficiency virus type 1 reverse transcriptase (RT) emerge from K103R polymorphism under non-nucleoside RT inhibitor pressure.

  Virology 20060120

• Development and validation of RP-HPLC and ultraviolet spectrophotometric methods of analysis for the quantitative estimation of antiretroviral drugs in pharmaceutical dosage forms.

  Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20060118

• Association of cord blood nevirapine concentration with reported timing of dose and HIV-1 transmission.

  AIDS (London, England) 20060109

• The controversies of nevirapine for preventing mother-to-child HIV transmission.

  AIDS (London, England) 20060109

• A validated new method for nevirapine quantitation in human plasma via high-performance liquid chromatography.

  Biomedical chromatography : BMC 20060101

• Simple adjustments for randomized trials with nonrandomly missing or censored outcomes arising from informative covariates.

  Biostatistics (Oxford, England) 20060101

• Suspected drug-induced liver fatalities reported to the WHO database.

  Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 20060101

• Addressing the paediatric HIV epidemic: a perspective from the Western Cape Region of South Africa.

  Transactions of the Royal Society of Tropical Medicine and Hygiene 20060101

• Maternal-fetal microtransfusions and HIV-1 mother-to-child transmission in Malawi.

  PLoS medicine 20060101

• Assessment of drug-drug interactions between tenofovir disoproxil fumarate and the nonnucleoside reverse transcriptase inhibitors nevirapine and efavirenz in HIV-infected patients.

  Journal of acquired immune deficiency syndromes (1999) 20060101

• Reasons for modification of generic highly active antiretroviral therapeutic regimens among patients in southern India.

  Journal of acquired immune deficiency syndromes (1999) 20060101

• Predictors of nonadherence to single-dose nevirapine therapy for the prevention of mother-to-child HIV transmission.

  Journal of acquired immune deficiency syndromes (1999) 20060101

• Predicting and diagnosing abacavir and nevirapine drug hypersensitivity: from bedside to bench and back again.

  Pharmacogenomics 20060101

• Acute and chronic chorioamnionitis and the risk of perinatal human immunodeficiency virus-1 transmission.

  American journal of obstetrics and gynecology 20060101

• Nevirapine toxicity in a cohort of HIV-1-infected pregnant women.

  American journal of obstetrics and gynecology 20060101

• The distribution of the anti-HIV drug, tenofovir (PMPA), into the brain, CSF and choroid plexuses.

  Cerebrospinal fluid research 20060101

• Impact of long-term viral suppression in CD4+ recovery of HIV-children on Highly Active Antiretroviral Therapy.

  BMC infectious diseases 20060101

• Longitudinal study on mitochondrial effects of didanosine-tenofovir combination.

  AIDS research and human retroviruses 20060101

• A prospective study of hearing changes after beginning zidovudine or didanosine in HIV-1 treatment-naïve people.

  BMC infectious diseases 20060101

• Direct and fast determination of antiretroviral drugs by automated online solid-phase extraction-liquid chromatography-tandem mass spectrometry in human plasma.

  Clinical chemistry and laboratory medicine 20060101

• DR_SEQAN: a PC/Windows-based software to evaluate drug resistance using human immunodeficiency virus type 1 genotypes.

  BMC infectious diseases 20060101

• CD4 cell count recovery among HIV-infected patients with very advanced immunodeficiency commencing antiretroviral treatment in sub-Saharan Africa.

  BMC infectious diseases 20060101

• Antiretroviral treatment of HIV infection: Swedish recommendations 2005.

  Scandinavian journal of infectious diseases 20060101

• Antiretroviral therapy at a district hospital in Ethiopia prevents death and tuberculosis in a cohort of HIV patients.

  AIDS research and therapy 20060101

• Efavirenz use during pregnancy and for women of child-bearing potential.

  AIDS research and therapy 20060101

• API consensus guidelines for use of antiretroviral therapy in adults (API-ART guidelines). Endorsed by the AIDS Society of India.

  The Journal of the Association of Physicians of India 20060101

• Antenatal HIV testing in rural eastern Uganda in 2003: incomplete rollout of the prevention of mother-to-child transmission of HIV programme?

  BMC international health and human rights 20060101

• HIV transmission and primary drug resistance.

  AIDS reviews 20060101

• Three-year final results of the NEFA simplification trial.

  AIDS reviews 20060101

• Treating HIV during pregnancy: an update on safety issues.

  Drug safety 20060101

• Drug-specific T cells in an HIV-positive patient with nevirapine-induced hepatitis.

  Antiviral therapy 20060101

• Tipranavir: a novel nonpeptidic protease inhibitor of HIV.

  Clinical pharmacokinetics 20060101

• Lopinavir/ritonavir: a review of its use in the management of HIV infection.

  Drugs 20060101

• Effects of highly active antiretroviral therapy with nelfinavir in vertically HIV-1 infected children: 3 years of follow-up. Long-term response to nelfinavir in children.

  BMC infectious diseases 20060101

• Design, synthesis, biological evaluation, and molecular modeling studies of TIBO-like cyclic sulfones as non-nucleoside HIV-1 reverse transcriptase inhibitors.

  ChemMedChem 20060101

• Reports from the 7th HIV Pharmacology Workshop.

  GMHC treatment issues : the Gay Men's Health Crisis newsletter of experimental AIDS therapies 20060101

• Affordable flow cytometry for enumeration of absolute CD4+ T-lymphocytes to identify subtype C HIV-1 infected adults requiring antiretroviral therapy (ART) and monitoring response to ART in a resource-limited setting.

  Journal of translational medicine 20060101

• Oral manifestations of HIV infection in children and adults receiving highly active anti-retroviral therapy [HAART] in Dar es Salaam, Tanzania.

  BMC oral health 20060101

• Outcome of different nevirapine administration strategies in preventing mother-to-child transmission (PMTCT) programs in Tanzania and Uganda.

  MedGenMed : Medscape general medicine 20060101

• Predictors of early death in a cohort of Ethiopian patients treated with HAART.

  BMC infectious diseases 20060101

• Indolyl aryl sulphones as HIV-1 non-nucleoside reverse transcriptase inhibitors: synthesis, biological evaluation and binding mode studies of new derivatives at indole-2-carboxamide.

  Antiviral chemistry & chemotherapy 20060101

• HIV among pregnant women in Moshi Tanzania: the role of sexual behavior, male partner characteristics and sexually transmitted infections.

  AIDS research and therapy 20060101

• Rapid propagation of low-fitness drug-resistant mutants of human immunodeficiency virus type 1 by a streptococcal metabolite sparsomycin.

  Antiviral chemistry & chemotherapy 20060101

• Antiretroviral therapy in AIDS patients with tuberculosis.

  AIDS reviews 20060101

• The stepped wedge trial design: a systematic review.

  BMC medical research methodology 20060101

• Cardiovascular risk in patients with HIV Infection: impact of antiretroviral therapy.

  Drugs 20060101

• Physicians' communication with patients about adherence to HIV medication in San Francisco and Copenhagen: a qualitative study using Grounded Theory.

  BMC health services research 20060101

• The ethics of placebo-controlled studies on perinatal HIV transmission and its treatment in the developing world.

  Penn bioethics journal 20060101

• The cost-effectiveness of antiretroviral treatment in Khayelitsha, South Africa--a primary data analysis.

  Cost effectiveness and resource allocation : C/E 20060101

• Field performance of a thin-layer chromatography assay for detection of nevirapine in umbilical cord blood.

  HIV clinical trials 20060101

• Antiretroviral therapy for prevention of mother-to-child HIV transmission : focus on single-dose nevirapine.

  Clinical drug investigation 20060101

• Tuberculosis and HIV co-infection: a practical therapeutic approach.

  Drugs 20060101

• Clinical outcome of HIV-infected patients with sustained virologic response to antiretroviral therapy: long-term follow-up of a multicenter cohort.

  PloS one 20060101

• Use of taste-masking product, FLAVORx, to assist Thai children to ingest generic antiretrovirals.

  AIDS research and therapy 20060101

• Cost to achieve an undetectable viral load using recommended antiretroviral regimens.

  HIV clinical trials 20060101

• Acceptance of anti-retroviral therapy among patients infected with HIV and tuberculosis in rural Malawi is low and associated with cost of transport.

  PloS one 20060101

• Switching strategies to improve lipid profile and morphologic changes.

  AIDS reviews 20060101

• Nevirapine-associated hepatotoxicity in virologically suppressed patients--role of gender and CD4+ cell counts.

  AIDS reviews 20060101

• Antiretroviral therapy at conception in pregnant women with HIV in Italy: wide range of variability and frequent exposure to contraindicated drugs.

  Antiviral therapy 20060101

• A pilot study to assess the immunologic and virologic efficacy of generic nevirapine, zidovudine and lamivudine in the treatment of HIV-1 infected women with pre-exposure to single dose nevirapine or short course zidovudine and their spouses in Chitungwiza, Zimbabwe.

  The Central African journal of medicine 20060101

• Acceptance of HIV screening in an antenatal population at a referral teaching hospital in Zimbabwe: a substudy of an operational research in prevention of mother to child HIV vertical transmission.

  The Central African journal of medicine 20060101

• Disease Management - Constructing Optimal NRTI-Based Combinations: Past, Present, and Future.

  Journal of the International AIDS Society 20060101

• Outcome of Different Nevirapine Administration Strategies in Preventin g Mother-to-Child Transmission (PMTCT) Programs in Tanzania and Uganda.

  Journal of the International AIDS Society 20060101

• Efficacy of cerebrospinal fluid (CSF)-penetrating antiretroviral drugs against HIV in the neurological compartment: different patterns of phenotypic resistance in CSF and plasma.

  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20051215

• Parallel solution-phase and microwave-assisted synthesis of new S-DABO derivatives endowed with subnanomolar anti-HIV-1 activity.

  Journal of medicinal chemistry 20051215

• Effect of a bound non-nucleoside RT inhibitor on the dynamics of wild-type and mutant HIV-1 reverse transcriptase.

  Journal of the American Chemical Society 20051214

• Resistance after single-dose nevirapine prophylaxis emerges in a high proportion of Malawian newborns.

  AIDS (London, England) 20051202

• Adherence to antiretroviral therapy: merging the clinical and social course of AIDS.

  PLoS medicine 20051201

• Integrating prevention of mother-to-child HIV transmission into routine antenatal care: the key to program expansion in Cameroon.

  Journal of acquired immune deficiency syndromes (1999) 20051201

• HIV-1 drug resistance in Thailand: before and after National Access to Antiretroviral Program.

  Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology 20051201

• Prevention of mother-to-child transmission of HIV: treatment options.

  Expert review of anti-infective therapy 20051201

• Allosteric modulation of anti-HIV drug and ferric heme binding to human serum albumin.

  The FEBS journal 20051201

• [Detection of HIV infection in pregnant women by rapid testing: a successful strategy to reduce its vertical transmission].

  Revista chilena de infectologia : organo oficial de la Sociedad Chilena de Infectologia 20051201

• Evidence of an immune-mediated mechanism for an idiosyncratic nevirapine-induced reaction in the female Brown Norway rat.

  Chemical research in toxicology 20051201

• High acceptability of voluntary counselling and HIV-testing but unacceptable loss to follow up in a prevention of mother-to-child HIV transmission programme in rural Malawi: scaling-up requires a different way of acting.

  Tropical medicine & international health : TM & IH 20051201

• Characterization of nevirapine (NVP) resistance mutations and HIV type 1 subtype in women from Abidjan (Côte d'Ivoire) after NVP single-dose prophylaxis of HIV type 1 mother-to-child transmission.

  AIDS research and human retroviruses 20051201

• Nevirapine-related adverse events in a patient receiving a fixed-drug combination pill.

  Journal of the National Medical Association 20051201

• T-cell response of advanced aids patients after highly active antiretroviral therapy.

  Chinese medical sciences journal = Chung-kuo i hsueh k'o hsueh tsa chih 20051201

• [Cutaneous drug-reactions to nevirapine: study of risk factors in 101 HIV-infected patients].

  Annales de dermatologie et de venereologie 20051201

• Role of animal models in the study of drug-induced hypersensitivity reactions.

  The AAPS journal 20051201

• Stevens - Johnson syndrome due to nevirapine.

  African health sciences 20051201

• HIV infection.

  Clinical evidence 20051201

• [Adverse effects of antiretroviral treatments].

  Presse medicale (Paris, France : 1983) 20051119

• [The treatment of HIV infection].

  Presse medicale (Paris, France : 1983) 20051119

• Specific targeting highly conserved residues in the HIV-1 reverse transcriptase primer grip region. Design, synthesis, and biological evaluation of novel, potent, and broad spectrum NNRTIs with antiviral activity.

  Journal of medicinal chemistry 20051117

• [Hepatic failure due to nevirapine treatment for HIV infection].

  Ugeskrift for laeger 20051114

• Timing of maternal and neonatal dosing of nevirapine and the risk of mother-to-child transmission of HIV-1: HIVNET 024.

  AIDS (London, England) 20051104

• Is there a difference in the efficacy of peripartum antiretroviral regimens in reducing mother-to-child transmission of HIV in Africa?

  AIDS (London, England) 20051104

• The effect of highly active antiretroviral treatment on viral load and antiretroviral drug levels in breast milk.

  AIDS (London, England) 20051104

• Quantum computational analysis for drug resistance of HIV-1 reverse transcriptase to nevirapine through point mutations.

  Proteins 20051101

• Initial response to highly active antiretroviral therapy in HIV-1C-infected adults in a public sector treatment program in Botswana.

  Journal of acquired immune deficiency syndromes (1999) 20051101

• Preventing mother-to-child transmission of HIV in Western Kenya: operational issues.

  Journal of acquired immune deficiency syndromes (1999) 20051101

• Anti-human immunodeficiency virus type 1 activity of the nonnucleoside reverse transcriptase inhibitor GW678248 in combination with other antiretrovirals against clinical isolate viruses and in vitro selection for resistance.

  Antimicrobial agents and chemotherapy 20051101

• High potency of indolyl aryl sulfone nonnucleoside inhibitors towards drug-resistant human immunodeficiency virus type 1 reverse transcriptase mutants is due to selective targeting of different mechanistic forms of the enzyme.

  Antimicrobial agents and chemotherapy 20051101

• Third-trimester maternal toxicity with nevirapine use in pregnancy.

  Obstetrics and gynecology 20051101

• Prenatal exposure to fluconazole: an identifiable dysmorphic phenotype.

  Birth defects research. Part A, Clinical and molecular teratology 20051101

• Triple nucleoside reverse transcriptase inhibitor- vs. nonnucleoside reverse transcriptase inhibitor-containing regimens as first-line therapy: efficacy and durability in a prospective cohort of French HIV-infected patients.

  HIV medicine 20051101

• Impact of antiretroviral choice on hypercholesterolaemia events: the role of the nucleoside reverse transcriptase inhibitor backbone.

  HIV medicine 20051101

• Drug-resistance mutations in antiretroviral-naïve patients with established HIV-1 infection in Mexico.

  HIV medicine 20051101

• Genotypic and phenotypic resistance testing of HIV-1 in routine clinical care.

  European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 20051101

• Antiretroviral treatment in the Northern Cape.

  South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde 20051101

• The rate of viral rebound after attainment of an HIV load <50 copies/mL according to specific antiretroviral drugs in use: results from a multicenter cohort study.

  The Journal of infectious diseases 20051015

• Determination of antiretroviral agents in human serum by capillary electrophoresis.

  Journal of chromatography. A 20051014

• Reverse transcriptase inhibitors down-regulate cell proliferation in vitro and in vivo and restore thyrotropin signaling and iodine uptake in human thyroid anaplastic carcinoma.

  The Journal of clinical endocrinology and metabolism 20051001

• Attitudes to voluntary counselling and testing prior to the offer of Nevirapine to prevent vertical transmission of HIV in northern Tanzania.

  AIDS care 20051001

• Breast-milk shedding of drug-resistant HIV-1 subtype C in women exposed to single-dose nevirapine.

  The Journal of infectious diseases 20051001

• Fat distribution in men with HIV infection.

  Journal of acquired immune deficiency syndromes (1999) 20051001

• Population pharmacokinetics of lopinavir in combination with ritonavir in HIV-1-infected patients.

  British journal of clinical pharmacology 20051001

• Antiviral activity of GW678248, a novel benzophenone nonnucleoside reverse transcriptase inhibitor.

  Antimicrobial agents and chemotherapy 20051001

• Efficacy, tolerability and pharmacokinetics of two nelfinavir-based regimens in human immunodeficiency virus-infected children and adolescents: pediatric AIDS clinical trials group protocol 403.

  The Pediatric infectious disease journal 20051001

• HIV antiretroviral agents inhibit protein synthesis and decrease ribosomal protein S6 and 4EBP1 phosphorylation in C2C12 myocytes.

  AIDS research and human retroviruses 20051001

• Meeting notes from the 3rd IAS Conference. Treating TB and HIV concurrently.

  AIDS clinical care 20051001

• Pharmacokinetic drug interactions with non-nucleoside reverse transcriptase inhibitors.

  Expert opinion on drug metabolism & toxicology 20051001

• Pharmacokinetics of nevirapine in HIV-infected children receiving an adult fixed-dose combination of stavudine, lamivudine and nevirapine.

  AIDS (London, England) 20050923

• Simultaneous quantification of stavudine, lamivudine and nevirapine by UV spectroscopy, reverse phase HPLC and HPTLC in tablets.

  Journal of pharmaceutical and biomedical analysis 20050915

• Genotypic and phenotypic resistance patterns at virological failure in a simplification trial with nevirapine, efavirenz or abacavir.

  AIDS (London, England) 20050902

• Breast milk HIV-1 suppression and decreased transmission: a randomized trial comparing HIVNET 012 nevirapine versus short-course zidovudine.

  AIDS (London, England) 20050902

• [Rashes in HIV-infected patients undergoing therapy with nevirapine or efavirenz].

  Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete 20050901

• The role of Thr139 in the human immunodeficiency virus type 1 reverse transcriptase sensitivity to (+)-calanolide A.

  Molecular pharmacology 20050901

• Pharmacokinetics of antivirals in neonate.

  Early human development 20050901

• Antiretroviral concentrations in breast-feeding infants of women in Botswana receiving antiretroviral treatment.

  The Journal of infectious diseases 20050901

• Preventing mother-to-child transmission of HIV: successes and challenges.

  BJOG : an international journal of obstetrics and gynaecology 20050901

• Population pharmacokinetics of indinavir alone and in combination with ritonavir in HIV-1-infected patients.

  British journal of clinical pharmacology 20050901

• Distinct patterns of emergence and fading of K103N and Y181C in women with subtype A vs. D after single-dose nevirapine: HIVNET 012.

  Journal of acquired immune deficiency syndromes (1999) 20050901

• Management of HIV-1 infection with a combination of nevirapine, stavudine, and lamivudine: a preliminary report on the Nigerian antiretroviral program.

  Journal of acquired immune deficiency syndromes (1999) 20050901

• Predictors of bone mineral density in human immunodeficiency virus-1 infected children.

  Journal of pediatric gastroenterology and nutrition 20050901

• Nevirapine derivatives with broad-spectrum chemotherapeutic properties for the effective treatment of HIV/AIDS.

  Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie 20050901

• Study of MMLV RT- binding with DNA using surface plasmon resonance biosensor.

  Acta biochimica et biophysica Sinica 20050901

• A randomized controlled trial investigating the efficacy and safety of switching from a protease inhibitor to nevirapine in patients with undetectable viral load.

  HIV medicine 20050901

• Health system constraints to optimal coverage of the prevention of mother-to-child HIV transmission programme in South Africa: lessons from the implementation of the national pilot programme.

  African health sciences 20050901

• Effect of system variables involved in packed column SFC of nevirapine as model analyte using response surface methodology: application to retention thermodynamics, solute transfer kinetic study and binary diffusion coefficient determination.

  Journal of biochemical and biophysical methods 20050831

• Comparison of mother-to-child transmission rates in Ugandan women with subtype A versus D HIV-1 who received single-dose nevirapine prophylaxis: HIV Network For Prevention Trials 012.

  Journal of acquired immune deficiency syndromes (1999) 20050815

• A randomized trial of two postexposure prophylaxis regimens to reduce mother-to-child HIV-1 transmission in infants of untreated mothers.

  AIDS (London, England) 20050812

• Effectiveness of a city-wide program to prevent mother-to-child HIV transmission in Lusaka, Zambia.

  AIDS (London, England) 20050812

• Transfer of antivirals across the human placenta.

  Early human development 20050801

• Impact of rosiglitazone treatment on the bioavailability of antiretroviral compounds in HIV-positive patients.

  The Journal of antimicrobial chemotherapy 20050801

• Investigation of HIV in amniotic fluid from HIV-infected pregnant women at full term.

  The Journal of infectious diseases 20050801

• Appropriate use of nevirapine for long-term therapy.

  The Journal of infectious diseases 20050801

• Atazanavir trough plasma concentration monitoring in a cohort of HIV-1-positive individuals receiving highly active antiretroviral therapy.

  The Journal of antimicrobial chemotherapy 20050801

• Nevirapine plasma concentrations are still detectable after more than 2 weeks in the majority of women receiving single-dose nevirapine: implications for intervention studies.

  Journal of acquired immune deficiency syndromes (1999) 20050801

• TDM: therapeutic drug measuring or therapeutic drug monitoring?

  Therapeutic drug monitoring 20050801

• Determination of nevirapine and efavirenz in plasma using GC/MS in selected ion monitoring mode.

  Therapeutic drug monitoring 20050801

• Anti-human immunodeficiency virus type 1 activity and resistance profile of 2',3'-didehydro-3'-deoxy-4'-ethynylthymidine in vitro.

  Antimicrobial agents and chemotherapy 20050801

• Intracellular and plasma pharmacokinetics of nevirapine in human immunodeficiency virus-infected individuals.

  Clinical pharmacology and therapeutics 20050801

• Virtual screening for anti-HIV-1 RT and anti-HIV-1 PR inhibitors from the Thai medicinal plants database: a combined docking with neural networks approach.

  Combinatorial chemistry & high throughput screening 20050801

• Treatment options for the prevention of mother-to-child transmission of HIV.

  Current opinion in investigational drugs (London, England : 2000) 20050801

• Antiretroviral therapy in HIV-1 infected children.

  Indian pediatrics 20050801

• No pharmacokinetic drug-drug interaction between nevirapine and paclitaxel.

  Anti-cancer drugs 20050701

• Efficacy of highly active antiretroviral therapy in HIV-infected children participating in Thailand's National Access to Antiretroviral Program.

  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20050701

• Single-dose nevirapine and drug resistance: the more you look, the more you find.

  The Journal of infectious diseases 20050701

• Emergence of drug-resistant HIV-1 after intrapartum administration of single-dose nevirapine is substantially underestimated.

  The Journal of infectious diseases 20050701

• Sensitive drug-resistance assays reveal long-term persistence of HIV-1 variants with the K103N nevirapine (NVP) resistance mutation in some women and infants after the administration of single-dose NVP: HIVNET 012.

  The Journal of infectious diseases 20050701

• Nevirapine (NVP) resistance in women with HIV-1 subtype C, compared with subtypes A and D, after the administration of single-dose NVP.

  The Journal of infectious diseases 20050701

• Substitution of nevirapine or efavirenz for protease inhibitor versus lipid-lowering therapy for the management of dyslipidaemia.

  AIDS (London, England) 20050701

• HIV-1 intermittent viraemia in patients treated by non-nucleoside reverse transcriptase inhibitor-based regimen.

  AIDS (London, England) 20050701

• Antiretroviral treatment simplification with 3 NRTIs or 2 NRTIs plus nevirapine in HIV-1-infected patients treated with successful first-line HAART.

  Journal of acquired immune deficiency syndromes (1999) 20050701

• HIV risk perception and prevalence in a program for prevention of mother-to-child HIV transmission: comparison of women who accept voluntary counseling and testing and those tested anonymously.

  Journal of acquired immune deficiency syndromes (1999) 20050701

• Roundtable. Revisiting the role of single-dose nevirapine for preventing perinatal HIV transmission.

  AIDS clinical care 20050701

• Effectiveness of the first district-wide programme for the prevention of mother-to-child transmission of HIV in South Africa.

  Bulletin of the World Health Organization 20050701

• Novel 1-[2-(diarylmethoxy)ethyl]-2-methyl-5-nitroimidazoles as HIV-1 non-nucleoside reverse transcriptase inhibitors. A structure-activity relationship investigation.

  Journal of medicinal chemistry 20050630

• Metabolic benefits 24 months after replacing a protease inhibitor with abacavir, efavirenz or nevirapine.

  AIDS (London, England) 20050610

• Nevirapine-induced Stevens-Johnson syndrome in a mother and son.

  AIDS (London, England) 20050610

• [Antiretroviral agents in HIV-infected patients with cirrhosis].

  Presse medicale (Paris, France : 1983) 20050604

• Inhibition of endogenous reverse transcriptase antagonizes human tumor growth.

  Oncogene 20050602

• Therapeutic drug monitoring of nevirapine reduces pharmacokinetic variability but does not affect toxicity or virologic success in the ATHENA study.

  Journal of acquired immune deficiency syndromes (1999) 20050601

• Simultaneous quantitative assay of atazanavir and 6 other HIV protease inhibitors by isocratic reversed-phase liquid chromatography in human plasma.

  Therapeutic drug monitoring 20050601

• Prediction of genotoxicity of chemical compounds by statistical learning methods.

  Chemical research in toxicology 20050601

• Comparison of efavirenz and nevirapine in HIV-infected patients (NEEF Cohort).

  International journal of STD & AIDS 20050601

• Changes in nevirapine plasma concentrations over time and its relationship with liver enzyme elevations.

  AIDS research and human retroviruses 20050601

• Nevirapine absorbed well despite chronic diarrhea.

  AIDS research and human retroviruses 20050601

• HIV: mother to child transmission.

  Clinical evidence 20050601

• Intracellular measurements of anti-HIV drugs indinavir, amprenavir, saquinavir, ritonavir, nelfinavir, lopinavir, atazanavir, efavirenz and nevirapine in peripheral blood mononuclear cells by liquid chromatography coupled to tandem mass spectrometry.

  Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20050525

• The molecular basis of resilience to the effect of the Lys103Asn mutation in non-nucleoside HIV-1 reverse transcriptase inhibitors studied by targeted molecular dynamics simulations.

  Journal of the American Chemical Society 20050525

• Nelfinavir and nevirapine side effects during pregnancy.

  AIDS (London, England) 20050520

• Reducing HIV vertical transmission scrutinized.

  JAMA 20050504

• Increased dose of lopinavir/ritonavir compensates for efavirenz-induced drug-drug interaction in HIV-1-infected children.

  Journal of acquired immune deficiency syndromes (1999) 20050501

• Nonnucleoside reverse transcriptase inhibitor phenotypic hypersusceptibility can be demonstrated in different assays.

  Journal of acquired immune deficiency syndromes (1999) 20050501

• Maternal self-medication and provision of nevirapine to newborns by women in Rakai, Uganda.

  Journal of acquired immune deficiency syndromes (1999) 20050501

• Discovery of small-molecule human immunodeficiency virus type 1 entry inhibitors that target the gp120-binding domain of CD4.

  Journal of virology 20050501

• Evaluation of antiretroviral therapy results in a resource-poor setting in Blantyre, Malawi.

  Tropical medicine & international health : TM & IH 20050501

• 2H-Pyrrolo[3,4-b] [1,5]benzothiazepine derivatives as potential inhibitors of HIV-1 reverse transcriptase.

  Farmaco (Societa chimica italiana : 1989) 20050501

• The development of vaginal microbicides for the prevention of HIV transmission.

  PLoS medicine 20050501

• Emerging anti-HIV drugs.

  Expert opinion on emerging drugs 20050501

• A drug is effective if better than a harmless control.

  Nature 20050428

• The N137 and P140 amino acids in the p51 and the P95 amino acid in the p66 subunit of human immunodeficiency virus type 1 (HIV-1) reverse transcriptase are instrumental to maintain catalytic activity and to design new classes of anti-HIV-1 drugs.

  FEBS letters 20050425

• [Reliability: nevirapine. Highly effective + favorable influence on lipid profile].

  MMW Fortschritte der Medizin 20050425

• [Efavirenz--comprehensive status of studies].

  MMW Fortschritte der Medizin 20050425

• Potential cost-effectiveness of maternal and infant antiretroviral interventions to prevent mother-to-child transmission during breast-feeding.

  Journal of acquired immune deficiency syndromes (1999) 20050415

• AIDS research. IOM panel clears HIV prevention study.

  Science (New York, N.Y.) 20050415

• Study gives backing to HIV drug for mothers.

  Nature 20050414

• A one-year clinical trial using didanosine, stavudine and nevirapine for highly active antiretroviral therapy.

  Chinese medical journal 20050405

• Pharmacotherapy of perinatal HIV.

  Seminars in fetal & neonatal medicine 20050401

• Low trough plasma concentrations of nevirapine associated with virologic rebounds in HIV-infected patients who switched from protease inhibitors.

  The Annals of pharmacotherapy 20050401

• Progression of liver fibrosis in patients coinfected with hepatitis C virus and human immunodeficiency virus undergoing antiretroviral therapy.

  The Journal of antimicrobial chemotherapy 20050401

• HIV in pregnancy.

  Current opinion in obstetrics & gynecology 20050401

• A population approach to study the influence of nevirapine administration on lopinavir pharmacokinetics in HIV-1 infected patients.

  European journal of clinical pharmacology 20050401

• Chronic hepatotoxicity after long-term antiretroviral treatment including nevirapine.

  The Journal of infection 20050401

• Simple and simultaneous determination of the hiv-protease inhibitors amprenavir, atazanavir, indinavir, lopinavir, nelfinavir, ritonavir and saquinavir plus M8 nelfinavir metabolite and the nonnucleoside reverse transcriptase inhibitors efavirenz and nevirapine in human plasma by reversed-phase liquid chromatography.

  Therapeutic drug monitoring 20050401

• [Toxic epidermal necrolysis associated with abacavir].

  Enfermedades infecciosas y microbiologia clinica 20050401

• Impact of HIV-1 subtype and antiretroviral therapy on protease and reverse transcriptase genotype: results of a global collaboration.

  PLoS medicine 20050401

• Averting drug resistance while preventing MTCT.

  The AIDS reader 20050401

• Aplastic anemia in an HIV infected child.

  Indian journal of pediatrics 20050401

• Nevirapine toxicity--implications for management of South African patients.

  South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde 20050401

• Genetic linkage of nevirapine resistance mutations in HIV type 1 seven days after single-dose nevirapine.

  AIDS research and human retroviruses 20050401

• Quantitative structure-activity relationship analysis of pyridinone HIV-1 reverse transcriptase inhibitors using the k nearest neighbor method and QSAR-based database mining.

  Journal of computer-aided molecular design 20050401

• The effect of baseline CD4 cell count and HIV-1 viral load on the efficacy and safety of nevirapine or efavirenz-based first-line HAART.

  AIDS (London, England) 20050325

• IOM: nevirapine study is reliable.

  AIDS treatment news 20050325

• From 4,5,6,7-tetrahydro-5-methylimidazo[4,5,1-jk](1,4)benzodiazepin-2(1H)-one (TIBO) to etravirine (TMC125): fifteen years of research on non-nucleoside inhibitors of HIV-1 reverse transcriptase.

  Journal of medicinal chemistry 20050324

• In search of a novel anti-HIV drug: multidisciplinary coordination in the discovery of 4-[[4-[[4-[(1E)-2-cyanoethenyl]-2,6-dimethylphenyl]amino]-2- pyrimidinyl]amino]benzonitrile (R278474, rilpivirine).

  Journal of medicinal chemistry 20050324

• 4-Benzyl and 4-benzoyl-3-dimethylaminopyridin-2(1H)-ones: in vitro evaluation of new C-3-amino-substituted and C-5,6-alkyl-substituted analogues against clinically important HIV mutant strains.

  Journal of medicinal chemistry 20050324

• Synthesis of novel diarylpyrimidine analogues and their antiviral activity against human immunodeficiency virus type 1.

  Journal of medicinal chemistry 20050324

• Women in couples antenatal HIV counseling and testing are not more likely to report adverse social events.

  AIDS (London, England) 20050324

• [Efficacy of anti-HIV treatment and drug-resistance mutations in some parts of China].

  Zhonghua yi xue za zhi 20050323

• Severe hepatotoxicity associated with nevirapine use in HIV-infected subjects.

  The Journal of infectious diseases 20050315

• 5-Alkyl-2-alkylamino-6-(2,6-difluorophenylalkyl)-3,4-dihydropyrimidin-4(3H)-ones, a new series of potent, broad-spectrum non-nucleoside reverse transcriptase inhibitors belonging to the DABO family.

  Bioorganic & medicinal chemistry 20050315

• HIV drug remains unproven without placebo trial.

  Nature 20050310

• Inhibition of phosphorolysis catalyzed by HIV-1 reverse transcriptase is responsible for the synergy found in combinations of 3'-azido-3'-deoxythymidine with nonnucleoside inhibitors.

  Biochemistry 20050308

• A combined-formulation tablet of lamivudine/nevirapine/stavudine: bioequivalence compared with concurrent administration of lamivudine, nevirapine, and stavudine in healthy Indian subjects.

  Journal of clinical pharmacology 20050301

• Contribution of cellular HIV-1 DNA quantification to the efficacy analysis of antiretroviral therapy: a randomized comparison of 2 regimens, including 3 drugs from 2 or 3 classes (TRIANON, ANRS 081).

  Journal of acquired immune deficiency syndromes (1999) 20050301

• Persistence of nevirapine exposure during the postpartum period after intrapartum single-dose nevirapine in addition to zidovudine prophylaxis for the prevention of mother-to-child transmission of HIV-1.

  Journal of acquired immune deficiency syndromes (1999) 20050301

• Plasma HIV-1 RNA decline within the first two weeks of treatment is comparable for nevirapine, efavirenz, or both drugs combined and is not predictive of long-term virologic efficacy: A 2NN substudy.

  Journal of acquired immune deficiency syndromes (1999) 20050301

• Activists angry at fallout from AIDS drug trial allegations.

  Nature medicine 20050301

• Reports on nevirapine threaten public health.

  Nature medicine 20050301

• Can we get more HIV-positive tuberculosis patients on antiretroviral treatment in a rural district of Malawi?

  The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease 20050301

• Adverse effects of antiretroviral therapy for HIV infection: a review of selected topics.

  Expert opinion on drug safety 20050301

• The safety of antiretroviral drugs in pregnancy.

  Expert opinion on drug safety 20050301

• Should nevirapine be used to prevent mother-to-child transmission of HIV among women of unknown serostatus?

  Bulletin of the World Health Organization 20050301

• Routine provision of nevirapine to women of unknown serostatus: at best a temporary solution to prevent MTCT.

  Bulletin of the World Health Organization 20050301

• Nevirapine-related death draws attention.

  AIDS patient care and STDs 20050301

• Resistance with short-course nevirapine.

  AIDS patient care and STDs 20050301

• The efficacy and adverse effects of GPO-VIR (stavudine+lamivudine+nevirapine) in treatment-naïve adult HIV patients.

  The Southeast Asian journal of tropical medicine and public health 20050301

• Preventing HIV transmission to children: quality of counselling of mothers in South Africa.

  Acta paediatrica (Oslo, Norway : 1992) 20050301

• HIV and pregnancy at the 12 CROI.

  The Hopkins HIV report : a bimonthly newsletter for healthcare providers 20050301

• 4'C-ethynyl-thymidine acts as a chain terminator during DNA-synthesis catalyzed by HIV-1 reverse transcriptase.

  Bioorganic & medicinal chemistry letters 20050215

• Human immunodeficiency virus-reverse transcriptase inhibition and hepatitis C virus RNA-dependent RNA polymerase inhibition activities of fullerene derivatives.

  Bioorganic & medicinal chemistry letters 20050215

• Influence of liver fibrosis on highly active antiretroviral therapy-associated hepatotoxicity in patients with HIV and hepatitis C virus coinfection.

  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20050215

• AIDS treatment. A step toward cheaper anti-HIV therapy.

  Science (New York, N.Y.) 20050204

• Development of an oral exposure mouse model to predict drug-induced hypersensitivity reactions by using reporter antigens.

  Toxicological sciences : an official journal of the Society of Toxicology 20050201

• Therapeutic response of HIV-1 subtype C in African patients coinfected with either Mycobacterium tuberculosis or human herpesvirus-8.

  The Journal of infectious diseases 20050201

• Variations of CYP3A activity induced by antiretroviral treatment in HIV-1 infected patients.

  European journal of clinical pharmacology 20050201

• Herb-drug interactions: an overview of the clinical evidence.

  Fundamental & clinical pharmacology 20050201

• An extremely different dysmetabolic profile between the two available nonnucleoside reverse transcriptase inhibitors: efavirenz and nevirapine.

  Journal of acquired immune deficiency syndromes (1999) 20050201

• Zidovudine monotherapy and the prevention of mother-to-child HIV-1 transmission.

  The Lancet. Infectious diseases 20050201

• Controversy around nevirapine trials continues.

  The Lancet. Infectious diseases 20050201

• 6-[1-(4-Fluorophenyl)methyl-1H-pyrrol-2-yl)]-2,4-dioxo-5-hexenoic acid ethyl ester a novel diketo acid derivative which selectively inhibits the HIV-1 viral replication in cell culture and the ribonuclease H activity in vitro.

  Antiviral research 20050201

• Field efficacy of zidovudine, lamivudine and single-dose nevirapine to prevent peripartum HIV transmission.

  AIDS (London, England) 20050201

• 1,5-Benzodiazepines XIV. Synthesis of new substituted 9H-bis-[1,2,4]triazolo[4,3-a:3',4'-d] [1,5]benzodiazepines and relate compounds endowed with in vitro cytotoxic properties.

  Farmaco (Societa chimica italiana : 1989) 20050201

• Mycotic brain abscess caused by opportunistic reptile pathogen.

  Emerging infectious diseases 20050201

• Incidence and risk factors for rash in Thai patients randomized to regimens with nevirapine, efavirenz or both drugs.

  AIDS (London, England) 20050128

• Early virological failure in treatment-naive HIV-infected adults receiving didanosine and tenofovir plus efavirenz or nevirapine.

  AIDS (London, England) 20050128

• FDA advisory on nevirapine.

  AIDS treatment news 20050128

• Human immunodeficiency virus protease inhibitors accumulate into cultured human adipocytes and alter expression of adipocytokines.

  The Journal of biological chemistry 20050121

• Efavirenz enhances the proteolytic processing of an HIV-1 pol polyprotein precursor and reverse transcriptase homodimer formation.

  FEBS letters 20050117

• HIV-reverse transcriptase inhibition: inclusion of ligand-induced fit by cross-docking studies.

  Journal of medicinal chemistry 20050113

• Docking and 3-D QSAR studies on indolyl aryl sulfones. Binding mode exploration at the HIV-1 reverse transcriptase non-nucleoside binding site and design of highly active N-(2-hydroxyethyl)carboxamide and N-(2-hydroxyethyl)carbohydrazide derivatives.

  Journal of medicinal chemistry 20050113

• Articles criticising nevirapine trial may endanger babies' lives.

  BMJ (Clinical research ed.) 20050108

• Emergence of antiretroviral resistance in HIV-positive women receiving combination antiretroviral therapy in pregnancy.

  AIDS (London, England) 20050103

• Predisposition to nevirapine hypersensitivity associated with HLA-DRB1*0101 and abrogated by low CD4 T-cell counts.

  AIDS (London, England) 20050103

• Correlation of in vitro-in vivo release rates for sustained release nevirapine implants in rats.

  Journal of controlled release : official journal of the Controlled Release Society 20050103

• Detection of minority populations of HIV-1 expressing the K103N resistance mutation in patients failing nevirapine.

  Journal of acquired immune deficiency syndromes (1999) 20050101

• Lopinavir/ritonavir plus nevirapine as a nucleoside-sparing approach in antiretroviral-experienced patients (NEKA study).

  Journal of acquired immune deficiency syndromes (1999) 20050101

• Modification of the incidence of drug-associated symmetrical peripheral neuropathy by host and disease factors in the HIV outpatient study cohort.

  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20050101

• Antiretroviral drug pharmacokinetics in hepatitis with hepatic dysfunction.

  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20050101

• Drug resistance mutations in the nucleotide binding pocket of human immunodeficiency virus type 1 reverse transcriptase differentially affect the phosphorolysis-dependent primer unblocking activity in the presence of stavudine and zidovudine and its inhibition by efavirenz.

  Antimicrobial agents and chemotherapy 20050101

• US AIDS chief altered report on nevirapine safety risks.

  Nature medicine 20050101

• Substituting abacavir for hyperlipidemia-associated protease inhibitors in HAART regimens improves fasting lipid profiles, maintains virologic suppression, and simplifies treatment.

  BMC infectious diseases 20050101

• Changes in lipids over twelve months after initiating protease inhibitor therapy among persons treated for HIV/AIDS.

  Lipids in health and disease 20050101

• Molecular strategies to inhibit HIV-1 replication.

  Retrovirology 20050101

• Top stories of 2004. Perinatal transmission interventions: the benefits come with resistance.

  AIDS clinical care 20050101

• Top stories of 2004. Nevirapine and efavirenz: similar efficacy, different toxicities, and better separately than combined.

  AIDS clinical care 20050101

• Maternal plasma viral load and neutralizing/enhancing antibodies in vertical transmission of HIV: a non-randomized prospective study.

  Virology journal 20050101

• Nevirapine and efavirenz pharmacokinetics and covariate analysis in the 2NN study.

  Antiviral therapy 20050101

• Quadruple-drug induction HAART in advanced HIV infection.

  HIV clinical trials 20050101

• Should non-nucleoside reverse transcriptase inhibitors be combined?

  Drugs in R&D 20050101

• Abacavir, efavirenz, didanosine, with or without hydroxyurea, in HIV-infected adults failing initial nucleoside/protease inhibitor-containing regimens.

  BMC infectious diseases 20050101

• The non-nukes. Sustiva. Viramune. The two major players.

  Positively aware : the monthly journal of the Test Positive Aware Network 20050101

• Practical guidelines to interpret plasma concentrations of antiretroviral drugs.

  Clinical pharmacokinetics 20050101

• Influence of CYP2B6 polymorphism on plasma and intracellular concentrations and toxicity of efavirenz and nevirapine in HIV-infected patients.

  Pharmacogenetics and genomics 20050101

• The HIV protease inhibitors nelfinavir and saquinavir, but not a variety of HIV reverse transcriptase inhibitors, adversely affect human proteasome function.

  Antiviral therapy 20050101

• Field assessment of generic antiretroviral drugs: a prospective cohort study in Cameroon.

  Antiviral therapy 20050101

• Rare one and two amino acid inserts adjacent to codon 103 of the HIV-1 reverse transcriptase (RT) affect susceptibility to non-nucleoside RT inhibitors.

  Antiviral therapy 20050101

• In vitro anti-HIV potency of stampidine alone and in combination with standard anti-HIV drugs.

  Arzneimittel-Forschung 20050101

• [Efavirenz and nevirapine plasma levels in HIV-infected patients with hemophilia].

  Enfermedades infecciosas y microbiologia clinica 20050101

• Case reports: treatment of nevirapine-associated dress syndrome with intravenous immune globulin (IVIG).

  Journal of drugs in dermatology : JDD 20050101

• Incidence and risk factors for liver enzyme elevation during highly active antiretroviral therapy in HIV-HCV co-infected patients: results from the Italian EPOKA-MASTER Cohort.

  BMC infectious diseases 20050101

• Cost-effectiveness of models for prevention of vertical HIV transmission - voluntary counseling and testing and choices of drug regimen.

  Cost effectiveness and resource allocation : C/E 20050101

• Are adverse events of nevirapine and efavirenz related to plasma concentrations?

  Antiviral therapy 20050101

• Reverse transcriptase inhibitors alter uncoupling protein-1 and mitochondrial biogenesis in brown adipocytes.

  Antiviral therapy 20050101

• Can context justify an ethical double standard for clinical research in developing countries?

  Globalization and health 20050101

• HIV/AIDS: global trends, global funds and delivery bottlenecks.

  Globalization and health 20050101

• Drug-drug interactions and the pharmacotherapy of HIV infection.

  Topics in HIV medicine : a publication of the International AIDS Society, USA 20050101

• Wastage in the health workforce: some perspectives from African countries.

  Human resources for health 20050101

• Safety and tolerability of nevirapine-based antiretroviral therapy in HIV-infected patients receiving fluconazole for cryptococcal prophylaxis: a retrospective cohort study.

  BMC infectious diseases 20050101

• An uncommon cause of scleroderma.

  Scandinavian journal of rheumatology 20050101

• Lipid profiles for antiretroviral-naive patients starting PI- and NNRTI-based therapy in the Swiss HIV cohort study.

  Antiviral therapy 20050101

• Efficacy and safety of once-daily combination therapy with didanosine, lamivudine and nevirapine in antiretroviral-naive HIV-infected patients.

  Antiviral therapy 20050101

• New strides in protecting infants from HIV. Researchers continue quest to give pregnant women better options to prevent mother-to-child transmission.

  IAVI report : newsletter on international AIDS vaccine research 20050101

• Virammune and women in the news.

  Survival news (Atlanta, Ga.) 20050101

• Will pharmacogenomic discoveries improve HIV therapeutics?

  Topics in HIV medicine : a publication of the International AIDS Society, USA 20050101

• The nonnucleoside reverse transcriptase inhibitors efavirenz and nevirapine in the treatment of HIV.

  HIV clinical trials 20050101

• Persistence of lipoatrophy after a four-year long interruption of antiretroviral therapy for HIV1 infection: case report.

  BMC infectious diseases 20050101

• Nevirapine concentration in cervicovaginal and oropharyngeal secretions after single-dose administration to the mother.

  Antiviral therapy 20050101

• Viral load responses to HAART is an independent predictor of a new AIDS event in late stage HIV infected patients: prospective cohort study.

  Journal of translational medicine 20050101

• Translating research into policy and practice in developing countries: a case study of magnesium sulphate for pre-eclampsia.

  BMC health services research 20050101

• Cerebrospinal fluid HIV infection and pleocytosis: relation to systemic infection and antiretroviral treatment.

  BMC infectious diseases 20050101

• Pharmacokinetic profiling and bioequivalence assessment of two marketed brands of nevirapine tablets in healthy Indian volunteers.

  Arzneimittel-Forschung 20050101

• First-line antiretroviral therapy in Africa--how evidence-base are our recommendations?

  AIDS reviews 20050101

• Comparison of two once-daily regimens with a regimen consisting of nelfinavir, didanosine, and stavudine in antiretroviral therapy-naïve adults: 48-week results from the Antiretroviral Regimen Evaluation Study (ARES).

  HIV clinical trials 20050101

• Pharmacokinetics of nevirapine: once-daily versus twice-daily dosing in the 2NN study.

  HIV clinical trials 20050101

• Are specific antiretrovirals associated with an increased risk of discontinuation due to toxicities or patient/physician choice in patients with hepatitis C virus coinfection?

  Antiviral therapy 20050101

• Do non-nucleoside reverse transcriptase inhibitors contribute to lipodystrophy?

  Drug safety 20050101

• Sex differences in antiretroviral therapy-associated intolerance and adverse events.

  Drug safety 20050101

• Prevalence and evolution of drug resistance HIV-1 variants in Henan, China.

  Cell research 20050101

• [Treatment of chronic hepatitis C in patients with HIV infection].

  Acta medica Croatica : casopis Hravatske akademije medicinskih znanosti 20050101

• Nevirapine plasma concentrations and concomitant use of rifampin in patients coinfected with HIV-1 and tuberculosis.

  Antiviral therapy 20050101

• Prospective, open-label comparative study of liver toxicity in an unselected population of HIV-infected patients treated for the first time with efavirenz or nevirapine.

  HIV clinical trials 20050101

• Higher virological effectiveness of NNRTI-based antiretroviral regimens containing nevirapine or efavirenz compared to a triple NRTI regimen as initial therapy in HIV-1-infected adults.

  HIV clinical trials 20050101

• 12th Retrovirus Conference. Viramune to prevent mother-to-child transmission. Moving from to consensus.

  Positively aware : the monthly journal of the Test Positive Aware Network 20050101

• HPLC analysis of generic antiretroviral drugs purchased in Rwanda.

  Bulletin de la Societe des sciences medicales du Grand-Duche de Luxembourg 20050101

• Antiretroviral Therapy in the Real World : Population-Based Pharmacoeconomic Analysis of Administration of Anti-HIV Regimens to 990 Patients.

  Clinical drug investigation 20050101

• [Efficacy and tolerance of non nucleosidic reverse transcriptase inhibitors containing tritherapy in HIV-1 infection].

  Dakar medical 20050101

• Evaluation of a lymph node proliferation assay for its ability to detect pharmaceuticals with potential to cause immune-mediated drug reactions.

  Journal of immunotoxicology 20050101

• Triple-nucleoside analog antiretroviral therapy: is there still a role in clinical practice? A review.

  Journal of the International AIDS Society 20050101

• Cytokine profiles in human immunodeficiency virus-infected children treated with highly active antiretroviral therapy.

  Journal of the International AIDS Society 20050101

• Hypertriglyceridemia in antiretroviral therapy.

  Journal of the International AIDS Society 20050101

• Initiating antiretrovirals in a resource-constrained setting: does one size fit all?

  Journal of the International AIDS Society 20050101

• Drug reaction. Rev. Jackson calls study 'crime against humanity'.

  AIDS policy & law 20041231

• Determination of atazanavir and other antiretroviral drugs (indinavir, amprenavir, nelfinavir and its active metabolite M8, saquinavir, ritonavir, lopinavir, nevirapine and efavirenz) plasma levels by high performance liquid chromatography with UV detection.

  Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20041225

• HIV transmission. Allegations raise fears of backlash against AIDS prevention strategy.

  Science (New York, N.Y.) 20041224

• Activists and researchers rally behind AIDS drug for mothers.

  Nature 20041223

• Phenotypic susceptibility to nonnucleoside inhibitors of virion-associated reverse transcriptase from different HIV types and groups.

  Journal of acquired immune deficiency syndromes (1999) 20041215

• Upregulatory mechanisms compensate for mitochondrial DNA depletion in asymptomatic individuals receiving stavudine plus didanosine.

  Journal of acquired immune deficiency syndromes (1999) 20041215

• Effectiveness of generic fixed-dose combinations of highly active antiretroviral therapy for treatment of HIV infection in India.

  Journal of acquired immune deficiency syndromes (1999) 20041215

• Antenatal couple counseling increases uptake of interventions to prevent HIV-1 transmission.

  Journal of acquired immune deficiency syndromes (1999) 20041215

• Research flawed on key AIDS medicine: Bush had planned its use in Africa.

  The Washington post 20041214

• PHI-443: a novel noncontraceptive broad-spectrum anti-human immunodeficiency virus microbicide.

  Biology of reproduction 20041201

• Flexible docking of pyridinone derivatives into the non-nucleoside inhibitor binding site of HIV-1 reverse transcriptase.

  Bioorganic & medicinal chemistry 20041201

• Studies of nonnucleoside HIV-1 reverse transcriptase inhibitors. Part 1: Design and synthesis of thiazolidenebenzenesulfonamides.

  Bioorganic & medicinal chemistry 20041201

• TMC125, a novel next-generation nonnucleoside reverse transcriptase inhibitor active against nonnucleoside reverse transcriptase inhibitor-resistant human immunodeficiency virus type 1.

  Antimicrobial agents and chemotherapy 20041201

• [Prevention of HIV mother to child transmission in Cotonou: child follow-up].

  Archives de pediatrie : organe officiel de la Societe francaise de pediatrie 20041201

• Reduction of materno-fetal transmission of HIV by improved delivery techniques combined with nevirapine treatment in women attending two family planning clinics in Yaounde, Cameroon.

  International journal of STD & AIDS 20041201

• Tolerance of a short course of nevirapine, associated with 2 nucleoside analogues, in postexposure prophylaxis of HIV.

  Journal of acquired immune deficiency syndromes (1999) 20041201

• Randomized, controlled trial of therapy interruption in chronic HIV-1 infection.

  PLoS medicine 20041201

• Prevention of mother-to-child transmission of HIV in Africa.

  Topics in HIV medicine : a publication of the International AIDS Society, USA 20041201

• Inhibitory drug levels found in breast milk.

  AIDS patient care and STDs 20041201

• Recent advances in prevention of mother to child (PMTCT) of HIV.

  African health sciences 20041201

• Effectiveness of nevirapine and zidovudine in a pilot program for the prevention of mother-to-child transmission of HIV-1 in Uganda.

  African health sciences 20041201

• Haematological changes in African children who received short-term prophylaxis with nevirapine and zidovudine at birth.

  Annals of tropical paediatrics 20041201

• Antiretroviral resistance and genetic diversity of human immunodeficiency virus type 1 isolates from the Federal District, Central Brazil.

  Memorias do Instituto Oswaldo Cruz 20041201

• Nevirapine misinformation: will it kill?

  IAPAC monthly 20041201

• Design of non-nucleoside inhibitors of HIV-1 reverse transcriptase with improved drug resistance properties. 1.

  Journal of medicinal chemistry 20041118

• Design of non-nucleoside inhibitors of HIV-1 reverse transcriptase with improved drug resistance properties. 2.

  Journal of medicinal chemistry 20041118

• Prevention of mother to child transmission of HIV: evaluation of a pilot programme in a district hospital in rural Zimbabwe.

  BMJ (Clinical research ed.) 20041113

• CADA, a novel CD4-targeted HIV inhibitor, is synergistic with various anti-HIV drugs in vitro.

  AIDS (London, England) 20041105

• Nevirapine plus zidovudine to prevent mother-to-child transmission of HIV.

  The New England journal of medicine 20041104

• Nevirapine plus zidovudine to prevent mother-to-child transmission of HIV.

  The New England journal of medicine 20041104

• Effects of the G190A substitution of HIV reverse transcriptase on phenotypic susceptibility of patient isolates to delavirdine.

  Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology 20041101

• [Risk factors for Abacavir-induced hypersensibility syndrome in the 'real world'].

  Pathologie-biologie 20041101

• Is the '3 by 5' initiative the best approach to tackling the HIV pandemic?

  PLoS medicine 20041101

• Pharmacokinetics of Telzir (fosamprenavir).

  Journal of HIV therapy 20041101

• Preventing mother-to-child transmission: factors affecting mothers' choice of feeding--a case study from Cameroon.

  SAHARA J : journal of Social Aspects of HIV/AIDS Research Alliance 20041101

• Warning on two specific 3-drug regimens: Viread + Didanosine + either Sustiva or Viramune.

  AIDS treatment news 20041029

• 4-benzyl- and 4-benzoyl-3-dimethylaminopyridin-2(1H)-ones, a new family of potent anti-HIV agents: optimization and in vitro evaluation against clinically important HIV mutant strains.

  Journal of medicinal chemistry 20041021

• Higher efavirenz concentrations determine the response to viruses carrying non-nucleoside reverse transcriptase resistance mutations.

  AIDS (London, England) 20041021

• Determination of the new HIV-protease inhibitor atazanavir by liquid chromatography after solid-phase extraction.

  Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20041015

• [Highly active antiretroviral therapy (HAART) in HIV-positive pregnant women in the Netherlands, 1997-2003: safe, effective and with few side effects].

  Nederlands tijdschrift voor geneeskunde 20041009

• Novel patterns of nevirapine resistance-associated mutations of human immunodeficiency virus type 1 in treatment-naïve patients.

  Virology 20041001

• Failure of cetirizine to prevent nevirapine-associated rash: a double-blind placebo-controlled trial for the GESIDA 26/01 Study.

  Journal of acquired immune deficiency syndromes (1999) 20041001

• Automated, fast, and sensitive quantification of drugs in human plasma by LC/LC-MS: quantification of 6 protease inhibitors and 3 nonnucleoside transcriptase inhibitors.

  Therapeutic drug monitoring 20041001

• Antiviral activity of diterpenes isolated from the Brazilian marine alga Dictyota menstrualis against human immunodeficiency virus type 1 (HIV-1).

  Antiviral research 20041001

• Long-term efficacy and safety of protease inhibitor switching to nevirapine in HIV-infected patients with undetectable virus load.

  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20041001

• Efavirenz for HIV-1 infection in adults: an overview.

  Expert review of anti-infective therapy 20041001

• Infant HIV infection: acceptability of preventive strategies in central Tanzania.

  AIDS education and prevention : official publication of the International Society for AIDS Education 20041001

• Severe leukopenia associated with mild hepatotoxicity in an HIV carrier treated with nevirapine.

  Japanese journal of infectious diseases 20041001

• Nevirapine and efavirenz elicit different changes in lipid profiles in antiretroviral-therapy-naive patients infected with HIV-1.

  PLoS medicine 20041001

• The efficacy-effectiveness gap in PMTCT.

  South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde 20041001

• Quality of life in patients treated with first-line antiretroviral therapy containing nevirapine and/or efavirenz.

  Antiviral therapy 20041001

• Rapid HIV type 1 testing of women presenting in late pregnancy with unknown HIV status in Lima, Peru.

  AIDS research and human retroviruses 20041001

• An assessment of mother-to-child HIV transmission prevention in 16 pilot antenatal clinics in Jamaica.

  The West Indian medical journal 20041001

• HIV seroprevalence, uptake of interventions to reduce mother-to-child transmission and birth outcomes in greater Kingston, Jamaica.

  The West Indian medical journal 20041001

• Uptake of interventions, outcomes and challenges in caring for HIV-exposed infants in Kingston, Jamaica.

  The West Indian medical journal 20041001

• Nevirapine-associated rash in a Jamaican child with HIV/AIDS.

  The West Indian medical journal 20041001

• Binding of anti-HIV drugs to human serum albumin.

  IUBMB life 20041001

• HIV-1 clade-C-associated 'ALS'-like disorder: first report from India.

  Journal of the neurological sciences 20040915

• Novel mechanism of inhibition of HIV-1 reverse transcriptase by a new non-nucleoside analog, KM-1.

  The Journal of biological chemistry 20040910

• Rate of viral rebound according to specific drugs in the regimen in 2120 patients with HIV suppression.

  AIDS (London, England) 20040903

• Low efficacy of nevirapine (HIVNET012) in preventing perinatal HIV-1 transmission in a real-life situation.

  AIDS (London, England) 20040903

• HIV-1 inhibitory compounds from Calophyllum brasiliense leaves.

  Biological & pharmaceutical bulletin 20040901

• Lopinavir/ritonavir treatment in HIV antiretroviral-experienced patients: evaluation of risk factors for liver enzyme elevation.

  HIV medicine 20040901

• Assessing the risk of birth defects associated with antiretroviral exposure during pregnancy.

  American journal of obstetrics and gynecology 20040901

• Perinatal HIV research unit clarifies nevirapine resistance and transmission issues.

  South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde 20040901

• Meeting report from the XV International AIDS Conference. Perinatal transmission.

  AIDS clinical care 20040901

• Follow-up measurements of Nevirapine plasma levels over a prolonged period.

  European journal of medical research 20040831

• Cost-effectiveness of nevirapine to prevent mother-to-child HIV transmission in eight African countries.

  AIDS (London, England) 20040820

• Nevirapine-containing regimens in HIV-infected naive patients with CD4 cell counts of 200 cells/microl or less.

  AIDS (London, England) 20040820

• Multiple validated measures of adherence indicate high levels of adherence to generic HIV antiretroviral therapy in a resource-limited setting.

  Journal of acquired immune deficiency syndromes (1999) 20040815

• Some design issues in trials of microbicides for the prevention of HIV infection.

  The Journal of infectious diseases 20040815

• A comparison of the CD4 response to antiretroviral regimens in patients commencing therapy with low CD4 counts.

  The Journal of antimicrobial chemotherapy 20040801

• Effect of stereochemistry on the anti-HIV activity of chiral thiourea compounds.

  Bioorganic & medicinal chemistry 20040801

• Race is not associated with nevirapine pharmacokinetics.

  Therapeutic drug monitoring 20040801

• Protease inhibitor-sparing simplified maintenance therapy: a need for perspective.

  The Journal of antimicrobial chemotherapy 20040801

• Issues in the design of a clinical trial with a behavioral intervention--the Zambia exclusive breast-feeding study.

  Controlled clinical trials 20040801

• 2-(2,6-Dihalophenyl)-3-(pyrimidin-2-yl)-1,3-thiazolidin-4-ones as non-nucleoside HIV-1 reverse transcriptase inhibitors.

  Antiviral research 20040801

• Serum adiponectin and metabolic parameters in HIV-1-infected patients after substitution of nevirapine for protease inhibitors.

  European journal of clinical investigation 20040801

• Mutations correlated to NVP concentrations.

  AIDS patient care and STDs 20040801

• [Progress in HIV non-nucleoside reverse transcriptase inhibitors (NNRTIs)].

  Yao xue xue bao = Acta pharmaceutica Sinica 20040801

• Health minister ignites row over drugs for HIV mothers.

  Nature 20040722

• Simple, short peptide derivatives of a sulfonylindolecarboxamide (L-737,126) active in vitro against HIV-1 wild type and variants carrying non-nucleoside reverse transcriptase inhibitor resistance mutations.

  Journal of medicinal chemistry 20040715

• Antiretroviral agents--how best to protect infants from HIV and save their mothers from AIDS.

  The New England journal of medicine 20040715

• Single-dose perinatal nevirapine plus standard zidovudine to prevent mother-to-child transmission of HIV-1 in Thailand.

  The New England journal of medicine 20040715

• Intrapartum exposure to nevirapine and subsequent maternal responses to nevirapine-based antiretroviral therapy.

  The New England journal of medicine 20040715

• Nevirapine and zidovudine at birth to reduce perinatal transmission of HIV in an African setting: a randomized controlled trial.

  JAMA 20040714

• South Africa rejects use of AIDS drug for women.

  The New York times on the Web 20040714

• No relationship between high nevirapine plasma concentration and hepatotoxicity in HIV-1-infected patients naive of antiretroviral treatment or switched from protease inhibitors.

  European journal of clinical pharmacology 20040701

• Maternal toxicity with continuous nevirapine in pregnancy: results from PACTG 1022.

  Journal of acquired immune deficiency syndromes (1999) 20040701

• Implementing a rural programme of prevention of mother-to-child transmission of HIV in Zimbabwe: first 18 months of experience.

  Tropical medicine & international health : TM & IH 20040701

• Generic antiretroviral drugs--will they be the answer to HIV in the developing world?

  Lancet (London, England) 20040701

• Effectiveness and safety of a generic fixed-dose combination of nevirapine, stavudine, and lamivudine in HIV-1-infected adults in Cameroon: open-label multicentre trial.

  Lancet (London, England) 20040701

• First-line and second-line antiretroviral therapy.

  Lancet (London, England) 20040701

• The relationship between nevirapine plasma concentrations and abnormal liver function tests.

  AIDS research and human retroviruses 20040701

• Mutations and polymorphisms associated with antiretroviral drugs in HIV-1C-infected African patients.

  Antiviral chemistry & chemotherapy 20040701

• Safety and efficacy of a simplified fixed-dose combination of stavudine, lamivudine and nevirapine (GPO-VIR) for the treatment of advanced HIV-infected patients: a 24-week study.

  Journal of the Medical Association of Thailand = Chotmaihet thangphaet 20040701

• 5-Alkyl-2-[(aryl and alkyloxylcarbonylmethyl)thio]-6-(1-naphthylmethyl) pyrimidin-4(3H)-ones as an unique HIV reverse transcriptase inhibitors of S-DABO series.

  Bioorganic & medicinal chemistry letters 20040621

• A trial of three antiretroviral regimens in HIV-1-infected children.

  The New England journal of medicine 20040610

• Antiviral drugs in current clinical use.

  Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology 20040601

• Styrylquinolines, integrase inhibitors acting prior to integration: a new mechanism of action for anti-integrase agents.

  Journal of virology 20040601

• Immune status and uptake of antiretroviral interventions to prevent mother-to-child transmission of HIV-1 in Africa.

  Journal of acquired immune deficiency syndromes (1999) 20040601

• HIV/AIDS news: comparable anti-HIV antiviral efficacy of Viramune and Efavirenz--the Lancet publishes first large-scale comparison study.

  Infection 20040601

• Evaluation of the virological and metabolic effects of switching protease inhibitor combination antiretroviral therapy to nevirapine-based therapy for the treatment of HIV infection.

  AIDS research and human retroviruses 20040601

• Comparison of nevirapine (NVP) resistance in Ugandan women 7 days vs. 6-8 weeks after single-dose nvp prophylaxis: HIVNET 012.

  AIDS research and human retroviruses 20040601

• Safety and efficacy of once-daily didanosine, tenofovir and nevirapine as a simplification antiretroviral approach.

  Antiviral therapy 20040601

• Pharmacokinetic interactions of drugs with St John's wort.

  Journal of psychopharmacology (Oxford, England) 20040601

• Nevirapine in the treatment of HIV.

  Expert review of anti-infective therapy 20040601

• Effect of stereo and regiochemistry towards wild and multidrug resistant HIV-1 virus: viral potency of chiral PETT derivatives.

  Biochemical pharmacology 20040515

• Roles of conformational and positional adaptability in structure-based design of TMC125-R165335 (etravirine) and related non-nucleoside reverse transcriptase inhibitors that are highly potent and effective against wild-type and drug-resistant HIV-1 variants.

  Journal of medicinal chemistry 20040506

• Predictors of virologic failure and resistance in HIV-infected patients treated with nevirapine- or efavirenz-based antiretroviral therapy.

  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20040501

• Clinical implications of stopping nevirapine-based antiretroviral therapy: relative pharmacokinetics and avoidance of drug resistance.

  HIV medicine 20040501

• Risk of archived resistance after intrapartum nevirapine.

  South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde 20040501

• Nevirapine-induced resistance is a problem.

  South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde 20040501

• Acceptability and utilisation of voluntary HIV testing and nevirapine to reduce mother-to-child transmission of HIV-1 integrated into routine clinical care.

  South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde 20040501

• Clinical utility of current NNRTIs and perspectives of new agents in this class under development.

  Antiviral chemistry & chemotherapy 20040501

• Docking-based CoMFA and CoMSIA studies of non-nucleoside reverse transcriptase inhibitors of the pyridinone derivative type.

  Journal of computer-aided molecular design 20040501

• The effect of Plasmodium falciparum malaria on peripheral and placental HIV-1 RNA concentrations in pregnant Malawian women.

  AIDS (London, England) 20040430

• [Favorable new data for nevirapine. Antiretroviral effect confirmed--and also lipid profile].

  MMW Fortschritte der Medizin 20040426

• [CROI--presentation of new study results. In a comparison of NNRTI nevirapine is equally effective].

  MMW Fortschritte der Medizin 20040426

• Antiretroviral therapy for previously untreated HIV-1-infected adults: 2NN, or just one?

  Lancet (London, England) 20040417

• Comparison of first-line antiretroviral therapy with regimens including nevirapine, efavirenz, or both drugs, plus stavudine and lamivudine: a randomised open-label trial, the 2NN Study.

  Lancet (London, England) 20040417

• Efavirenz versus nevirapine in current clinical practice: a prospective, open-label observational study.

  Journal of acquired immune deficiency syndromes (1999) 20040415

• Hepatotoxicity associated with nevirapine use.

  Journal of acquired immune deficiency syndromes (1999) 20040415

• Assessment of cetirizine, an antihistamine, to prevent cutaneous reactions to nevirapine therapy: results of the viramune-zyrtec double-blind, placebo-controlled trial.

  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20040415

• Genetic variation at NNRTI resistance-associated positions in patients infected with HIV-1 subtype C.

  AIDS (London, England) 20040409

• Universal nevirapine upon presentation in labor to prevent mother-to-child HIV transmission in high prevalence settings.

  AIDS (London, England) 20040409

• Therapeutic drug monitoring of lopinavir/ritonavir given alone or with a non-nucleoside reverse transcriptase inhibitor.

  British journal of clinical pharmacology 20040401

• Inhibition of HIV-1 reverse transcriptase and protease by phlorotannins from the brown alga Ecklonia cava.

  Biological & pharmaceutical bulletin 20040401

• Anti-HIV-1 cycloartanes from leaves and twigs of Gardenia thailandica.

  Planta medica 20040401

• Pharmacokinetic evaluation and short-term activity of stavudine, nevirapine, and nelfinavir therapy in HIV-1-infected adults.

  Journal of acquired immune deficiency syndromes (1999) 20040401

• Pharmacokinetic characteristics of ritonavir, zidovudine, lamivudine, and stavudine in children with human immunodeficiency virus infection.

  Pharmacotherapy 20040401

• Retrovirus conferees discuss new strategies.

  American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20040401

• Immune restoration in HIV-positive, antiretroviral-naive patients after 1 year of zidovudine/lamivudine plus nelfinavir or nevirapine.

  Antiviral therapy 20040401

• PMTCT from research to reality--results from a routine service.

  South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde 20040401

• Nevirapine warning.

  AIDS patient care and STDs 20040401

• Nevirapine may promote resistance.

  AIDS patient care and STDs 20040401

• Maternal malaria and perinatal HIV transmission, western Kenya.

  Emerging infectious diseases 20040401

• Prevention of mother-to-child transmission of HIV at Maiduguri, Nigeria.

  Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology 20040401

• In vivo dynamics of the 103N mutation following the withdrawal of non-nucleoside reverse transcriptase inhibitors in HIV-infected patients: preliminary results.

  The new microbiologica 20040401

• HIV drug nevirapine (Viramune): risk of severe hepatotoxicity.

  CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne 20040330

• Effect of antiretroviral drugs on liver fibrosis in HIV-infected patients with chronic hepatitis C: harmful impact of nevirapine.

  AIDS (London, England) 20040326

• HPTLC method for determination of nevirapine in pharmaceutical dosage form.

  Talanta 20040310

• [Assessment of nevirapine liver toxicity in patients with HIV and HVC coinfection].

  Medicina clinica 20040306

• Evaluation of nevirapine and/or hydroxyurea with nucleoside reverse transcriptase inhibitors in treatment-naive HIV-1-infected subjects.

  AIDS (London, England) 20040305

• The distribution of the HIV protease inhibitor, ritonavir, to the brain, cerebrospinal fluid, and choroid plexuses of the guinea pig.

  The Journal of pharmacology and experimental therapeutics 20040301

• Nurses in Zambia gain access to antiretroviral treatment.

  International nursing review 20040301

• Drug-induced liver injury.

  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20040301

• Liver toxicity in epidemiological cohorts.

  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20040301

• Drug-induced liver injury associated with the use of nonnucleoside reverse-transcriptase inhibitors.

  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20040301

• Differential CD4 T-cell response in HIV-1-infected patients using protease inhibitor-based or nevirapine-based highly active antiretroviral therapy.

  HIV medicine 20040301

• Nevirapine- versus efavirenz-based highly active antiretroviral therapy regimens in antiretroviral-naïve patients with advanced HIV infection.

  HIV medicine 20040301

• Treatment of HIV-infected patients with a combination of efavirenz, nevirapine and nucleoside reverse transcriptase inhibitors.

  HIV medicine 20040301

• Drug interactions with St. John's Wort (Hypericum perforatum): a review of the clinical evidence.

  International journal of clinical pharmacology and therapeutics 20040301

• Newly identified human retrovirus receptor; new ways to prevent viral infections.

  The AIDS reader 20040301

• Prevention of mother to child transmission of HIV.

  Indian journal of pediatrics 20040301

• Severe lactic acidosis in association with reverse transcriptase inhibitors with potential response to L-carnitine in a pediatric HIV-positive patient.

  AIDS patient care and STDs 20040301

• HIV type 1 pol gene diversity and archived nevirapine resistance mutation in pregnant women in Rwanda.

  AIDS research and human retroviruses 20040301

• New nevirapine label underscores the risk for hepatotoxicity in key populations.

  AIDS clinical care 20040301

• Nevirapine precautions published.

  AIDS treatment news 20040227

• Novel benzophenones as non-nucleoside reverse transcriptase inhibitors of HIV-1.

  Journal of medicinal chemistry 20040226

• Defining a molecular mechanism of synergy between nucleoside and nonnucleoside AIDS drugs.

  The Journal of biological chemistry 20040220

• Unexpected CD4 cell count decline in patients receiving didanosine and tenofovir-based regimens despite undetectable viral load.

  AIDS (London, England) 20040220

• Dose escalation or immediate full dose when switching from efavirenz to nevirapine-based highly active antiretroviral therapy in HIV-1-infected individuals?

  AIDS (London, England) 20040220

• Crystal structures of HIV-1 reverse transcriptases mutated at codons 100, 106 and 108 and mechanisms of resistance to non-nucleoside inhibitors.

  Journal of molecular biology 20040220

• Computer-aided design, synthesis, and anti-HIV-1 activity in vitro of 2-alkylamino-6-[1-(2,6-difluorophenyl)alkyl]-3,4-dihydro-5-alkylpyrimidin-4(3H)-ones as novel potent non-nucleoside reverse transcriptase inhibitors, also active against the Y181C variant.

  Journal of medicinal chemistry 20040212

• Novel nevirapine-like inhibitors with improved activity against NNRTI-resistant HIV: 8-heteroarylthiomethyldipyridodiazepinone derivatives.

  Bioorganic & medicinal chemistry letters 20040209

• Serious adverse cutaneous and hepatic toxicities associated with nevirapine use by non-HIV-infected individuals.

  Journal of acquired immune deficiency syndromes (1999) 20040201

• Characterization of nevirapine resistance mutations in women with subtype A vs. D HIV-1 6-8 weeks after single-dose nevirapine (HIVNET 012).

  Journal of acquired immune deficiency syndromes (1999) 20040201

• Detection of nevirapine in plasma using thin-layer chromatography.

  Journal of acquired immune deficiency syndromes (1999) 20040201

• Maternal toxicity and pregnancy complications in human immunodeficiency virus-infected women receiving antiretroviral therapy: PACTG 316.

  American journal of obstetrics and gynecology 20040201

• Mitochondrial effects of antiretroviral therapies in asymptomatic patients.

  Antiviral therapy 20040201

• Susceptibility of HIV-2, SIV and SHIV to various anti-HIV-1 compounds: implications for treatment and postexposure prophylaxis.

  Antiviral therapy 20040201

• Clinical efficacy of antiretroviral combination therapy based on protease inhibitors or non-nucleoside analogue reverse transcriptase inhibitors: indirect comparison of controlled trials.

  BMJ (Clinical research ed.) 20040131

• HIVNET 012 and Petra.

  Lancet (London, England) 20040117

• HIVNET 012 and Petra.

  Lancet (London, England) 20040117

• HIVNET 012 and Petra.

  Lancet (London, England) 20040117

• HIVNET 012 and Petra.

  Lancet (London, England) 20040117

• Stereoselective metabolism of methadone N-demethylation by cytochrome P4502B6 and 2C19.

  Chirality 20040101

• The effect of nevirapine on the pharmacokinetics of indinavir/ritonavir 800/100 mg BID.

  Journal of acquired immune deficiency syndromes (1999) 20040101

• Effects of concentration and temperature on the stability of nevirapine in whole blood and serum.

  Clinical chemistry 20040101

• Susceptibility of feline immunodeficiency virus/human immunodeficiency virus type 1 reverse transcriptase chimeras to non-nucleoside RT inhibitors.

  Molecular pharmacology 20040101

• Risk factors and occurrence of rash in HIV-positive patients not receiving nonnucleoside reverse transcriptase inhibitor: data from a randomized study evaluating use of protease inhibitors in nucleoside-experienced patients with very low CD4 levels (<50 cells/microL).

  HIV medicine 20040101

• Treatment of HIV infection in pregnant women: antiretroviral management options.

  Drugs 20040101

• In vitro activity of stampidine against primary clinical human immunodeficiency virus isolates.

  Arzneimittel-Forschung 20040101

• Long-term efficacy of a protease inhibitor-sparing, nucleoside reverse transcriptase inhibitor-limiting antiretroviral regimen with nevirapine, lamivudine, and reduced standard stavudine dosage.

  HIV clinical trials 20040101

• Cost-effectiveness of interventions to reduce vertical HIV transmission from pregnant women who have not received prenatal care.

  Medical decision making : an international journal of the Society for Medical Decision Making 20040101

• Synthesis and evaluation of a novel synthetic phosphocholine lipid-AZT conjugate that double-targets wild-type and drug resistant variants of HIV.

  Nucleosides, nucleotides & nucleic acids 20040101

• Safe substitution for efavirenz.

  AIDS patient care and STDs 20040101

• Mother-to-child transmission. How will AZT and nevirapine use for MTCT affect future treatment? Two studies provide clues.

  BETA : bulletin of experimental treatments for AIDS : a publication of the San Francisco AIDS Foundation 20040101

• WHO hopes 3-by-5 plan will reverse Africa's HIV/AIDS epidemic.

  Bulletin of the World Health Organization 20040101

• Advances in antiretroviral therapy. Highlights of the 11th Conference on Retroviruses and Opportunistic Infections, February 8-11, 2004, San Francisco, California, USA.

  Topics in HIV medicine : a publication of the International AIDS Society, USA 20040101

• Anti-HIV drug distribution to the central nervous system.

  Current pharmaceutical design 20040101

• Current status of the non-nucleoside reverse transcriptase inhibitors of human immunodeficiency virus type 1.

  Current topics in medicinal chemistry 20040101

• [Antiretroviral therapy of acute HIV-infection].

  Terapevticheskii arkhiv 20040101

• Recent advances in the development of next generation non-nucleoside reverse transcriptase inhibitors.

  Current topics in medicinal chemistry 20040101

• Endogenous reverse transcriptase: a mediator of cell proliferation and differentiation.

  Cytogenetic and genome research 20040101

• Pre-exposure chemoprophylaxis for HIV: it is time.

  Retrovirology 20040101

• Health-related quality of life in HIV-infected naive patients treated with nelfinavir or nevirapine associated with ZDV/3TC (the COMBINE-QoL substudy).

  HIV clinical trials 20040101

• Efficacy of quality criteria to identify potentially harmful information: a cross-sectional survey of complementary and alternative medicine web sites.

  Journal of medical Internet research 20040101

• Hepatitis B virus variants in an HIV-HBV co-infected patient at different periods of antiretroviral treatment with and without lamivudine.

  BMC infectious diseases 20040101

• Effect of mycophenolate mofetil on the pharmacokinetics of antiretroviral drugs and on intracellular nucleoside triphosphate pools.

  Clinical pharmacokinetics 20040101

• Practical guidelines to interpret plasma concentrations of antiretroviral drugs.

  Clinical pharmacokinetics 20040101

• Antiretrovirals, Part II: focus on non-protease inhibitor antiretrovirals (NRTIs, NNRTIs, and fusion inhibitors).

  Psychosomatics 20040101

• Spectrum of clinical disease in a series of 135 hospitalised HIV-infected patients from north India.

  BMC infectious diseases 20040101

• Pharmacokinetics of antiretrovirals in pregnant women.

  Clinical pharmacokinetics 20040101

• The unmasking of Pneumocystis jiroveci pneumonia during reversal of immunosuppression: case reports and literature review.

  BMC infectious diseases 20040101

• [Combined antiretroviral therapy with nevirapine of HIV-infected adults].

  Terapevticheskii arkhiv 20040101

• Behind 'AIDS breakthrough' headlines, December 2004: important research, not so new.

  AIDS treatment news 20040101

• Nevirapine misinformation: will it kill?

  AIDS treatment news 20040101

• Single dose theory.

  GMHC treatment issues : the Gay Men's Health Crisis newsletter of experimental AIDS therapies 20040101

• Single-dose jeopardizes long-term therapy.

  GMHC treatment issues : the Gay Men's Health Crisis newsletter of experimental AIDS therapies 20040101

• Time to move on. More questions about single-dose nevirapine.

  GMHC treatment issues : the Gay Men's Health Crisis newsletter of experimental AIDS therapies 20040101

• Pediatric AIDS Foundation on single-dose nevirapine.

  GMHC treatment issues : the Gay Men's Health Crisis newsletter of experimental AIDS therapies 20040101

• Comments by Global Strategies for HIV Prevention on nevirapine resistance.

  GMHC treatment issues : the Gay Men's Health Crisis newsletter of experimental AIDS therapies 20040101

• Unhealthy drug donations.

  Indian journal of medical ethics 20040101

• Implementation of the prevention of mother-to-child transmission of HIV programme in Zimbabwe: achievements and challenges.

  The Central African journal of medicine 20040101

• Non-nucleoside reverse transcriptase inhibitors (NNRTIs): past, present, and future.

  Chemistry & biodiversity 20040101

• Direct interaction between substrates and endogenous steroids in the active site may change the activity of cytochrome P450 3A4.

  Biochemistry 20031230

• Substitution for protease inhibitors in HIV therapy.

  The New England journal of medicine 20031218

• 3-iodo-4-phenoxypyridinones (IOPY's), a new family of highly potent non-nucleoside inhibitors of HIV-1 reverse transcriptase.

  Bioorganic & medicinal chemistry letters 20031215

• Safety and trough concentrations of nevirapine prophylaxis given daily, twice weekly, or weekly in breast-feeding infants from birth to 6 months.

  Journal of acquired immune deficiency syndromes (1999) 20031215

• Preventing mother-to-child HIV transmission in a developing country: the Dominican Republic experience.

  Journal of acquired immune deficiency syndromes (1999) 20031215

• Performance characteristics of HIV-1 culture and HIV-1 DNA and RNA amplification assays for early diagnosis of perinatal HIV-1 infection.

  Journal of acquired immune deficiency syndromes (1999) 20031215

• HIV-1 seroprevalence rates in women and relinquishment of infants to the state in St Petersburg, Russia, 2002.

  Lancet (London, England) 20031213

• TMC125 exerts similar initial antiviral potency as a five-drug, triple class antiretroviral regimen.

  AIDS (London, England) 20031205

• Provider bias in the selection of non-nucleoside reverse transcriptase inhibitor and protease inhibitor-based highly active antiretroviral therapy and HIV treatment outcomes in observational studies.

  AIDS (London, England) 20031205

• An open-label assessment of TMC 125--a new, next-generation NNRTI, for 7 days in HIV-1 infected individuals with NNRTI resistance.

  AIDS (London, England) 20031205

• Therapeutic drug monitoring of the HIV/AIDS drugs abacavir, zidovudine, efavirenz, nevirapine, indinavir, lopinavir, and nelfinavir.

  Pharmacology 20031201

• Nevirapine plus efavirenz plus didanosine: a simple, safe, and effective once-daily regimen for patients with HIV infection.

  Journal of the National Medical Association 20031201

• A randomized trial comparing initial HAART regimens of nelfinavir/nevirapine and ritonavir/saquinavir in combination with two nucleoside reverse transcriptase inhibitors.

  Antiviral therapy 20031201

• The continuing evolution of HIV therapy.

  The AIDS reader 20031201

• Nevirapine to prevent mother-to-child transmission of HIV-1 among women of unknown serostatus.

  Lancet (London, England) 20031129

• Meta-analysis of randomized controlled trials of simplified versus continued protease inhibitor-based antiretroviral therapy in HIV-1-infected patients.

  AIDS (London, England) 20031121

• Breastfeeding and HIV transmission.

  AIDS (London, England) 20031121

• Effects of imatinib mesylate (STI571, Glivec) on the pharmacokinetics of simvastatin, a cytochrome p450 3A4 substrate, in patients with chronic myeloid leukaemia.

  British journal of cancer 20031117

• Immune reconstitution is comparable in antiretroviral-naive subjects after 1 year of successful therapy with a nucleoside reverse-transcriptase inhibitor- or protease inhibitor-containing antiretroviral regimen.

  The Journal of infectious diseases 20031115

• Resolution of HCV infection in a HIV-infected patient under HAART after several hepatitis flare-ups.

  European journal of medical research 20031112

• PA-457: a potent HIV inhibitor that disrupts core condensation by targeting a late step in Gag processing.

  Proceedings of the National Academy of Sciences of the United States of America 20031111

• Sex differences in nevirapine disposition in HIV-infected patients.

  AIDS (London, England) 20031107

• Role of endogenous reverse transcriptase in murine early embryo development.

  Molecular reproduction and development 20031101

• The relationship between prevention of mother to child transmission of HIV and stakeholder decision making in Uganda: implications for health policy.

  Health policy (Amsterdam, Netherlands) 20031101

• Low rate of mother-to-child transmission of HIV-1 after nevirapine intervention in a pilot public health program in Yaoundé, Cameroon.

  Journal of acquired immune deficiency syndromes (1999) 20031101

• CD4 cell count response to nonnucleoside reverse transcriptase inhibitor- or protease inhibitor-based highly active antiretroviral therapy in an observational cohort study.

  Journal of acquired immune deficiency syndromes (1999) 20031101

• Does prior short-course nevirapine reduce the effectiveness of subsequent combination treatment with efavirenz?

  Journal of acquired immune deficiency syndromes (1999) 20031101

• A comparison of the effects of nevirapine and nelfinavir on metabolism and body habitus in antiretroviral-naive human immunodeficiency virus-infected patients: a randomized controlled study.

  The Journal of clinical endocrinology and metabolism 20031101

• Risk and determinants of developing severe liver toxicity during therapy with nevirapine-and efavirenz-containing regimens in HIV-infected patients.

  International journal of STD & AIDS 20031101

• Antiretroviral therapy-related hepatotoxicity: predictors and clinical management.

  Journal of HIV therapy 20031101

• Potent and selective inhibition of HIV and SIV by prostratin interacting with viral entry.

  Antiviral chemistry & chemotherapy 20031101

• Non-nucleoside inhibitors of HIV-1 reverse transcriptase inhibit phosphorolysis and resensitize the 3'-azido-3'-deoxythymidine (AZT)-resistant polymerase to AZT-5'-triphosphate.

  The Journal of biological chemistry 20031024

• Risk of severe hepatotoxicity associated with antiretroviral therapy in the HIV-NAT Cohort, Thailand, 1996-2001.

  AIDS (London, England) 20031017

• Case series of acute hepatitis in a non-selected group of HIV-infected patients on nevirapine-containing antiretroviral treatment.

  AIDS (London, England) 20031017

• The safety, tolerability and effectiveness of generic antiretroviral drug regimens for HIV-infected patients in south India.

  AIDS (London, England) 20031017

• Failures of 1 week on, 1 week off antiretroviral therapies in a randomized trial.

  AIDS (London, England) 20031017

• Short postexposure prophylaxis in newborn babies to reduce mother-to-child transmission of HIV-1: NVAZ randomised clinical trial.

  Lancet (London, England) 20031011

• [Interaction between methadone and antiretrovirals (stavudine, indinavir, ritonavir, nevirapine)].

  Medicina clinica 20031004

• Anti-HIV active petrosins from the marine sponge Petrosia similis.

  Biological & pharmaceutical bulletin 20031001

• Mutation patterns of the reverse transcriptase genes in HIV-1 infected patients receiving combinations of nucleoside and non nucleoside inhibitors.

  International journal of antimicrobial agents 20031001

• Issues in antiretroviral toxicity.

  The AIDS reader 20031001

• Successful treatment of hepatitis C in a patient with advanced AIDS and decompensated cirrhosis.

  The AIDS reader 20031001

• Modest decreases in NNRTI susceptibility do not influence virological outcome in patients receiving initial NNRTI-containing triple therapy.

  Antiviral therapy 20031001

• Mother-to-child transmission of human immunodeficiency virus type 1 in relation to the season in Yaounde, Cameroon.

  The American journal of tropical medicine and hygiene 20031001

• Decreased likelihood [correction of likelyhood] of infants contracting HIV when taking nevirapine.

  Expert review of anti-infective therapy 20031001

• Low efficacy and high frequency of adverse events in a randomized trial of the triple nucleoside regimen abacavir, stavudine and didanosine.

  AIDS (London, England) 20030926

• Decision analysis to guide choice of interventions to reduce mother-to-child transmission of HIV.

  AIDS (London, England) 20030926

• Thailand's do-it-yourself therapy.

  Science (New York, N.Y.) 20030919

• Long-term findings of HIVNET 012: the next steps.

  Lancet (London, England) 20030913

• Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: 18-month follow-up of the HIVNET 012 randomised trial.

  Lancet (London, England) 20030913

• Nevirapine reduced mother-to-child transmission better than AZT--at 70 times less the cost.

  AIDS treatment news 20030912

• Substitution of nevirapine, efavirenz, or abacavir for protease inhibitors in patients with human immunodeficiency virus infection.

  The New England journal of medicine 20030911

• [Antiretroviral-induced toxiderma in HIV-infected patients].

  Presse medicale (Paris, France : 1983) 20030906

• Drug-induced aminotransferase alterations during antiretroviral HIV post-exposure prophylaxis.

  AIDS (London, England) 20030905

• Increased VLDL-apoB and IDL-apoB production rates in nonlipodystrophic HIV-infected patients on a protease inhibitor-containing regimen: a stable isotope kinetic study.

  Journal of lipid research 20030901

• Cost-effectiveness of strategies to reduce mother-to-child HIV transmission in Mexico, a low-prevalence setting.

  Health policy and planning 20030901

• Incidence and risk factors for nevirapine-associated rash.

  European journal of clinical pharmacology 20030901

• Inhibition of human immunodeficiency virus by a new class of pyridine oxide derivatives.

  Antimicrobial agents and chemotherapy 20030901

• Nelfinavir pharmacokinetics in stable human immunodeficiency virus-positive children: Pediatric AIDS Clinical Trials Group Protocol 377.

  Pediatrics 20030901

• South African to distribute AIDS drug.

  Nature medicine 20030901

• Characterization of a potential animal model of an idiosyncratic drug reaction: nevirapine-induced skin rash in the rat.

  Chemical research in toxicology 20030901

• Synthesis and investigation of alpha-hydroxy-N,N-didesmethyltamoxifen as a proximate carcinogen in the metabolic activation of tamoxifen.

  Chemical research in toxicology 20030901

• Perspectives on HAART: switch maintenance therapy.

  International journal of STD & AIDS 20030901

• Cryptosporidium muris, a rodent pathogen, recovered from a human in Perú.

  Emerging infectious diseases 20030901

• HIV resistance to nevirapine and other non-nucleoside reverse transcriptase inhibitors.

  Journal of acquired immune deficiency syndromes (1999) 20030901

• Pharmacokinetic drug interactions with nevirapine.

  Journal of acquired immune deficiency syndromes (1999) 20030901

• Defining the toxicity profile of nevirapine and other antiretroviral drugs.

  Journal of acquired immune deficiency syndromes (1999) 20030901

• A comprehensive hepatic safety analysis of nevirapine in different populations of HIV infected patients.

  Journal of acquired immune deficiency syndromes (1999) 20030901

• Efficacy and durability of nevirapine in antiretroviral drug näive patients.

  Journal of acquired immune deficiency syndromes (1999) 20030901

• Efficacy and durability of nevirapine in antiretroviral-experienced patients.

  Journal of acquired immune deficiency syndromes (1999) 20030901

• Prevention of mother-to-child transmission of HIV--what next?

  Journal of acquired immune deficiency syndromes (1999) 20030901

• Impact of nevirapine on lipid metabolism.

  Journal of acquired immune deficiency syndromes (1999) 20030901

• Mitochondrial toxicity in the era of HAART: evaluating venous lactate and peripheral blood mitochondrial DNA in HIV-infected patients taking antiretroviral therapy.

  Journal of acquired immune deficiency syndromes (1999) 20030901

• Drug resistance profiles of recombinant reverse transcriptases from human immunodeficiency virus type 1 subtypes A/E, B, and C.

  AIDS research and human retroviruses 20030901

• Aid for AIDS--at last.

  South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde 20030901

• Monitoring nevirapine-based programmes for prevention of mother-to-child transmission of HIV-1.

  Lancet (London, England) 20030823

• The effects of protease inhibitors and nonnucleoside reverse transcriptase inhibitors on p-glycoprotein expression in peripheral blood mononuclear cells in vitro.

  Journal of acquired immune deficiency syndromes (1999) 20030815

• [Antiviral agents for reduction of mother-to-child transmission of HIV infection].

  Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke 20030814

• South African government to withdraw antiretrovirals for pregnant mothers.

  BMJ (Clinical research ed.) 20030809

• South African government threatens to ban nevirapine. Move would take away option for treating vertical HIV transmission.

  Lancet (London, England) 20030809

• Scaling the frontier--should traditional birth attendants also be used to provide nevirapine for PMTCT in Uganda?

  African health sciences 20030801

• Hyperlipidaemia in patients with HIV-1 infection receiving highly active antiretroviral therapy: epidemiology, pathogenesis, clinical course and management.

  International journal of antimicrobial agents 20030801

• [Exanthema simulating measles without measles virus? Allergic reaction to a non-nucleoside reverse transcriptase inhibitor in an HIV infected boy treated with HAART].

  Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete 20030801

• [A short-term trial of Didanosine, stavudine, and nevirapine combination therapy for human immunodeficiency virus infection].

  Hunan yi ke da xue xue bao = Hunan yike daxue xuebao = Bulletin of Hunan Medical University 20030801

• Feeding risk cut for HIV-infected women.

  Lancet (London, England) 20030726

• Nevirapine use in HIV-1-infected children.

  AIDS (London, England) 20030725

• Timing of the maternal drug dose and risk of perinatal HIV transmission in the setting of intrapartum and neonatal single-dose nevirapine.

  AIDS (London, England) 20030725

• Low frequency of the V106M mutation among HIV-1 subtype C-infected pregnant women exposed to nevirapine.

  AIDS (London, England) 20030725

• Simple and rapid method for the simultaneous determination of the non-nucleoside reverse transcriptase inhibitors efavirenz and nevirapine in human plasma using liquid chromatography.

  Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20030725

• Simultaneous determination of six HIV nucleoside analogue reverse transcriptase inhibitors and nevirapine by liquid chromatography with ultraviolet absorbance detection.

  Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20030705

• Use of HIV-1 reverse transcriptase recovered from human plasma for phenotypic drug susceptibility testing.

  AIDS (London, England) 20030704

• Nevirapine-selected mutations Y181I/C of HIV-1 reverse transcriptase confer cross-resistance to stavudine.

  AIDS (London, England) 20030704

• 'All-in-One Assay', a direct phenotypic anti-human immunodeficiency virus type 1 drug resistance assay for three-drug combination therapies that takes into consideration in vivo drug concentrations.

  Journal of virological methods 20030701

• NNRTI choice: has 2NN changed our practice?

  The AIDS reader 20030701

• Prevalence of genotypic and phenotypic HIV-1 drug-resistant strains among patients who have rebound in viral load while receiving antiretroviral therapy in the UNAIDS-Drug Access Initiative in Abidjan, Côte d'Ivoire.

  AIDS (London, England) 20030701

• Preventing neonatal HIV: a review.

  Current HIV research 20030701

• Mitochondrial:nuclear DNA ratios in peripheral blood cells from human immunodeficiency virus (HIV)-infected patients who received selected HIV antiretroviral drug regimens.

  The Journal of infectious diseases 20030615

• Prevention of mother-to-child transmission of HIV in Africa: successes and challenges in scaling-up a nevirapine-based program in Lusaka, Zambia.

  AIDS (London, England) 20030613

• Hypersusceptibility to non-nucleoside reverse transcriptase inhibitors in HIV-1.

  AIDS (London, England) 20030613

• The right to health and the nevirapine case in South Africa.

  The New England journal of medicine 20030612

• The right to health and the nevirapine case in South Africa.

  The New England journal of medicine 20030612

• Simultaneous determination of the HIV drugs indinavir, amprenavir, saquinavir, ritonavir, lopinavir, nelfinavir, the nelfinavir hydroxymetabolite M8, and nevirapine in human plasma by reversed-phase high-performance liquid chromatography.

  Therapeutic drug monitoring 20030601

• Predose infant nevirapine concentration with the two-dose intrapartum neonatal nevirapine regimen: association with timing of maternal intrapartum nevirapine dose.

  Journal of acquired immune deficiency syndromes (1999) 20030601

• HIV transmission through breastfeeding: problems and prevention.

  Annals of tropical paediatrics 20030601

• Synthesis of 2-methylsulfanyl-1H-imidazoles as novel non-nucleoside reverse transcriptase inhibitors (NNRTIs).

  Archiv der Pharmazie 20030601

• Use of SAM2 biotin capture membrane in microarrayed compound screening (muARCS) format for nucleic acid polymerization assays.

  Journal of biomolecular screening 20030601

• Comparison of nine resistance interpretation systems for HIV-1 genotyping.

  Antiviral therapy 20030601

• Polyphenotypic expression of mitochondrial toxicity caused by nucleoside reverse transcriptase inhibitors.

  Antiviral therapy 20030601

• Protease inhibitor-sparing regimens: new evidence strengthens position.

  Journal of acquired immune deficiency syndromes (1999) 20030601

• HIV: mother to child transmission.

  Clinical evidence 20030601

• Analysis of generic nevirapine products in developing countries.

  JAMA 20030528

• Suppression of cerebrospinal fluid HIV burden in antiretroviral naive patients on a potent four-drug antiretroviral regimen.

  AIDS (London, England) 20030523

• Mother-to-child HIV transmission in resource poor settings: how to improve coverage?

  AIDS (London, England) 20030523

• [Assessment of adherence to antiretroviral: role of determination of plasma levels of non nucleosides anologues].

  Medicina clinica 20030517

• [Decrease of HIV-1 virus load by nevirapin/efavirenz].

  Deutsche medizinische Wochenschrift (1946) 20030509

• Exposure of normal and transformed cells to nevirapine, a reverse transcriptase inhibitor, reduces cell growth and promotes differentiation.

  Oncogene 20030508

• Nevirapine resistance mutation at codon 181 of the HIV-1 reverse transcriptase confers stavudine resistance by increasing nucleotide substrate discrimination and phosphorolytic activity.

  The Journal of biological chemistry 20030502

• A randomized trial to study first-line combination therapy with or without a protease inhibitor in HIV-1-infected patients.

  AIDS (London, England) 20030502

• A review of studies assessing the costs and consequences of interventions to reduce mother-to-child HIV transmission in sub-Saharan Africa.

  AIDS (London, England) 20030502

• Once-a-day highly active antiretroviral therapy: a systematic review.

  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20030501

• Drug rash with eosinophilia and systemic symptoms syndrome and renal toxicity with a nevirapine-containing regimen in a pregnant patient with human immunodeficiency virus.

  Obstetrics and gynecology 20030501

• Randomized, controlled study of the effects of a short course of prednisone on the incidence of rash associated with nevirapine in patients infected with HIV-1.

  Journal of acquired immune deficiency syndromes (1999) 20030501

• Toxicity of non-nucleoside analogue reverse transcriptase inhibitors.

  Seminars in liver disease 20030501

• Nevirapine-based fixed-dose combination ARVs.

  GMHC treatment issues : the Gay Men's Health Crisis newsletter of experimental AIDS therapies 20030501

• [A 'once daily' drug that with proven effectiveness. Efavirenz has successful outcome also in direct comparisons].

  MMW Fortschritte der Medizin 20030428

• [Nevirapine has gained acceptance. Good antiretroviral effect--favorable lipid profile].

  MMW Fortschritte der Medizin 20030428

• [CROI highlights of D:A:D Study (Data Collection on Adverse Events of Anti-HIV Drugs Study) and 2NN Study. Stepping into the grease pot].

  MMW Fortschritte der Medizin 20030428

• Comparison of two strategies for administering nevirapine to prevent perinatal HIV transmission in high-prevalence, resource-poor settings.

  Journal of acquired immune deficiency syndromes (1999) 20030415

• An LC-MS-MS method for the determination of nevirapine, a non-nucleoside reverse transcriptase inhibitor, in human plasma.

  Journal of pharmaceutical and biomedical analysis 20030401

• Antiretroviral therapy-induced psychosis: case report and brief review of the literature.

  HIV medicine 20030401

• Report from the Tenth Retrovirus Conference. Comparing efavirenz and nevirapine: the 2NN study.

  AIDS clinical care 20030401

• Resistant HIV in breast milk.

  AIDS patient care and STDs 20030401

• Maternal complications after Caesarean section in HIV-infected pregnant women.

  The Australian & New Zealand journal of obstetrics & gynaecology 20030401

• Negligence. Liver transplant patient too late to sue Viramune maker.

  AIDS policy & law 20030328

• Retroviruses Conference clinical news; interview with Cal Cohen, M.D. Interview by John S. James.

  AIDS treatment news 20030314

• Preventing HIV transmission.

  Lancet (London, England) 20030308

• A phase I/II study of nevirapine for pre-exposure prophylaxis of HIV-1 transmission in uninfected subjects at high risk.

  AIDS (London, England) 20030307

• Co-administration of rifampin and nevirapine in HIV-infected patients with tuberculosis.

  AIDS (London, England) 20030307

• Novel pharmacophore-based methods reveal gossypol as a reverse transcriptase inhibitor.

  Journal of molecular graphics & modelling 20030301

• A multicenter randomized controlled trial of nevirapine versus a combination of zidovudine and lamivudine to reduce intrapartum and early postpartum mother-to-child transmission of human immunodeficiency virus type 1.

  The Journal of infectious diseases 20030301

• Evaluation of antiretroviral drug measurements by an interlaboratory quality control program.

  Journal of acquired immune deficiency syndromes (1999) 20030301

• Forty-eight-week evaluation of lopinavir/ritonavir, a new protease inhibitor, in human immunodeficiency virus-infected children.

  The Pediatric infectious disease journal 20030301

• Short communication: interactions between nevirapine plasma levels, chronic hepatitis C, and the development of liver toxicity in HIV-infected patients.

  AIDS research and human retroviruses 20030301

• Bystander CD4+ T lymphocytes survive in HIV-infected human lymphoid tissue.

  AIDS research and human retroviruses 20030301

• 'Buffalo-hump' dermatitis: a hat trick of antiretroviral side-effects.

  Contact dermatitis 20030301

• PMTCT court order: Manana in contempt?

  South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde 20030301

• Design, synthesis, SAR, and molecular modeling studies of acylthiocarbamates: a novel series of potent non-nucleoside HIV-1 reverse transcriptase inhibitors structurally related to phenethylthiazolylthiourea derivatives.

  Journal of medicinal chemistry 20030227

• The right to health and the nevirapine case in South Africa.

  The New England journal of medicine 20030220

• Genotype and phenotype at baseline and at failure in human immunodeficiency virus-infected antiretroviral-naive patients in a randomized trial comparing zidovudine and lamivudine plus nelfinavir or nevirapine.

  The Journal of infectious diseases 20030215

• Preventive strategies of perinatal HIV-1 transmission: an experience from Thailand.

  Expert opinion on pharmacotherapy 20030201

• Non-nucleoside reverse transcriptase inhibitors--an overview.

  International journal of STD & AIDS 20030201

• Simplification of protease inhibitor-containing regimens with efavirenz, nevirapine or abacavir: safety and efficacy outcomes.

  Antiviral therapy 20030201

• [Antiretrovirals].

  Nihon rinsho. Japanese journal of clinical medicine 20030201

• Lipid profiles associated with antiretroviral drug choices.

  Current opinion in infectious diseases 20030201

• Inhibition of TNF-alpha mediated cell death by HIV-1 specific protease inhibitors.

  European journal of medical research 20030128

• Compliance with antiretroviral regimens to prevent perinatal HIV-1 transmission in Kenya.

  AIDS (London, England) 20030103

• A V106M mutation in HIV-1 clade C viruses exposed to efavirenz confers cross-resistance to non-nucleoside reverse transcriptase inhibitors.

  AIDS (London, England) 20030103

• Amino acid substitutions at position 190 of human immunodeficiency virus type 1 reverse transcriptase increase susceptibility to delavirdine and impair virus replication.

  Journal of virology 20030101

• Multiple relapses of human cytomegalovirus retinitis during HAART in an AIDS patient with reconstitution of CD4+ T cell count in the absence of HCMV-specific CD4+ T cell response.

  Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology 20030101

• In vitro activity of potential anti-poxvirus agents.

  Antiviral research 20030101

• Severe cutaneous reactions associated with the use of human immunodeficiency virus medications.

  Acta dermato-venereologica 20030101

• Prevalence of genotypic HIV-1 drug resistance in Thailand, 2002.

  Annals of clinical microbiology and antimicrobials 20030101

• The use of a physiologically based pharmacokinetic model to evaluate deconvolution measurements of systemic absorption.

  BMC clinical pharmacology 20030101

• Therapeutic drug monitoring: an aid to optimising response to antiretroviral drugs?

  Drugs 20030101

• Lopinavir/ritonavir: a review of its use in the management of HIV infection.

  Drugs 20030101

• Incidence of liver injury after beginning antiretroviral therapy with efavirenz or nevirapine.

  HIV clinical trials 20030101

• Nevirapine found to be as effective as efavirenz.

  TreatmentUpdate 20030101

• Low nevirapine plasma concentrations predict virological failure in an unselected HIV-1-infected population.

  Clinical pharmacokinetics 20030101

• Does Viramune = Sustiva?

  Positively aware : the monthly journal of the Test Positive Aware Network 20030101

• Replacement of protease inhibitors by nevirapine or efavirenz in simplification and rescue interventions: which works better?

  HIV clinical trials 20030101

• Sustained efficacy of nevirapine in combination with two nucleoside analogues in the treatment of HIV-infected patients: a 48-week retrospective multicenter study.

  HIV clinical trials 20030101

• Combined analysis of two-year follow-up from two open-label randomized trials comparing efficacy of three nucleoside reverse transcriptase inhibitor backbones for previously untreated HIV-1 infection: OzCombo 1 and 2.

  HIV clinical trials 20030101

• Clinical vignette in antiretroviral therapy: rash illness.

  Journal of the International Association of Physicians in AIDS Care (Chicago, Ill. : 2002) 20030101

• [Decrease of HIV-1 replicative capacity after serial passage in MT-4 cells under conditions of the combined antiretroviral therapy].

  Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic] 20030101

• Comparison of efficacy of efavirenz and nevirapine: lessons learned for cohort analysis in light of the 2NN Study.

  HIV clinical trials 20030101

• Long-term safety and efficacy of NNRTI within the central nervous system.

  HIV clinical trials 20030101

• Evolution of phage with chemically ambiguous proteomes.

  BMC evolutionary biology 20030101

• [HIV-1 transmission from mother to child and its prevention].

  Medecine tropicale : revue du Corps de sante colonial 20030101

• Access to health care services as a justiciable socio-economic right under the South African constitution.

  Medical law international 20030101

• Genotypic resistance tests for the management of patients at simplification of highly active antiretroviral therapy.

  Scandinavian journal of infectious diseases. Supplementum 20030101

• European participation in an international perinatal trial.

  Medycyna wieku rozwojowego 20030101

• Report from the 4th International Workshop on Clinical Pharmacology of HIV Therapy. Nevirapine levels in the blood found higher in women.

  TreatmentUpdate 20030101

• A Comparison of the Therapeutic Plan Costs in the Treatment of HIV-Positive Patients.

  Clinical drug investigation 20030101

• Drug Interaction of Fluvoxamine and Fluoxetine with Nevirapine in HIV-1-Infected Individuals.

  Clinical drug investigation 20030101

• Substitution of conserved hydrophobic residues in motifs B and C of HIV-1 RT alters the geometry of its catalytic pocket.

  Biochemistry 20021231

• Synthesis of novel N-1 (allyloxymethyl) analogues of 6-benzyl-1-(ethoxymethyl)-5-isopropyluracil (MKC-442, emivirine) with improved activity against HIV-1 and its mutants.

  Journal of medicinal chemistry 20021219

• Time-dependent changes in HIV nucleoside analogue phosphorylation and the effect of hydroxyurea.

  AIDS (London, England) 20021206

• Docking of non-nucleoside inhibitors: neotripterifordin and its derivatives to HIV-1 reverse transcriptase.

  Proteins 20021201

• Structural requirements for potent anti-human immunodeficiency virus (HIV) and sperm-immobilizing activities of cyclohexenyl thiourea and urea non-nucleoside inhibitors of HIV-1 reverse transcriptase.

  Biology of reproduction 20021201

• Mass treatment with nevirapine to prevent mother-to-child transmission of HIV/AIDS in sub-Saharan African countries.

  The journal of obstetrics and gynaecology research 20021201

• Post-exposure prophylaxis.

  International journal of STD & AIDS 20021201

• Genotypic and phenotypic resistance patterns in early-stage HIV-1-infected patients failing initial therapy with stavudine, didanosine and nevirapine.

  Antiviral therapy 20021201

• Nevirapine all set to succeed in Gauteng.

  South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde 20021201

• Mother to child transmission of HIV.

  Clinical evidence 20021201

• Gateways to clinical trials.

  Methods and findings in experimental and clinical pharmacology 20021201

• South Africa: highest court orders government to provide antiretrovirals to prevent mother-to-child transmission.

  Canadian HIV/AIDS policy & law review 20021201

• South Africa: voluntary licence to generic drug company for nevirapine.

  Canadian HIV/AIDS policy & law review 20021201

• South Africa: TAC, COSATU and allies file complaint of excessive pricing.

  Canadian HIV/AIDS policy & law review 20021201

• Nevirapine patient assistance program: model for better administration?

  AIDS treatment news 20021122

• A cohort study of nevirapine tolerance in clinical practice: French Aquitaine Cohort, 1997-1999.

  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20021115

• Determinations of zidovudine/didanosine/nevirapine and zidovudine/didanosine/ritonavir in human serum by micellar electrokinetic chromatography.

  Journal of pharmaceutical and biomedical analysis 20021107

• Underpowered clinical trials of antiretroviral treatment.

  JAMA 20021106

• Antiretroviral drug resistance among HIV-1 infected children failing treatment.

  Journal of medical virology 20021101

• Polymorphisms of cytotoxic T-lymphocyte (CTL) and T-helper epitopes within reverse transcriptase (RT) of HIV-1 subtype C from Ethiopia and Botswana following selection of antiretroviral drug resistance.

  Antiviral research 20021101

• New anti-HIV agents and targets.

  Medicinal research reviews 20021101

• Nevirapine or lamivudine plus stavudine and indinavir: examples of 2-class versus 3-class regimens for the treatment of human immunodeficiency virus type 1.

  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20021101

• Survival of Ugandan infants with subtype A and D HIV-1 infection (HIVNET 012).

  Journal of acquired immune deficiency syndromes (1999) 20021101

• Children and multidrug-resistant tuberculosis in Mumbai (Bombay), India.

  Emerging infectious diseases 20021101

• NNRTI hepatotoxicity: efavirenz versus nevirapine.

  Journal of HIV therapy 20021101

• Hypersusceptibility to non-nucleoside reverse transcriptase inhibitors in HIV-1: clinical, phenotypic and genotypic correlates.

  AIDS (London, England) 20021018

• Inhibitor binding alters the directions of domain motions in HIV-1 reverse transcriptase.

  Proteins 20021001

• Inhibition of human immunodeficiency virus type 1 integration by diketo derivatives.

  Antimicrobial agents and chemotherapy 20021001

• Interactions between recreational drugs and antiretroviral agents.

  The Annals of pharmacotherapy 20021001

• Regression of HIV parotid swellings after antiviral therapy: case reports with computed tomographic scan evidence.

  Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics 20021001

• Population pharmacokinetics of nevirapine in an unselected cohort of HIV-1-infected individuals.

  British journal of clinical pharmacology 20021001

• Gateways to clinical trials.

  Methods and findings in experimental and clinical pharmacology 20021001

• Nevirapine-induced neuropsychiatric complications, a class effect of non-nucleoside reverse transcriptase inhibitors?

  AIDS (London, England) 20020906

• Hepatotoxicity following nevirapine-containing regimens in HIV-1-infected individuals.

  Pharmacological research 20020901

• Antiretroviral treatment in developing countries.

  The Hopkins HIV report : a bimonthly newsletter for healthcare providers 20020901

• WHO takes major steps to make HIV treatment accessible.

  Journal of advanced nursing 20020901

• WHO and UNAIDS continue to support use of nevirapine for prevention of mother-to-child HIV transmission.

  Journal of advanced nursing 20020901

• Two drugs reduce transmission.

  AIDS patient care and STDs 20020901

• Cross-resistance among nonnucleoside reverse transcriptase inhibitors limits recycling efavirenz after nevirapine failure.

  AIDS research and human retroviruses 20020810

• Simultaneous determination of zidovudine and nevirapine in human plasma by RP-LC.

  Journal of pharmaceutical and biomedical analysis 20020801

• Simultaneous quantitative assay of six HIV protease inhibitors, one metabolite, and two non-nucleoside reverse transcriptase inhibitors in human plasma by isocratic reversed-phase liquid chromatography.

  Therapeutic drug monitoring 20020801

• Court ruling orders South Africa to provide nevirapine.

  The Lancet. Infectious diseases 20020801

• New class of HIV integrase inhibitors that block viral replication in cell culture.

  Current biology : CB 20020723

• South African government forced to give mothers antiretroviral drug.

  BMJ (Clinical research ed.) 20020720

• Extent and importance of cross-resistance to efavirenz after nevirapine failure.

  AIDS research and human retroviruses 20020720

• New developments in anti-HIV chemotherapy.

  Biochimica et biophysica acta 20020718

• Hepatotoxicity after prophylaxis with a nevirapine-containing antiretroviral regimen.

  Annals of internal medicine 20020716

• Determination of lopinavir and nevirapine by high-performance liquid chromatography after solid-phase extraction: application for the assessment of their transplacental passage at delivery.

  Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20020715

• Development of resistance mutations in women receiving standard antiretroviral therapy who received intrapartum nevirapine to prevent perinatal human immunodeficiency virus type 1 transmission: a substudy of pediatric AIDS clinical trials group protocol 316.

  The Journal of infectious diseases 20020715

• Two-dose intrapartum/newborn nevirapine and standard antiretroviral therapy to reduce perinatal HIV transmission: a randomized trial.

  JAMA 20020710

• Simple and rapid quantification of the non-nucleoside reverse transcriptase inhibitors nevirapine, delavirdine, and efavirenz in human blood plasma using high-performance liquid chromatography with ultraviolet absorbance detection.

  Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20020705

• Reversal of atherogenic lipoprotein profile in HIV-1 infected patients with lipodystrophy after replacing protease inhibitors by nevirapine.

  AIDS (London, England) 20020705

• Prediction of activity for nonnucleoside inhibitors with HIV-1 reverse transcriptase based on Monte Carlo simulations.

  Journal of medicinal chemistry 20020704

• Genetic divergence of human immunodeficiency virus type 1 Ethiopian clade C reverse transcriptase (RT) and rapid development of resistance against nonnucleoside inhibitors of RT.

  Antimicrobial agents and chemotherapy 20020701

• Incidence of and risk factors for severe hepatotoxicity associated with antiretroviral combination therapy.

  The Journal of infectious diseases 20020701

• Attenuated infectivity of HIV type 1 from epithelial cells pretreated with a tight-binding nonnucleoside reverse transcriptase inhibitor.

  AIDS research and human retroviruses 20020701

• Differential modulation of P-glycoprotein expression and activity by non-nucleoside HIV-1 reverse transcriptase inhibitors in cell culture.

  Pharmaceutical research 20020701

• Association between sexual disturbances and sexual hormones with specific antiretroviral drugs.

  AIDS (London, England) 20020614

• Potency of nonnucleoside reverse transcriptase inhibitors (NNRTIs) used in combination with other human immunodeficiency virus NNRTIs, NRTIs, or protease inhibitors.

  Antimicrobial agents and chemotherapy 20020601

• High-performance liquid chromatographic method for the simultaneous determination of the six HIV-protease inhibitors and two non-nucleoside reverse transcriptase inhibitors in human plasma.

  Therapeutic drug monitoring 20020601

• Determination of zidovudine/lamivudine/nevirapine in human plasma using ion-pair HPLC.

  Journal of pharmaceutical and biomedical analysis 20020601

• Antiretroviral prophylaxis of perinatal HIV-1 transmission and the potential impact of antiretroviral resistance.

  Journal of acquired immune deficiency syndromes (1999) 20020601

• NNRTIs compared in switch group.

  AIDS patient care and STDs 20020601

• South Africa shifts position on antiretroviral drugs.

  The Lancet. Infectious diseases 20020601

• An interim plan to reduce mother-to-child HIV infection in South Africa.

  South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde 20020601

• Pharmacokinetic interactions between herbal remedies and medicinal drugs.

  Xenobiotica; the fate of foreign compounds in biological systems 20020601

• A randomized clinical trial comparing nelfinavir or nevirapine associated to zidovudine/lamivudine in HIV-infected naive patients (the Combine Study).

  Antiviral therapy 20020601

• Mother to child transmission of HIV.

  Clinical evidence 20020601

• Stevens-Johnson syndrome in HIV patients treated with nevirapine: two case reports.

  AIDS (London, England) 20020524

• HIV-1 subtype C reverse transcriptase sequences from drug-naive pregnant women in South Africa.

  AIDS research and human retroviruses 20020520

• Effects of endogenous steroids on CYP3A4-mediated drug metabolism by human liver microsomes.

  Drug metabolism and disposition: the biological fate of chemicals 20020501

• Long-term safety and efficacy of nevirapine tolerance induction.

  Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology 20020501

• Paracardial lipodystrophy versus pericardial effusion in HIV positive patients.

  Heart (British Cardiac Society) 20020501

• Low risk of treatment failure after substitution of nevirapine for protease inhibitors among human immunodeficiency virus-infected patients with virus suppression.

  The Journal of infectious diseases 20020501

• Paying to waste lives: the affordability of reducing mother-to-child transmission of HIV in South Africa.

  Journal of health economics 20020501

• Anti-HIV activity of thiosemicarbazone and semicarbazone derivatives of (+/-)-3-menthone.

  Archiv der Pharmazie 20020501

• Thailand markets low-cost, 3-in-1 antiretroviral medication.

  AIDS policy & law 20020426

• South African leader relents in storm over HIV drugs for women.

  Nature 20020425

• Virologic and immunologic response to regimens containing nevirapine or efavirenz in combination with 2 nucleoside analogues in the Italian Cohort Naive Antiretrovirals (I.Co.N.A.) study.

  The Journal of infectious diseases 20020415

• Immunologic reconstitution after 1 year of highly active antiretroviral therapy, with or without protease inhibitors.

  Journal of acquired immune deficiency syndromes (1999) 20020415

• Pharmacokinetic interaction between nevirapine and ethinyl estradiol/norethindrone when administered concurrently to HIV-infected women.

  Journal of acquired immune deficiency syndromes (1999) 20020415

• Drug points: Neuropsychiatric complications of nevirapine treatment.

  BMJ (Clinical research ed.) 20020413

• Effect of HIV-1 antiretroviral prophylaxis on hepatic and hematological parameters of African infants.

  AIDS (London, England) 20020412

• Transplacental passage of protease inhibitors at delivery.

  AIDS (London, England) 20020412

• Feasibility of antenatal and late HIV testing in pregnant women in Phnom Penh Cambodia: the PERIKAM/ANRS1205 study.

  AIDS (London, England) 20020412

• FDA application withdrawn to market Viramune for new use.

  AIDS policy & law 20020412

• Synthesis, biological evaluation, and binding mode of novel 1-[2-(diarylmethoxy)ethyl]-2-methyl-5-nitroimidazoles targeted at the HIV-1 reverse transcriptase.

  Journal of medicinal chemistry 20020411

• [Delayed virus suppression has its price. Heart and liver are no longer secondary theaters].

  MMW Fortschritte der Medizin 20020409

• [Hepatotoxicity with antiretroviral therapy. The liver is affected as well].

  MMW Fortschritte der Medizin 20020409

• HIV drug under review as firm withdraws FDA application.

  BMJ (Clinical research ed.) 20020406

• Mothers, orphans, and prevention of paediatric AIDS.

  Lancet (London, England) 20020406

• Nucleoside-analogue reverse-transcriptase inhibitors plus nevirapine, nelfinavir, or ritonavir for pretreated children infected with human immunodeficiency virus type 1.

  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20020401

• Simultaneous determination of the six HIV protease inhibitors (amprenavir, indinavir, lopinavir, nelfinavir, ritonavir, and saquinavir) plus M8 nelfinavir metabolite and the nonnucleoside reverse transcription inhibitor efavirenz in human plasma by solid-phase extraction and column liquid chromatography.

  Therapeutic drug monitoring 20020401

• Lack of hepatotoxicity associated with nonnucleoside reverse transcriptase inhibitors.

  Journal of acquired immune deficiency syndromes (1999) 20020401

• Therapeutic effects of nonnucleoside reverse transcriptase inhibitors on the central nervous system in HIV-1-infected patients.

  Journal of acquired immune deficiency syndromes (1999) 20020401

• Higher rate of toxicity with no increased efficacy when hydroxyurea is added to a regimen of stavudine plus didanosine and nevirapine in primary HIV infection.

  Journal of acquired immune deficiency syndromes (1999) 20020401

• Reported adherence as a determinant of response to highly active antiretroviral therapy in children who have human immunodeficiency virus infection.

  Pediatrics 20020401

• Enough time wasted in South Africa.

  The Lancet. Infectious diseases 20020401

• Nevirapine quantification in human plasma by high-performance liquid chromatography coupled to electrospray tandem mass spectrometry. Application to bioequivalence study.

  Journal of mass spectrometry : JMS 20020401

• Switch studies: a review.

  HIV medicine 20020401

• PMTCT--who decides on the right to life?

  South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde 20020401

• Policy watch. Good news, bad news.

  The AIDS reader 20020401

• Nevirapine-associated toxicity.

  The AIDS reader 20020401

• Gateways to Clinical Trials.

  Methods and findings in experimental and clinical pharmacology 20020401

• South African court again tells government to increase access to AIDS drug.

  Lancet (London, England) 20020330

• Improved long-term suppression of HIV-1 replication with a triple-class multidrug regimen compared with standard of care antiretroviral therapy.

  AIDS (London, England) 20020329

• Determinants of recurrent toxicity-driven switches of highly active antiretroviral therapy. The ATHENA cohort.

  AIDS (London, England) 20020329

• Vertical HIV transmission in South Africa: translating research into policy and practice.

  Lancet (London, England) 20020323

• South African judge reaffirms judgement to expand access to AIDS drug.

  Lancet (London, England) 20020316

• A South African perspective on 2001.

  Science (New York, N.Y.) 20020315

• Confusion over Mandela's 'support' of ANC HIV policy.

  Lancet (London, England) 20020309

• Safety and antiviral activity at 48 weeks of lopinavir/ritonavir plus nevirapine and 2 nucleoside reverse-transcriptase inhibitors in human immunodeficiency virus type 1-infected protease inhibitor-experienced patients.

  The Journal of infectious diseases 20020301

• Effect of nevirapine toxicity on choice of perinatal HIV prevention strategies.

  American journal of public health 20020301

• Structural basis for the inhibitory efficacy of efavirenz (DMP-266), MSC194 and PNU142721 towards the HIV-1 RT K103N mutant.

  European journal of biochemistry 20020301

• South African nevirapine policy faces growing pressure.

  The Lancet. Infectious diseases 20020301

• Let nevirapine do what it does best.

  GMHC treatment issues : the Gay Men's Health Crisis newsletter of experimental AIDS therapies 20020301

• Judasa, HPCSA and CMSA take up cudgels.

  South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde 20020301

• No acceptable excuse for inaction.

  IAPAC monthly 20020301

• Preventing mother-to-child transmission: landmark decision by South African court.

  Canadian HIV/AIDS policy & law review 20020301

• South Africa: defiance campaign continues.

  Canadian HIV/AIDS policy & law review 20020301

• South African President hints at expansion of HIV-drug pilot programmes.

  Lancet (London, England) 20020216

• Virological, immunological, and clinical impact of switching from protease inhibitors to nevirapine or to efavirenz in patients with human immunodeficiency virus infection and long-lasting viral suppression.

  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20020215

• Resuppression of virus load after interruption in treatment with nevirapine and 2 nucleoside reverse-transcriptase inhibitors.

  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20020215

• Primary HIV-1 drug resistance in Abidjan (Côte d'Ivoire): a genotypic and phenotypic study.

  AIDS (London, England) 20020215

• South African government procrastinates over policy on HIV drug.

  Lancet (London, England) 20020209

• Rapid determination of nevirapine in human plasma by gas chromatography.

  Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20020205

• S Africa state offers HIV drug to pregnant women.

  Lancet (London, England) 20020202

• Severe ototoxicity in a health care worker who received postexposure prophylaxis with stavudine, lamivudine, and nevirapine after occupational exposure to HIV.

  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20020201

• Chimeric human immunodeficiency virus type 1 and feline immunodeficiency virus reverse transcriptases: role of the subunits in resistance/sensitivity to non-nucleoside reverse transcriptase inhibitors.

  Molecular pharmacology 20020201

• Stavudine, nevirapine and ritonavir in stable antiretroviral therapy-experienced children with human immunodeficiency virus infection.

  The Pediatric infectious disease journal 20020201

• Nevirapine + efavirenz based salvage therapy in heavily pretreated HIV infected patients.

  Sexually transmitted infections 20020201

• Factors related to virologic failure among HIV-positive injecting drug users treated with combination antiretroviral therapy including two nucleoside reverse transcriptase inhibitors and nevirapine.

  AIDS patient care and STDs 20020201

• Stage of the epidemic and viral phenotype should influence recommendations regarding mother-to-child transmission of HIV-1.

  The Lancet. Infectious diseases 20020201

• Efficacy of highly active antiretroviral therapy in HIV-1 infected children.

  The Lancet. Infectious diseases 20020201

• Nevirapine levels may predict toxicity.

  TreatmentUpdate 20020201

• Comparing liver toxicity between efavirenz and nevirapine.

  TreatmentUpdate 20020201

• Different degree of immune recovery using antiretroviral regimens with protease inhibitors or non-nucleosides.

  AIDS (London, England) 20020125

• Liver toxicity caused by nevirapine.

  AIDS (London, England) 20020125

• Virological suppression at 6 months is related to choice of initial regimen in antiretroviral-naive patients: a cohort study.

  AIDS (London, England) 20020104

• In vitro analysis of human immunodeficiency virus type 1 resistance to nevirapine and fitness determination of resistant variants.

  The Journal of general virology 20020101

• Dioxolane guanosine, the active form of the prodrug diaminopurine dioxolane, is a potent inhibitor of drug-resistant HIV-1 isolates from patients for whom standard nucleoside therapy fails.

  Journal of acquired immune deficiency syndromes (1999) 20020101

• Faculty demands AIDS drugs for all.

  Nature medicine 20020101

• Hepatotoxicity associated with nevirapine or efavirenz-containing antiretroviral therapy: role of hepatitis C and B infections.

  Hepatology (Baltimore, Md.) 20020101

• Development of resistance mutations to nevirapine as part of triple-drug therapy in children.

  Pharmacotherapy 20020101

• Continuation of postpartum antiretroviral therapy in a cohort of women infected with human immunodeficiency virus.

  The Journal of the Association of Nurses in AIDS Care : JANAC 20020101

• Interventions for reducing the risk of mother-to-child transmission of HIV infection.

  The Cochrane database of systematic reviews 20020101

• Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection.

  The Cochrane database of systematic reviews 20020101

• Treatment of sexually transmitted infections with single-dose therapy: a double-edged sword.

  Drugs 20020101

• Inhibition of HIV-1 reverse transcriptase by aryl-substituted naphto- and anthraquinones.

  Doklady. Biochemistry and biophysics 20020101

• Non-nucleoside HIV-1 reverse transcriptase (RT) inhibitors: past, present, and future perspectives.

  Current pharmaceutical design 20020101

• Genotype resistance profiles in patients failing an NNRTI-containing regimen, and modifications after stopping NNRTI therapy.

  Journal of clinical laboratory analysis 20020101

• Randomized, open-label, comparative trial to evaluate the efficacy and safety of three antiretroviral drug combinations including two nucleoside analogues and nevirapine for previously untreated HIV-1 Infection: the OzCombo 2 study.

  HIV clinical trials 20020101

• SENC (Spanish efavirenz vs. nevirapine comparison) trial: a randomized, open-label study in HIV-infected naive individuals.

  HIV clinical trials 20020101

• Court orders South Africa to treat pregnant HIV-positive women with nevirapine.

  Bulletin of the World Health Organization 20020101

• Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection.

  The Cochrane database of systematic reviews 20020101

• HIV does cause AIDS but it's hard to prescribe the drugs, says South Africa's ANC.

  Bulletin of the World Health Organization 20020101

• Zidovudine: a review of its use in the management of vertically-acquired pediatric HIV infection.

  Paediatric drugs 20020101

• South Africans win MTCT court case.

  WORLD (Oakland, Calif. : 1993) 20020101

• Nevirapine resistance after single dose prophylaxis.

  AIDS reviews 20020101

• Clinical implications of CNS penetration of antiretroviral drugs.

  CNS drugs 20020101

• [Plasmatic dosage of antiretroviral drugs by high performance liquid chromathography ].

  Therapie 20020101

• [Post-marketing surveillance information transmitted via electronic mail in a University Hospital].

  Therapie 20020101

• Safety and tolerance of efavirenz in different antiretroviral regimens: results from a national multicenter prospective study in 1,033 HIV-infected patients.

  HIV clinical trials 20020101

• Comparison of nevirapine- and efavirenz-containing antiretroviral regimens in antiretroviral-naïve patients: a cohort study.

  HIV clinical trials 20020101

• AIDS in Africa among women and infants: a human rights framework.

  The Hastings Center report 20020101

• Antiretroviral pharmacokinetics in the paediatric population: a review.

  Clinical pharmacokinetics 20020101

• Interindividual variability of the clinical pharmacokinetics of methadone: implications for the treatment of opioid dependence.

  Clinical pharmacokinetics 20020101

• Interactions between antiretroviral drugs and drugs used for the therapy of the metabolic complications encountered during HIV infection.

  Clinical pharmacokinetics 20020101

• NNRTI plus PI combinations in the perspective of nucleoside-sparing or nucleoside-failing antiretroviral regimens.

  AIDS reviews 20020101

• Hepatic adverse events during highly active antiretroviral therapy containing nevirapine: a case report.

  Annals of clinical microbiology and antimicrobials 20020101

• Does an increase in nevirapine plasma levels cause complete virologic suppression in patients experiencing early virologic failure?

  HIV clinical trials 20020101

• Determination of lamivudine/didanosine/nevirapine in human serum using capillary zone electrophoresis.

  Journal of capillary electrophoresis and microchip technology 20020101

• Simplification of antiretroviral treatment--how to sustain success, reduce toxicity and ensure adherence avoiding PI use.

  AIDS reviews 20020101

• A saga in international HIV policy modeling: preventing mother-to-child HIV transmission.

  Journal of policy analysis and management : [the journal of the Association for Public Policy Analysis and Management] 20020101

• Management of protease inhibitor-associated hyperlipidemia.

  American journal of cardiovascular drugs : drugs, devices, and other interventions 20020101

• Sex differences in nevirapine rash.

  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20011215

• Pharmacokinetic interaction between nevirapine and rifampicin in HIV-infected patients with tuberculosis.

  Journal of acquired immune deficiency syndromes (1999) 20011215

• Viral load outcome of non-nucleoside reverse transcriptase inhibitor regimens for 2203 mainly antiretroviral-experienced patients.

  AIDS (London, England) 20011207

• Nevirapine-containing antiretroviral therapy in HIV-1 infected patients results in an anti-atherogenic lipid profile.

  AIDS (London, England) 20011207

• Prednisolone does not prevent hypersensitivity reactions in antiretroviral drug regimens containing abacavir with or without nevirapine.

  AIDS (London, England) 20011207

• Mechanism of virologic failure after substitution of a protease inhibitor by nevirapine in patients with suppressed plasma HIV-1 RNA.

  Journal of acquired immune deficiency syndromes (1999) 20011201

• Baseline CD4(+) cell count, not viral load, correlates with virologic suppression induced by potent antiretroviral therapy.

  Journal of acquired immune deficiency syndromes (1999) 20011201

• S Africa must treat HIV-infected pregnant women, says high court judge.

  Lancet (London, England) 20011201

• Limited sampling strategies for the estimation of the systemic exposure to the HIV-1 nonnucleoside reverse transcriptase inhibitor nevirapine.

  Therapeutic drug monitoring 20011201

• The role of nevirapine in the treatment of HIV-1 disease.

  Expert opinion on pharmacotherapy 20011201

• HIV-1 drug resistance and mother-to-child transmission.

  SADJ : journal of the South African Dental Association = tydskrif van die Suid-Afrikaanse Tandheelkundige Vereniging 20011201

• The stereoselective targeting of a specific enzyme-substrate complex is the molecular mechanism for the synergic inhibition of HIV-1 reverse transcriptase by (R)-(-)-PPO464: a novel generation of nonnucleoside inhibitors.

  The Journal of biological chemistry 20011130

• Drugs for HIV infection.

  The Medical letter on drugs and therapeutics 20011126

• Pharmacokinetics of amprenavir and lopinavir in combination with nevirapine in highly pretreated HIV-infected patients.

  AIDS (London, England) 20011123

• South Africa: activists, physicians sue government to prevent maternal transmission, ask international support.

  AIDS treatment news 20011123

• The biological effects of structural variation at the meta position of the aromatic rings and at the end of the alkenyl chain in the alkenyldiarylmethane series of non-nucleoside reverse transcriptase inhibitors.

  Journal of medicinal chemistry 20011122

• Rapid alternation of drug therapy is highly efficient in suppressing the emergence of mutant drug-resistant HIV strains in cell culture.

  AIDS research and human retroviruses 20011120

• Anti-human immunodeficiency virus drugs are ineffective against Pneumocystis carinii in vitro and in vivo.

  The Journal of infectious diseases 20011115

• DRESS syndrome associated with nevirapine therapy.

  Archives of internal medicine 20011112

• Zambian women's attitudes toward mass nevirapine therapy to prevent perinatal transmission of HIV.

  Lancet (London, England) 20011110

• South Africa's stance on nevirapine on trial.

  Lancet (London, England) 20011103

• New developments in anti-HIV chemotherapy.

  Current medicinal chemistry 20011101

• Pharmacokinetic interactions of nevirapine and methadone and guidelines for use of nevirapine to treat injection drug users.

  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20011101

• The role of NNRTIs in antiretroviral combination therapy: an introduction.

  International journal of STD & AIDS 20011101

• Comparison of NNRTIs in antiretroviral-naïve patients.

  International journal of STD & AIDS 20011101

• Comparison of NNRTIs in antiretroviral-experienced patients.

  International journal of STD & AIDS 20011101

• Factors affecting adherence and convenience in antiretroviral therapy.

  International journal of STD & AIDS 20011101

• Other issues: penetration into sanctuary sites, immune reconstitution and NNRTI sequencing.

  International journal of STD & AIDS 20011101

• Resistance profile and cross-resistance of HIV-1 among patients failing a non-nucleoside reverse transcriptase inhibitor-containing regimen.

  Journal of medical virology 20011101

• Switching to nevirapine decreases insulin levels but does not improve subcutaneous adipocyte apoptosis in patients with highly active antiretroviral therapy-associated lipodystrophy.

  The Journal of infectious diseases 20011101

• Giving away HIV drugs is not as easy as it seems.

  AIDS alert 20011101

• I want to see them grow up.

  WORLD (Oakland, Calif. : 1993) 20011101

• The faces of AIDS in Uganda: Mulago Hospital.

  WORLD (Oakland, Calif. : 1993) 20011101

• Optimal treatment of nevirapine-associated hepatotoxicity remains uncertain.

  The AIDS reader 20011101

• Toxic epidermal necrolysis induced by nevirapine therapy: description of two cases and review of the literature.

  The Journal of infection 20011101

• Conformational analysis of nevirapine, a non-nucleoside HIV-1 reverse transcriptase inhibitor, based on quantum mechanical calculations.

  Journal of computer-aided molecular design 20011101

• Selection and fading of resistance mutations in women and infants receiving nevirapine to prevent HIV-1 vertical transmission (HIVNET 012).

  AIDS (London, England) 20011019

• Impact of human immunodeficiency virus type 1 (hiv-1) subtype on women receiving single-dose nevirapine prophylaxis to prevent hiv-1 vertical transmission (hiv network for prevention trials 012 study).

  The Journal of infectious diseases 20011001

• Structural mechanisms of drug resistance for mutations at codons 181 and 188 in HIV-1 reverse transcriptase and the improved resilience of second generation non-nucleoside inhibitors.

  Journal of molecular biology 20010928

• HIV protease inhibitor substitution in patients with lipodystrophy: a randomized, controlled, open-label, multicentre study.

  AIDS (London, England) 20010928

• Nevirapine and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis.

  AIDS (London, England) 20010928

• Limited patient adherence to highly active antiretroviral therapy for HIV-1 infection in an observational cohort study.

  Archives of internal medicine 20010910

• Evolution of anti-HIV drug candidates. Part 1: From alpha-anilinophenylacetamide (alpha-APA) to imidoyl thiourea (ITU).

  Bioorganic & medicinal chemistry letters 20010903

• Evolution of anti-HIV drug candidates. Part 3: Diarylpyrimidine (DAPY) analogues.

  Bioorganic & medicinal chemistry letters 20010903

• Mismatched double-stranded RNA (polyI-polyC(12)U) is synergistic with multiple anti-HIV drugs and is active against drug-sensitive and drug-resistant HIV-1 in vitro.

  Antiviral research 20010901

• Sensitivity of human immunodeficiency virus type 1 to fusion inhibitors targeted to the gp41 first heptad repeat involves distinct regions of gp41 and is consistently modulated by gp120 interactions with the coreceptor.

  Journal of virology 20010901

• Highly active antiretroviral therapy in human immunodeficiency virus type 1-infected children: analysis of cellular immune responses.

  Clinical and diagnostic laboratory immunology 20010901

• High hepatotoxicity rate seen among HAART patients.

  AIDS alert 20010901

• Taking HIV to court.

  Lancet (London, England) 20010901

• [U.S. warns on some use of anti-AIDS drug].

  Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan 20010901

• Novel deletion of HIV type 1 reverse transcriptase residue 69 conferring selective high-level resistance to nevirapine.

  AIDS research and human retroviruses 20010901

• Failure of a short-term prednisone regimen to prevent nevirapine-associated rash: a double-blind placebo-controlled trial: the GESIDA 09/99 study.

  Journal of acquired immune deficiency syndromes (1999) 20010901

• Lymphoid tissue viral burden and duration of viral suppression in plasma.

  AIDS (London, England) 20010817

• Female sex and the use of anti-allergic agents increase the risk of developing cutaneous rash associated with nevirapine therapy.

  AIDS (London, England) 20010817

• AIDS campaigners to take South Africa's health ministry to court.

  BMJ (Clinical research ed.) 20010811

• Adverse effects of nevirapine.

  Lancet (London, England) 20010811

• Adverse effects of nevirapine.

  Lancet (London, England) 20010811

• Structure-based design, synthesis, and biological evaluation of conformationally restricted novel 2-alkylthio-6-[1-(2,6-difluorophenyl)alkyl]-3,4-dihydro-5-alkylpyrimidin-4(3H)-ones as non-nucleoside inhibitors of HIV-1 reverse transcriptase.

  Journal of medicinal chemistry 20010802

• Antiviral drugs: current state of the art.

  Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology 20010801

• Neuropsychiatric reaction induced by clarithromycin in a patient on highly active antiretroviral therapy (HAART).

  Sexually transmitted infections 20010801

• Comparison of virologic, immunologic, and clinical response to five different initial protease inhibitor-containing and nevirapine-containing regimens.

  Journal of acquired immune deficiency syndromes (1999) 20010801

• Antiretrovirals: simultaneous determination of five protease inhibitors and three nonnucleoside transcriptase inhibitors in human plasma by a rapid high-performance liquid chromatography--mass spectrometry assay.

  Therapeutic drug monitoring 20010801

• To test or not to test--ethical dilemmas and practical realities in the use of co-trimoxazole and nevirapine in HIV-infected adults.

  South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde 20010801

• Switching to nevirapine--results after one year.

  TreatmentUpdate 20010801

• Pharmacokinetics of nelfinavir in human immunodeficiency virus-infected infants.

  The Pediatric infectious disease journal 20010801

• Nevirapine pharmacokinetics in pregnant women and in their infants after in utero exposure.

  The Pediatric infectious disease journal 20010801

• HIV and drug allergy.

  Current opinion in allergy and clinical immunology 20010801

• Nevirapine: an option for preventing as well as treating paediatric HIV infection.

  African health sciences 20010801

• High-performance liquid chromatographic assay to determine the plasma levels of HIV-protease inhibitors (amprenavir, indinavir, nelfinavir, ritonavir and saquinavir) and the non-nucleoside reverse transcriptase inhibitor (nevirapine) after liquid-liquid extraction.

  Journal of chromatography. B, Biomedical sciences and applications 20010715

• Hepatotoxicity in HIV-1-infected patients receiving nevirapine-containing antiretroviral therapy.

  AIDS (London, England) 20010706

• Development of drug resistance in patients receiving combinations of zidovudine, didanosine and nevirapine.

  AIDS (London, England) 20010706

• The steady-state pharmacokinetics of efavirenz and nevirapine when used in combination in human immunodeficiency virus type 1-infected persons.

  The Journal of infectious diseases 20010701

• Distribution of K103N and/or Y181C HIV-1 mutations by exposure to zidovudine and non-nucleoside reverse transcriptase inhibitors.

  The Journal of antimicrobial chemotherapy 20010701

• Sequence-specific detection of individual DNA strands using engineered nanopores.

  Nature biotechnology 20010701

• Antiretroviral treatment simplification with nevirapine in protease inhibitor-experienced patients with hiv-associated lipodystrophy: 1-year prospective follow-up of a multicenter, randomized, controlled study.

  Journal of acquired immune deficiency syndromes (1999) 20010701

• Nevirapine-induced hepatitis: a case series and review of the literature.

  The AIDS reader 20010701

• [Immunologic response to antiretroviral treatment with combined stavudine, didanosine and nevirapine].

  Presse medicale (Paris, France : 1983) 20010701

• Clinical manifestations and management of pediatric HIV infection.

  Indian journal of pediatrics 20010701

• Spanish study looks at the effect of nevirapine on the liver.

  TreatmentUpdate 20010701

• Stereochemistry as a major determinant of the anti-HIV activity of chiral naphthyl thiourea compounds.

  Antiviral chemistry & chemotherapy 20010701

• South Africa in crisis on HIV/AIDS treatment.

  Science (New York, N.Y.) 20010629

• Analysis of human immunodeficiency virus type 1 drug resistance in children receiving nucleoside analogue reverse-transcriptase inhibitors plus nevirapine, nelfinavir, or ritonavir (Pediatric AIDS Clinical Trials Group 377).

  The Journal of infectious diseases 20010615

• High exposure to nevirapine in plasma is associated with an improved virological response in HIV-1-infected individuals.

  AIDS (London, England) 20010615

• Phenotypic hypersusceptibility to non-nucleoside reverse transcriptase inhibitors in treatment-experienced HIV-infected patients: impact on virological response to efavirenz-based therapy.

  AIDS (London, England) 20010615

• 2-Amino-6-arylsulfonylbenzonitriles as non-nucleoside reverse transcriptase inhibitors of HIV-1.

  Journal of medicinal chemistry 20010607

• Saliva as an alternative body fluid for therapeutic drug monitoring of the nonnucleoside reverse transcription inhibitor nevirapine.

  Therapeutic drug monitoring 20010601

• Severe lactic acidosis and thiamine administration in an HIV-infected patient on HAART.

  International journal of STD & AIDS 20010601

• Limits of deep salvage antiretroviral therapy with nelfinavir plus either efavirenz or nevirapine, in highly pre-treated patients with HIV disease.

  International journal of antimicrobial agents 20010601

• The effect of nevirapine in combination with nelfinavir in heavily pretreated HIV-1-infected patients: a prospective, open-label, controlled, randomized study.

  Journal of acquired immune deficiency syndromes (1999) 20010601

• In vitro anti-HIV-1 synergy between non-nucleoside reverse transcriptase inhibitors nevirapine and efavirenz.

  Antiviral therapy 20010601

• HIV in body fluids during primary HIV infection: implications for pathogenesis, treatment and public health.

  AIDS (London, England) 20010504

• Jaundice and hepatocellular damage associated with nevirapine therapy.

  The American journal of gastroenterology 20010501

• An in vivo model for HIV resistance development.

  AIDS research and human retroviruses 20010501

• Long-term follow-up of antiretroviral-naive HIV-positive patients treated with nevirapine.

  Journal of acquired immune deficiency syndromes (1999) 20010415

• High prevalence of genotypic and phenotypic HIV-1 drug-resistant strains among patients receiving antiretroviral therapy in Abidjan, Côte d'Ivoire.

  Journal of acquired immune deficiency syndromes (1999) 20010415

• Determination of serum levels of thirteen human immunodeficiency virus-suppressing drugs by high-performance liquid chromatography.

  Journal of chromatography. A 20010413

• Long-term safety and efficacy of nevirapine, stavudine and lamivudine in a real-world setting.

  AIDS (London, England) 20010413

• [Results of the AIDS-In-Europe Study. Non-nucleoside reverse transcriptase inhibitor does not equal non-nucleoside reverse transcriptase inhibitor].

  MMW Fortschritte der Medizin 20010402

• [Highly active antiretroviral therapy with nevirapine. Therapy compliance determines success].

  MMW Fortschritte der Medizin 20010402

• Inhibitors of human immunodeficiency virus type 1 reverse transcriptase target distinct phases of early reverse transcription.

  Journal of virology 20010401

• Resolution of chronic parvovirus b19-induced anemia, by use of highly active antiretroviral therapy, in a patient with acquired immunodeficiency syndrome.

  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20010401

• Amino acid deletion at codon 67 and Thr-to-Gly change at codon 69 of human immunodeficiency virus type 1 reverse transcriptase confer novel drug resistance profiles.

  Journal of virology 20010401

• Rwanda to receive cheaper anti-HIV drugs for chronic treatment and free viramune to prevent viral transmission from mother to child.

  SADJ : journal of the South African Dental Association = tydskrif van die Suid-Afrikaanse Tandheelkundige Vereniging 20010401

• Experience of nevirapine use in a London cohort of HIV-infected pregnant women.

  HIV medicine 20010401

• [Cutaneous adverse events related to simultaneous nevirapine treatment and pneumococcal vaccination in HIV-infected patients].

  Medicina clinica 20010331

• Sequencing antiretroviral drugs.

  AIDS (London, England) 20010330

• Efficiency comparisons of rank and permutation tests based on summary statistics computed from repeated measures data.

  Statistics in medicine 20010315

• Prophylaxis with a nevirapine-containing triple regimen after exposure to HIV-1.

  Lancet (London, England) 20010303

• Indinavir, nevirapine, stavudine, and lamivudine for human immunodeficiency virus-infected, amprenavir-experienced subjects: AIDS Clinical Trials Group protocol 373.

  The Journal of infectious diseases 20010301

• Pharmacokinetics of ritonavir and nevirapine in peritoneal dialysis.

  Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20010301

• International perspectives on antiretroviral resistance. Nonnucleoside reverse transcriptase inhibitor resistance.

  Journal of acquired immune deficiency syndromes (1999) 20010301

• [Nevirapine and clinical withdrawal syndrome].

  Revista clinica espanola 20010301

• Nevirapine use to reduce mother-to-child transmission of HIV in Canada.

  Paediatrics & child health 20010301

• Anti-HIV activity of aromatic and heterocyclic thiazolyl thiourea compounds.

  Bioorganic & medicinal chemistry letters 20010226

• Simple and rapid determination of nevirapine in human serum by reversed-phase high-performance liquid chromatography.

  Journal of chromatography. B, Biomedical sciences and applications 20010225

• Nevirapine and postexposure prophylaxis for human immunodeficiency virus.

  JAMA 20010221

• Drug interaction between St John's wort and nevirapine.

  AIDS (London, England) 20010216

• Indian company offers cheap anti-AIDS drugs.

  Nature 20010215

• South Africa's AIDS activists say new neviripine programme is not enough.

  Lancet (London, England) 20010210

• Galactorrhoea, hyperprolactinaemia, and protease inhibitors.

  Lancet (London, England) 20010210

• Prevention of nevirapine-associated rash.

  Lancet (London, England) 20010203

• SJ-3366, a unique and highly potent nonnucleoside reverse transcriptase inhibitor of human immunodeficiency virus type 1 (HIV-1) that also inhibits HIV-2.

  Antimicrobial agents and chemotherapy 20010201

• Ritonavir, efavirenz, and nelfinavir inhibit CYP2B6 activity in vitro: potential drug interactions with bupropion.

  Drug metabolism and disposition: the biological fate of chemicals 20010201

• Stevens-Johnson syndrome caused by the antiretroviral drug nevirapine.

  Journal of the American Academy of Dermatology 20010201

• Revised nevirapine insert.

  AIDS patient care and STDs 20010201

• South Africa cuts agreement for one AIDS drug but ignores another.

  IAPAC monthly 20010201

• Quinoxalinylethylpyridylthioureas (QXPTs) as potent non-nucleoside HIV-1 reverse transcriptase (RT) inhibitors. Further SAR studies and identification of a novel orally bioavailable hydrazine-based antiviral agent.

  Journal of medicinal chemistry 20010201

• Need for increased dose of warfarin in HIV patients taking nevirapine.

  AIDS (London, England) 20010126

• Nevirapine should not be prescribed for needlestick injuries.

  BMJ (Clinical research ed.) 20010120

• Efficacy, tolerance, and pharmacokinetics of the combination of stavudine, nevirapine, nelfinavir, and saquinavir as salvage regimen after ritonavir or indinavir failure.

  AIDS research and human retroviruses 20010120

• Estimation of binding affinities for HEPT and nevirapine analogues with HIV-1 reverse transcriptase via Monte Carlo simulations.

  Journal of medicinal chemistry 20010118

• Nevirapine warning on post-exposure prophylaxis.

  AIDS treatment news 20010112

• Serious adverse events attributed to nevirapine regimens for postexposure prophylaxis after HIV exposures--worldwide, 1997-2000.

  MMWR. Morbidity and mortality weekly report 20010105

• Sex differences in nevirapine rash.

  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20010101

• Ritonavir-induced carbamazepine toxicity.

  The Annals of pharmacotherapy 20010101

• Pharmacokinetic of nevirapine in haemodialysis.

  Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20010101

• The emerging roles of non-nucleoside reverse transcriptase inhibitors in antiretroviral therapy.

  Drugs 20010101

• Inhibition of human cytochrome P450 isoforms by nonnucleoside reverse transcriptase inhibitors.

  Journal of clinical pharmacology 20010101

• Further views by the Erice working group on mother-to-child transmission of HIV type 1.

  Acta paediatrica (Oslo, Norway : 1992) 20010101

• From the Centers for Disease Control and Prevention. Serious adverse events attributed to nevirapine regimens for postexposure prophylaxis after HIV exposures--worldwide, 1997-2000.

  JAMA 20010101

• New developments in anti-HIV chemotherapy.

  Farmaco (Societa chimica italiana : 1989) 20010101

• A single amino acid change at Leu-188 in the reverse transcriptase of HIV-2 and SIV renders them sensitive to non-nucleoside reverse transcriptase inhibitors.

  Archives of virology 20010101

• Hypersensitivity syndrome (DRESS) and meningoencephalitis associated with nevirapine therapy.

  Scandinavian journal of infectious diseases 20010101

• [Drug interactions with antiretroviral agents].

  Therapie 20010101

• Simplified antiviral prophylaxis with or and without artificial feeding to reduce mother-to-child transmission of HIV in low and middle income countries: modelling positive and negative impact on child survival.

  Medical science monitor : international medical journal of experimental and clinical research 20010101

• St. John's wort found to lower nevirapine levels.

  TreatmentUpdate 20010101

• Differential human immunodeficiency virus-suppressive activity of reverse transcription inhibitors in resting and activated peripheral blood lymphocytes: implications for therapy.

  Journal of human virology 20010101

• Human immunodeficiency virus-hepatitis C coinfection: swapping new problems for newer ones.

  Internal medicine journal 20010101

• Nelfinavir plus nevirapine plus two NRTIS as salvage therapy for HIV-infected patients receiving long-term antiretroviral treatment.

  HIV clinical trials 20010101

• Nevirapine or efavirenz combined with two nucleoside reverse transcriptase inhibitors compared to HAART: a meta-analysis of randomized clinical trials.

  HIV clinical trials 20010101

• Efficacy of nevirapine-based HAART in HIV-1-infected, treatment-naive persons with high and low baseline viral loads.

  HIV clinical trials 20010101

• DABOs as candidates to prevent mucosal HIV transmission.

  Antiviral chemistry & chemotherapy 20010101

• Clinical pharmacokinetics of non-nucleoside reverse transcriptase inhibitors.

  Clinical pharmacokinetics 20010101

• Analysis of HIV-1 drug resistant mutations by line probe assay and direct sequencing in a cohort of therapy naive HIV-1 infected Italian patients.

  BMC microbiology 20010101

• Effectiveness and tolerability of nevirapine, stavudine, and lamivudine in clinical practice.

  HIV clinical trials 20010101

• 1,5-Benzodiazepines. Part XII. Synthesis and biological evaluation of tricyclic and tetracyclic 1,5-benzodiazepine derivatives as nevirapine analogues.

  European journal of medicinal chemistry 20010101

• Prevention of mother-to-child transmission of HIV: challenges for the current decade.

  Bulletin of the World Health Organization 20010101

• Serious adverse events attributed to nevirapine regimens for post-exposure prophylaxis after HIV exposures--Worldwide, '97-'00.

  HIV clinician 20010101

• Needlestick injury. Anti-HIV drug branded 'lethal'.

  Nursing times 20010101

• Side effects. Severe nevirapine rash found more likely in women than men.

  TreatmentUpdate 20010101

• Nevirapine use to reduce mother-to-child transmission of HIV in Canada.

  The Canadian journal of infectious diseases = Journal canadien des maladies infectieuses 20010101

• Increasing cerebrospinal fluid chemokine concentrations despite undetectable cerebrospinal fluid HIV RNA in HIV-1-infected patients receiving antiretroviral therapy.

  Journal of acquired immune deficiency syndromes (1999) 20001215

• Synthesis and antiviral activity of 4-benzyl pyridinone derivatives as potent and selective non-nucleoside human immunodeficiency virus type 1 reverse transcriptase inhibitors.

  Journal of medicinal chemistry 20001019

• Stereochemistry of halopyridyl and thiazolyl thiourea compounds is a major determinant of their potency as nonnucleoside inhibitors of HIV-1 reverse transcriptase.

  Bioorganic & medicinal chemistry letters 20000918

• The tolerability of efavirenz after nevirapine-related adverse events.

  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20000901

• Computer-assisted design, synthesis and biological evaluation of novel pyrrolyl heteroaryl sulfones targeted at HIV-1 reverse transcriptase as non-nucleoside inhibitors.

  Bioorganic & medicinal chemistry 20000901

• Piperidinylethyl, phenoxyethyl and fluoroethyl bromopyridyl thiourea compounds with potent anti-HIV activity.

  Antiviral chemistry & chemotherapy 20000901

• Prevalence and characteristics of multinucleoside-resistant human immunodeficiency virus type 1 among European patients receiving combinations of nucleoside analogues.

  Antimicrobial agents and chemotherapy 20000801

• Didanosine-induced hepatitis.

  The American journal of gastroenterology 20000801

• Drug resistance and drug combination features of the human immunodeficiency virus inhibitor, BCH-10652 [(+/-)-2'-deoxy-3'-oxa-4'-thiocytidine, dOTC].

  Antiviral chemistry & chemotherapy 20000701

• Presence of 2',5'-Bis-O-(tert-butyldimethylsilyl)-3'-spiro-5'-(4'-amino-1',2'-oxath iole-2',2'-dioxide) (TSAO)-resistant virus strains in TSAO-inexperienced HIV patients.

  AIDS research and human retroviruses 20000610

• Inhibition of clinically relevant mutant variants of HIV-1 by quinazolinone non-nucleoside reverse transcriptase inhibitors.

  Journal of medicinal chemistry 20000518

• Structure-based design, synthesis, and biological evaluation of novel pyrrolyl aryl sulfones: HIV-1 non-nucleoside reverse transcriptase inhibitors active at nanomolar concentrations.

  Journal of medicinal chemistry 20000504

• Selection and characterization of human immunodeficiency virus type 1 variants resistant to the (+) and (-) enantiomers of 2'-deoxy-3'-oxa-4'-thio-5-fluorocytidine.

  Antimicrobial agents and chemotherapy 20000501

• Mutational analysis of trp-229 of human immunodeficiency virus type 1 reverse transcriptase (RT) identifies this amino acid residue as a prime target for the rational design of new non-nucleoside RT inhibitors.

  Molecular pharmacology 20000501

• Long-term exposure of HIV type 1-infected cell cultures to combinations of the novel quinoxaline GW420867X with lamivudine, abacavir, and a variety of nonnucleoside reverse transcriptase inhibitors.

  AIDS research and human retroviruses 20000410

• [Methadone withdrawal syndrome induced by nevirapine].

  Medicina clinica 20000318

• Novel 1,5-diphenylpyrazole nonnucleoside HIV-1 reverse transcriptase inhibitors with enhanced activity versus the delavirdine-resistant P236L mutant: lead identification and SAR of 3- and 4-substituted derivatives.

  Journal of medicinal chemistry 20000309

• Non-nucleoside HIV-1 reverse transcriptase inhibitors: synthesis and biological evaluation of novel quinoxalinylethylpyridylthioureas as potent antiviral agents.

  Antiviral chemistry & chemotherapy 20000301

• Human immunodeficiency virus type 1 reverse transcriptase dimer destabilization by 1-[Spiro[4'-amino-2',2' -dioxo-1',2' -oxathiole-5',3'-[2', 5'-bis-O-(tert-butyldimethylsilyl)-beta-D-ribofuranosyl]]]-3-ethylthy mine.

  Biochemistry 20000215

• 1-[2-(Diphenylmethoxy)ethyl]-2-methyl-5-nitroimidazole: a potent lead for the design of novel NNRTIs.

  Bioorganic & medicinal chemistry letters 20000207

• Novel 2,2-dioxide-4,4-disubstituted-1,3-H-2,1,3-benzothiadiazines as non-nucleoside reverse transcriptase inhibitors.

  Bioorganic & medicinal chemistry letters 20000117

• N'-[2-(2-thiophene)ethyl]-N'-[2-(5-bromopyridyl)] thiourea as a potent inhibitor of NNI-resistant and multidrug-resistant human immunodeficiency virus-1.

  Bioorganic & medicinal chemistry letters 19991220

• Expanded-spectrum nonnucleoside reverse transcriptase inhibitors inhibit clinically relevant mutant variants of human immunodeficiency virus type 1.

  Antimicrobial agents and chemotherapy 19991201

• Synthesis and anti-HIV activity of 1,1,3-trioxo-2H,4H-thieno[3,4-e][1,2,4]thiadiazines (TTDs): a new family of HIV-1 specific non-nucleoside reverse transcriptase inhibitors.

  Bioorganic & medicinal chemistry 19991201

• Pyrrolobenzoxazepinone derivatives as non-nucleoside HIV-1 RT inhibitors: further structure-activity relationship studies and identification of more potent broad-spectrum HIV-1 RT inhibitors with antiviral activity.

  Journal of medicinal chemistry 19991021

• Urea-PETT compounds as a new class of HIV-1 reverse transcriptase inhibitors. 3. Synthesis and further structure-activity relationship studies of PETT analogues.

  Journal of medicinal chemistry 19991007

• A novel genotype encoding a single amino acid insertion and five other substitutions between residues 64 and 74 of the HIV-1 reverse transcriptase confers high-level cross-resistance to nucleoside reverse transcriptase inhibitors. Abacavir CNA2007 International Study Group.

  Journal of acquired immune deficiency syndromes (1999) 19991001

• N-[2-(1-cyclohexenyl)ethyl]-N'-[2-(5-bromopyridyl)]-thiourea and N'-[2-(1-cyclohexenyl)ethyl]-N'-[2-(5-chloropyridyl)]-thiourea as potent inhibitors of multidrug-resistant human immunodeficiency virus-1.

  Bioorganic & medicinal chemistry letters 19990920

• Structure-based design of non-nucleoside reverse transcriptase inhibitors of drug-resistant human immunodeficiency virus.

  Antiviral chemistry & chemotherapy 19990901

• Activity of non-nucleoside reverse transcriptase inhibitors against HIV-2 and SIV.

  AIDS (London, England) 19990820

• Unique anti-human immunodeficiency virus activities of the nonnucleoside reverse transcriptase inhibitors calanolide A, costatolide, and dihydrocostatolide.

  Antimicrobial agents and chemotherapy 19990801

• Severe hepatic failure related to nevirapine treatment.

  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 19990801

• Susceptibility of lamivudine-resistant hepatitis B virus to other reverse transcriptase inhibitors.

  The Journal of clinical investigation 19990615

• Rational design of N-[2-(2,5-dimethoxyphenylethyl)]-N'-[2-(5-bromopyridyl)]-thiourea (HI-236) as a potent non-nucleoside inhibitor of drug-resistant human immunodeficiency virus.

  Bioorganic & medicinal chemistry letters 19990607

• Pyrido [1,2a] indole derivatives identified as novel non-nucleoside reverse transcriptase inhibitors of human immunodeficiency virus type 1.

  Antiviral chemistry & chemotherapy 19990301

• 5-Alkyl-2-(alkylthio)-6-(2,6-dihalophenylmethyl)-3, 4-dihydropyrimidin-4(3H)-ones: novel potent and selective dihydro-alkoxy-benzyl-oxopyrimidine derivatives.

  Journal of medicinal chemistry 19990225

• Molecular basis for the enantioselectivity of HIV-1 reverse transcriptase: role of the 3'-hydroxyl group of the L-(beta)-ribose in chiral discrimination between D- and L-enantiomers of deoxy- and dideoxy-nucleoside triphosphate analogs.

  Nucleic acids research 19990215

• Effect of nucleoside analogs and non-nucleoside inhibitors of HIV-1 reverse transcriptase on cell-free virions.

  Archives of virology 19990101

• Sensitivity and resistance to (+)-calanolide A of wild-type and mutated forms of HIV-1 reverse transcriptase.

  Antiviral therapy 19990101

• Biochemical characterization of HIV-1 reverse transcriptases encoding mutations at amino acid residues 161 and 208 involved in resistance to phosphonoformate.

  Biochemical pharmacology 19981215

• Patterns of resistance and cross-resistance to human immunodeficiency virus type 1 reverse transcriptase inhibitors in patients treated with the nonnucleoside reverse transcriptase inhibitor loviride.

  Antimicrobial agents and chemotherapy 19981201

• Structure-based design of novel dihydroalkoxybenzyloxopyrimidine derivatives as potent nonnucleoside inhibitors of the human immunodeficiency virus reverse transcriptase.

  Antimicrobial agents and chemotherapy 19981201

• Structures of Tyr188Leu mutant and wild-type HIV-1 reverse transcriptase complexed with the non-nucleoside inhibitor HBY 097: inhibitor flexibility is a useful design feature for reducing drug resistance.

  Journal of molecular biology 19981127

• Synthesis and anti-human immunodeficiency virus type 1 integrase activity of hydroxybenzoic and hydroxycinnamic acid flavon-3-yl esters.

  Antiviral chemistry & chemotherapy 19981101

• Geometrically and conformationally restrained cinnamoyl compounds as inhibitors of HIV-1 integrase: synthesis, biological evaluation, and molecular modeling.

  Journal of medicinal chemistry 19981008

• Novel 1,1,3-trioxo-2H,4H-thieno[3,4-e][1,2,4]thiadiazine derivatives as non-nucleoside reverse transcriptase inhibitors that inhibit human immunodeficiency virus type 1 replication.

  Journal of medicinal chemistry 19981008

• Broad-spectrum antiviral activity and mechanism of antiviral action of the fluoroquinolone derivative K-12.

  Antiviral chemistry & chemotherapy 19980901

• 3-(5-Dimethylamino-1-naphthalenesulphonyl)-2-(3-pyridyl)thiazolidine (YHI-1) selectively inhibits human immunodeficiency virus type 1.

  Antiviral chemistry & chemotherapy 19980901

• A dipyrido [2,3-b:3',2'-f]azepine analog of the HIV-1 reverse transcriptase inhibitor nevirapine.

  Bioorganic & medicinal chemistry letters 19980818

• Novel nonnucleoside inhibitors of HIV-1 reverse transcriptase. 7. 8-Arylethyldipyridodiazepinones as potent broad-spectrum inhibitors of wild-type and mutant enzymes.

  Journal of medicinal chemistry 19980730

• Novel nonnucleoside inhibitors of HIV-1 reverse transcriptase. 8. 8-Aryloxymethyl- and 8-arylthiomethyldipyridodiazepinones.

  Journal of medicinal chemistry 19980730

• Preclinical studies on thiocarboxanilide UC-781 as a virucidal agent.

  AIDS (London, England) 19980709

• Synthesis and anti-HIV activities of urea-PETT analogs belonging to a new class of potent non-nucleoside HIV-1 reverse transcriptase inhibitors.

  Bioorganic & medicinal chemistry letters 19980616

• S-1153 inhibits replication of known drug-resistant strains of human immunodeficiency virus type 1.

  Antimicrobial agents and chemotherapy 19980601

• A proline-to-histidine substitution at position 225 of human immunodeficiency virus type 1 (HIV-1) reverse transcriptase (RT) sensitizes HIV-1 RT to BHAP U-90152.

  The Journal of general virology 19980601

• Human immunodeficiency virus type 1 subtype F reverse transcriptase sequence and drug susceptibility.

  Journal of virology 19980501

• Imidazo[1,5-b]pyridazine-d4T conjugates: synthesis and anti-human immunodeficiency virus evaluation.

  Antiviral chemistry & chemotherapy 19980501

• Anti-HIV agents that selectively target retroviral nucleocapsid protein zinc fingers without affecting cellular zinc finger proteins.

  Journal of medicinal chemistry 19980423

• Retention of marked sensitivity to (S)-4-isopropoxycarbonyl-6-methoxy-3-(methylthiomethyl)-3,4-di hydroquin oxaline-2(1H)-thione (HBY 097) by an azidothymidine (AZT)-resistant human immunodeficiency virus type 1 (HIV-1) strain subcultured in the combined presence of quinoxaline HBY 097 and 2',3'-dideoxy-3'-thiacytidine (lamivudine).

  Biochemical pharmacology 19980301

• 1,1,3-Trioxo-2H,4H-thieno[3,4-e][1,2,4]thiadiazine (TTD) derivatives: a new class of nonnucleoside human immunodeficiency virus type 1 (HIV-1) reverse transcriptase inhibitors with anti-HIV-1 activity.

  Antimicrobial agents and chemotherapy 19980301

• 1,2,5-Benzothiadiazepine and pyrrolo[2,1-d]-[1,2,5]benzothiadiazepine derivatives with specific anti-human immunodeficiency virus type 1 activity.

  Antiviral chemistry & chemotherapy 19980301

• Synthesis and biological evaluation of 5H-indolo [3,2-b][1,5]benzothiazepine derivatives, designed as conformationally constrained analogues of the human immunodeficiency virus type 1 reverse transcriptase inhibitor L-737,126.

  Antiviral chemistry & chemotherapy 19980301

• Colorimetric assays for evaluation of the mode of action of human immunodeficiency virus type 1 non-nucleoside reverse transcriptase inhibitors.

  Antiviral chemistry & chemotherapy 19980301

• A novel mutation (F227L) arises in the reverse transcriptase of human immunodeficiency virus type 1 on dose-escalating treatment of HIV type 1-infected cell cultures with the nonnucleoside reverse transcriptase inhibitor thiocarboxanilide UC-781.

  AIDS research and human retroviruses 19980210

• Drug susceptibility of subtypes A,B,C,D, and E human immunodeficiency virus type 1 primary isolates.

  AIDS research and human retroviruses 19980120

• In-vitro selection of HIV-1 variants resistant to non-nucleoside reverse transcriptase inhibitors in monocyte-derived macrophages.

  The Journal of antimicrobial chemotherapy 19971201

• Characteristics of the Pro225His mutation in human immunodeficiency virus type 1 (HIV-1) reverse transcriptase that appears under selective pressure of dose-escalating quinoxaline treatment of HIV-1.

  Journal of virology 19971101

• Susceptibility of human immunodeficiency virus type 1 group O isolates to antiretroviral agents: in vitro phenotypic and genotypic analyses.

  Journal of virology 19971101

• Zidovudine-resistant human immunodeficiency virus type 1 strains subcultured in the presence of both lamivudine and quinoxaline HBY 097 retain marked sensitivity to HBY 097 but not to lamivudine.

  The Journal of infectious diseases 19971101

• Novel non-nucleoside inhibitors of human immunodeficiency virus type 1 reverse transcriptase. 6. 2-Indol-3-yl- and 2-azaindol-3-yl-dipyridodiazepinones.

  Journal of medicinal chemistry 19970718

• Sequence and drug susceptibility of subtype C reverse transcriptase from human immunodeficiency virus type 1 seroconverters in Zimbabwe.

  Journal of virology 19970701

• Tetrahydronaphthalene lignan compounds as potent anti-HIV type 1 agents.

  AIDS research and human retroviruses 19970520

• Dihydro(alkylthio)(naphthylmethyl)oxopyrimidines: novel non-nucleoside reverse transcriptase inhibitors of the S-DABO series.

  Journal of medicinal chemistry 19970509

• Antiviral properties of palinavir, a potent inhibitor of the human immunodeficiency virus type 1 protease.

  Antimicrobial agents and chemotherapy 19970501

• In vitro selection for different mutational patterns in the HIV-1 reverse transcriptase using high and low selective pressure of the nonnucleoside reverse transcriptase inhibitor HBY 097.

  Virology 19970428

• Highly potent oxathiin carboxanilide derivatives with efficacy against nonnucleoside reverse transcriptase inhibitor-resistant human immunodeficiency virus isolates.

  Antimicrobial agents and chemotherapy 19970401

• A novel approach to assessing the drug susceptibility and replication of human immunodeficiency virus type 1 isolates.

  The Journal of infectious diseases 19970301

• Impaired fitness of human immunodeficiency virus type 1 variants with high-level resistance to protease inhibitors.

  Journal of virology 19970201

• Stavudine selectively induces apoptosis in HIV type 1-infected cells.

  AIDS research and human retroviruses 19970120

• Antiviral activity and mechanism of action of calanolide A against the human immunodeficiency virus type-1.

  The Journal of pharmacology and experimental therapeutics 19961101

• Phenethylthiazolylthiourea (PETT) compounds as a new class of HIV-1 reverse transcriptase inhibitors. 2. Synthesis and further structure-activity relationship studies of PETT analogs.

  Journal of medicinal chemistry 19961011

• In vitro selection and molecular characterization of human immunodeficiency virus type 1 with reduced sensitivity to 9-[2-(phosphonomethoxy)ethyl]adenine (PMEA).

  Antiviral research 19961001

• Targeting delavirdine/atevirdine resistant HIV-1: identification of (alkylamino)piperidine-containing bis(heteroaryl)piperazines as broad spectrum HIV-1 reverse transcriptase inhibitors.

  Journal of medicinal chemistry 19960913

• Anti-HIV and anti-HBV activity and resistance profile of 2',3'-dideoxy-3'-thiacytidine (3TC) and its arylphosphoramidate derivative CF 1109.

  Biochemical and biophysical research communications 19960814

• Highly favorable antiviral activity and resistance profile of the novel thiocarboxanilide pentenyloxy ether derivatives UC-781 and UC-82 as inhibitors of human immunodeficiency virus type 1 replication.

  Molecular pharmacology 19960801

• Pyrrolobenzothiazepinones and pyrrolobenzoxazepinones: novel and specific non-nucleoside HIV-1 reverse transcriptase inhibitors with antiviral activity.

  Journal of medicinal chemistry 19960705

• The nucleoside analog-resistant E89G mutant of human immunodeficiency virus type 1 reverse transcriptase displays a broader cross-resistance that extends to nonnucleoside inhibitors.

  Antimicrobial agents and chemotherapy 19960701

• Complete inhibition of viral breakthrough by combination of MKC-442 with AZT during a long-term culture of HIV-1 infected cells.

  Antiviral research 19960601

• Anti-HIV-1 activity of thiadiazole derivatives: structure-activity relationship, reverse transcriptase inhibition, and lipophilicity.

  Antiviral research 19960601

• 5H-pyrrolo[1,2-b] [1,2,5]benzothiadiazepines (PBTDs): a novel class of non-nucleoside reverse transcriptase inhibitors.

  Bioorganic & medicinal chemistry 19960601

• Marked inhibitory activity of non-nucleoside reverse transcriptase inhibitors against human immunodeficiency virus type 1 when combined with (-)2',3'-dideoxy-3'-thiacytidine.

  Molecular pharmacology 19960501

• Inhibitory effect of 4-(2, 6-dichlorophenyl)-1, 2, 5-thiadiazol-3-yl-N-methyl, N-ethylcarbamate on replication of human immunodeficiency virus type 1 and the mechanism of action.

  Biochemistry and molecular biology international 19960501

• All-atom models for the non-nucleoside binding site of HIV-1 reverse transcriptase complexed with inhibitors: a 3D QSAR approach.

  Journal of medicinal chemistry 19960412

• Non-nucleoside reverse transcriptase inhibitors (NNRTIs) for the treatment of human immunodeficiency virus type 1 (HIV-1) infections: strategies to overcome drug resistance development.

  Medicinal research reviews 19960301

• Betulinic acid derivatives: a new class of specific inhibitors of human immunodeficiency virus type 1 entry.

  Journal of medicinal chemistry 19960301

• 2-Sulfonyl-4-chloroanilino moiety: a potent pharmacophore for the anti-human immunodeficiency virus type 1 activity of pyrrolyl aryl sulfones.

  Journal of medicinal chemistry 19960119

• Selective pressure of a quinoxaline nonnucleoside inhibitor of human immunodeficiency virus type 1 (HIV-1) reverse transcriptase (RT) on HIV-1 replication results in the emergence of nucleoside RT-inhibitor-specific (RT Leu-74-->Val or Ile and Val-75-->Leu or Ile) HIV-1 mutants.

  Proceedings of the National Academy of Sciences of the United States of America 19960109

• Biological and biochemical anti-human immunodeficiency virus activity of UC 38, a new non-nucleoside reverse transcriptase inhibitor.

  The Journal of pharmacology and experimental therapeutics 19960101

• Phenethylthiazolethiourea (PETT) compounds, a new class of HIV-1 reverse transcriptase inhibitors. 1. Synthesis and basic structure-activity relationship studies of PETT analogs.

  Journal of medicinal chemistry 19951208

• Structure-activity and cross-resistance evaluations of a series of human immunodeficiency virus type-1-specific compounds related to oxathiin carboxanilide.

  Antimicrobial agents and chemotherapy 19951201

• Novel non-nucleoside inhibitors of human immunodeficiency virus type 1 (HIV-1) reverse transcriptase. 4. 2-Substituted dipyridodiazepinones as potent inhibitors of both wild-type and cysteine-181 HIV-1 reverse transcriptase enzymes.

  Journal of medicinal chemistry 19951124

• Novel non-nucleoside inhibitors of human immunodeficiency virus type 1 reverse transcriptase. 5. 4-Substituted and 2,4-disubstituted analogs of nevirapine.

  Journal of medicinal chemistry 19951124

• Potent inhibition of human immunodeficiency virus by MDL 101028, a novel sulphonic acid polymer.

  Antiviral research 19951001

• Preclinical evaluation of HBY 097, a new nonnucleoside reverse transcriptase inhibitor of human immunodeficiency virus type 1 replication.

  Antimicrobial agents and chemotherapy 19951001

• Characterisation of foscarnet-resistant strains of human immunodeficiency virus type 1.

  Virology 19950910

• Anti-human immunodeficiency virus (HIV) activities of halogenated gomisin J derivatives, new nonnucleoside inhibitors of HIV type 1 reverse transcriptase.

  Antimicrobial agents and chemotherapy 19950901

• Synthesis and anti-HIV-1 activity of thio analogues of dihydroalkoxybenzyloxopyrimidines.

  Journal of medicinal chemistry 19950818

• Simultaneous mutations at Tyr-181 and Tyr-188 in HIV-1 reverse transcriptase prevents inhibition of RNA-dependent DNA polymerase activity by the bisheteroarylpiperazine (BHAP) U-90152s.

  FEBS letters 19950814

• Resistance to 1-[(2-hydroxyethoxy)methyl]-6-(phenylthio)thymine derivatives is generated by mutations at multiple sites in the HIV-1 reverse transcriptase.

  Virology 19950620

• Thiadiazole derivatives: highly potent and specific HIV-1 reverse transcriptase inhibitors.

  Journal of medicinal chemistry 19950609

• Design and synthesis of novel inhibitors of HIV-1 reverse transcriptase.

  Journal of medicinal chemistry 19950609

• Suppression of the breakthrough of human immunodeficiency virus type 1 (HIV-1) in cell culture by thiocarboxanilide derivatives when used individually or in combination with other HIV-1-specific inhibitors (i.e., TSAO derivatives).

  Proceedings of the National Academy of Sciences of the United States of America 19950606

• The PETT series, a new class of potent nonnucleoside inhibitors of human immunodeficiency virus type 1 reverse transcriptase.

  Antimicrobial agents and chemotherapy 19950601

• Benzophenone derivatives: a novel series of potent and selective inhibitors of human immunodeficiency virus type 1 reverse transcriptase.

  Journal of medicinal chemistry 19950512

• Novel mutations in reverse transcriptase of human immunodeficiency virus type 1 reduce susceptibility to foscarnet in laboratory and clinical isolates.

  Antimicrobial agents and chemotherapy 19950501

• Novel non-nucleoside inhibitors of HIV-1 reverse transcriptase. 3. Dipyrido[2,3-b:2',3'-e]diazepinones.

  Journal of medicinal chemistry 19950414

• Carboxanilide derivative non-nucleoside inhibitors of HIV-1 reverse transcriptase interact with different mechanistic forms of the enzyme.

  Biochemistry 19950404

• Comparative anti-HIV evaluation of diverse HIV-1-specific reverse transcriptase inhibitor-resistant virus isolates demonstrates the existence of distinct phenotypic subgroups.

  Antiviral research 19950301

• The inhibition of human immunodeficiency virus type 1 in vitro by a non-nucleoside reverse transcriptase inhibitor MKC-442, alone and in combination with other anti-HIV compounds.

  Antiviral research 19950301

• Phase I/II evaluation of nevirapine alone and in combination with zidovudine for infection with human immunodeficiency virus.

  Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association 19950201

• Action of uracil analogs on human immunodeficiency virus type 1 and its reverse transcriptase.

  Antimicrobial agents and chemotherapy 19950201

• Resistance pattern of human immunodeficiency virus type 1 reverse transcriptase to quinoxaline S-2720.

  Journal of virology 19941201

• Inhibition of human immunodeficiency virus type 1 replication in cytokine-stimulated monocytes/macrophages by combination therapy.

  The Journal of infectious diseases 19941201

• 1,2,3-Triazole-[2',5'-bis-O-(tert-butyldimethylsilyl)-beta-D- ribofuranosyl]-3'-spiro-5'-(4'-amino-1',2'-oxathiole 2',2'-dioxide) (TSAO) analogues: synthesis and anti-HIV-1 activity.

  Journal of medicinal chemistry 19941125

• Resistance of human immunodeficiency virus type 1 to acyclic 6-phenylselenenyl- and 6-phenylthiopyrimidines.

  Antimicrobial agents and chemotherapy 19941001

• Synthesis of a series of 4-(arylethynyl)-6-chloro-4-cyclopropyl-3,4-dihydroquinazolin-2(1H)-ones as novel non-nucleoside HIV-1 reverse transcriptase inhibitors.

  Journal of medicinal chemistry 19940722

• Human immunodeficiency virus 1 (HIV-1)-specific reverse transcriptase (RT) inhibitors may suppress the replication of specific drug-resistant (E138K)RT HIV-1 mutants or select for highly resistant (Y181C-->C181I)RT HIV-1 mutants.

  Proceedings of the National Academy of Sciences of the United States of America 19940705

• Susceptibilities of human immunodeficiency virus type 1 enzyme and viral variants expressing multiple resistance-engendering amino acid substitutions to reserve transcriptase inhibitors.

  Antimicrobial agents and chemotherapy 19940601

• Preclinical evaluation of MKC-442, a highly potent and specific inhibitor of human immunodeficiency virus type 1 in vitro.

  Antimicrobial agents and chemotherapy 19940401

• Nevirapine resistance mutations of human immunodeficiency virus type 1 selected during therapy.

  Journal of virology 19940301

• Combinative interactions of a human immunodeficiency virus (HIV) Tat antagonist with HIV reverse transcriptase inhibitors and an HIV protease inhibitor.

  Antimicrobial agents and chemotherapy 19940201

• HIV resistance to reverse transcriptase inhibitors.

  Biochemical pharmacology 19940120

• Identification of the amino acid in the human immunodeficiency virus type 1 reverse transcriptase involved in the pyrophosphate binding of antiviral nucleoside triphosphate analogs and phosphonoformate. Implications for multiple drug resistance.

  Biochemical pharmacology 19931214

• Viral resistance to the thiazolo-iso-indolinones, a new class of nonnucleoside inhibitors of human immunodeficiency virus type 1 reverse transcriptase.

  Antimicrobial agents and chemotherapy 19931201

• Synthesis and anti-HIV-1 activity of a series of imidazo[1,5-b]pyridazines.

  Journal of medicinal chemistry 19931126

• Substituted naphthalenones as a new structural class of HIV-1 reverse transcriptase inhibitors.

  Antiviral research 19931001

• Knocking-out concentrations of HIV-1-specific inhibitors completely suppress HIV-1 infection and prevent the emergence of drug-resistant virus.

  Virology 19931001

• Human immunodeficiency virus type 1 drug-resistance patterns with different 1-[(2-hydroxyethoxy)methyl]-6-(phenylthio)thymine derivatives.

  Molecular pharmacology 19931001

• Selective and synergistic inhibition of human immunodeficiency virus type 1 reverse transcriptase by a non-nucleoside inhibitor, MKC-442.

  Molecular pharmacology 19931001

• Nevirapine synergistically inhibits HIV-1 replication in combination with zidovudine, interferon or CD4 immunoadhesin.

  AIDS (London, England) 19930901

• Selective non-nucleoside HIV-1 reverse transcriptase inhibitors. New 2,3-dihydrothiazolo[2,3-a]isoindol-5(9bH)-ones and related compounds with anti-HIV-1 activity.

  Journal of medicinal chemistry 19930820

• Human immunodeficiency virus type 1 (HIV-1) strains selected for resistance against the HIV-1-specific [2',5'-bis-O-(tert-butyldimethylsilyl)-3'-spiro- 5''-(4''-amino-1'',2''-oxathiole-2'',2''-dioxide)]-beta-D-pentofurano syl (TSAO) nucleoside analogues retain sensitivity to HIV-1-specific nonnucleoside inhibitors.

  Proceedings of the National Academy of Sciences of the United States of America 19930801

• Comprehensive mutant enzyme and viral variant assessment of human immunodeficiency virus type 1 reverse transcriptase resistance to nonnucleoside inhibitors.

  Antimicrobial agents and chemotherapy 19930801

• Activity of a novel quinoxaline derivative against human immunodeficiency virus type 1 reverse transcriptase and viral replication.

  Antimicrobial agents and chemotherapy 19930801

• Effect of human serum on the in vitro anti-HIV-1 activity of 1-[(2-hydroxyethoxy)methyl]-6-(phenylthio)thymine (HEPT) derivatives as related to their lipophilicity and serum protein binding.

  Biochemical pharmacology 19930622

• Rapid in vitro selection of human immunodeficiency virus type 1 resistant to 3'-thiacytidine inhibitors due to a mutation in the YMDD region of reverse transcriptase.

  Proceedings of the National Academy of Sciences of the United States of America 19930615

• A mutation in reverse transcriptase of bis(heteroaryl)piperazine-resistant human immunodeficiency virus type 1 that confers increased sensitivity to other nonnucleoside inhibitors.

  Proceedings of the National Academy of Sciences of the United States of America 19930515

• Bis(heteroaryl)piperazine (BHAP) reverse transcriptase inhibitors: structure-activity relationships of novel substituted indole analogues and the identification of 1-[(5-methanesulfonamido-1H-indol-2-yl)-carbonyl]-4-[3- [(1-methylethyl)amino]-pyridinyl]piperazine monomethanesulfonate (U-90152S), a second-generation clinical candidate.

  Journal of medicinal chemistry 19930514

• U-90152, a potent inhibitor of human immunodeficiency virus type 1 replication.

  Antimicrobial agents and chemotherapy 19930501

• 5-chloro-3-(phenylsulfonyl)indole-2-carboxamide: a novel, non-nucleoside inhibitor of HIV-1 reverse transcriptase.

  Journal of medicinal chemistry 19930430

• Diarylsulfones, a new chemical class of nonnucleoside antiviral inhibitors of human immunodeficiency virus type 1 reverse transcriptase.

  Antimicrobial agents and chemotherapy 19930401

• Non-nucleoside inhibitors of HIV-1 reverse transcriptase: molecular modeling and X-ray structure investigations.

  Journal of medicinal chemistry 19930319

• Synthesis and evaluation of 2-pyridinone derivatives as specific HIV-1 reverse transcriptase inhibitors. 3. Pyridyl and phenyl analogs of 3-aminopyridin-2(1H)-one.

  Journal of medicinal chemistry 19930122

• Human immunodeficiency virus type 1-specific [2',5'-bis-O-(tert- butyldimethylsilyl)-beta-D-ribofuranosyl]-3'-spiro-5'-(4'-amino-1',2'- oxathiole-2',2'-dioxide)-purine analogues show a resistance spectrum that is different from that of the human immunodeficiency virus type 1-specific non-nucleoside analogues.

  Molecular pharmacology 19930101

• A single conservative amino acid substitution in the reverse transcriptase of human immunodeficiency virus-1 confers resistance to (+)-(5S)-4,5,6,7-tetrahydro-5-methyl-6-(3-methyl-2-butenyl)imidazo[4,5, 1- jk][1,4]benzodiazepin-2(1H)-thione (TIBO R82150).

  Molecular pharmacology 19930101

• HIV-1-specific reverse transcriptase inhibitors show differential activity against HIV-1 mutant strains containing different amino acid substitutions in the reverse transcriptase.

  Virology 19930101

• 3'-Azido-3'-deoxythymidine resistance suppressed by a mutation conferring human immunodeficiency virus type 1 resistance to nonnucleoside reverse transcriptase inhibitors.

  Antimicrobial agents and chemotherapy 19921201

• Selective inhibition of human immunodeficiency viruses by racemates and enantiomers of cis-5-fluoro-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]cytosine.

  Antimicrobial agents and chemotherapy 19921101

• Synthesis and evaluation of 2-pyridinone derivatives as HIV-1-specific reverse transcriptase inhibitors. 2. Analogues of 3-aminopyridin-2(1H)-one.

  Journal of medicinal chemistry 19921016

• Functional analysis of HIV-1 reverse transcriptase amino acids involved in resistance to multiple nonnucleoside inhibitors.

  The Journal of biological chemistry 19920905

• TSAO analogues. Stereospecific synthesis and anti-HIV-1 activity of 1-[2',5'-bis-O-(tert-butyldimethylsilyl)-beta-D-ribofuranosyl]-3'-spiro -5''- (4''-amino-1'',2''-oxathiole 2'',2''-dioxide) pyrimidine and pyrimidine-modified nucleosides.

  Journal of medicinal chemistry 19920807

• 3'-Spiro nucleosides, a new class of specific human immunodeficiency virus type 1 inhibitors: synthesis and antiviral activity of [2'-5'-bis-O-(tert-butyldimethylsilyl)-beta-D-xylo- and -ribofuranose]-3'-spiro-5'-[4'-amino-1',2'-oxathiole 2',2'-dioxide] (TSAO) pyrimidine nucleosides.

  Journal of medicinal chemistry 19920724

• Identification of the human immunodeficiency virus reverse transcriptase residues that contribute to the activity of diverse nonnucleoside inhibitors.

  Antimicrobial agents and chemotherapy 19920701

• Kinetics of inhibition of human immunodeficiency virus type 1 (HIV-1) reverse transcriptase by the novel HIV-1-specific nucleoside analogue [2',5'-bis-O-(tert-butyldimethylsilyl)-beta-D-ribofuranosyl]-3'-spiro-5 '- (4'-amino-1',2'-oxathiole-2',2'-dioxide)thymine (TSAO-T).

  The Journal of biological chemistry 19920615

• HIV-1 reverse transcriptase inhibition by a dipyridodiazepinone derivative: BI-RG-587.

  Biochemical pharmacology 19920317

• In vitro selection and molecular characterization of human immunodeficiency virus-1 resistant to non-nucleoside inhibitors of reverse transcriptase.

  Molecular pharmacology 19920301

• The binding of a novel bisheteroarylpiperazine mediates inhibition of human immunodeficiency virus type 1 reverse transcriptase.

  The Journal of biological chemistry 19920105

• Specific HIV-1 reverse transcriptase inhibitors.

  Journal of enzyme inhibition 19920101

• Human immunodeficiency virus type 1 mutants resistant to nonnucleoside inhibitors of reverse transcriptase arise in tissue culture.

  Proceedings of the National Academy of Sciences of the United States of America 19911215

• Chimeric human immunodeficiency virus type 1/type 2 reverse transcriptases display reversed sensitivity to nonnucleoside analog inhibitors.

  Proceedings of the National Academy of Sciences of the United States of America 19911101

• Viral resistance to human immunodeficiency virus type 1-specific pyridinone reverse transcriptase inhibitors.

  Journal of virology 19910901

• 2-Pyridinone derivatives: a new class of nonnucleoside, HIV-1-specific reverse transcriptase inhibitors.

  Journal of medicinal chemistry 19910901

• Novel non-nucleoside inhibitors of HIV-1 reverse transcriptase. 1. Tricyclic pyridobenzo- and dipyridodiazepinones.

  Journal of medicinal chemistry 19910701

• Inhibition of human immunodeficiency virus type 1 (HIV-1) replication by the dipyridodiazepinone BI-RG-587.

  The Journal of infectious diseases 19910501

• A novel dipyridodiazepinone inhibitor of HIV-1 reverse transcriptase acts through a nonsubstrate binding site.

  Biochemistry 19910226

• BI-RG-587 is active against zidovudine-resistant human immunodeficiency virus type 1 and synergistic with zidovudine.

  Antimicrobial agents and chemotherapy 19910201

• Inhibition of HIV-1 replication by a nonnucleoside reverse transcriptase inhibitor.

  Science (New York, N.Y.) 19901207